data_2n14_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n14 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 CA--C 1.546 0.793 0 CA-C-O 122.577 1.179 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -172.57 3.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.823 3.249 . . . . 0.0 108.434 -168.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.56 169.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 -168.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -164.75 141.03 4.84 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 130.443 3.497 . . . . 0.0 108.82 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 11.5 Cg_endo -102.7 175.3 0.19 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.897 3.064 . . . . 0.0 113.944 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -97.05 163.44 12.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.524 1.53 . . . . 0.0 110.287 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -42.59 -55.68 6.73 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.95 -21.13 50.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.721 2.281 . . . . 0.0 114.339 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.4 mt -90.63 -33.38 15.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.484 1.114 . . . . 0.0 111.914 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.03 -34.97 72.51 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.978 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -54.84 -35.2 63.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.908 2.083 . . . . 0.0 112.964 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -73.99 -47.5 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.515 1.526 . . . . 0.0 109.675 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.267 2.2 mp -70.75 -30.56 67.1 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.533 -0.729 . . . . 0.0 112.486 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -60.65 -35.95 77.47 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.692 -1.255 . . . . 0.0 112.78 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.16 -21.96 64.26 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.028 0.831 . . . . 0.0 113.218 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.08 17.0 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.057 1.743 . . . . 0.0 113.616 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.19 15.15 76.69 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.43 -157.75 0.34 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.869 1.268 . . . . 0.0 112.282 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -136.32 54.21 1.9 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.82 1.648 . . . . 0.0 111.902 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.8 -170.39 40.25 Favored Glycine 0 C--O 1.216 -0.979 0 C-N-CA 124.466 1.032 . . . . 0.0 112.184 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' H ' ' HG3' ' A' ' 29' ' ' PRO . 45.9 mt-10 -79.16 18.97 0.59 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.016 1.727 . . . . 0.0 113.808 173.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.9 ttp -74.26 48.65 0.33 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.296 2.238 . . . . 0.0 115.036 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' CZ ' ' CD2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -170.75 177.15 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.971 2.108 . . . . 0.0 112.597 -175.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 164.32 10.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.173 2.189 . . . . 0.0 113.737 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.9 -45.34 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 126.026 1.73 . . . . 0.0 112.533 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -66.96 -30.29 70.38 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -46.2 17.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.361 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 m -58.02 -43.63 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 120.415 1.461 . . . . 0.0 113.348 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.2 ptm -68.08 -25.25 65.24 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.47 -59.65 3.46 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.866 1.267 . . . . 0.0 110.911 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.428 ' CD2' ' CZ ' ' A' ' 47' ' ' PHE . 82.2 m-85 -58.09 -33.55 69.21 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.1 tp -69.17 -41.32 77.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.135 0.879 . . . . 0.0 112.212 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.41 86.14 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 119.237 0.926 . . . . 0.0 112.038 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.259 8.0 pt20 -70.93 -31.6 68.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.483 -1.01 . . . . 0.0 112.969 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -56.9 -54.54 45.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.68 1.127 . . . . 0.0 110.157 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.9 mt -59.83 -39.23 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 118.868 0.758 . . . . 0.0 110.119 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 tpt -65.42 -35.84 82.13 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.38 -50.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.502 1.046 . . . . 0.0 111.17 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -67.46 -15.77 63.85 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.576 1.55 . . . . 0.0 113.179 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 5.0 pt20 46.92 41.88 11.42 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.657 2.783 . . . . 0.0 113.767 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -83.43 54.15 2.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.859 1.664 . . . . 0.0 111.15 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -139.36 167.72 21.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.182 1.393 . . . . 0.0 112.937 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.37 144.01 40.36 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.704 -0.622 . . . . 0.0 111.933 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.15 -46.04 79.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.252 1.021 . . . . 0.0 113.374 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -80.75 -8.85 59.8 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.582 0.753 . . . . 0.0 112.937 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -157.4 86.59 0.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.486 1.136 . . . . 0.0 112.546 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -55.72 -20.47 14.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.198 1.399 . . . . 0.0 112.396 170.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -25.52 67.82 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.067 1.347 . . . . 0.0 113.031 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 tpt -104.72 127.16 52.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.328 1.451 . . . . 0.0 110.798 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 t -110.4 134.38 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.446 1.498 . . . . 0.0 110.456 -170.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -132.72 102.53 5.71 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.111 2.564 . . . . 0.0 110.307 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 98.6 m -97.78 28.88 3.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.496 2.319 . . . . 0.0 113.781 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.83 115.16 6.45 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 121.681 -0.637 . . . . 0.0 112.99 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.22 10.99 75.06 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.288 1.423 . . . . 0.0 115.969 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.2 151.62 19.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 120.241 2.021 . . . . 0.0 112.395 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 mp -57.24 -27.89 62.44 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.824 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.76 -40.15 88.16 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.219 0.918 . . . . 0.0 112.671 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.97 -39.16 96.27 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -65.62 -37.7 87.31 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.889 -0.771 . . . . 0.0 112.464 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.0 tp -66.6 -45.56 78.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.141 1.376 . . . . 0.0 112.296 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.5 -23.04 34.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 113.222 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.35 7.46 86.53 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.856 1.217 . . . . 0.0 114.403 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 147.11 30.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.446 1.899 . . . . 0.0 110.836 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -97.18 9.79 41.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.7 p -152.47 148.38 27.35 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -162.43 176.27 10.66 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.582 2.353 . . . . 0.0 109.764 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.5 p -140.2 168.7 19.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.821 -1.174 . . . . 0.0 112.528 174.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.71 -9.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -95.01 -26.06 16.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.338 1.455 . . . . 0.0 112.456 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -124.06 67.19 42.96 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.434 1.893 . . . . 0.0 112.095 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.05 6.43 5.58 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.287 3.325 . . . . 0.0 114.708 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.5 m -47.41 -34.32 4.69 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -57.75 -26.21 72.29 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.163 2.575 . . . . 0.0 115.884 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.46 -50.55 36.99 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.518 1.054 . . . . 0.0 110.081 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.08 -29.15 68.84 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.332 -0.855 . . . . 0.0 112.561 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.6 -31.35 72.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.152 0.981 . . . . 0.0 112.733 169.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.64 71.57 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.057 1.343 . . . . 0.0 111.835 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.4 mt -83.61 -39.72 19.95 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.096 1.359 . . . . 0.0 113.551 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -56.55 -29.53 62.08 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.6 1.56 . . . . 0.0 113.681 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.53 -28.33 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.347 1.859 . . . . 0.0 112.543 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 123.779 0.832 . . . . 0.0 113.089 175.509 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.39 -178.85 5.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.729 2.812 . . . . 0.0 110.743 -168.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 169.2 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.795 0.438 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -164.72 135.46 3.2 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 128.266 2.626 . . . . 0.0 107.789 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 10.9 Cg_endo -99.18 176.23 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.9 2.4 . . . . 0.0 114.934 -169.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -104.57 159.72 15.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.595 2.358 . . . . 0.0 106.815 166.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.49 -40.62 77.04 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -67.33 -25.46 42.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.623 2.215 . . . . 0.0 114.246 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.29 -37.17 20.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.215 1.006 . . . . 0.0 111.267 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.72 -31.9 70.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.102 0.961 . . . . 0.0 111.431 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.56 -38.76 72.36 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.61 1.564 . . . . 0.0 112.596 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.6 mt -70.78 -46.73 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.17 1.788 . . . . 0.0 109.552 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.69 -31.41 68.29 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.75 -0.594 . . . . 0.0 112.026 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -65.36 -34.92 79.45 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.468 -1.395 . . . . 0.0 112.979 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.99 64.6 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.19 0.904 . . . . 0.0 112.926 171.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.19 16.78 24.35 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.985 1.714 . . . . 0.0 114.035 172.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.73 15.64 73.69 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.434 1.016 . . . . 0.0 115.549 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.4 -162.92 0.72 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.905 1.282 . . . . 0.0 112.311 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -133.47 68.63 1.49 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.724 1.61 . . . . 0.0 111.074 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.37 -144.22 37.04 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.482 0.563 . . . . 0.0 112.583 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.7 mt-10 -125.06 16.45 8.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.55 1.94 . . . . 0.0 112.266 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.8 ttt -79.51 58.28 2.64 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.493 1.117 . . . . 0.0 112.963 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -170.37 175.07 4.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.338 1.855 . . . . 0.0 113.413 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.05 165.23 16.17 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.261 2.224 . . . . 0.0 114.308 -172.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.9 t -47.85 -45.27 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.27 1.828 . . . . 0.0 112.359 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -66.29 -30.57 71.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.62 -47.6 16.79 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.635 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.41 -46.17 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 120.373 1.442 . . . . 0.0 112.676 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -70.63 -27.83 64.36 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.95 -59.7 4.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 110.703 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -55.85 -37.21 68.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.149 0.979 . . . . 0.0 113.548 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.28 -36.72 79.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.844 1.202 . . . . 0.0 113.008 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 -47.37 88.41 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.882 1.219 . . . . 0.0 112.256 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.274 13.3 pt20 -70.91 -31.61 68.29 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.474 -1.015 . . . . 0.0 113.09 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.61 -53.82 49.54 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.562 1.528 . . . . 0.0 110.346 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.25 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.532 1.133 . . . . 0.0 110.382 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttm -69.04 -30.51 68.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.33 -50.84 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.12 0.968 . . . . 0.0 111.239 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.02 -15.94 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.947 0.899 . . . . 0.0 113.239 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.29 6.4 pt20 43.97 44.22 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 128.152 2.581 . . . . 0.0 113.582 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.63 16.53 23.12 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.863 1.665 . . . . 0.0 112.843 -169.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -81.96 165.64 20.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.378 1.471 . . . . 0.0 112.269 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.73 147.98 45.09 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 122.196 0.998 . . . . 0.0 112.989 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.534 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.8 -37.86 76.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.92 1.688 . . . . 0.0 111.483 -176.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -91.33 -20.94 21.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.698 1.599 . . . . 0.0 112.38 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.25 92.02 2.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.365 1.079 . . . . 0.0 112.268 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -57.21 -18.79 17.37 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.419 1.488 . . . . 0.0 112.776 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -24.72 66.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.377 1.071 . . . . 0.0 113.041 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -99.9 133.13 44.73 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.424 1.889 . . . . 0.0 110.776 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.61 132.62 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.543 1.537 . . . . 0.0 110.489 -171.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -113.69 165.71 12.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.871 1.668 . . . . 0.0 110.989 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.7 m -134.8 -25.51 1.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.431 1.093 . . . . 0.0 113.824 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 53.4 31.65 43.54 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.19 13.61 65.74 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.784 1.183 . . . . 0.0 115.758 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -69.3 167.24 16.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.511 1.656 . . . . 0.0 111.904 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.34 -27.99 64.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.648 1.179 . . . . 0.0 112.514 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.11 -41.56 86.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.516 -0.74 . . . . 0.0 112.109 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.73 96.65 Favored Glycine 0 N--CA 1.472 1.04 0 O-C-N 121.696 -0.627 . . . . 0.0 112.215 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.71 -36.86 84.83 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.554 -0.968 . . . . 0.0 112.066 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.41 -43.36 81.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.808 1.243 . . . . 0.0 112.497 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.79 -18.89 42.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.383 1.073 . . . . 0.0 112.975 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.63 -14.22 25.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.985 1.755 . . . . 0.0 113.963 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -125.98 138.74 53.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.762 2.425 . . . . 0.0 108.954 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -98.53 16.3 22.27 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -153.29 146.38 24.62 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.269 -0.894 . . . . 0.0 112.663 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -164.14 174.42 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.528 1.931 . . . . 0.0 110.12 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 p -139.1 171.7 13.92 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.752 -1.218 . . . . 0.0 111.996 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.56 -8.32 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.07 -23.8 17.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.216 1.406 . . . . 0.0 112.574 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -130.38 65.4 75.81 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.49 1.916 . . . . 0.0 111.965 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.1 0.44 9.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.409 3.406 . . . . 0.0 113.888 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.0 m -46.1 -35.35 4.1 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -54.36 -31.21 66.65 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.741 2.294 . . . . 0.0 115.758 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.54 -50.8 33.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.692 1.197 . . . . 0.0 110.488 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -62.89 -37.46 87.04 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.666 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.22 -31.78 72.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 0.0 112.92 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -45.91 90.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.475 1.11 . . . . 0.0 111.117 170.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -93.82 -19.69 20.77 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -27.08 69.09 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.996 1.271 . . . . 0.0 112.904 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.9 -29.94 71.16 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.778 2.431 . . . . 0.0 112.259 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 123.607 0.763 . . . . 0.0 112.826 169.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 CA--C 1.546 0.814 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.67 -178.79 3.91 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.719 2.408 . . . . 0.0 113.981 -167.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 t -93.59 172.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.467 1.907 . . . . 0.0 108.941 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -162.44 139.12 6.0 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 129.908 3.283 . . . . 0.0 107.474 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -99.73 168.37 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.514 2.809 . . . . 0.0 113.997 -171.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -86.62 162.81 17.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.014 1.326 . . . . 0.0 110.444 168.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.8 mt -49.18 -48.19 74.19 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.14 -28.61 34.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.2 1.822 . . . . 0.0 113.856 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.23 -37.74 37.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.842 0.747 . . . . 0.0 111.266 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.75 -34.81 73.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.826 1.25 . . . . 0.0 111.169 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -59.28 -40.77 87.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.762 1.225 . . . . 0.0 113.182 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.5 -50.91 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.238 1.415 . . . . 0.0 109.595 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.354 12.5 mt -70.94 -30.37 66.66 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -63.18 -37.91 89.11 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 119.885 -1.76 . . . . 0.0 111.921 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.94 -18.42 65.23 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.794 0.725 . . . . 0.0 112.745 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.03 5.03 46.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.586 1.555 . . . . 0.0 114.332 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.46 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.564 1.078 . . . . 0.0 114.94 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.68 -164.0 1.09 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.432 1.493 . . . . 0.0 112.716 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -124.58 43.18 3.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 110.88 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.19 -113.87 3.76 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.879 -1.138 . . . . 0.0 112.446 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.25 19.29 2.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.555 1.942 . . . . 0.0 111.431 -174.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.2 ptm -71.54 38.82 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.585 1.554 . . . . 0.0 115.192 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -166.27 174.78 8.83 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.441 1.897 . . . . 0.0 113.967 -167.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -68.4 168.1 13.32 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.656 2.382 . . . . 0.0 113.628 -172.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -53.01 -43.52 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 126.29 1.836 . . . . 0.0 111.804 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -65.79 -30.06 70.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.47 -46.93 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.014 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.42 -44.8 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 119.929 1.241 . . . . 0.0 112.752 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.9 ptm -71.47 -27.47 63.26 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -61.44 -58.77 6.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.558 1.143 . . . . 0.0 110.395 170.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -56.34 -39.21 72.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.094 0.958 . . . . 0.0 113.253 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.09 -35.02 69.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.624 1.102 . . . . 0.0 112.702 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -47.48 90.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.157 0.89 . . . . 0.0 112.219 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.45 -31.56 71.82 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.419 -1.047 . . . . 0.0 112.378 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -58.53 -53.57 56.81 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.558 1.072 . . . . 0.0 111.654 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -56.25 -42.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.534 0.734 . . . . 0.0 109.983 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.38 -36.14 83.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.25 -48.94 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.06 0.944 . . . . 0.0 111.122 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -66.84 -15.92 63.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.982 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.313 5.3 pt20 46.23 39.63 6.42 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.389 2.676 . . . . 0.0 113.803 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt -84.86 58.23 4.86 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.586 1.554 . . . . 0.0 110.579 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -136.98 168.03 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.172 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.4 135.32 48.64 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.498 -0.751 . . . . 0.0 111.742 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -39.38 25.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.923 1.689 . . . . 0.0 113.867 171.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -90.18 -15.95 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.984 1.313 . . . . 0.0 113.407 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.66 95.03 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.713 1.244 . . . . 0.0 112.396 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -57.75 -18.66 22.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.625 1.57 . . . . 0.0 112.72 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -14.56 61.42 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -110.74 119.86 40.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.602 1.561 . . . . 0.0 110.357 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -96.8 135.01 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.453 1.501 . . . . 0.0 110.555 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -135.75 95.81 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.95 2.5 . . . . 0.0 109.699 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 97.6 m -79.52 -24.03 42.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.104 1.761 . . . . 0.0 114.671 -169.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 50.97 35.74 32.98 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.7 1.143 . . . . 0.0 115.87 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.46 62.54 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.84 158.18 25.8 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.731 1.766 . . . . 0.0 111.441 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.18 -27.84 48.63 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.463 -0.773 . . . . 0.0 112.832 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.1 tp -57.09 -47.98 79.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.899 1.28 . . . . 0.0 111.643 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.79 94.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.834 0.73 . . . . 0.0 112.417 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -65.21 -37.73 88.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.135 0.968 . . . . 0.0 111.992 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.95 -46.87 79.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.17 1.388 . . . . 0.0 111.815 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -79.07 -17.37 55.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.69 -2.3 83.38 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.963 1.268 . . . . 0.0 114.47 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -146.66 142.23 27.66 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 128.084 2.554 . . . . 0.0 109.123 172.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -96.43 12.97 29.42 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.564 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.2 p -147.1 141.33 26.2 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.95 -1.094 . . . . 0.0 112.929 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -164.63 173.38 12.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.214 2.205 . . . . 0.0 109.873 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 p -142.95 175.18 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.087 -1.008 . . . . 0.0 112.624 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.5 m -67.68 -13.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -93.06 -21.94 19.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.713 1.205 . . . . 0.0 113.0 172.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -126.14 60.58 36.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.911 1.684 . . . . 0.0 112.58 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.94 0.3 9.98 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.195 3.263 . . . . 0.0 113.652 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.0 m -45.91 -33.55 2.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 127.079 2.152 . . . . 0.0 116.322 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.24 -29.47 90.42 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.227 1.831 . . . . 0.0 114.769 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.48 -49.34 63.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.263 0.938 . . . . 0.0 110.531 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.54 -34.07 77.38 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.674 -0.641 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -68.52 -31.59 70.95 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -34.46 77.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.341 1.456 . . . . 0.0 111.314 170.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.3 mt -92.89 -37.23 12.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.114 1.366 . . . . 0.0 114.243 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -56.45 -25.92 52.17 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.726 1.611 . . . . 0.0 113.845 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.17 -26.55 63.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.506 1.923 . . . . 0.0 112.636 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 175.221 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m120 . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 122.388 1.09 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.31 -174.68 3.89 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.782 2.833 . . . . 0.0 109.637 -168.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.73 172.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.456 1.502 . . . . 0.0 112.259 -169.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -161.38 145.4 9.88 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 130.652 3.581 . . . . 0.0 108.165 168.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -103.72 172.15 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.834 3.023 . . . . 0.0 114.181 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -86.51 158.57 19.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 108.062 167.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.7 -46.09 71.59 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -66.03 -24.96 51.97 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.711 2.274 . . . . 0.0 114.643 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.37 -35.86 16.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.243 1.017 . . . . 0.0 111.952 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.26 -31.9 72.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.636 1.575 . . . . 0.0 111.36 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -56.17 -38.68 71.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.459 1.504 . . . . 0.0 112.607 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -66.85 -50.9 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.068 1.747 . . . . 0.0 109.417 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.324 12.3 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.748 -0.595 . . . . 0.0 112.571 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -61.81 -33.19 73.68 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.643 -1.285 . . . . 0.0 112.576 169.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.82 -22.61 62.47 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.379 0.99 . . . . 0.0 113.263 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.67 24.45 12.64 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.012 1.725 . . . . 0.0 113.334 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.94 14.02 80.46 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.785 1.183 . . . . 0.0 115.824 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.9 -169.27 2.42 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.46 1.13 . . . . 0.0 113.438 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.53 45.22 2.5 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.69 1.996 . . . . 0.0 110.917 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.71 -119.95 5.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.093 1.33 . . . . 0.0 112.637 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.4 17.04 3.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.557 1.943 . . . . 0.0 110.589 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 58.1 ttp -76.52 50.52 0.67 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.116 1.767 . . . . 0.0 112.889 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -174.37 171.16 3.47 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.438 2.295 . . . . 0.0 112.208 -168.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 168.76 10.83 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.47 1.908 . . . . 0.0 114.092 -171.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.3 t -47.78 -44.14 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.518 1.927 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -67.64 -30.59 70.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -80.46 -44.29 19.46 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.961 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.47 -46.24 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.252 1.387 . . . . 0.0 112.622 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.2 ptm -69.86 -23.96 63.35 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.89 -59.75 3.54 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.975 1.31 . . . . 0.0 110.961 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -56.14 -37.14 69.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.258 1.023 . . . . 0.0 113.281 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tt -72.57 -38.07 68.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.897 0.879 . . . . 0.0 111.623 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.09 -47.4 87.83 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.898 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.257 13.7 pt20 -69.91 -31.54 69.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.416 -1.049 . . . . 0.0 112.873 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -55.66 -51.51 67.01 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.442 1.473 . . . . 0.0 110.457 169.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.2 mt -58.12 -44.89 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.999 0.92 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.0 ttm -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.62 -51.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.36 1.064 . . . . 0.0 111.355 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 -15.97 64.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.92 0.888 . . . . 0.0 113.282 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.3 pt20 43.79 43.51 5.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 128.164 2.585 . . . . 0.0 113.483 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -99.67 23.19 9.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.818 1.647 . . . . 0.0 112.9 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -87.01 163.69 16.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.707 1.603 . . . . 0.0 111.337 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -75.13 134.55 41.25 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.157 -0.964 . . . . 0.0 111.904 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -35.72 61.64 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.637 1.575 . . . . 0.0 113.515 171.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -82.2 -26.6 33.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 112.398 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.7 93.9 1.92 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 122.425 1.107 . . . . 0.0 111.558 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -58.87 -17.68 26.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 112.606 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.06 69.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.249 1.02 . . . . 0.0 112.913 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.3 tpt -98.4 133.06 43.32 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.981 1.712 . . . . 0.0 110.962 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.0 t -125.83 131.83 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.073 1.349 . . . . 0.0 110.957 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -108.51 163.51 13.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.575 1.55 . . . . 0.0 111.795 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 m -145.24 29.69 1.16 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.872 2.069 . . . . 0.0 111.489 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.47 113.44 3.81 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 121.612 -0.68 . . . . 0.0 114.048 -169.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.74 11.76 66.4 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.07 -1.406 . . . . 0.0 115.775 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -100.04 159.18 15.29 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 120.421 2.111 . . . . 0.0 111.99 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.34 -28.04 68.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.093 0.957 . . . . 0.0 111.863 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.9 tp -67.2 -37.88 84.39 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.339 -0.85 . . . . 0.0 112.38 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.43 -39.24 94.06 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.839 -0.538 . . . . 0.0 111.891 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -65.0 -36.95 86.04 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.795 -0.827 . . . . 0.0 112.138 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.04 -43.57 82.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.665 1.186 . . . . 0.0 112.395 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.78 -21.51 37.73 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.2 -0.31 89.39 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.629 1.109 . . . . 0.0 114.583 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -145.75 156.11 43.39 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.128 1.771 . . . . 0.0 111.897 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -99.55 16.32 23.71 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.0 p -153.57 152.93 31.47 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 169.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -163.12 179.54 7.41 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.62 2.368 . . . . 0.0 109.58 170.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 p -145.26 171.2 14.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.294 -1.504 . . . . 0.0 112.705 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.0 m -73.49 -6.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -95.11 -28.39 15.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.331 . . . . 0.0 112.345 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -128.71 70.62 80.7 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.287 1.835 . . . . 0.0 111.498 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.82 1.62 8.69 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.334 3.356 . . . . 0.0 113.527 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -45.47 -34.46 2.45 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.935 2.094 . . . . 0.0 115.924 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.59 -26.41 80.45 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.362 2.041 . . . . 0.0 114.876 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.34 -46.03 57.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.191 0.905 . . . . 0.0 110.424 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -67.15 -31.68 72.28 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.518 -0.739 . . . . 0.0 112.404 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.68 -31.59 71.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.177 0.899 . . . . 0.0 112.798 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -36.38 81.9 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.076 1.35 . . . . 0.0 111.6 169.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.7 -39.77 15.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.002 1.321 . . . . 0.0 114.233 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -57.71 -28.36 63.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.416 1.486 . . . . 0.0 113.787 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -71.0 -26.69 63.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.855 2.062 . . . . 0.0 112.735 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 m120 . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.604 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.8 -178.23 4.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.427 2.691 . . . . 0.0 113.647 -167.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.418 ' CG2' ' H ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -92.29 172.16 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.448 1.499 . . . . 0.0 109.99 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.418 ' H ' ' CG2' ' A' ' 27' ' ' VAL . 37.5 ttp-105 -159.94 141.83 9.58 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 130.723 3.609 . . . . 0.0 108.708 169.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -99.38 169.58 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.892 3.062 . . . . 0.0 113.858 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -82.88 160.44 22.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.983 1.313 . . . . 0.0 109.177 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.36 -47.75 67.57 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.42 -28.1 33.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 CA-C-N 122.299 1.857 . . . . 0.0 113.339 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.35 -35.66 54.43 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.282 -0.886 . . . . 0.0 111.568 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.3 -35.03 76.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.994 1.318 . . . . 0.0 110.951 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -59.73 -43.22 94.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.547 1.539 . . . . 0.0 112.648 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.0 mt -59.25 -52.87 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 109.492 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.347 11.1 mt -70.79 -30.5 66.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -61.45 -33.82 74.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.689 -1.257 . . . . 0.0 112.417 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.88 -21.78 61.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.299 0.954 . . . . 0.0 113.456 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.54 24.02 13.67 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.773 1.629 . . . . 0.0 113.517 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.87 15.03 78.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.552 1.072 . . . . 0.0 115.743 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.16 -166.86 1.46 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.672 1.189 . . . . 0.0 112.932 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -125.44 48.29 2.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.621 1.969 . . . . 0.0 110.587 169.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.29 -116.55 5.26 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.086 1.327 . . . . 0.0 113.107 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -139.08 19.95 2.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.066 2.146 . . . . 0.0 110.954 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 58.0 ttp -78.08 47.59 0.67 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.4 1.48 . . . . 0.0 112.924 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -170.58 175.6 4.62 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.111 1.764 . . . . 0.0 113.635 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.55 167.08 11.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.508 2.323 . . . . 0.0 113.721 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.4 -43.27 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.245 1.818 . . . . 0.0 111.804 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -64.34 -30.07 71.13 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -79.97 -48.17 13.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.932 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -55.34 -44.44 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.025 1.284 . . . . 0.0 112.788 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -71.31 -28.65 64.25 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.74 -59.37 5.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 110.874 170.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -55.51 -36.05 66.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.233 1.013 . . . . 0.0 113.592 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.52 -39.07 74.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.63 1.104 . . . . 0.0 113.383 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.71 -47.27 79.18 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 119.697 1.135 . . . . 0.0 112.134 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.01 -31.61 66.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.457 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.1 -51.53 68.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.887 1.676 . . . . 0.0 110.78 169.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -58.52 -44.25 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.952 0.901 . . . . 0.0 110.379 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 36.5 tpp -66.67 -31.6 72.38 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -74.39 -49.38 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.693 1.197 . . . . 0.0 111.414 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -66.02 -16.13 63.64 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.5 pt20 43.35 42.72 3.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.153 2.581 . . . . 0.0 113.259 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -100.65 22.04 12.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.895 1.678 . . . . 0.0 112.66 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -88.29 165.53 14.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.644 1.578 . . . . 0.0 112.069 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -71.21 138.36 49.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.228 -0.92 . . . . 0.0 112.13 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -38.4 51.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.244 1.418 . . . . 0.0 113.482 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -98.69 -16.56 18.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.0 1.32 . . . . 0.0 113.709 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.11 94.34 2.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.786 1.234 . . . . 0.0 109.768 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -63.89 -14.12 50.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.165 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.09 -19.74 61.1 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -96.77 128.08 43.37 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.254 1.822 . . . . 0.0 109.858 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.77 131.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.676 1.59 . . . . 0.0 110.921 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -104.45 161.87 13.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.258 1.423 . . . . 0.0 110.992 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.5 m -145.95 29.57 1.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.515 1.926 . . . . 0.0 111.812 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.89 114.31 6.64 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.357 -0.839 . . . . 0.0 112.339 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.11 72.02 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.001 1.286 . . . . 0.0 115.435 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -96.41 146.45 24.75 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.01 1.905 . . . . 0.0 110.826 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.12 -27.66 62.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.419 0.688 . . . . 0.0 112.477 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.6 tp -65.69 -38.83 90.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.679 0.792 . . . . 0.0 112.581 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.87 -39.56 93.43 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 121.409 -0.807 . . . . 0.0 111.781 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -63.54 -37.32 86.87 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 117.714 0.757 . . . . 0.0 112.005 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.92 -46.02 63.22 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.091 1.357 . . . . 0.0 112.695 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.21 -21.4 53.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.068 0.947 . . . . 0.0 113.052 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 1.07 90.37 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.701 1.143 . . . . 0.0 114.394 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -144.76 148.66 34.37 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.337 1.855 . . . . 0.0 111.458 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.82 12.24 32.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.457 1.103 . . . . 0.0 113.423 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -151.98 146.43 25.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -160.31 176.82 11.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.042 2.137 . . . . 0.0 110.15 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 p -147.59 173.86 12.31 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.543 -1.348 . . . . 0.0 113.166 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.62 -21.12 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.872 0.869 . . . . 0.0 111.732 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -88.88 -28.89 20.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.101 1.36 . . . . 0.0 113.008 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -121.02 65.55 13.64 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.298 1.839 . . . . 0.0 112.207 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.0 -0.9 10.22 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.969 3.113 . . . . 0.0 113.725 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -47.31 -34.37 4.56 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -58.84 -32.15 96.67 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.369 2.046 . . . . 0.0 114.645 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -64.95 -48.32 74.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.176 0.99 . . . . 0.0 110.623 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -69.12 -31.35 69.98 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.427 -0.796 . . . . 0.0 111.922 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.83 -33.05 71.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.097 0.862 . . . . 0.0 113.08 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -64.51 -39.69 94.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.892 1.277 . . . . 0.0 110.271 169.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.0 mt -82.65 -42.43 18.17 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -56.53 -28.48 60.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.686 1.194 . . . . 0.0 113.868 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.99 -26.58 63.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.91 2.084 . . . . 0.0 112.977 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 CA--C 1.551 0.982 0 C-N-CA 124.561 1.145 . . . . 0.0 112.762 173.845 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 122.432 1.11 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.23 -160.14 0.58 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 129.229 3.012 . . . . 0.0 108.656 -168.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.29 172.33 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.497 1.519 . . . . 0.0 110.512 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -160.7 137.97 6.79 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 131.177 3.791 . . . . 0.0 106.867 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -101.05 168.71 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.197 2.598 . . . . 0.0 114.432 -170.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.41 159.14 23.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.085 1.354 . . . . 0.0 108.2 167.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -53.11 -39.58 72.09 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -65.3 -29.97 54.38 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.42 2.08 . . . . 0.0 114.109 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.86 -36.65 27.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.508 1.123 . . . . 0.0 111.333 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.87 -45.77 93.26 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.077 1.351 . . . . 0.0 111.207 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 38.0 pttt -70.54 -26.15 63.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.41 -54.39 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.478 1.111 . . . . 0.0 108.765 169.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.251 35.0 mt -70.93 -30.77 67.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.77 0.828 . . . . 0.0 112.32 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -34.1 77.54 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.702 -1.249 . . . . 0.0 113.017 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.49 64.45 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -102.84 22.92 12.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.01 1.724 . . . . 0.0 113.549 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.35 80.85 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.512 1.053 . . . . 0.0 115.721 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.89 -164.61 0.76 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.449 1.125 . . . . 0.0 113.074 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -130.44 48.65 2.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 127.194 2.197 . . . . 0.0 109.193 168.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 -111.77 3.79 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.361 1.458 . . . . 0.0 113.276 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.07 16.78 2.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.588 1.955 . . . . 0.0 111.594 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -75.97 49.83 0.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.515 1.526 . . . . 0.0 113.235 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -173.2 172.12 3.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.461 2.305 . . . . 0.0 112.481 -169.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.38 167.35 16.7 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.121 2.168 . . . . 0.0 114.139 -171.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.78 -43.29 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.779 2.032 . . . . 0.0 112.31 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.54 -30.14 70.38 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -80.54 -46.41 15.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.4 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.17 -44.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 120.03 1.287 . . . . 0.0 112.684 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.04 -28.51 66.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.46 -58.25 7.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.964 171.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -56.69 -37.0 70.27 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.57 -41.73 75.45 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.15 0.886 . . . . 0.0 111.46 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.92 -47.48 88.64 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 112.907 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -70.51 -31.58 68.73 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.527 -0.984 . . . . 0.0 112.598 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -58.19 -52.1 66.96 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.887 1.222 . . . . 0.0 110.964 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -53.68 -46.29 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.045 0.839 . . . . 0.0 109.711 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -33.88 76.06 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.18 -47.42 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.302 1.041 . . . . 0.0 110.883 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -66.69 -11.24 53.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.046 0.938 . . . . 0.0 112.944 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.336 3.0 pt20 46.66 45.55 14.46 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 129.655 3.182 . . . . 0.0 113.311 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.08 58.21 4.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.245 1.418 . . . . 0.0 110.982 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -143.55 164.84 29.25 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.003 1.321 . . . . 0.0 112.574 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -72.86 135.58 45.18 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.649 -0.657 . . . . 0.0 111.721 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -40.23 36.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.162 1.385 . . . . 0.0 113.037 171.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -89.14 -19.16 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.227 1.411 . . . . 0.0 113.094 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -152.69 94.83 1.93 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.404 1.097 . . . . 0.0 111.742 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.92 -17.84 28.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.131 1.372 . . . . 0.0 112.636 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -21.57 65.45 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.091 0.957 . . . . 0.0 112.973 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.5 tpt -104.65 124.1 48.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.303 1.841 . . . . 0.0 110.73 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.96 138.17 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.127 1.771 . . . . 0.0 110.282 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -135.14 94.72 3.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.288 2.235 . . . . 0.0 110.535 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -88.53 30.69 0.88 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.67 2.788 . . . . 0.0 113.472 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.88 116.52 9.15 Favored Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 112.671 -170.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.86 11.3 78.19 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.364 1.459 . . . . 0.0 115.737 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.06 147.93 22.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.363 2.081 . . . . 0.0 111.792 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.99 -27.59 63.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.5 tp -65.93 -43.24 88.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.998 0.919 . . . . 0.0 112.694 171.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.24 -38.31 95.0 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 118.993 0.815 . . . . 0.0 111.719 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -65.07 -38.0 89.36 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.925 -0.75 . . . . 0.0 111.793 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.33 -48.87 63.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.071 0.948 . . . . 0.0 112.399 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.35 -20.35 61.48 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 112.701 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.93 -0.21 89.85 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.732 1.158 . . . . 0.0 114.075 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -145.6 145.29 30.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.38 1.872 . . . . 0.0 111.316 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.99 2.69 55.38 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.413 1.085 . . . . 0.0 113.086 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.5 p -147.39 140.23 24.94 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -160.65 176.48 11.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.959 2.503 . . . . 0.0 109.155 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.6 p -144.19 174.98 10.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.852 -1.155 . . . . 0.0 112.164 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.97 -8.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 169.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.04 -22.84 17.65 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.323 1.449 . . . . 0.0 113.139 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -124.22 62.14 28.87 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 126.116 1.766 . . . . 0.0 112.012 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.2 2.5 7.95 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.053 3.169 . . . . 0.0 114.258 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 m -46.85 -34.68 4.19 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -33.58 97.02 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 122.989 2.103 . . . . 0.0 114.679 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tp -57.78 -56.88 16.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 123.022 1.392 . . . . 0.0 110.219 171.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -70.49 -29.2 65.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.455 -0.778 . . . . 0.0 112.035 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.04 -31.51 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.6 1.091 . . . . 0.0 113.193 173.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.6 ttp -68.41 -37.11 80.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.363 1.065 . . . . 0.0 110.773 169.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.07 -31.48 18.02 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -29.3 65.16 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.463 1.505 . . . . 0.0 113.361 175.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.83 -29.0 70.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.273 1.829 . . . . 0.0 112.473 172.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.18 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -125.94 -175.64 3.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.304 2.642 . . . . 0.0 113.671 -166.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.3 t -92.2 172.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.813 1.645 . . . . 0.0 109.298 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -164.24 131.98 2.56 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 129.831 3.253 . . . . 0.0 107.15 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -96.59 174.27 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.974 2.449 . . . . 0.0 115.466 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -98.88 160.35 14.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.42 2.288 . . . . 0.0 107.516 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -53.39 -38.81 66.03 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -69.09 -32.53 21.15 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.21 1.94 . . . . 0.0 113.593 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.26 -37.32 61.02 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 111.037 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.74 -40.18 91.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.877 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -53.8 -42.61 68.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.706 1.202 . . . . 0.0 113.329 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -64.18 -50.11 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.565 1.546 . . . . 0.0 109.937 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.36 -37.39 80.41 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.645 -0.659 . . . . 0.0 111.167 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -71.37 -30.63 66.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.886 -1.134 . . . . 0.0 113.404 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.33 -22.7 54.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.495 0.718 . . . . 0.0 112.874 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.14 25.37 11.08 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.959 1.704 . . . . 0.0 113.563 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.48 17.33 79.82 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.36 -161.2 0.3 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.947 1.299 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -132.67 48.65 2.39 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.022 1.729 . . . . 0.0 110.746 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.16 -119.6 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.178 0.894 . . . . 0.0 112.66 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -141.39 19.62 2.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.891 1.677 . . . . 0.0 112.624 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -77.64 47.55 0.61 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.1 1.36 . . . . 0.0 112.783 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -168.73 174.47 6.6 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.417 1.887 . . . . 0.0 113.157 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.62 164.97 10.94 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.783 2.433 . . . . 0.0 113.91 -171.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.21 -42.42 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 126.017 1.727 . . . . 0.0 111.874 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.7 -30.19 71.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -79.18 -48.23 14.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.965 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.94 -47.01 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 119.699 1.136 . . . . 0.0 112.066 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -71.49 -23.84 61.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.06 -59.64 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.35 0.977 . . . . 0.0 110.659 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -55.99 -40.72 73.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.873 1.269 . . . . 0.0 113.298 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 tt -73.29 -32.29 64.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.365 1.066 . . . . 0.0 111.515 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.9 -47.31 89.88 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.696 -1.253 . . . . 0.0 112.736 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.01 -31.59 72.24 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.414 -1.05 . . . . 0.0 112.375 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.85 -54.44 47.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.838 1.199 . . . . 0.0 111.077 169.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -52.89 -42.96 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.342 0.974 . . . . 0.0 110.292 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.2 tpp -70.45 -35.27 73.24 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.26 -47.57 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.505 1.122 . . . . 0.0 111.341 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -65.0 -12.1 46.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.502 1.121 . . . . 0.0 112.745 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.33 3.9 pt20 47.92 46.13 18.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 129.407 3.083 . . . . 0.0 113.149 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.22 56.79 4.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.368 1.467 . . . . 0.0 110.887 -171.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.86 166.97 24.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.843 1.257 . . . . 0.0 112.747 -173.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -73.52 148.63 42.89 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.146 0.974 . . . . 0.0 113.279 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.541 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.43 -35.99 76.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.974 1.71 . . . . 0.0 111.716 -176.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -93.1 -20.75 20.2 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.554 1.542 . . . . 0.0 112.335 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -145.95 94.96 2.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.195 0.998 . . . . 0.0 112.69 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -59.01 -17.96 29.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.815 1.246 . . . . 0.0 112.896 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -22.26 66.57 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.339 1.055 . . . . 0.0 112.913 174.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.4 tpt -102.12 128.77 48.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.578 1.551 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.9 t -108.92 134.48 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.876 1.671 . . . . 0.0 110.6 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -136.67 96.93 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 110.468 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.5 m -89.55 27.51 1.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 128.35 2.66 . . . . 0.0 113.686 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.39 118.89 14.9 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.486 -0.759 . . . . 0.0 113.064 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.69 8.97 82.38 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.285 1.421 . . . . 0.0 115.719 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.32 149.2 21.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.132 1.966 . . . . 0.0 112.025 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.3 tp -59.18 -27.8 66.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.529 1.131 . . . . 0.0 111.291 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.1 tp -63.95 -48.98 74.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.326 1.05 . . . . 0.0 111.895 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.48 -37.46 93.77 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 118.621 0.646 . . . . 0.0 112.376 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -64.15 -37.34 87.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.85 0.86 . . . . 0.0 112.006 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.13 -45.96 53.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.876 0.871 . . . . 0.0 112.019 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.43 -28.68 69.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.046 0.938 . . . . 0.0 112.639 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 0.46 89.0 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.559 1.076 . . . . 0.0 114.024 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.66 147.81 32.39 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.847 1.659 . . . . 0.0 111.768 170.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -100.19 5.66 44.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.763 1.225 . . . . 0.0 113.06 -171.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -147.59 145.51 29.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -164.29 -177.37 4.9 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.17 2.588 . . . . 0.0 109.308 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 p -137.36 170.72 15.61 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.682 -1.261 . . . . 0.0 112.331 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.26 -15.69 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -94.37 -18.91 21.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -131.34 63.89 71.4 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.48 1.512 . . . . 0.0 112.587 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.78 13.98 1.99 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 125.11 3.873 . . . . 0.0 114.564 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.1 p -50.67 -27.62 1.61 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 117.648 2.462 . . . . 0.0 117.648 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -60.81 -27.84 85.46 Favored 'Trans proline' 0 C--N 1.357 1.012 0 CA-C-N 123.898 2.428 . . . . 0.0 114.437 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.41 -48.72 66.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.609 0.719 . . . . 0.0 110.297 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -66.85 -30.74 71.0 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.557 -0.714 . . . . 0.0 112.02 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -68.13 -31.63 71.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.293 1.037 . . . . 0.0 112.988 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -35.68 75.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.353 1.461 . . . . 0.0 111.197 169.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -88.33 -36.44 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -58.67 -27.34 64.71 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.071 1.749 . . . . 0.0 114.351 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -71.15 -26.17 62.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.465 1.906 . . . . 0.0 112.593 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 125.442 1.497 . . . . 0.0 112.915 -179.472 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.408 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.7 m120 . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.408 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -129.2 -174.88 3.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.492 2.317 . . . . 0.0 112.697 -167.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.14 172.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 0.0 109.102 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -165.08 131.3 2.15 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 128.766 2.826 . . . . 0.0 108.24 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -104.11 174.57 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.995 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -106.79 167.7 9.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.782 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -42.15 -53.79 8.21 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.67 -27.56 45.05 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.494 2.129 . . . . 0.0 114.293 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.8 mt -84.39 -34.29 23.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.511 0.725 . . . . 0.0 112.101 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.29 -35.39 77.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.132 0.973 . . . . 0.0 110.957 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -39.35 73.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.9 1.28 . . . . 0.0 112.627 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -63.41 -54.37 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.464 1.505 . . . . 0.0 109.251 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.282 4.7 mp -70.77 -30.36 66.83 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.332 -0.855 . . . . 0.0 113.156 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -35.49 78.33 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.434 -1.416 . . . . 0.0 112.901 169.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.13 -21.15 64.8 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.175 0.898 . . . . 0.0 112.853 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.68 18.72 19.66 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.402 1.881 . . . . 0.0 113.715 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.11 15.5 76.6 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.71 -165.55 1.08 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.795 1.238 . . . . 0.0 112.734 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -131.5 56.73 1.79 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.968 1.707 . . . . 0.0 111.318 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.78 -126.17 7.32 Favored Glycine 0 C--O 1.218 -0.86 0 C-N-CA 124.32 0.962 . . . . 0.0 112.134 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -141.62 11.26 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.825 2.05 . . . . 0.0 111.716 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.5 ttt -76.12 54.56 0.87 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.39 1.476 . . . . 0.0 113.445 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -170.65 171.42 6.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.582 1.953 . . . . 0.0 113.037 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 164.84 7.4 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.176 2.19 . . . . 0.0 114.309 -169.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -51.52 -45.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 126.089 1.756 . . . . 0.0 111.929 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.88 -30.11 71.23 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.23 -47.82 15.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.02 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.0 -45.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 120.027 1.285 . . . . 0.0 112.688 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.7 ptm -70.64 -25.28 62.94 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -64.97 -57.85 7.66 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.969 1.307 . . . . 0.0 110.809 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -55.94 -35.85 67.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.918 0.887 . . . . 0.0 113.071 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tt -71.34 -38.58 71.64 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.245 -0.91 . . . . 0.0 112.155 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.57 -47.47 88.1 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 120.848 -1.158 . . . . 0.0 112.589 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.302 11.2 pt20 -70.24 -31.45 68.86 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.997 . . . . 0.0 112.719 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -55.68 -50.43 70.3 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.558 1.526 . . . . 0.0 111.6 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -57.11 -47.23 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.605 0.762 . . . . 0.0 109.762 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.63 71.65 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -73.48 -50.19 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.142 1.377 . . . . 0.0 111.312 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.31 -15.94 63.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.895 0.878 . . . . 0.0 112.9 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.288 6.2 pt20 43.55 43.53 4.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.72 2.808 . . . . 0.0 113.348 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -103.77 33.23 3.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 112.656 -169.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -99.87 165.44 11.56 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.188 1.795 . . . . 0.0 111.821 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.81 135.76 50.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.341 -0.85 . . . . 0.0 111.967 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.51 -45.54 62.91 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.304 1.042 . . . . 0.0 113.186 169.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -80.85 -13.94 58.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 112.497 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.17 98.28 1.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 112.282 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -59.28 -17.56 29.84 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.541 1.137 . . . . 0.0 112.867 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -20.4 62.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.254 1.421 . . . . 0.0 110.456 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.23 140.41 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.384 1.474 . . . . 0.0 111.489 -169.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.35 165.72 14.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.973 2.109 . . . . 0.0 111.178 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.4 m -139.51 -29.57 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.745 1.218 . . . . 0.0 114.15 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 52.72 -126.02 31.19 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.154 0.888 . . . . 0.0 111.878 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.05 14.2 50.46 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.78 150.71 45.59 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.676 2.238 . . . . 0.0 112.475 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.09 -27.85 35.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.452 1.101 . . . . 0.0 112.086 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 tp -65.69 -44.88 84.84 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.661 0.784 . . . . 0.0 112.256 173.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 118.773 0.715 . . . . 0.0 111.932 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -64.51 -37.69 88.41 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 117.683 0.742 . . . . 0.0 112.069 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.8 tp -70.63 -46.13 63.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.741 1.216 . . . . 0.0 112.484 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.85 -28.72 64.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.217 1.007 . . . . 0.0 113.06 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.13 -0.45 73.47 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 123.903 0.763 . . . . 0.0 113.396 -169.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -135.05 137.34 42.83 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 128.245 2.618 . . . . 0.0 109.624 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -103.52 11.83 35.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.783 0.833 . . . . 0.0 113.011 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.5 p -153.84 140.66 19.11 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.683 1.193 . . . . 0.0 111.624 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -162.61 175.34 11.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.41 1.884 . . . . 0.0 110.15 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.4 p -143.89 173.83 11.36 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.899 -1.125 . . . . 0.0 113.342 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.02 -20.84 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.107 0.963 . . . . 0.0 112.132 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.2 -19.39 21.49 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.88 1.272 . . . . 0.0 113.644 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -128.59 63.38 64.61 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.976 1.71 . . . . 0.0 112.402 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.56 -2.05 11.3 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.171 3.248 . . . . 0.0 113.783 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.1 m -41.91 -43.36 6.65 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -23.31 70.7 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 122.925 2.08 . . . . 0.0 114.465 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.67 -51.95 50.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.518 1.054 . . . . 0.0 110.147 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -62.87 -37.7 87.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.442 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.01 -31.54 72.83 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 173.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.3 -47.91 80.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.873 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.29 -21.86 21.87 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -63.75 -25.04 68.01 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.8 1.182 . . . . 0.0 113.27 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -70.05 -25.94 63.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.467 2.307 . . . . 0.0 112.549 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.571 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 N--CA 1.475 0.804 0 CA-C-O 122.344 1.068 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.38 -176.91 5.0 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.006 2.922 . . . . 0.0 109.818 -171.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.33 172.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.888 0.875 . . . . 0.0 111.869 -169.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -162.14 134.12 4.09 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 128.903 2.881 . . . . 0.0 107.588 172.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -98.66 -178.61 0.27 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.212 2.608 . . . . 0.0 114.574 -169.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -120.65 165.77 14.6 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.301 2.24 . . . . 0.0 108.651 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -39.59 -57.81 2.3 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.467 1.907 . . . . 0.0 116.136 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.83 -25.23 33.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.467 2.111 . . . . 0.0 114.109 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.08 -39.15 23.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.813 0.845 . . . . 0.0 111.065 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.22 -31.58 70.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.678 1.191 . . . . 0.0 111.662 170.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -58.86 -37.62 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.121 1.368 . . . . 0.0 112.787 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.25 -42.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.484 1.514 . . . . 0.0 110.14 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.59 -30.82 67.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.797 -0.564 . . . . 0.0 111.964 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -65.85 -37.13 85.37 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.964 -1.71 . . . . 0.0 112.164 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.65 -22.56 67.01 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.883 0.765 . . . . 0.0 112.435 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.4 2.58 39.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.144 1.378 . . . . 0.0 114.183 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.78 17.31 79.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.492 1.044 . . . . 0.0 114.998 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.27 -166.72 1.65 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.602 1.561 . . . . 0.0 112.792 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.38 65.67 1.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.911 1.684 . . . . 0.0 111.101 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.12 -138.81 23.27 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.732 0.682 . . . . 0.0 112.83 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -131.79 18.06 4.69 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.393 1.877 . . . . 0.0 112.29 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.94 52.64 1.28 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.466 1.506 . . . . 0.0 112.345 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -169.62 170.16 8.25 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.368 1.867 . . . . 0.0 113.209 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.38 165.49 14.09 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.358 2.263 . . . . 0.0 114.663 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -50.83 -44.54 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 126.243 1.817 . . . . 0.0 112.152 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.76 -30.08 71.08 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.09 -48.62 14.01 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.022 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -55.34 -44.96 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 120.194 1.361 . . . . 0.0 112.506 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 14.4 ptm -72.27 -24.95 61.43 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.07 10.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.713 1.205 . . . . 0.0 110.313 169.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -55.56 -42.31 74.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.077 0.951 . . . . 0.0 112.907 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.13 -38.0 89.49 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.04 1.291 . . . . 0.0 112.609 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.25 -47.43 89.5 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 119.487 1.04 . . . . 0.0 112.894 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.44 -31.67 67.47 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.548 -0.972 . . . . 0.0 112.873 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.08 -53.63 55.88 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.928 1.24 . . . . 0.0 110.29 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.7 mt -57.72 -42.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.677 0.791 . . . . 0.0 110.192 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.75 -32.22 73.64 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.13 -50.38 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.661 1.185 . . . . 0.0 111.495 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.08 -15.89 64.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.072 1.349 . . . . 0.0 113.11 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.304 6.1 pt20 46.77 43.44 13.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.625 2.77 . . . . 0.0 114.117 172.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.99 3.63 33.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.914 1.285 . . . . 0.0 113.423 -176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -78.73 164.58 24.45 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.666 -1.271 . . . . 0.0 113.413 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -73.14 139.35 46.34 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.682 -0.636 . . . . 0.0 111.986 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -40.38 65.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.376 1.47 . . . . 0.0 112.893 172.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -89.41 -20.35 24.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 112.932 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.21 96.49 2.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.463 1.105 . . . . 0.0 111.538 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -61.24 -14.64 27.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.955 0.902 . . . . 0.0 112.821 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -21.29 66.19 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.996 0.918 . . . . 0.0 112.97 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.8 tpt -104.87 136.01 45.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.662 1.985 . . . . 0.0 110.999 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.56 131.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.686 1.594 . . . . 0.0 110.764 -170.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -99.34 170.54 8.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.369 1.467 . . . . 0.0 111.317 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.03 24.71 0.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 113.457 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.3 113.45 5.45 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.43 -0.794 . . . . 0.0 112.638 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.74 12.81 71.15 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.095 1.331 . . . . 0.0 115.884 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.21 148.28 22.27 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.631 2.216 . . . . 0.0 111.18 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -27.72 63.05 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.53 0.732 . . . . 0.0 112.248 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.13 -40.7 90.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.626 0.77 . . . . 0.0 112.558 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.15 92.64 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 119.101 0.864 . . . . 0.0 112.286 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.24 -40.47 96.1 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.271 1.036 . . . . 0.0 111.539 171.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.25 -44.87 82.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.568 1.147 . . . . 0.0 112.621 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.26 -23.0 43.96 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 113.449 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.91 84.12 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.232 0.92 . . . . 0.0 114.015 -171.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -136.65 137.86 40.51 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.338 1.855 . . . . 0.0 112.526 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -98.64 7.98 45.47 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.601 1.161 . . . . 0.0 113.415 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.4 p -157.09 140.9 16.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 168.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -159.51 176.41 12.1 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.504 1.922 . . . . 0.0 110.506 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 p -143.41 173.33 11.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.764 -1.21 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.67 -20.87 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -94.97 -16.33 22.86 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -125.05 65.39 47.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.85 1.66 . . . . 0.0 112.062 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.03 4.69 5.95 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.364 3.376 . . . . 0.0 113.309 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.6 m -38.88 -45.89 3.08 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 127.717 2.407 . . . . 0.0 116.616 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.42 -20.5 66.25 Favored 'Trans proline' 0 C--N 1.355 0.909 0 CA-C-N 122.521 1.936 . . . . 0.0 115.073 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.52 -49.66 62.37 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.264 1.031 . . . . 0.0 109.722 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -66.77 -30.52 70.75 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.043 -1.035 . . . . 0.0 112.043 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.64 -32.52 74.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.091 -1.006 . . . . 0.0 112.935 170.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -34.15 72.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.235 1.414 . . . . 0.0 111.629 170.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.82 -26.26 21.77 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -26.2 68.61 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.215 1.371 . . . . 0.0 114.394 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.29 -28.84 69.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.389 1.075 . . . . 0.0 111.952 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 171.347 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 CA--C 1.552 1.036 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -124.28 -175.88 3.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.238 2.615 . . . . 0.0 113.857 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.49 172.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.563 1.145 . . . . 0.0 111.393 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -164.34 132.28 2.59 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 129.799 3.24 . . . . 0.0 106.889 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -100.24 174.9 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.024 2.483 . . . . 0.0 115.024 -169.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.88 160.23 14.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.949 2.1 . . . . 0.0 107.03 166.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -44.91 -46.28 28.01 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -68.85 -28.2 30.14 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 122.317 1.863 . . . . 0.0 114.037 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.68 -37.02 28.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.39 1.076 . . . . 0.0 111.011 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -57.72 -40.24 79.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 0.0 110.362 170.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -51.62 -41.62 61.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.692 1.597 . . . . 0.0 113.438 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.89 -51.68 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.297 1.039 . . . . 0.0 110.102 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.69 -31.67 68.64 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 111.925 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -31.87 69.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.793 -1.192 . . . . 0.0 112.86 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.05 -20.98 58.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.201 0.6 . . . . 0.0 112.605 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.46 21.65 17.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.381 1.872 . . . . 0.0 113.796 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.42 17.48 78.97 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.89 -161.12 0.32 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.993 1.317 . . . . 0.0 112.86 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -136.76 59.22 1.7 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.36 -130.85 10.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.859 1.219 . . . . 0.0 113.175 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -138.89 19.37 2.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.882 2.073 . . . . 0.0 111.589 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.6 ttt -77.7 50.34 0.83 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.698 1.199 . . . . 0.0 112.953 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -168.07 171.05 9.89 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.885 1.674 . . . . 0.0 113.876 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -65.38 167.68 8.23 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.555 2.342 . . . . 0.0 114.222 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.05 -42.24 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.801 2.041 . . . . 0.0 111.802 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -65.15 -33.91 77.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -79.01 -45.94 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.504 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.04 -47.16 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.875 1.216 . . . . 0.0 112.453 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.2 ptm -71.66 -24.01 61.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.69 -59.7 4.25 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.529 1.132 . . . . 0.0 110.744 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -55.25 -37.34 67.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.411 1.084 . . . . 0.0 113.214 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.06 -34.2 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.209 -0.932 . . . . 0.0 112.062 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.06 -47.37 91.11 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.711 -1.243 . . . . 0.0 112.154 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.291 13.9 pt20 -68.48 -31.44 70.72 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.147 -1.207 . . . . 0.0 112.925 172.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -54.6 -53.23 57.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 120.544 1.52 . . . . 0.0 110.467 169.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.4 -43.26 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.753 0.821 . . . . 0.0 110.399 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -34.78 78.51 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -78.13 -49.81 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.987 1.315 . . . . 0.0 111.847 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.04 -15.81 62.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.551 1.141 . . . . 0.0 112.858 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 6.4 pt20 47.72 43.49 16.82 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.003 2.521 . . . . 0.0 113.385 172.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.64 11.69 32.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.983 1.713 . . . . 0.0 112.902 -169.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -86.23 164.85 16.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.725 1.61 . . . . 0.0 112.222 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -71.76 146.69 47.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.135 0.969 . . . . 0.0 113.216 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.549 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -67.93 -34.84 77.38 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.004 1.722 . . . . 0.0 111.819 -175.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.54 -20.61 18.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.629 1.572 . . . . 0.0 112.483 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -144.79 93.29 2.39 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.851 0.834 . . . . 0.0 112.352 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -56.79 -21.25 27.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.27 1.428 . . . . 0.0 112.881 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -31.46 65.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.294 1.437 . . . . 0.0 113.018 171.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -98.7 130.08 45.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.117 1.367 . . . . 0.0 111.101 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -122.57 128.01 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.42 1.488 . . . . 0.0 110.258 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.42 166.59 10.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.069 1.348 . . . . 0.0 111.076 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.98 24.87 0.93 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 112.594 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.56 114.35 6.44 Favored Glycine 0 CA--C 1.533 1.169 0 O-C-N 121.531 -0.731 . . . . 0.0 112.741 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.73 11.67 66.21 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.063 1.316 . . . . 0.0 115.778 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -91.8 149.32 21.65 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 120.491 2.146 . . . . 0.0 111.44 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.23 -27.43 63.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.89 0.876 . . . . 0.0 111.991 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 tp -67.14 -40.33 86.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.796 0.838 . . . . 0.0 112.891 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.73 -36.25 92.9 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 119.132 0.878 . . . . 0.0 111.968 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -66.35 -37.43 85.31 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 112.095 171.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.2 tp -66.96 -46.96 73.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.709 0.803 . . . . 0.0 112.176 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.7 mt -77.96 -24.04 48.27 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.485 1.114 . . . . 0.0 113.101 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.73 8.85 87.19 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.253 0.93 . . . . 0.0 113.925 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -140.37 145.89 37.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.035 1.734 . . . . 0.0 113.091 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -104.29 8.29 35.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.364 1.065 . . . . 0.0 113.606 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -157.09 145.3 19.41 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -161.32 -177.42 6.0 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.544 2.338 . . . . 0.0 109.88 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.6 p -141.01 170.5 15.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.419 -1.426 . . . . 0.0 112.965 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.48 -11.24 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -88.24 -32.68 18.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.883 1.273 . . . . 0.0 111.873 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -127.19 71.47 76.23 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.926 1.69 . . . . 0.0 112.232 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.31 8.2 3.02 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.586 3.524 . . . . 0.0 113.734 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -46.13 -34.08 2.86 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 127.334 2.254 . . . . 0.0 116.772 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -59.81 -29.32 89.29 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 122.349 1.875 . . . . 0.0 114.318 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.79 -47.87 73.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.931 0.787 . . . . 0.0 110.579 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -65.52 -32.97 74.85 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.775 -0.578 . . . . 0.0 111.463 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.87 -31.62 68.35 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.174 0.897 . . . . 0.0 113.363 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -35.73 81.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.768 1.227 . . . . 0.0 110.768 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.84 -41.05 12.71 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.89 1.276 . . . . 0.0 114.14 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -27.61 64.84 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.671 1.588 . . . . 0.0 115.183 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.02 -24.63 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.491 1.517 . . . . 0.0 113.085 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -167.938 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 122.264 1.031 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.12 -178.68 6.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.481 2.712 . . . . 0.0 109.829 -168.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.5 172.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.107 0.963 . . . . 0.0 111.303 -169.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -163.42 136.54 4.28 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 128.719 2.808 . . . . 0.0 108.006 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -101.36 174.21 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.311 2.674 . . . . 0.0 114.956 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -98.95 159.52 14.9 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.416 1.886 . . . . 0.0 107.798 167.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.1 tp -47.2 -43.8 46.97 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -66.76 -29.57 42.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.304 2.003 . . . . 0.0 114.119 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.4 mt -84.91 -33.03 22.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.627 0.771 . . . . 0.0 111.839 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.68 -35.77 77.09 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.901 0.881 . . . . 0.0 110.974 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -40.16 68.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.771 1.228 . . . . 0.0 112.717 177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -65.43 -51.92 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.859 1.664 . . . . 0.0 109.409 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.67 -30.3 66.86 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.433 -0.792 . . . . 0.0 112.932 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -34.3 76.67 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.396 -1.44 . . . . 0.0 112.878 169.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.81 -20.23 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 119.288 0.949 . . . . 0.0 112.997 170.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.74 17.51 24.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.343 1.857 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 17.52 75.62 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.98 -165.4 1.19 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.114 1.366 . . . . 0.0 112.616 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.65 52.82 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.231 1.412 . . . . 0.0 110.99 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.79 -124.26 7.39 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.303 -0.873 . . . . 0.0 112.145 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -140.27 20.26 2.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.933 1.693 . . . . 0.0 111.902 -176.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -77.63 42.48 0.37 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.199 1.8 . . . . 0.0 114.361 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -166.29 174.6 8.97 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 -167.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.74 165.89 11.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.051 2.14 . . . . 0.0 114.297 -169.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.36 -44.55 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.848 1.659 . . . . 0.0 112.012 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -64.52 -30.12 71.15 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.46 -48.58 13.69 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.35 -0.834 . . . . 0.0 111.157 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.59 -44.88 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 120.425 1.466 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.5 ptm -71.71 -28.81 63.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.72 -59.14 5.86 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.162 . . . . 0.0 110.501 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -57.62 -33.17 67.97 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -34.7 70.19 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.159 1.345 . . . . 0.0 113.92 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.36 88.15 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 120.151 1.342 . . . . 0.0 111.769 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.261 13.5 pt20 -70.56 -31.63 68.74 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 118.071 -0.966 . . . . 0.0 113.18 173.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -55.66 -53.56 55.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.847 1.658 . . . . 0.0 110.945 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.18 -42.34 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.321 1.048 . . . . 0.0 110.071 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 31.8 tpp -67.18 -30.39 70.32 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.674 0.991 . . . . 0.0 113.674 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.66 -50.59 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.754 1.221 . . . . 0.0 111.489 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -15.99 63.25 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.496 1.118 . . . . 0.0 112.951 175.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.3 pt20 45.55 42.64 8.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.261 2.624 . . . . 0.0 113.448 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.4 19.5 16.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.843 1.657 . . . . 0.0 112.552 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -88.92 166.59 13.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.951 1.701 . . . . 0.0 111.86 171.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -76.33 135.22 39.55 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.234 -0.916 . . . . 0.0 112.07 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -38.84 42.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.263 1.425 . . . . 0.0 113.208 171.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -89.79 -18.26 26.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.214 1.406 . . . . 0.0 113.067 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.91 92.33 1.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.518 1.127 . . . . 0.0 111.257 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -57.51 -18.74 20.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 112.484 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -24.81 67.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.646 1.178 . . . . 0.0 112.957 175.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -102.01 132.66 47.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.444 1.898 . . . . 0.0 110.843 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.3 t -126.8 130.18 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.67 1.588 . . . . 0.0 110.333 -170.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -101.88 165.1 11.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.057 1.343 . . . . 0.0 111.381 172.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.5 m -150.44 23.62 0.81 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.225 1.81 . . . . 0.0 112.75 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.17 114.79 7.03 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 121.409 -0.807 . . . . 0.0 112.645 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.95 12.74 65.51 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.107 1.337 . . . . 0.0 115.528 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.36 149.49 21.19 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.087 1.944 . . . . 0.0 111.452 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -58.04 -27.72 63.84 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.683 -0.635 . . . . 0.0 111.666 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.7 tp -67.19 -39.15 86.33 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.358 -0.839 . . . . 0.0 112.598 172.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.57 90.54 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 118.659 0.663 . . . . 0.0 112.211 171.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.9 -38.0 85.43 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.398 1.099 . . . . 0.0 112.189 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.44 -46.14 70.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.479 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.41 -20.67 43.41 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.457 1.103 . . . . 0.0 113.074 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.16 -9.66 52.81 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.747 1.642 . . . . 0.0 114.407 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -124.84 142.5 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.419 1.888 . . . . 0.0 111.518 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -97.58 12.48 33.37 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.5 p -157.14 148.44 22.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.586 1.154 . . . . 0.0 112.549 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.3 173.92 15.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.392 1.877 . . . . 0.0 110.401 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.0 p -141.4 171.35 14.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.659 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -71.73 -8.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.0 -24.32 16.98 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.346 1.459 . . . . 0.0 112.854 169.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -128.82 63.42 66.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.204 1.802 . . . . 0.0 112.217 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.64 6.18 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.075 3.183 . . . . 0.0 114.077 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.8 m -44.97 -37.96 5.59 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -172.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -56.58 -30.17 82.02 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.634 2.223 . . . . 0.0 115.38 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.53 -53.04 62.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.301 1.524 . . . . 0.0 110.663 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.63 -29.23 63.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.719 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.12 -31.6 72.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.884 0.873 . . . . 0.0 112.582 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.15 -40.08 82.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.515 1.126 . . . . 0.0 110.812 169.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.26 -36.13 35.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.723 1.209 . . . . 0.0 113.842 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -25.38 65.52 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.365 1.439 . . . . 0.0 114.312 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -67.5 -31.84 72.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.644 1.977 . . . . 0.0 112.27 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.7 m120 . . . . . 0 CA--C 1.544 0.748 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.789 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -126.09 -174.94 3.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.261 2.624 . . . . 0.0 113.01 -167.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.47 171.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.077 0.951 . . . . 0.0 110.321 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -164.73 130.43 2.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 127.964 2.505 . . . . 0.0 107.786 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -96.45 172.95 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.886 2.391 . . . . 0.0 114.254 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.1 159.3 15.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.654 1.981 . . . . 0.0 108.192 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.05 -52.9 14.54 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 -22.12 37.23 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.552 2.168 . . . . 0.0 114.008 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.3 mt -84.34 -36.75 22.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.901 0.88 . . . . 0.0 111.979 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.9 -35.95 78.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 111.166 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -51.74 -38.17 54.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.455 1.502 . . . . 0.0 112.77 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -67.49 -51.52 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.74 -30.64 67.21 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -35.14 79.47 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.477 -1.389 . . . . 0.0 112.789 171.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.41 -21.52 62.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.31 21.5 17.05 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.32 1.848 . . . . 0.0 113.661 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.43 78.01 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.981 1.152 . . . . 0.0 115.981 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.08 -164.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.0 1.32 . . . . 0.0 113.035 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -129.19 50.1 2.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.997 1.719 . . . . 0.0 111.674 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.3 -122.49 5.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.425 1.012 . . . . 0.0 113.046 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -143.59 14.8 1.78 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.041 1.736 . . . . 0.0 112.684 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -79.17 52.29 1.29 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.084 1.354 . . . . 0.0 112.549 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -168.89 169.73 9.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.176 1.79 . . . . 0.0 112.532 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 164.78 6.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 127.34 2.256 . . . . 0.0 114.109 -170.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -52.72 -44.13 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.317 1.847 . . . . 0.0 111.786 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.22 -30.08 71.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.65 -47.77 14.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.106 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.25 -46.84 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 120.183 1.356 . . . . 0.0 112.499 173.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.6 ptm -69.46 -24.81 63.85 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.05 -59.66 3.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.822 1.249 . . . . 0.0 110.751 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -56.05 -36.34 67.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.945 0.898 . . . . 0.0 113.05 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -70.88 -38.91 73.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.061 0.944 . . . . 0.0 112.01 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.22 -47.43 89.49 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.865 -1.147 . . . . 0.0 112.54 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.265 13.2 pt20 -68.71 -31.6 70.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.504 -0.997 . . . . 0.0 112.755 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -57.52 -51.08 70.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.123 1.329 . . . . 0.0 111.027 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.16 -41.96 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.198 0.908 . . . . 0.0 110.08 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.25 -34.43 78.08 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.1 -52.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.598 1.159 . . . . 0.0 111.594 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -67.23 -15.76 63.89 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.323 1.049 . . . . 0.0 113.335 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.3 5.6 pt20 46.13 47.14 13.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.445 2.698 . . . . 0.0 113.912 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.8 4.49 32.73 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.75 1.22 . . . . 0.0 113.624 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -78.53 163.3 25.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 112.706 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.57 150.11 41.68 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.952 0.882 . . . . 0.0 112.682 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.533 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -64.14 -31.84 73.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.964 1.306 . . . . 0.0 112.65 -174.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -102.66 -30.04 11.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.674 1.59 . . . . 0.0 110.461 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -110.35 80.07 1.27 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.247 1.019 . . . . 0.0 111.789 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -57.3 -22.42 41.63 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.028 -0.42 . . . . 0.0 111.605 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -26.19 54.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.9 tpt -88.62 127.55 35.57 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.087 1.312 . . . . 0.0 110.854 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 t -120.07 125.69 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.394 1.078 . . . . 0.0 110.98 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.86 167.38 10.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.914 1.285 . . . . 0.0 111.065 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.1 m -148.62 29.24 0.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.916 1.686 . . . . 0.0 112.082 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.74 113.85 6.15 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.35 -0.844 . . . . 0.0 112.542 -170.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.37 12.05 72.39 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.08 1.324 . . . . 0.0 115.576 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.21 150.8 19.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.161 1.98 . . . . 0.0 111.4 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -58.06 -27.74 63.9 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.82 -37.64 84.9 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.377 -0.827 . . . . 0.0 112.482 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.43 -38.21 94.63 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.504 -0.748 . . . . 0.0 112.008 170.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -65.8 -37.61 86.74 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.229 1.014 . . . . 0.0 112.262 172.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.87 -44.64 76.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 112.248 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -79.22 -25.0 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.391 0.676 . . . . 0.0 112.626 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.16 4.55 83.87 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.423 1.011 . . . . 0.0 113.437 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -138.24 141.72 39.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.618 1.967 . . . . 0.0 111.492 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -101.97 10.1 39.95 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 -172.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.0 p -154.52 148.87 26.1 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.54 179.05 8.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.957 2.503 . . . . 0.0 109.57 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 p -144.78 172.73 12.6 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.184 -1.572 . . . . 0.0 113.286 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.05 -21.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.422 0.689 . . . . 0.0 112.096 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.72 -21.64 19.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.12 77.21 67.94 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 111.541 174.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.84 3.62 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.394 3.396 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 m -46.68 -37.6 9.4 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.874 1.67 . . . . 0.0 115.343 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.58 -27.25 68.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.407 2.738 . . . . 0.0 116.661 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.96 -49.5 57.45 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 123.021 1.391 . . . . 0.0 110.136 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -67.94 -29.15 68.15 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 121.22 -0.925 . . . . 0.0 112.157 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.56 -31.33 72.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.356 1.062 . . . . 0.0 112.179 169.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -40.52 72.26 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.256 1.022 . . . . 0.0 111.484 169.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.45 -30.78 26.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -59.74 -26.54 65.74 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.627 1.571 . . . . 0.0 113.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -69.6 -31.04 68.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.588 1.955 . . . . 0.0 112.252 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 t30 . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 171.85 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.99 -177.2 4.19 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.969 2.507 . . . . 0.0 112.054 -168.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.99 172.31 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.362 1.065 . . . . 0.0 109.621 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.18 135.9 4.79 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 129.31 3.044 . . . . 0.0 107.344 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 24.1 Cg_endo -93.72 175.74 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.995 2.463 . . . . 0.0 115.468 -168.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -107.67 160.55 15.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.975 2.51 . . . . 0.0 107.65 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.3 tp -40.27 -55.76 3.89 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 126.271 1.828 . . . . 0.0 115.822 -175.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.94 -25.06 28.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.223 1.949 . . . . 0.0 113.452 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.34 -35.47 35.54 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.452 -0.78 . . . . 0.0 111.582 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.53 -32.73 73.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.706 0.802 . . . . 0.0 110.93 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -59.23 -40.22 85.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.919 1.288 . . . . 0.0 112.759 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -65.76 -46.08 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.196 1.398 . . . . 0.0 109.98 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.6 -30.81 67.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.081 0.552 . . . . 0.0 112.225 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -66.37 -37.2 84.74 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.095 -1.628 . . . . 0.0 112.178 169.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.89 -24.07 67.42 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.952 0.796 . . . . 0.0 112.033 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.51 4.81 30.14 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.65 1.58 . . . . 0.0 114.339 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.56 78.43 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.529 1.061 . . . . 0.0 115.364 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.01 -160.93 0.78 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.899 1.68 . . . . 0.0 113.092 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -137.28 68.84 1.41 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.63 -146.09 32.28 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.903 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 48.2 mt-10 -129.48 19.06 5.77 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.235 2.214 . . . . 0.0 112.092 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.1 ttt -79.71 52.73 1.49 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.928 1.291 . . . . 0.0 112.38 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -166.35 175.87 7.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.41 1.884 . . . . 0.0 114.179 -169.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -78.13 170.19 17.02 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.782 2.433 . . . . 0.0 114.379 -169.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.4 t -52.77 -42.84 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 126.866 2.066 . . . . 0.0 111.773 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -65.98 -30.11 70.61 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.33 -47.87 13.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.022 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -55.21 -45.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 120.193 1.36 . . . . 0.0 112.697 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.7 ptm -70.75 -25.65 63.01 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.49 -59.8 3.61 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -55.73 -39.97 71.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.038 0.935 . . . . 0.0 112.849 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.84 -43.03 90.65 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.299 -0.876 . . . . 0.0 112.898 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.12 -46.86 84.32 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.259 0.936 . . . . 0.0 112.595 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 14.2 pt20 -71.8 -31.62 66.76 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.741 -0.858 . . . . 0.0 113.312 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -59.09 -51.7 68.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.622 1.556 . . . . 0.0 111.253 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.55 -43.34 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.22 1.008 . . . . 0.0 110.081 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.6 tpp -67.48 -32.52 73.42 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.9 t -75.45 -51.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.728 1.211 . . . . 0.0 111.446 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -66.75 -16.02 63.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.895 0.878 . . . . 0.0 112.88 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.296 6.2 pt20 44.25 43.7 6.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 128.36 2.664 . . . . 0.0 113.635 175.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -102.08 21.96 13.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.713 1.605 . . . . 0.0 112.848 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -87.54 169.74 11.92 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.414 1.886 . . . . 0.0 111.895 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.38 144.24 44.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.255 -0.903 . . . . 0.0 112.678 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.495 ' NE2' ' H ' ' A' ' 68' ' ' GLN . 0.6 OUTLIER -64.14 -39.89 94.99 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.543 1.937 . . . . 0.0 112.417 -177.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -92.38 -21.84 20.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.3 1.44 . . . . 0.0 112.362 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -138.99 88.27 2.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.393 1.092 . . . . 0.0 112.93 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -56.17 -17.84 8.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.418 1.087 . . . . 0.0 112.918 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -25.43 68.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.452 1.101 . . . . 0.0 112.978 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -103.11 134.32 46.74 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.884 1.674 . . . . 0.0 111.241 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -126.42 132.48 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.442 1.497 . . . . 0.0 110.778 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -112.9 162.47 15.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.915 1.686 . . . . 0.0 111.35 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.6 m -146.19 28.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.309 1.443 . . . . 0.0 111.864 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.99 106.43 0.23 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.464 1.031 . . . . 0.0 114.642 -169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.86 14.76 65.96 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.994 1.283 . . . . 0.0 115.493 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.35 153.95 20.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.2 1.5 . . . . 0.0 112.365 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -57.55 -27.93 63.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.564 0.746 . . . . 0.0 111.994 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.58 -41.32 88.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.1 0.864 . . . . 0.0 112.213 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.42 -37.79 94.93 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.724 -0.61 . . . . 0.0 111.825 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -66.53 -38.4 87.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.024 0.929 . . . . 0.0 112.274 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 tp -65.6 -46.06 80.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.054 1.342 . . . . 0.0 112.102 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -76.48 -26.81 55.74 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.29 2.01 71.84 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.009 0.814 . . . . 0.0 112.862 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -142.01 136.02 29.86 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 129.807 3.243 . . . . 0.0 108.058 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.284 9.0 pt20 -112.16 17.67 19.33 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.8 p -153.4 145.33 23.6 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.089 -1.007 . . . . 0.0 113.07 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -161.0 170.47 20.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.836 1.655 . . . . 0.0 111.208 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.0 p -137.32 170.88 15.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.671 0.788 . . . . 0.0 111.753 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -7.58 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -95.11 -27.13 15.73 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.133 1.373 . . . . 0.0 112.73 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -131.4 78.67 71.38 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.648 1.579 . . . . 0.0 111.199 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.15 5.44 6.24 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.273 3.315 . . . . 0.0 113.799 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -44.53 -38.0 4.98 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -173.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -59.07 -28.83 88.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.966 2.444 . . . . 0.0 115.932 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 tp -58.87 -53.3 59.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 123.158 1.456 . . . . 0.0 109.929 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.56 -29.17 62.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.296 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -64.38 -31.34 72.51 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.441 1.019 . . . . 0.0 112.529 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.5 ttp -72.2 -42.72 65.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.053 0.941 . . . . 0.0 110.335 169.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.14 -32.25 44.34 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -59.24 -28.1 66.39 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.772 1.629 . . . . 0.0 114.026 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.4 -26.57 58.52 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.629 1.971 . . . . 0.0 112.837 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 124.58 1.152 . . . . 0.0 113.839 -174.698 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -127.61 -175.54 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 129.216 3.007 . . . . 0.0 112.032 -167.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -92.5 172.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.862 1.265 . . . . 0.0 109.9 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.3 ttp85 -164.77 142.66 5.32 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 130.108 3.363 . . . . 0.0 107.722 168.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -105.67 170.86 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.198 2.599 . . . . 0.0 114.111 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -83.44 158.76 21.95 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.727 1.211 . . . . 0.0 108.149 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.44 -50.43 22.85 Favored Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.43 -25.53 35.5 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.168 1.912 . . . . 0.0 114.274 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -81.19 -37.79 28.12 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.518 0.727 . . . . 0.0 111.436 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.67 -42.57 98.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.091 1.356 . . . . 0.0 111.719 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 40.2 pttt -68.49 -22.95 64.52 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -62.12 -52.79 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 109.347 169.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.69 -30.58 67.2 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -32.16 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.818 -1.176 . . . . 0.0 113.271 170.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.27 -22.64 63.34 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.136 0.88 . . . . 0.0 112.955 170.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.5 23.65 13.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.089 1.756 . . . . 0.0 113.462 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.73 15.6 79.4 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.43 -163.55 0.58 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.384 1.092 . . . . 0.0 113.173 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -132.32 49.2 2.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.019 2.128 . . . . 0.0 109.842 168.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.99 -115.73 4.77 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.737 1.16 . . . . 0.0 112.721 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.86 17.39 3.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.142 1.777 . . . . 0.0 111.241 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.5 ttt -74.52 50.73 0.43 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.314 1.846 . . . . 0.0 113.482 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -173.5 170.92 4.04 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.66 1.984 . . . . 0.0 112.666 -169.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.25 165.74 11.05 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.277 2.231 . . . . 0.0 113.594 -172.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -51.55 -44.68 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 126.581 1.952 . . . . 0.0 112.043 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -65.15 -30.18 71.08 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -80.38 -45.39 17.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.124 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -57.35 -45.04 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 120.075 1.307 . . . . 0.0 112.506 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.9 ptm -70.05 -24.16 63.21 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -66.78 -57.72 6.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.127 1.371 . . . . 0.0 110.983 170.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -56.48 -36.84 69.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.026 0.93 . . . . 0.0 113.145 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tt -71.79 -40.36 69.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.483 -0.761 . . . . 0.0 111.742 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.51 -47.43 89.97 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.9 -1.125 . . . . 0.0 112.807 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -69.59 -31.54 69.75 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.212 -1.17 . . . . 0.0 112.641 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.11 -50.61 72.27 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.957 1.253 . . . . 0.0 110.942 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mt -57.89 -43.74 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.706 0.684 . . . . 0.0 110.242 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.16 -32.97 74.72 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.53 -50.9 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.412 1.085 . . . . 0.0 111.518 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -15.87 63.66 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.376 1.07 . . . . 0.0 113.181 176.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.2 pt20 45.44 43.43 8.68 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.331 2.652 . . . . 0.0 113.62 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.03 8.39 43.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.668 1.587 . . . . 0.0 112.936 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -74.39 162.96 28.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.693 1.197 . . . . 0.0 112.268 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.48 147.77 41.61 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -47.1 78.56 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -76.77 -19.92 57.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.41 94.92 2.28 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.462 1.125 . . . . 0.0 113.311 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.84 -17.96 28.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.299 1.44 . . . . 0.0 112.876 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -25.17 65.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.943 0.897 . . . . 0.0 113.104 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.8 tpp -93.95 129.18 40.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 109.742 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.12 113.03 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.812 1.645 . . . . 0.0 109.806 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -86.91 165.12 16.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.783 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.74 25.28 1.18 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.584 1.553 . . . . 0.0 112.596 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.54 114.82 6.64 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.561 -0.712 . . . . 0.0 112.948 -169.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.74 10.93 72.72 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.144 1.354 . . . . 0.0 115.853 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.38 150.01 21.06 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.404 2.102 . . . . 0.0 111.437 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.01 -27.66 63.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.535 -0.728 . . . . 0.0 112.735 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.45 -39.74 94.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.383 0.992 . . . . 0.0 112.068 171.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.61 95.78 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.501 0.572 . . . . 0.0 112.146 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.98 -43.13 95.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.122 0.961 . . . . 0.0 111.995 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -70.65 -46.16 63.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.242 1.017 . . . . 0.0 111.892 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -71.82 -27.76 63.13 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.072 0.949 . . . . 0.0 112.563 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.03 7.24 83.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.345 1.45 . . . . 0.0 114.499 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.54 147.94 30.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.072 1.749 . . . . 0.0 111.721 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -101.98 9.87 40.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 113.448 -173.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -153.25 144.08 22.79 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.82 170.82 20.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.955 2.102 . . . . 0.0 110.67 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -136.58 154.4 50.7 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.701 0.8 . . . . 0.0 112.023 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.29 -14.89 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.87 -7.12 57.63 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.424 1.49 . . . . 0.0 113.731 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -145.24 64.27 10.69 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.707 1.603 . . . . 0.0 111.48 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.73 2.77 7.89 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.206 3.271 . . . . 0.0 114.714 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.9 m -48.5 -33.1 4.48 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -54.5 -31.0 67.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.115 2.543 . . . . 0.0 115.812 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.5 -48.76 46.93 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.621 1.169 . . . . 0.0 110.379 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -67.02 -29.24 69.0 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.011 -1.056 . . . . 0.0 112.177 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.95 -31.56 72.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.708 1.203 . . . . 0.0 112.526 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -32.5 70.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.866 1.267 . . . . 0.0 112.236 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.5 -31.62 16.69 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -62.73 -27.86 69.56 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.855 1.262 . . . . 0.0 113.935 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -62.44 -29.04 70.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.948 0.899 . . . . 0.0 112.109 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 . . . . . 0 CA--C 1.547 0.852 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.51 169.588 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 122.337 1.065 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.55 -173.06 3.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 130.389 3.476 . . . . 0.0 108.457 -169.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.08 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.983 -1.073 . . . . 0.0 111.55 -172.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -158.19 139.18 9.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 131.329 3.852 . . . . 0.0 106.729 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -96.72 167.01 1.04 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.242 2.628 . . . . 0.0 113.681 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -79.93 161.48 25.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.399 1.08 . . . . 0.0 108.597 167.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.92 -42.03 66.92 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -68.61 -29.32 30.26 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.264 1.976 . . . . 0.0 114.246 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.89 -31.2 25.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.955 0.902 . . . . 0.0 112.108 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.25 -43.23 87.76 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.943 0.897 . . . . 0.0 111.056 173.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.309 16.9 pttp -72.76 -24.84 61.0 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.67 -52.08 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 109.475 170.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.54 -30.72 70.44 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.483 -0.761 . . . . 0.0 112.463 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -29.9 69.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.678 -1.264 . . . . 0.0 113.378 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.33 59.78 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.4 21.81 16.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.157 1.783 . . . . 0.0 113.684 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.25 17.03 78.63 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.24 -156.23 0.16 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.859 1.264 . . . . 0.0 112.731 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -141.24 60.15 1.51 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.569 1.948 . . . . 0.0 109.624 168.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.29 18.02 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.584 -172.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -135.64 20.4 3.33 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.699 2.0 . . . . 0.0 110.923 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -76.07 54.74 0.88 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.876 1.67 . . . . 0.0 112.955 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -173.29 172.21 3.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.286 1.834 . . . . 0.0 112.384 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 167.07 13.76 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.814 2.045 . . . . 0.0 114.084 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -49.45 -45.88 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.455 1.902 . . . . 0.0 112.169 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -65.09 -30.07 70.99 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.79 -46.72 16.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.137 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -55.71 -46.72 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 120.477 1.489 . . . . 0.0 112.337 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 23.1 ptm -69.51 -27.44 65.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -62.47 -58.07 8.93 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.558 1.143 . . . . 0.0 110.758 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -58.31 -32.56 68.58 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.13 -41.27 81.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.559 1.072 . . . . 0.0 112.82 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.44 -47.42 88.2 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.963 0.801 . . . . 0.0 112.093 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.252 11.5 pt20 -70.72 -31.7 68.63 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.554 -0.968 . . . . 0.0 113.08 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.45 -51.93 66.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.454 1.479 . . . . 0.0 111.014 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.5 mt -60.59 -41.61 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.068 0.947 . . . . 0.0 110.272 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 37.7 tpp -67.78 -31.97 72.23 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.08 -50.4 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.357 1.063 . . . . 0.0 111.347 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -16.03 63.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.968 0.907 . . . . 0.0 113.125 175.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.4 pt20 43.49 43.07 4.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.455 2.702 . . . . 0.0 113.647 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 tp -99.51 20.21 14.28 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.523 1.529 . . . . 0.0 112.689 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -83.88 165.71 18.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 111.883 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.46 148.52 45.04 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.169 0.985 . . . . 0.0 113.026 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.536 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.7 -38.41 76.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.833 1.653 . . . . 0.0 111.43 -176.343 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -90.94 -20.39 22.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.585 1.554 . . . . 0.0 112.295 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -144.04 93.18 2.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.415 1.103 . . . . 0.0 112.414 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -57.69 -18.51 21.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.152 1.381 . . . . 0.0 112.821 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.78 63.64 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.24 1.016 . . . . 0.0 113.133 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -97.86 129.81 44.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.063 1.745 . . . . 0.0 110.302 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.03 131.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.114 1.366 . . . . 0.0 110.65 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -105.62 165.71 10.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.297 1.439 . . . . 0.0 111.6 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.02 24.24 1.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.151 1.781 . . . . 0.0 112.771 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.38 113.68 5.71 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.603 -0.685 . . . . 0.0 112.647 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.98 13.03 66.07 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.12 1.343 . . . . 0.0 115.676 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -95.25 148.42 22.43 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.39 2.095 . . . . 0.0 111.382 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.88 -27.8 63.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.47 0.708 . . . . 0.0 111.943 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.11 -39.95 90.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.4 -0.812 . . . . 0.0 112.465 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.93 92.59 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 118.543 0.61 . . . . 0.0 112.223 172.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -65.11 -36.68 85.07 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 117.893 0.846 . . . . 0.0 112.19 171.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.27 -50.51 53.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.606 1.162 . . . . 0.0 111.2 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.67 -24.02 58.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.123 0.969 . . . . 0.0 113.082 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.47 7.78 85.87 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.161 1.362 . . . . 0.0 114.634 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 150.19 33.84 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.886 1.674 . . . . 0.0 111.854 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -99.1 11.49 38.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.118 0.967 . . . . 0.0 113.434 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -155.32 149.73 26.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.86 177.84 10.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.65 1.98 . . . . 0.0 111.129 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 t -140.2 154.55 46.96 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.011 -1.056 . . . . 0.0 111.892 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.2 m -66.22 -12.92 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 169.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -83.18 -17.2 43.69 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.65 1.18 . . . . 0.0 113.026 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -140.38 69.87 32.92 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 111.478 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.75 3.95 4.5 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.21 3.273 . . . . 0.0 114.564 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -45.4 -35.45 3.22 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 126.364 1.866 . . . . 0.0 115.736 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -56.69 -30.09 82.56 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.95 2.433 . . . . 0.0 115.73 173.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.74 -45.56 61.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.177 0.899 . . . . 0.0 110.142 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.45 -30.25 69.92 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.621 -0.674 . . . . 0.0 112.275 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -66.72 -31.31 71.88 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.858 1.263 . . . . 0.0 112.872 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -33.33 67.44 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.292 1.437 . . . . 0.0 112.207 170.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.98 -27.02 18.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.959 1.704 . . . . 0.0 114.545 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -61.46 -23.37 65.82 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.4 1.48 . . . . 0.0 113.963 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -65.69 -27.31 68.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.546 1.938 . . . . 0.0 112.344 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 CA--C 1.548 0.882 0 C-N-CA 124.147 0.979 . . . . 0.0 113.331 172.428 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -129.64 -177.66 4.36 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 128.42 2.688 . . . . 0.0 113.114 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.68 172.23 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.851 1.661 . . . . 0.0 111.677 -176.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -163.35 143.42 6.91 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 130.173 3.389 . . . . 0.0 108.22 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -102.65 169.37 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.783 2.989 . . . . 0.0 113.843 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -87.4 164.45 16.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 109.792 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.5 tp -42.82 -56.32 6.22 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.926 1.69 . . . . 0.0 115.377 -172.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.89 -26.8 37.67 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.215 1.943 . . . . 0.0 113.821 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.7 mt -80.83 -34.59 33.78 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.363 -0.836 . . . . 0.0 112.243 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.39 -32.16 73.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.795 1.238 . . . . 0.0 110.988 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -58.57 -41.69 86.28 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.42 1.488 . . . . 0.0 112.861 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.86 -51.31 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.187 1.395 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.32 13.6 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -61.43 -33.96 74.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.613 -1.304 . . . . 0.0 112.399 169.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.05 62.35 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.247 0.93 . . . . 0.0 113.317 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 23.52 13.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.008 1.723 . . . . 0.0 113.434 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.26 79.62 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.676 1.131 . . . . 0.0 115.687 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.0 -169.58 2.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.466 1.106 . . . . 0.0 113.247 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -123.39 44.74 2.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.678 1.991 . . . . 0.0 110.841 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.74 -115.33 4.12 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.983 1.278 . . . . 0.0 112.646 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -139.51 15.77 2.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.741 2.016 . . . . 0.0 110.769 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 56.6 ttp -77.0 52.39 0.87 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.609 1.564 . . . . 0.0 112.772 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -171.61 171.48 5.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.521 1.929 . . . . 0.0 112.693 -168.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -65.63 165.63 12.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.501 1.92 . . . . 0.0 112.214 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.86 -37.92 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.16 0.984 . . . . 0.0 112.185 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.33 -30.04 69.26 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -80.52 -43.48 20.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.512 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 m -54.96 -50.01 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 120.551 1.523 . . . . 0.0 113.016 175.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -68.49 -23.98 64.63 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.043 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.18 -59.17 3.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.989 1.316 . . . . 0.0 111.033 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -56.19 -36.83 68.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.133 0.973 . . . . 0.0 113.119 174.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.86 -42.53 73.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.939 0.895 . . . . 0.0 112.707 174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.49 -47.36 76.92 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.398 -0.814 . . . . 0.0 111.813 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.93 -31.55 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.543 -0.974 . . . . 0.0 113.555 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -55.34 -50.41 69.72 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.727 1.603 . . . . 0.0 111.06 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.8 mt -63.45 -42.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.151 0.98 . . . . 0.0 110.531 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -45.36 92.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.634 1.174 . . . . 0.0 111.467 177.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.62 -48.39 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.079 0.952 . . . . 0.0 111.72 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -67.1 -16.11 64.13 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.284 6.3 pt20 41.93 42.88 2.44 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.868 2.467 . . . . 0.0 113.462 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -98.32 16.28 22.0 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.511 1.524 . . . . 0.0 113.309 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -81.71 160.4 23.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.985 1.314 . . . . 0.0 111.178 169.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -74.45 133.46 42.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.038 -1.039 . . . . 0.0 112.048 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.46 -33.66 60.04 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.876 1.67 . . . . 0.0 113.579 171.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -83.82 -27.38 28.8 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.012 1.325 . . . . 0.0 112.422 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.33 95.63 1.95 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.546 1.138 . . . . 0.0 111.655 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -60.51 -14.92 22.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.737 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.38 69.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.629 0.772 . . . . 0.0 112.743 173.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.5 tpp -91.84 130.6 37.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.021 1.729 . . . . 0.0 110.356 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.06 118.09 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.041 1.737 . . . . 0.0 109.764 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.41 162.06 14.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.538 1.135 . . . . 0.0 111.736 171.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -153.88 27.12 0.48 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.065 2.146 . . . . 0.0 112.21 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 118.6 13.08 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.33 -0.856 . . . . 0.0 113.349 -169.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.52 8.61 67.25 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.005 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -98.53 156.1 16.95 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 120.573 2.187 . . . . 0.0 112.272 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.56 -27.62 66.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.713 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 tp -66.84 -44.29 81.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.224 -0.922 . . . . 0.0 112.9 173.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.02 86.12 Favored Glycine 0 N--CA 1.477 1.424 0 CA-C-O 118.151 -1.361 . . . . 0.0 112.411 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.48 -40.03 92.63 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.014 1.907 . . . . 0.0 112.334 170.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -70.32 -51.73 28.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.082 0.953 . . . . 0.0 111.144 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.9 -20.14 61.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 112.198 176.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.73 13.04 82.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.749 1.642 . . . . 0.0 114.686 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -129.31 -25.17 2.73 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 121.63 3.937 . . . . 0.0 121.63 -169.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 55.05 2.85 0.05 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.3 p -157.22 138.3 13.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.837 1.255 . . . . 0.0 112.68 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.89 176.11 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.121 1.768 . . . . 0.0 110.681 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 t -140.5 156.93 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.135 -0.978 . . . . 0.0 111.363 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.08 -18.03 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.668 -0.645 . . . . 0.0 112.446 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.15 -1.89 50.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 113.897 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -137.81 60.58 25.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.889 1.676 . . . . 0.0 111.803 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -79.15 -0.11 10.48 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.946 3.097 . . . . 0.0 113.908 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.2 m -46.82 -32.45 2.11 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.72 -24.57 68.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.157 1.904 . . . . 0.0 114.132 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.82 -47.4 53.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.853 0.861 . . . . 0.0 110.11 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -68.22 -30.52 69.61 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.518 -0.739 . . . . 0.0 112.462 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.54 -31.52 72.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.471 1.032 . . . . 0.0 112.917 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -34.2 73.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.39 1.476 . . . . 0.0 112.099 171.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.65 -33.8 15.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 114.443 -175.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -58.25 -28.36 64.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.206 1.403 . . . . 0.0 113.689 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.15 -27.14 68.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.847 2.059 . . . . 0.0 112.556 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 . . . . . 0 CA--C 1.548 0.894 0 C-N-CA 124.72 1.208 . . . . 0.0 113.177 173.234 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.408 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.9 m120 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.408 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -131.37 -177.65 4.49 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.432 2.293 . . . . 0.0 112.558 -167.475 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 m -94.55 172.13 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.528 1.131 . . . . 0.0 110.289 -175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -162.21 144.14 8.39 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 128.089 2.555 . . . . 0.0 109.001 -172.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 8.5 Cg_endo -98.52 176.27 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.143 2.562 . . . . 0.0 114.705 -169.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -105.83 157.37 17.51 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.674 1.99 . . . . 0.0 107.507 167.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.8 mt -47.37 -46.01 56.93 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.87 -21.74 20.86 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.922 1.748 . . . . 0.0 114.015 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.24 -34.15 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.934 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.5 -41.62 81.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 111.629 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.269 18.3 pttp -72.52 -21.84 61.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.6 mt -69.69 -45.8 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.648 1.179 . . . . 0.0 110.083 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.67 -37.21 86.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.466 -0.771 . . . . 0.0 111.233 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.829 -1.169 . . . . 0.0 113.436 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.43 -22.26 61.22 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 112.99 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.13 22.12 14.59 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.074 1.75 . . . . 0.0 113.543 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 17.55 78.66 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.75 -156.07 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.89 1.276 . . . . 0.0 112.996 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -148.41 67.28 1.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.312 1.845 . . . . 0.0 110.489 169.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.13 -146.62 36.6 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.749 -172.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 45.4 mt-10 -122.19 15.39 10.62 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.868 2.067 . . . . 0.0 111.958 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.6 ttt -79.45 59.15 2.84 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.874 1.27 . . . . 0.0 113.705 -168.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -170.41 177.75 3.96 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.296 1.838 . . . . 0.0 113.719 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.35 165.64 13.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.521 2.328 . . . . 0.0 114.387 -172.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.4 t -52.12 -47.01 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 125.958 1.703 . . . . 0.0 111.843 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -62.52 -30.08 71.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -78.83 -47.93 15.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.067 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -55.88 -45.42 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 120.463 1.483 . . . . 0.0 112.376 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.5 ptm -70.26 -26.28 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -64.61 -59.43 4.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.162 1.385 . . . . 0.0 110.868 171.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -56.41 -36.25 68.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.784 0.834 . . . . 0.0 113.189 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.99 -44.64 88.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.054 0.941 . . . . 0.0 112.343 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.831 0.741 . . . . 0.0 112.249 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.28 11.2 pt20 -70.67 -31.54 68.48 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.392 -1.063 . . . . 0.0 113.087 176.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -55.97 -54.48 44.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.247 1.385 . . . . 0.0 110.496 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.34 -42.25 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.809 0.843 . . . . 0.0 110.146 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -34.93 79.49 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.9 t -78.24 -50.28 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 111.174 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.3 64.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.963 0.905 . . . . 0.0 112.665 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.333 5.8 pt20 46.44 39.44 6.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.667 2.787 . . . . 0.0 114.523 176.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -91.6 51.44 1.87 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.249 1.42 . . . . 0.0 111.42 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -124.97 162.51 24.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.787 2.035 . . . . 0.0 111.376 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.25 138.5 47.52 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.349 -0.844 . . . . 0.0 111.837 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -48.51 79.0 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.06 -1.025 . . . . 0.0 112.864 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -80.93 -6.39 58.64 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.128 0.876 . . . . 0.0 113.031 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.7 86.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.573 1.177 . . . . 0.0 111.365 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.07 -15.42 32.46 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.145 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -22.2 65.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.84 1.256 . . . . 0.0 113.146 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 43.2 tpp -107.24 134.6 50.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.073 2.149 . . . . 0.0 111.143 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.02 133.24 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.996 1.718 . . . . 0.0 110.275 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.41 84.88 2.11 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.301 2.241 . . . . 0.0 110.603 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -80.39 38.59 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.187 2.595 . . . . 0.0 113.451 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 113.03 2.49 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.305 -0.872 . . . . 0.0 114.609 -168.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.59 11.61 77.15 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.057 1.313 . . . . 0.0 116.187 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.93 156.8 20.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.944 1.872 . . . . 0.0 112.366 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.56 -28.06 59.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 112.755 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.23 -37.62 81.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.17 -0.956 . . . . 0.0 112.21 171.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.66 -39.93 98.06 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.415 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -64.83 -38.48 91.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.841 1.321 . . . . 0.0 112.07 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -69.56 -46.48 66.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.258 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.08 -18.64 45.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.816 1.246 . . . . 0.0 113.297 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.01 73.93 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.84 1.686 . . . . 0.0 114.937 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.39 -36.89 0.71 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -169.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 5.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.5 p -145.78 135.53 23.4 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.468 1.485 . . . . 0.0 114.586 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -169.94 168.28 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.717 2.407 . . . . 0.0 109.521 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 p -132.86 171.48 13.86 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.424 -0.797 . . . . 0.0 111.282 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.81 -9.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.261 -0.899 . . . . 0.0 113.378 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -95.05 -25.58 16.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.238 1.415 . . . . 0.0 112.984 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -130.63 70.92 82.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 125.973 1.709 . . . . 0.0 111.907 174.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -88.09 16.31 1.92 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 125.02 3.813 . . . . 0.0 114.853 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.1 p -50.85 -31.01 4.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.3 -31.72 52.37 Favored 'Trans proline' 0 C--N 1.357 0.987 0 CA-C-N 123.959 2.449 . . . . 0.0 114.108 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.4 -49.21 72.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.174 1.39 . . . . 0.0 110.531 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.05 -29.19 57.95 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.366 -0.834 . . . . 0.0 112.452 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.06 -32.96 72.81 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.295 -0.878 . . . . 0.0 113.241 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.3 ttp -68.52 -41.36 80.04 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.267 1.427 . . . . 0.0 110.617 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.04 -48.68 56.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.315 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -58.13 -31.92 67.66 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.92 -26.42 64.14 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.738 2.015 . . . . 0.0 112.917 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 110.55 174.011 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 CA--C 1.544 0.737 0 CA-C-O 122.544 1.164 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.18 -176.62 4.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.055 2.942 . . . . 0.0 109.159 -168.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.46 171.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 120.987 -1.071 . . . . 0.0 111.818 -169.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -162.67 140.48 6.38 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 129.527 3.131 . . . . 0.0 107.279 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 1.1 Cg_endo -103.57 179.37 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.048 2.499 . . . . 0.0 115.28 -169.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -108.73 158.47 17.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.784 2.433 . . . . 0.0 107.213 167.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -45.24 -47.05 33.51 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 -23.13 30.89 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.058 1.839 . . . . 0.0 114.694 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.19 -35.47 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.376 0.67 . . . . 0.0 111.865 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.47 -41.88 81.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.329 1.052 . . . . 0.0 111.601 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -71.38 -20.44 62.14 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.55 -51.68 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 109.285 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.97 -34.2 76.09 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.605 -0.685 . . . . 0.0 111.753 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -30.7 68.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.892 -1.13 . . . . 0.0 113.188 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.98 60.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.519 0.727 . . . . 0.0 112.869 169.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.77 22.35 15.3 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.195 1.798 . . . . 0.0 113.533 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.64 16.98 78.99 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.644 1.018 . . . . 0.0 115.644 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.73 -156.7 0.16 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.97 1.308 . . . . 0.0 112.729 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.27 59.94 1.55 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.559 1.544 . . . . 0.0 110.364 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.64 -141.7 27.88 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.848 -172.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.445 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.3 mt-10 -121.72 21.33 10.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.799 2.04 . . . . 0.0 112.138 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.5 ptm -74.72 41.17 0.15 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -169.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -166.62 174.48 8.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.707 1.603 . . . . 0.0 113.979 -168.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.66 167.66 16.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.32 2.248 . . . . 0.0 114.236 -169.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -49.15 -43.43 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 126.317 1.847 . . . . 0.0 112.75 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -31.28 70.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -77.76 -46.43 21.74 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.098 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.45 -46.24 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 120.319 1.418 . . . . 0.0 112.586 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.2 ptm -69.46 -28.21 65.9 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.52 -59.04 6.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.618 1.167 . . . . 0.0 110.851 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -55.81 -36.77 67.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 113.386 173.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.17 -36.98 80.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.839 1.199 . . . . 0.0 113.129 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.74 -47.42 90.41 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.927 1.24 . . . . 0.0 112.232 173.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.272 13.4 pt20 -70.22 -31.5 68.95 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.451 -1.029 . . . . 0.0 113.081 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -55.89 -54.5 43.95 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.207 1.367 . . . . 0.0 110.07 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.3 mt -59.03 -39.98 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.931 0.892 . . . . 0.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.8 tpp -69.11 -32.35 71.7 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.23 -51.35 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.028 -1.045 . . . . 0.0 111.344 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -68.08 -12.96 61.79 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.307 1.443 . . . . 0.0 113.064 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.31 5.8 pt20 48.76 50.18 17.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.37 3.068 . . . . 0.0 114.023 169.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.6 mt -88.4 3.91 48.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.531 1.133 . . . . 0.0 113.741 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -89.11 162.2 16.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.455 1.102 . . . . 0.0 113.015 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -78.9 152.3 31.25 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.79 -47.34 63.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -77.7 -17.33 57.76 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -149.61 87.07 1.48 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.059 0.933 . . . . 0.0 111.787 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -55.94 -22.81 28.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.763 1.625 . . . . 0.0 112.44 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.09 -34.35 56.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.301 1.84 . . . . 0.0 112.987 170.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tpt -99.51 135.33 41.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.002 1.721 . . . . 0.0 111.158 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -132.08 136.73 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.025 1.73 . . . . 0.0 110.487 -170.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -105.94 175.0 5.64 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.187 1.795 . . . . 0.0 112.194 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.88 20.24 0.32 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.714 1.606 . . . . 0.0 113.733 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.3 115.75 5.01 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.845 0.736 . . . . 0.0 114.115 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.34 6.97 71.38 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.305 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -96.6 158.81 15.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 121.089 2.445 . . . . 0.0 112.506 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -27.69 68.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.996 0.918 . . . . 0.0 112.13 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.38 -41.57 96.62 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.38 -0.825 . . . . 0.0 111.994 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.22 96.94 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 119.339 0.972 . . . . 0.0 112.654 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -43.89 95.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.479 1.14 . . . . 0.0 111.722 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.73 -46.38 66.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.326 1.05 . . . . 0.0 112.245 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.28 -25.71 63.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.804 1.241 . . . . 0.0 113.035 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 4.67 75.5 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.394 0.997 . . . . 0.0 113.796 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -138.39 141.25 39.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 112.393 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -102.99 7.76 39.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.719 1.208 . . . . 0.0 113.27 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.0 p -155.92 143.42 19.41 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.498 1.119 . . . . 0.0 112.462 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.73 178.7 8.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.117 2.167 . . . . 0.0 110.262 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.7 p -142.98 170.38 15.81 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.649 -1.282 . . . . 0.0 112.969 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.51 -19.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.898 0.879 . . . . 0.0 112.943 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.08 -10.74 29.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.037 1.335 . . . . 0.0 113.803 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -132.61 62.73 64.41 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.832 1.653 . . . . 0.0 112.639 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.08 0.17 9.63 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.106 3.204 . . . . 0.0 114.09 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.6 m -42.77 -39.32 3.55 Favored Pre-proline 0 N--CA 1.472 0.663 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.42 -24.19 71.14 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 123.242 2.194 . . . . 0.0 114.89 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.44 -47.47 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.233 1.378 . . . . 0.0 109.802 170.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.11 -33.0 74.77 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.686 -0.633 . . . . 0.0 111.941 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.34 -31.47 69.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.457 1.026 . . . . 0.0 113.401 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.38 77.63 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.986 1.314 . . . . 0.0 111.234 169.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.6 mt -91.16 -34.92 14.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.357 1.463 . . . . 0.0 114.483 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -28.08 62.92 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.562 1.545 . . . . 0.0 113.692 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.69 -28.14 69.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.743 2.017 . . . . 0.0 112.847 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.382 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -128.31 -176.44 3.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.846 2.858 . . . . 0.0 113.085 -167.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.2 172.4 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.269 1.427 . . . . 0.0 109.163 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -164.25 139.93 4.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 130.459 3.503 . . . . 0.0 108.145 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -102.15 164.04 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.123 3.215 . . . . 0.0 113.744 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -82.13 158.78 23.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.585 1.154 . . . . 0.0 108.89 168.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.8 tp -41.79 -49.92 10.26 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.35 -21.55 35.26 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.092 1.862 . . . . 0.0 114.629 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.66 -32.59 16.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.196 0.999 . . . . 0.0 112.422 173.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.8 tt -61.73 -39.02 90.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.28 1.832 . . . . 0.0 112.032 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -72.42 -22.51 61.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -59.14 -52.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.929 1.292 . . . . 0.0 108.978 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.272 0.2 OUTLIER -70.72 -30.49 67.05 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.178 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -60.91 -32.76 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.569 1.532 . . . . 0.0 112.642 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.64 56.43 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.549 1.068 . . . . 0.0 113.434 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.52 19.16 21.04 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.218 1.807 . . . . 0.0 113.807 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 14.27 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.543 1.068 . . . . 0.0 115.495 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.98 -163.51 0.93 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.019 1.328 . . . . 0.0 112.547 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.84 58.1 1.78 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.002 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 -118.79 5.86 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.089 1.328 . . . . 0.0 112.956 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -143.72 17.64 1.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.513 1.925 . . . . 0.0 110.987 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.6 ttp -76.3 49.13 0.56 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.113 1.765 . . . . 0.0 113.128 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -170.02 173.87 5.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.272 1.829 . . . . 0.0 113.42 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 166.11 10.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.103 2.561 . . . . 0.0 113.983 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.1 t -50.95 -46.95 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.414 1.886 . . . . 0.0 112.078 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.57 -30.08 71.1 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -79.0 -46.3 18.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.6 -0.714 . . . . 0.0 110.885 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.69 -45.45 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.257 1.389 . . . . 0.0 112.883 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.4 ptm -68.89 -27.91 66.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -64.37 -59.8 3.93 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 110.987 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -56.79 -35.06 68.27 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.917 0.887 . . . . 0.0 113.216 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.13 -39.43 72.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.086 0.857 . . . . 0.0 112.987 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -47.35 89.04 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 119.316 0.962 . . . . 0.0 111.799 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 12.7 pt20 -69.85 -31.5 69.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.114 -0.945 . . . . 0.0 113.031 174.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.18 -54.08 49.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.822 1.646 . . . . 0.0 110.837 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.13 -44.37 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.595 0.758 . . . . 0.0 110.246 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -33.99 77.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.18 -51.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.339 1.455 . . . . 0.0 111.746 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -66.42 -15.99 63.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.447 0.699 . . . . 0.0 112.423 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.6 pt20 46.97 43.27 13.52 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 128.085 2.554 . . . . 0.0 113.287 172.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.18 18.04 15.86 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.893 1.677 . . . . 0.0 112.847 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -85.91 166.36 16.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.253 1.421 . . . . 0.0 112.799 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.26 135.72 49.23 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.446 -0.784 . . . . 0.0 112.301 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -36.52 44.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.167 1.387 . . . . 0.0 113.365 172.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -91.73 -20.37 21.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.915 1.286 . . . . 0.0 113.021 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -153.55 102.63 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.336 1.054 . . . . 0.0 111.976 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -59.81 -17.42 35.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.924 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -21.55 62.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.67 0.788 . . . . 0.0 113.026 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.6 tpt -96.79 125.57 41.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 109.787 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.7 120.99 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.987 1.315 . . . . 0.0 110.345 -169.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -88.59 165.87 14.52 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.35 1.06 . . . . 0.0 111.422 172.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -151.62 23.85 0.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.478 1.511 . . . . 0.0 113.058 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.2 108.58 2.11 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.311 -0.868 . . . . 0.0 112.732 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 14.13 72.59 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.452 1.025 . . . . 0.0 115.127 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.16 147.64 22.92 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.751 1.775 . . . . 0.0 110.571 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.1 mt -58.51 -27.52 64.57 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.363 -0.836 . . . . 0.0 112.06 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.82 -37.23 85.68 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.303 -0.873 . . . . 0.0 112.525 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.13 -39.03 94.46 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.558 0.617 . . . . 0.0 112.346 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 117.975 0.887 . . . . 0.0 111.607 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.83 -45.77 67.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.519 1.128 . . . . 0.0 113.062 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.25 -19.72 39.05 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 113.494 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.04 8.61 87.22 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.422 1.011 . . . . 0.0 114.754 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.4 154.73 41.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.348 1.459 . . . . 0.0 112.849 172.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.2 11.9 32.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.8 p -157.17 144.59 18.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -155.74 175.82 13.42 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.787 2.035 . . . . 0.0 109.565 172.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 p -149.16 175.29 11.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.347 -1.471 . . . . 0.0 113.226 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.08 -19.95 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.592 0.757 . . . . 0.0 112.098 170.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -90.36 -21.0 22.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.272 1.429 . . . . 0.0 113.495 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -122.33 61.07 14.12 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 126.405 1.882 . . . . 0.0 112.149 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.49 -4.54 10.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.575 2.85 . . . . 0.0 113.84 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -46.53 -35.5 4.96 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.3 -31.79 95.68 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.33 2.02 . . . . 0.0 114.665 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 tt -66.76 -54.87 18.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.202 1.401 . . . . 0.0 109.904 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -61.84 -36.61 81.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.482 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.83 -45.12 91.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.957 0.799 . . . . 0.0 112.411 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ttp -56.15 -39.18 71.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.623 1.569 . . . . 0.0 111.288 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . 0.286 4.5 pp -85.79 -40.79 15.66 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -64.11 -30.57 71.63 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 120.484 1.493 . . . . 0.0 113.485 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -68.32 -22.61 64.69 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.578 0.751 . . . . 0.0 112.525 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 173.027 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -178.7 4.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.639 2.776 . . . . 0.0 111.351 -168.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.74 172.66 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.536 1.534 . . . . 0.0 110.077 -170.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -162.26 144.6 8.54 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 130.211 3.404 . . . . 0.0 108.308 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -104.61 170.47 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -83.26 156.98 22.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.848 1.259 . . . . 0.0 107.895 167.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -50.87 -40.82 67.98 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.84 -23.55 47.71 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.579 2.186 . . . . 0.0 115.08 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.5 mt -92.45 -34.76 13.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.294 1.037 . . . . 0.0 112.027 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.55 -38.26 89.35 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.822 1.649 . . . . 0.0 112.074 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.278 44.3 pttt -70.09 -24.47 63.22 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.68 -53.56 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.439 1.496 . . . . 0.0 109.225 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.3 12.9 mt -70.88 -30.94 67.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -64.4 -32.33 73.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.374 -1.454 . . . . 0.0 112.844 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.43 63.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.447 1.021 . . . . 0.0 113.025 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 25.57 10.78 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.026 1.731 . . . . 0.0 113.375 172.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.15 12.22 81.63 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.75 1.167 . . . . 0.0 115.884 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.17 -169.72 2.67 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 118.714 1.257 . . . . 0.0 113.272 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -125.95 47.95 2.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.787 2.035 . . . . 0.0 110.985 169.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.49 -119.78 5.22 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.98 1.276 . . . . 0.0 112.561 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.02 18.96 3.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.516 1.927 . . . . 0.0 110.853 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 58.7 ttp -75.22 47.1 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.903 2.081 . . . . 0.0 113.067 -170.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -171.82 175.92 3.77 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.312 2.245 . . . . 0.0 112.788 -168.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -74.37 170.31 15.89 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.932 2.093 . . . . 0.0 113.564 -171.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -47.87 -46.55 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 127.01 2.124 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -66.95 -30.13 70.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.31 -45.24 18.19 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.859 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -58.09 -46.1 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.442 1.474 . . . . 0.0 112.763 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.8 ptm -70.02 -26.97 64.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.93 -58.57 6.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.074 1.35 . . . . 0.0 110.766 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -56.73 -36.9 70.26 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.78 -42.86 81.01 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.163 0.892 . . . . 0.0 112.166 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.79 -47.28 89.75 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.843 0.735 . . . . 0.0 112.414 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.254 12.5 pt20 -70.67 -31.65 68.63 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.65 -0.912 . . . . 0.0 112.998 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.11 -51.5 69.44 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.515 1.507 . . . . 0.0 110.833 169.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -57.87 -42.99 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.671 0.789 . . . . 0.0 110.326 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.3 tpp -68.84 -32.0 71.37 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.57 -50.33 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.481 1.112 . . . . 0.0 111.352 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -66.4 -16.08 63.81 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.784 0.834 . . . . 0.0 112.876 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.295 6.5 pt20 45.15 42.86 7.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.191 2.597 . . . . 0.0 113.427 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -99.46 19.87 14.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.653 1.581 . . . . 0.0 112.758 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -84.28 165.45 18.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.61 1.564 . . . . 0.0 111.916 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.91 135.54 48.03 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.243 -0.91 . . . . 0.0 111.913 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -45.28 63.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.244 1.017 . . . . 0.0 113.17 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -81.42 -12.35 58.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.769 0.828 . . . . 0.0 112.488 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.7 93.92 1.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.553 1.141 . . . . 0.0 112.126 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -58.63 -17.62 23.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.721 1.208 . . . . 0.0 112.843 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -26.06 67.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.502 1.121 . . . . 0.0 112.862 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -101.28 130.19 47.38 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.993 1.717 . . . . 0.0 110.918 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.82 133.37 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 110.805 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -111.81 158.46 19.36 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.567 1.547 . . . . 0.0 111.377 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 66.7 m -146.67 28.09 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.33 115.17 7.29 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 121.672 -0.642 . . . . 0.0 112.612 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.97 12.82 65.68 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.062 1.315 . . . . 0.0 115.36 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.63 150.06 21.09 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 119.793 1.797 . . . . 0.0 112.014 -175.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.51 -27.74 64.76 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.606 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.46 -39.19 91.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.705 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.68 -37.67 89.31 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.786 -0.571 . . . . 0.0 111.702 173.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -65.63 -37.36 86.35 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 117.984 0.892 . . . . 0.0 112.279 171.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.16 -44.72 79.06 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.008 1.323 . . . . 0.0 112.305 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.65 -18.41 31.38 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.72 5.05 89.53 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.57 1.081 . . . . 0.0 114.38 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -138.76 144.27 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.22 1.808 . . . . 0.0 111.555 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -94.59 6.92 47.41 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.9 p -154.23 149.88 27.46 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 169.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -161.14 176.84 10.86 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.066 2.146 . . . . 0.0 109.734 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.5 p -142.44 171.58 13.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.72 -1.238 . . . . 0.0 112.226 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 m -72.35 -7.24 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.45 -24.82 17.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.195 1.398 . . . . 0.0 112.45 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -129.35 64.56 71.72 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.312 1.845 . . . . 0.0 111.985 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.3 0.04 10.2 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.165 3.243 . . . . 0.0 113.836 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 m -46.29 -34.79 3.64 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -59.47 -28.05 86.53 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.306 2.004 . . . . 0.0 114.941 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tt -68.2 -52.41 34.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.794 1.238 . . . . 0.0 110.405 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -64.92 -36.21 83.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.734 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.76 -31.53 72.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.634 0.773 . . . . 0.0 112.925 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -47.03 83.51 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.247 1.019 . . . . 0.0 111.19 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -92.5 -20.3 21.1 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -62.22 -27.15 68.79 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.943 1.247 . . . . 0.0 112.948 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -65.4 -27.25 68.41 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.051 2.54 . . . . 0.0 112.741 171.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m120 . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.042 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 . . . . . 0 CA--C 1.546 0.811 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.8 pt -60.13 158.99 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.008 1.323 . . . . 0.0 114.21 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.27 48.04 1.56 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.304 1.442 . . . . 0.0 112.674 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -172.57 3.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.823 3.249 . . . . 0.0 108.434 -168.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.56 169.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 -168.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -164.75 141.03 4.84 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 130.443 3.497 . . . . 0.0 108.82 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 11.5 Cg_endo -102.7 175.3 0.19 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.897 3.064 . . . . 0.0 113.944 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -97.05 163.44 12.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.524 1.53 . . . . 0.0 110.287 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -42.59 -55.68 6.73 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.95 -21.13 50.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.721 2.281 . . . . 0.0 114.339 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.4 mt -90.63 -33.38 15.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.484 1.114 . . . . 0.0 111.914 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.03 -34.97 72.51 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.978 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -54.84 -35.2 63.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.908 2.083 . . . . 0.0 112.964 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -73.99 -47.5 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.515 1.526 . . . . 0.0 109.675 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.267 2.2 mp -70.75 -30.56 67.1 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.533 -0.729 . . . . 0.0 112.486 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -60.65 -35.95 77.47 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.692 -1.255 . . . . 0.0 112.78 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.16 -21.96 64.26 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.028 0.831 . . . . 0.0 113.218 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.08 17.0 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.057 1.743 . . . . 0.0 113.616 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.19 15.15 76.69 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.43 -157.75 0.34 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.869 1.268 . . . . 0.0 112.282 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -136.32 54.21 1.9 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.82 1.648 . . . . 0.0 111.902 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.8 -170.39 40.25 Favored Glycine 0 C--O 1.216 -0.979 0 C-N-CA 124.466 1.032 . . . . 0.0 112.184 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' H ' ' HG3' ' A' ' 29' ' ' PRO . 45.9 mt-10 -79.16 18.97 0.59 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.016 1.727 . . . . 0.0 113.808 173.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.9 ttp -74.26 48.65 0.33 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.296 2.238 . . . . 0.0 115.036 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' CZ ' ' CD2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -170.75 177.15 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.971 2.108 . . . . 0.0 112.597 -175.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 164.32 10.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.173 2.189 . . . . 0.0 113.737 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.9 -45.34 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 126.026 1.73 . . . . 0.0 112.533 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -66.96 -30.29 70.38 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -46.2 17.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.361 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 m -58.02 -43.63 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 120.415 1.461 . . . . 0.0 113.348 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.2 ptm -68.08 -25.25 65.24 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.47 -59.65 3.46 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.866 1.267 . . . . 0.0 110.911 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.428 ' CD2' ' CZ ' ' A' ' 47' ' ' PHE . 82.2 m-85 -58.09 -33.55 69.21 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.1 tp -69.17 -41.32 77.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.135 0.879 . . . . 0.0 112.212 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.41 86.14 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 119.237 0.926 . . . . 0.0 112.038 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.259 8.0 pt20 -70.93 -31.6 68.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.483 -1.01 . . . . 0.0 112.969 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -56.9 -54.54 45.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.68 1.127 . . . . 0.0 110.157 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.9 mt -59.83 -39.23 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 118.868 0.758 . . . . 0.0 110.119 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 tpt -65.42 -35.84 82.13 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.38 -50.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.502 1.046 . . . . 0.0 111.17 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -67.46 -15.77 63.85 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.576 1.55 . . . . 0.0 113.179 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 5.0 pt20 46.92 41.88 11.42 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.657 2.783 . . . . 0.0 113.767 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -83.43 54.15 2.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.859 1.664 . . . . 0.0 111.15 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -139.36 167.72 21.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.182 1.393 . . . . 0.0 112.937 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.37 144.01 40.36 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.704 -0.622 . . . . 0.0 111.933 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.15 -46.04 79.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.252 1.021 . . . . 0.0 113.374 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -80.75 -8.85 59.8 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.582 0.753 . . . . 0.0 112.937 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -157.4 86.59 0.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.486 1.136 . . . . 0.0 112.546 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -55.72 -20.47 14.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.198 1.399 . . . . 0.0 112.396 170.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -25.52 67.82 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.067 1.347 . . . . 0.0 113.031 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 tpt -104.72 127.16 52.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.328 1.451 . . . . 0.0 110.798 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 t -110.4 134.38 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.446 1.498 . . . . 0.0 110.456 -170.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -132.72 102.53 5.71 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.111 2.564 . . . . 0.0 110.307 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 98.6 m -97.78 28.88 3.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.496 2.319 . . . . 0.0 113.781 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.83 115.16 6.45 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 121.681 -0.637 . . . . 0.0 112.99 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.22 10.99 75.06 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.288 1.423 . . . . 0.0 115.969 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.2 151.62 19.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 120.241 2.021 . . . . 0.0 112.395 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 mp -57.24 -27.89 62.44 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.824 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.76 -40.15 88.16 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.219 0.918 . . . . 0.0 112.671 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.97 -39.16 96.27 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -65.62 -37.7 87.31 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.889 -0.771 . . . . 0.0 112.464 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.0 tp -66.6 -45.56 78.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.141 1.376 . . . . 0.0 112.296 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.5 -23.04 34.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 113.222 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.35 7.46 86.53 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.856 1.217 . . . . 0.0 114.403 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 147.11 30.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.446 1.899 . . . . 0.0 110.836 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -97.18 9.79 41.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.7 p -152.47 148.38 27.35 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -162.43 176.27 10.66 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.582 2.353 . . . . 0.0 109.764 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.5 p -140.2 168.7 19.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.821 -1.174 . . . . 0.0 112.528 174.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.71 -9.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -95.01 -26.06 16.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.338 1.455 . . . . 0.0 112.456 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -124.06 67.19 42.96 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.434 1.893 . . . . 0.0 112.095 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.05 6.43 5.58 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.287 3.325 . . . . 0.0 114.708 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.5 m -47.41 -34.32 4.69 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -57.75 -26.21 72.29 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.163 2.575 . . . . 0.0 115.884 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.46 -50.55 36.99 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.518 1.054 . . . . 0.0 110.081 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.08 -29.15 68.84 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.332 -0.855 . . . . 0.0 112.561 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.6 -31.35 72.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.152 0.981 . . . . 0.0 112.733 169.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.64 71.57 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.057 1.343 . . . . 0.0 111.835 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.4 mt -83.61 -39.72 19.95 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.096 1.359 . . . . 0.0 113.551 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -56.55 -29.53 62.08 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.6 1.56 . . . . 0.0 113.681 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.53 -28.33 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.347 1.859 . . . . 0.0 112.543 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -93.14 -62.97 1.27 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.779 0.832 . . . . 0.0 113.089 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -123.44 150.96 43.18 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.845 1.258 . . . . 0.0 112.717 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.04 117.24 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.4 t -150.31 -176.78 5.61 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.911 1.284 . . . . 0.0 111.663 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.63 160.55 16.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.594 1.558 . . . . 0.0 112.696 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -153.27 176.43 11.97 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.405 1.482 . . . . 0.0 111.818 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.119 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.413 ' C6 ' ' C4 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.6 pt -134.78 167.71 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 127.36 2.264 . . . . 0.0 112.679 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -82.15 29.37 0.41 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.476 1.51 . . . . 0.0 114.45 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.39 -178.85 5.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.729 2.812 . . . . 0.0 110.743 -168.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 169.2 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.795 0.438 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -164.72 135.46 3.2 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 128.266 2.626 . . . . 0.0 107.789 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 10.9 Cg_endo -99.18 176.23 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.9 2.4 . . . . 0.0 114.934 -169.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -104.57 159.72 15.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.595 2.358 . . . . 0.0 106.815 166.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.49 -40.62 77.04 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -67.33 -25.46 42.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.623 2.215 . . . . 0.0 114.246 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.29 -37.17 20.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.215 1.006 . . . . 0.0 111.267 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.72 -31.9 70.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.102 0.961 . . . . 0.0 111.431 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.56 -38.76 72.36 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.61 1.564 . . . . 0.0 112.596 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.6 mt -70.78 -46.73 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.17 1.788 . . . . 0.0 109.552 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.69 -31.41 68.29 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.75 -0.594 . . . . 0.0 112.026 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -65.36 -34.92 79.45 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.468 -1.395 . . . . 0.0 112.979 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.99 64.6 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.19 0.904 . . . . 0.0 112.926 171.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.19 16.78 24.35 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.985 1.714 . . . . 0.0 114.035 172.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.73 15.64 73.69 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.434 1.016 . . . . 0.0 115.549 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.4 -162.92 0.72 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.905 1.282 . . . . 0.0 112.311 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -133.47 68.63 1.49 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.724 1.61 . . . . 0.0 111.074 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.37 -144.22 37.04 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.482 0.563 . . . . 0.0 112.583 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.7 mt-10 -125.06 16.45 8.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.55 1.94 . . . . 0.0 112.266 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.8 ttt -79.51 58.28 2.64 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.493 1.117 . . . . 0.0 112.963 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -170.37 175.07 4.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.338 1.855 . . . . 0.0 113.413 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.05 165.23 16.17 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.261 2.224 . . . . 0.0 114.308 -172.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.9 t -47.85 -45.27 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.27 1.828 . . . . 0.0 112.359 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -66.29 -30.57 71.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.62 -47.6 16.79 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.635 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.41 -46.17 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 120.373 1.442 . . . . 0.0 112.676 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -70.63 -27.83 64.36 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.95 -59.7 4.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 110.703 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -55.85 -37.21 68.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.149 0.979 . . . . 0.0 113.548 173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.28 -36.72 79.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.844 1.202 . . . . 0.0 113.008 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 -47.37 88.41 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.882 1.219 . . . . 0.0 112.256 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.274 13.3 pt20 -70.91 -31.61 68.29 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.474 -1.015 . . . . 0.0 113.09 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.61 -53.82 49.54 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.562 1.528 . . . . 0.0 110.346 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.25 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.532 1.133 . . . . 0.0 110.382 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttm -69.04 -30.51 68.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.33 -50.84 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.12 0.968 . . . . 0.0 111.239 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.02 -15.94 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.947 0.899 . . . . 0.0 113.239 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.29 6.4 pt20 43.97 44.22 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 128.152 2.581 . . . . 0.0 113.582 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.63 16.53 23.12 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.863 1.665 . . . . 0.0 112.843 -169.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -81.96 165.64 20.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.378 1.471 . . . . 0.0 112.269 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.73 147.98 45.09 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 122.196 0.998 . . . . 0.0 112.989 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.534 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.8 -37.86 76.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.92 1.688 . . . . 0.0 111.483 -176.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -91.33 -20.94 21.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.698 1.599 . . . . 0.0 112.38 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.25 92.02 2.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.365 1.079 . . . . 0.0 112.268 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -57.21 -18.79 17.37 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.419 1.488 . . . . 0.0 112.776 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -24.72 66.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.377 1.071 . . . . 0.0 113.041 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -99.9 133.13 44.73 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.424 1.889 . . . . 0.0 110.776 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.61 132.62 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.543 1.537 . . . . 0.0 110.489 -171.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -113.69 165.71 12.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.871 1.668 . . . . 0.0 110.989 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.7 m -134.8 -25.51 1.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.431 1.093 . . . . 0.0 113.824 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 53.4 31.65 43.54 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.19 13.61 65.74 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.784 1.183 . . . . 0.0 115.758 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -69.3 167.24 16.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.511 1.656 . . . . 0.0 111.904 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.34 -27.99 64.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.648 1.179 . . . . 0.0 112.514 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.11 -41.56 86.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.516 -0.74 . . . . 0.0 112.109 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.73 96.65 Favored Glycine 0 N--CA 1.472 1.04 0 O-C-N 121.696 -0.627 . . . . 0.0 112.215 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.71 -36.86 84.83 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.554 -0.968 . . . . 0.0 112.066 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.41 -43.36 81.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.808 1.243 . . . . 0.0 112.497 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.79 -18.89 42.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.383 1.073 . . . . 0.0 112.975 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.63 -14.22 25.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.985 1.755 . . . . 0.0 113.963 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -125.98 138.74 53.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.762 2.425 . . . . 0.0 108.954 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -98.53 16.3 22.27 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -153.29 146.38 24.62 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.269 -0.894 . . . . 0.0 112.663 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -164.14 174.42 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.528 1.931 . . . . 0.0 110.12 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 p -139.1 171.7 13.92 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.752 -1.218 . . . . 0.0 111.996 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.56 -8.32 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.07 -23.8 17.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.216 1.406 . . . . 0.0 112.574 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -130.38 65.4 75.81 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.49 1.916 . . . . 0.0 111.965 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.1 0.44 9.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.409 3.406 . . . . 0.0 113.888 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.0 m -46.1 -35.35 4.1 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -54.36 -31.21 66.65 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.741 2.294 . . . . 0.0 115.758 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.54 -50.8 33.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.692 1.197 . . . . 0.0 110.488 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -62.89 -37.46 87.04 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.666 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.22 -31.78 72.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 0.0 112.92 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -45.91 90.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.475 1.11 . . . . 0.0 111.117 170.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -93.82 -19.69 20.77 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -27.08 69.09 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.996 1.271 . . . . 0.0 112.904 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.9 -29.94 71.16 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.778 2.431 . . . . 0.0 112.259 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -84.68 -67.63 0.78 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.607 0.763 . . . . 0.0 112.826 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -113.32 143.06 45.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.668 1.187 . . . . 0.0 113.086 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.51 112.26 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 t -153.76 175.98 12.66 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.013 0.925 . . . . 0.0 112.997 -171.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.49 157.05 20.54 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.064 1.746 . . . . 0.0 112.373 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.8 172.55 13.48 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.446 1.499 . . . . 0.0 112.22 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.359 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.452 ' H31' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.963 0.411 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 pt -135.23 166.14 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.874 1.67 . . . . 0.0 113.055 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.4 36.52 0.48 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.863 1.665 . . . . 0.0 114.218 -172.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.67 -178.79 3.91 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.719 2.408 . . . . 0.0 113.981 -167.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 t -93.59 172.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.467 1.907 . . . . 0.0 108.941 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -162.44 139.12 6.0 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 129.908 3.283 . . . . 0.0 107.474 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -99.73 168.37 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.514 2.809 . . . . 0.0 113.997 -171.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -86.62 162.81 17.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.014 1.326 . . . . 0.0 110.444 168.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.8 mt -49.18 -48.19 74.19 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.14 -28.61 34.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.2 1.822 . . . . 0.0 113.856 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.23 -37.74 37.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.842 0.747 . . . . 0.0 111.266 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.75 -34.81 73.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.826 1.25 . . . . 0.0 111.169 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -59.28 -40.77 87.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.762 1.225 . . . . 0.0 113.182 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.5 -50.91 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.238 1.415 . . . . 0.0 109.595 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.354 12.5 mt -70.94 -30.37 66.66 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -63.18 -37.91 89.11 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 119.885 -1.76 . . . . 0.0 111.921 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.94 -18.42 65.23 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.794 0.725 . . . . 0.0 112.745 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.03 5.03 46.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.586 1.555 . . . . 0.0 114.332 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.46 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.564 1.078 . . . . 0.0 114.94 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.68 -164.0 1.09 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.432 1.493 . . . . 0.0 112.716 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -124.58 43.18 3.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 110.88 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.19 -113.87 3.76 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.879 -1.138 . . . . 0.0 112.446 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.25 19.29 2.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.555 1.942 . . . . 0.0 111.431 -174.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.2 ptm -71.54 38.82 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.585 1.554 . . . . 0.0 115.192 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -166.27 174.78 8.83 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.441 1.897 . . . . 0.0 113.967 -167.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -68.4 168.1 13.32 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.656 2.382 . . . . 0.0 113.628 -172.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -53.01 -43.52 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 126.29 1.836 . . . . 0.0 111.804 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -65.79 -30.06 70.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.47 -46.93 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.014 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.42 -44.8 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 119.929 1.241 . . . . 0.0 112.752 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.9 ptm -71.47 -27.47 63.26 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -61.44 -58.77 6.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.558 1.143 . . . . 0.0 110.395 170.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -56.34 -39.21 72.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.094 0.958 . . . . 0.0 113.253 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.09 -35.02 69.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.624 1.102 . . . . 0.0 112.702 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -47.48 90.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.157 0.89 . . . . 0.0 112.219 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.45 -31.56 71.82 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.419 -1.047 . . . . 0.0 112.378 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -58.53 -53.57 56.81 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.558 1.072 . . . . 0.0 111.654 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -56.25 -42.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.534 0.734 . . . . 0.0 109.983 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.38 -36.14 83.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.25 -48.94 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.06 0.944 . . . . 0.0 111.122 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -66.84 -15.92 63.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.982 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.313 5.3 pt20 46.23 39.63 6.42 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.389 2.676 . . . . 0.0 113.803 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt -84.86 58.23 4.86 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.586 1.554 . . . . 0.0 110.579 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -136.98 168.03 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.172 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.4 135.32 48.64 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.498 -0.751 . . . . 0.0 111.742 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -39.38 25.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.923 1.689 . . . . 0.0 113.867 171.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -90.18 -15.95 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.984 1.313 . . . . 0.0 113.407 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.66 95.03 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.713 1.244 . . . . 0.0 112.396 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -57.75 -18.66 22.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.625 1.57 . . . . 0.0 112.72 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -14.56 61.42 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -110.74 119.86 40.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.602 1.561 . . . . 0.0 110.357 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -96.8 135.01 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.453 1.501 . . . . 0.0 110.555 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -135.75 95.81 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.95 2.5 . . . . 0.0 109.699 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 97.6 m -79.52 -24.03 42.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.104 1.761 . . . . 0.0 114.671 -169.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 50.97 35.74 32.98 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.7 1.143 . . . . 0.0 115.87 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.46 62.54 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.84 158.18 25.8 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.731 1.766 . . . . 0.0 111.441 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.18 -27.84 48.63 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.463 -0.773 . . . . 0.0 112.832 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.1 tp -57.09 -47.98 79.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.899 1.28 . . . . 0.0 111.643 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.79 94.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.834 0.73 . . . . 0.0 112.417 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -65.21 -37.73 88.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.135 0.968 . . . . 0.0 111.992 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.95 -46.87 79.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.17 1.388 . . . . 0.0 111.815 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -79.07 -17.37 55.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.69 -2.3 83.38 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.963 1.268 . . . . 0.0 114.47 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -146.66 142.23 27.66 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 128.084 2.554 . . . . 0.0 109.123 172.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -96.43 12.97 29.42 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.564 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.2 p -147.1 141.33 26.2 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.95 -1.094 . . . . 0.0 112.929 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -164.63 173.38 12.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.214 2.205 . . . . 0.0 109.873 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 p -142.95 175.18 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.087 -1.008 . . . . 0.0 112.624 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.5 m -67.68 -13.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -93.06 -21.94 19.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.713 1.205 . . . . 0.0 113.0 172.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -126.14 60.58 36.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.911 1.684 . . . . 0.0 112.58 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.94 0.3 9.98 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.195 3.263 . . . . 0.0 113.652 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.0 m -45.91 -33.55 2.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 127.079 2.152 . . . . 0.0 116.322 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.24 -29.47 90.42 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.227 1.831 . . . . 0.0 114.769 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.48 -49.34 63.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.263 0.938 . . . . 0.0 110.531 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.54 -34.07 77.38 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.674 -0.641 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -68.52 -31.59 70.95 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -34.46 77.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.341 1.456 . . . . 0.0 111.314 170.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.3 mt -92.89 -37.23 12.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.114 1.366 . . . . 0.0 114.243 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -56.45 -25.92 52.17 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.726 1.611 . . . . 0.0 113.845 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.17 -26.55 63.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.506 1.923 . . . . 0.0 112.636 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -112.2 -64.93 1.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.88 140.86 57.8 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.828 1.251 . . . . 0.0 109.571 171.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.22 74.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.434 -0.791 . . . . 0.0 109.12 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.3 t -129.52 171.15 12.87 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.689 1.596 . . . . 0.0 113.007 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.52 148.45 24.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.786 1.634 . . . . 0.0 111.993 -173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.24 175.6 11.63 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.718 1.607 . . . . 0.0 111.778 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.11 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.435 ' H31' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.0 pt -136.58 158.57 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.771 1.629 . . . . 0.0 113.049 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -91.83 54.42 2.43 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.186 1.395 . . . . 0.0 112.185 -171.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.31 -174.68 3.89 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.782 2.833 . . . . 0.0 109.637 -168.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.73 172.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.456 1.502 . . . . 0.0 112.259 -169.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -161.38 145.4 9.88 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 130.652 3.581 . . . . 0.0 108.165 168.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -103.72 172.15 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.834 3.023 . . . . 0.0 114.181 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -86.51 158.57 19.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 108.062 167.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.7 -46.09 71.59 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -66.03 -24.96 51.97 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.711 2.274 . . . . 0.0 114.643 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.37 -35.86 16.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.243 1.017 . . . . 0.0 111.952 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.26 -31.9 72.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.636 1.575 . . . . 0.0 111.36 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -56.17 -38.68 71.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.459 1.504 . . . . 0.0 112.607 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -66.85 -50.9 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.068 1.747 . . . . 0.0 109.417 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.324 12.3 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.748 -0.595 . . . . 0.0 112.571 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -61.81 -33.19 73.68 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.643 -1.285 . . . . 0.0 112.576 169.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.82 -22.61 62.47 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.379 0.99 . . . . 0.0 113.263 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.67 24.45 12.64 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.012 1.725 . . . . 0.0 113.334 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.94 14.02 80.46 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.785 1.183 . . . . 0.0 115.824 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.9 -169.27 2.42 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.46 1.13 . . . . 0.0 113.438 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.53 45.22 2.5 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.69 1.996 . . . . 0.0 110.917 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.71 -119.95 5.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.093 1.33 . . . . 0.0 112.637 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.4 17.04 3.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.557 1.943 . . . . 0.0 110.589 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 58.1 ttp -76.52 50.52 0.67 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.116 1.767 . . . . 0.0 112.889 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -174.37 171.16 3.47 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.438 2.295 . . . . 0.0 112.208 -168.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 168.76 10.83 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.47 1.908 . . . . 0.0 114.092 -171.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.3 t -47.78 -44.14 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.518 1.927 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -67.64 -30.59 70.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -80.46 -44.29 19.46 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.961 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.47 -46.24 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.252 1.387 . . . . 0.0 112.622 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.2 ptm -69.86 -23.96 63.35 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.89 -59.75 3.54 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.975 1.31 . . . . 0.0 110.961 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -56.14 -37.14 69.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.258 1.023 . . . . 0.0 113.281 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tt -72.57 -38.07 68.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.897 0.879 . . . . 0.0 111.623 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.09 -47.4 87.83 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.898 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.257 13.7 pt20 -69.91 -31.54 69.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.416 -1.049 . . . . 0.0 112.873 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -55.66 -51.51 67.01 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.442 1.473 . . . . 0.0 110.457 169.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.2 mt -58.12 -44.89 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.999 0.92 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.0 ttm -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.62 -51.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.36 1.064 . . . . 0.0 111.355 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 -15.97 64.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.92 0.888 . . . . 0.0 113.282 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.3 pt20 43.79 43.51 5.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 128.164 2.585 . . . . 0.0 113.483 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -99.67 23.19 9.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.818 1.647 . . . . 0.0 112.9 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -87.01 163.69 16.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.707 1.603 . . . . 0.0 111.337 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -75.13 134.55 41.25 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.157 -0.964 . . . . 0.0 111.904 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -35.72 61.64 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.637 1.575 . . . . 0.0 113.515 171.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -82.2 -26.6 33.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 112.398 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.7 93.9 1.92 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 122.425 1.107 . . . . 0.0 111.558 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -58.87 -17.68 26.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 112.606 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.06 69.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.249 1.02 . . . . 0.0 112.913 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.3 tpt -98.4 133.06 43.32 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.981 1.712 . . . . 0.0 110.962 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.0 t -125.83 131.83 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.073 1.349 . . . . 0.0 110.957 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -108.51 163.51 13.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.575 1.55 . . . . 0.0 111.795 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 m -145.24 29.69 1.16 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.872 2.069 . . . . 0.0 111.489 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.47 113.44 3.81 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 121.612 -0.68 . . . . 0.0 114.048 -169.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.74 11.76 66.4 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.07 -1.406 . . . . 0.0 115.775 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -100.04 159.18 15.29 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 120.421 2.111 . . . . 0.0 111.99 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.34 -28.04 68.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.093 0.957 . . . . 0.0 111.863 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.9 tp -67.2 -37.88 84.39 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.339 -0.85 . . . . 0.0 112.38 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.43 -39.24 94.06 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.839 -0.538 . . . . 0.0 111.891 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -65.0 -36.95 86.04 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.795 -0.827 . . . . 0.0 112.138 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.04 -43.57 82.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.665 1.186 . . . . 0.0 112.395 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.78 -21.51 37.73 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.2 -0.31 89.39 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.629 1.109 . . . . 0.0 114.583 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -145.75 156.11 43.39 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.128 1.771 . . . . 0.0 111.897 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -99.55 16.32 23.71 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.0 p -153.57 152.93 31.47 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 169.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -163.12 179.54 7.41 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.62 2.368 . . . . 0.0 109.58 170.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 p -145.26 171.2 14.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.294 -1.504 . . . . 0.0 112.705 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.0 m -73.49 -6.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -95.11 -28.39 15.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.331 . . . . 0.0 112.345 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -128.71 70.62 80.7 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.287 1.835 . . . . 0.0 111.498 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.82 1.62 8.69 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.334 3.356 . . . . 0.0 113.527 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -45.47 -34.46 2.45 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.935 2.094 . . . . 0.0 115.924 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.59 -26.41 80.45 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.362 2.041 . . . . 0.0 114.876 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.34 -46.03 57.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.191 0.905 . . . . 0.0 110.424 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -67.15 -31.68 72.28 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.518 -0.739 . . . . 0.0 112.404 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.68 -31.59 71.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.177 0.899 . . . . 0.0 112.798 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -36.38 81.9 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.076 1.35 . . . . 0.0 111.6 169.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.7 -39.77 15.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.002 1.321 . . . . 0.0 114.233 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -57.71 -28.36 63.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.416 1.486 . . . . 0.0 113.787 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -71.0 -26.69 63.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.855 2.062 . . . . 0.0 112.735 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -105.0 -42.1 5.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -128.11 147.52 50.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.793 1.237 . . . . 0.0 112.087 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -76.06 114.09 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 170.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.6 t -152.86 172.88 16.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.081 0.952 . . . . 0.0 112.869 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.1 mt -81.48 158.45 24.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.738 1.615 . . . . 0.0 111.921 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.11 169.17 19.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.816 1.246 . . . . 0.0 113.145 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.717 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.426 ' H31' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 pt -83.05 167.74 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.98 1.312 . . . . 0.0 112.656 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -80.05 32.62 0.27 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.577 1.551 . . . . 0.0 113.964 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.8 -178.23 4.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.427 2.691 . . . . 0.0 113.647 -167.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.418 ' CG2' ' H ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -92.29 172.16 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.448 1.499 . . . . 0.0 109.99 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.418 ' H ' ' CG2' ' A' ' 27' ' ' VAL . 37.5 ttp-105 -159.94 141.83 9.58 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 130.723 3.609 . . . . 0.0 108.708 169.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -99.38 169.58 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.892 3.062 . . . . 0.0 113.858 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -82.88 160.44 22.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.983 1.313 . . . . 0.0 109.177 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.36 -47.75 67.57 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.42 -28.1 33.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 CA-C-N 122.299 1.857 . . . . 0.0 113.339 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.35 -35.66 54.43 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.282 -0.886 . . . . 0.0 111.568 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.3 -35.03 76.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.994 1.318 . . . . 0.0 110.951 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -59.73 -43.22 94.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.547 1.539 . . . . 0.0 112.648 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.0 mt -59.25 -52.87 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 109.492 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.347 11.1 mt -70.79 -30.5 66.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -61.45 -33.82 74.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.689 -1.257 . . . . 0.0 112.417 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.88 -21.78 61.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.299 0.954 . . . . 0.0 113.456 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.54 24.02 13.67 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.773 1.629 . . . . 0.0 113.517 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.87 15.03 78.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.552 1.072 . . . . 0.0 115.743 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.16 -166.86 1.46 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.672 1.189 . . . . 0.0 112.932 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -125.44 48.29 2.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.621 1.969 . . . . 0.0 110.587 169.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.29 -116.55 5.26 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.086 1.327 . . . . 0.0 113.107 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -139.08 19.95 2.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.066 2.146 . . . . 0.0 110.954 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 58.0 ttp -78.08 47.59 0.67 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.4 1.48 . . . . 0.0 112.924 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -170.58 175.6 4.62 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.111 1.764 . . . . 0.0 113.635 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.55 167.08 11.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.508 2.323 . . . . 0.0 113.721 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.4 -43.27 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.245 1.818 . . . . 0.0 111.804 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -64.34 -30.07 71.13 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -79.97 -48.17 13.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.932 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -55.34 -44.44 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.025 1.284 . . . . 0.0 112.788 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -71.31 -28.65 64.25 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.74 -59.37 5.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 110.874 170.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -55.51 -36.05 66.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.233 1.013 . . . . 0.0 113.592 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.52 -39.07 74.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.63 1.104 . . . . 0.0 113.383 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.71 -47.27 79.18 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 119.697 1.135 . . . . 0.0 112.134 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.01 -31.61 66.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.457 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.1 -51.53 68.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.887 1.676 . . . . 0.0 110.78 169.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -58.52 -44.25 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.952 0.901 . . . . 0.0 110.379 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 36.5 tpp -66.67 -31.6 72.38 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -74.39 -49.38 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.693 1.197 . . . . 0.0 111.414 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -66.02 -16.13 63.64 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.5 pt20 43.35 42.72 3.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.153 2.581 . . . . 0.0 113.259 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -100.65 22.04 12.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.895 1.678 . . . . 0.0 112.66 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -88.29 165.53 14.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.644 1.578 . . . . 0.0 112.069 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -71.21 138.36 49.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.228 -0.92 . . . . 0.0 112.13 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -38.4 51.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.244 1.418 . . . . 0.0 113.482 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -98.69 -16.56 18.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.0 1.32 . . . . 0.0 113.709 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.11 94.34 2.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.786 1.234 . . . . 0.0 109.768 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -63.89 -14.12 50.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.165 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.09 -19.74 61.1 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -96.77 128.08 43.37 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.254 1.822 . . . . 0.0 109.858 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.77 131.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.676 1.59 . . . . 0.0 110.921 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -104.45 161.87 13.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.258 1.423 . . . . 0.0 110.992 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.5 m -145.95 29.57 1.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.515 1.926 . . . . 0.0 111.812 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.89 114.31 6.64 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.357 -0.839 . . . . 0.0 112.339 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.11 72.02 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.001 1.286 . . . . 0.0 115.435 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -96.41 146.45 24.75 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.01 1.905 . . . . 0.0 110.826 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.12 -27.66 62.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.419 0.688 . . . . 0.0 112.477 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.6 tp -65.69 -38.83 90.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.679 0.792 . . . . 0.0 112.581 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.87 -39.56 93.43 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 121.409 -0.807 . . . . 0.0 111.781 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -63.54 -37.32 86.87 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 117.714 0.757 . . . . 0.0 112.005 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.92 -46.02 63.22 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.091 1.357 . . . . 0.0 112.695 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.21 -21.4 53.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.068 0.947 . . . . 0.0 113.052 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 1.07 90.37 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.701 1.143 . . . . 0.0 114.394 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -144.76 148.66 34.37 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.337 1.855 . . . . 0.0 111.458 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.82 12.24 32.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.457 1.103 . . . . 0.0 113.423 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -151.98 146.43 25.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -160.31 176.82 11.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.042 2.137 . . . . 0.0 110.15 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 p -147.59 173.86 12.31 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.543 -1.348 . . . . 0.0 113.166 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.62 -21.12 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.872 0.869 . . . . 0.0 111.732 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -88.88 -28.89 20.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.101 1.36 . . . . 0.0 113.008 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -121.02 65.55 13.64 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.298 1.839 . . . . 0.0 112.207 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.0 -0.9 10.22 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.969 3.113 . . . . 0.0 113.725 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -47.31 -34.37 4.56 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -58.84 -32.15 96.67 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.369 2.046 . . . . 0.0 114.645 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -64.95 -48.32 74.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.176 0.99 . . . . 0.0 110.623 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -69.12 -31.35 69.98 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.427 -0.796 . . . . 0.0 111.922 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.83 -33.05 71.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.097 0.862 . . . . 0.0 113.08 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -64.51 -39.69 94.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.892 1.277 . . . . 0.0 110.271 169.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.0 mt -82.65 -42.43 18.17 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -56.53 -28.48 60.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.686 1.194 . . . . 0.0 113.868 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.99 -26.58 63.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.91 2.084 . . . . 0.0 112.977 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -96.7 -88.87 0.28 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.561 1.145 . . . . 0.0 112.762 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -80.58 149.76 29.79 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 120.135 1.334 . . . . 0.0 112.098 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.31 112.87 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 t -155.75 -177.63 6.7 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.96 0.904 . . . . 0.0 112.977 -172.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.11 158.03 36.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.425 1.89 . . . . 0.0 112.172 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.55 176.18 11.58 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.151 1.38 . . . . 0.0 112.124 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -174.659 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.401 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 pt -66.0 156.37 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -89.07 52.63 2.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.225 1.41 . . . . 0.0 112.287 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.23 -160.14 0.58 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 129.229 3.012 . . . . 0.0 108.656 -168.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.29 172.33 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.497 1.519 . . . . 0.0 110.512 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -160.7 137.97 6.79 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 131.177 3.791 . . . . 0.0 106.867 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -101.05 168.71 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.197 2.598 . . . . 0.0 114.432 -170.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.41 159.14 23.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.085 1.354 . . . . 0.0 108.2 167.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -53.11 -39.58 72.09 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -65.3 -29.97 54.38 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.42 2.08 . . . . 0.0 114.109 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.86 -36.65 27.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.508 1.123 . . . . 0.0 111.333 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.87 -45.77 93.26 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.077 1.351 . . . . 0.0 111.207 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 38.0 pttt -70.54 -26.15 63.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.41 -54.39 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.478 1.111 . . . . 0.0 108.765 169.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.251 35.0 mt -70.93 -30.77 67.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.77 0.828 . . . . 0.0 112.32 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -34.1 77.54 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.702 -1.249 . . . . 0.0 113.017 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.49 64.45 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -102.84 22.92 12.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.01 1.724 . . . . 0.0 113.549 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.35 80.85 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.512 1.053 . . . . 0.0 115.721 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.89 -164.61 0.76 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.449 1.125 . . . . 0.0 113.074 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -130.44 48.65 2.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 127.194 2.197 . . . . 0.0 109.193 168.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 -111.77 3.79 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.361 1.458 . . . . 0.0 113.276 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.07 16.78 2.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.588 1.955 . . . . 0.0 111.594 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -75.97 49.83 0.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.515 1.526 . . . . 0.0 113.235 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -173.2 172.12 3.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.461 2.305 . . . . 0.0 112.481 -169.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.38 167.35 16.7 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.121 2.168 . . . . 0.0 114.139 -171.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.78 -43.29 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.779 2.032 . . . . 0.0 112.31 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.54 -30.14 70.38 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -80.54 -46.41 15.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.4 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.17 -44.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 120.03 1.287 . . . . 0.0 112.684 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.04 -28.51 66.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.46 -58.25 7.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.964 171.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -56.69 -37.0 70.27 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.57 -41.73 75.45 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.15 0.886 . . . . 0.0 111.46 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.92 -47.48 88.64 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 112.907 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -70.51 -31.58 68.73 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.527 -0.984 . . . . 0.0 112.598 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -58.19 -52.1 66.96 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.887 1.222 . . . . 0.0 110.964 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -53.68 -46.29 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.045 0.839 . . . . 0.0 109.711 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -33.88 76.06 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.18 -47.42 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.302 1.041 . . . . 0.0 110.883 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -66.69 -11.24 53.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.046 0.938 . . . . 0.0 112.944 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.336 3.0 pt20 46.66 45.55 14.46 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 129.655 3.182 . . . . 0.0 113.311 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.08 58.21 4.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.245 1.418 . . . . 0.0 110.982 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -143.55 164.84 29.25 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.003 1.321 . . . . 0.0 112.574 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -72.86 135.58 45.18 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.649 -0.657 . . . . 0.0 111.721 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -40.23 36.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.162 1.385 . . . . 0.0 113.037 171.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -89.14 -19.16 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.227 1.411 . . . . 0.0 113.094 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -152.69 94.83 1.93 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.404 1.097 . . . . 0.0 111.742 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.92 -17.84 28.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.131 1.372 . . . . 0.0 112.636 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -21.57 65.45 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.091 0.957 . . . . 0.0 112.973 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.5 tpt -104.65 124.1 48.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.303 1.841 . . . . 0.0 110.73 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.96 138.17 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.127 1.771 . . . . 0.0 110.282 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -135.14 94.72 3.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.288 2.235 . . . . 0.0 110.535 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -88.53 30.69 0.88 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.67 2.788 . . . . 0.0 113.472 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.88 116.52 9.15 Favored Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 112.671 -170.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.86 11.3 78.19 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.364 1.459 . . . . 0.0 115.737 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.06 147.93 22.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.363 2.081 . . . . 0.0 111.792 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.99 -27.59 63.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.5 tp -65.93 -43.24 88.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.998 0.919 . . . . 0.0 112.694 171.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.24 -38.31 95.0 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 118.993 0.815 . . . . 0.0 111.719 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -65.07 -38.0 89.36 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.925 -0.75 . . . . 0.0 111.793 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.33 -48.87 63.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.071 0.948 . . . . 0.0 112.399 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.35 -20.35 61.48 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 112.701 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.93 -0.21 89.85 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.732 1.158 . . . . 0.0 114.075 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -145.6 145.29 30.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.38 1.872 . . . . 0.0 111.316 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.99 2.69 55.38 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.413 1.085 . . . . 0.0 113.086 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.5 p -147.39 140.23 24.94 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -160.65 176.48 11.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.959 2.503 . . . . 0.0 109.155 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.6 p -144.19 174.98 10.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.852 -1.155 . . . . 0.0 112.164 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.97 -8.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 169.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.04 -22.84 17.65 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.323 1.449 . . . . 0.0 113.139 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -124.22 62.14 28.87 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 126.116 1.766 . . . . 0.0 112.012 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.2 2.5 7.95 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.053 3.169 . . . . 0.0 114.258 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 m -46.85 -34.68 4.19 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -33.58 97.02 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 122.989 2.103 . . . . 0.0 114.679 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tp -57.78 -56.88 16.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 123.022 1.392 . . . . 0.0 110.219 171.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -70.49 -29.2 65.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.455 -0.778 . . . . 0.0 112.035 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.04 -31.51 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.6 1.091 . . . . 0.0 113.193 173.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.6 ttp -68.41 -37.11 80.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.363 1.065 . . . . 0.0 110.773 169.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.07 -31.48 18.02 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -29.3 65.16 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.463 1.505 . . . . 0.0 113.361 175.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.83 -29.0 70.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.273 1.829 . . . . 0.0 112.473 172.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -91.94 -65.57 1.0 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -120.89 148.25 44.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.688 1.195 . . . . 0.0 112.901 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.42 126.18 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.5 t -149.12 177.92 9.18 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.544 1.137 . . . . 0.0 112.159 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.33 151.53 46.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.627 1.571 . . . . 0.0 112.802 -175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.51 174.75 12.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.641 1.576 . . . . 0.0 112.01 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -174.765 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.72 167.04 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.083 1.753 . . . . 0.0 112.097 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -82.15 35.43 0.43 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.56 1.544 . . . . 0.0 114.034 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -125.94 -175.64 3.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.304 2.642 . . . . 0.0 113.671 -166.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.3 t -92.2 172.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.813 1.645 . . . . 0.0 109.298 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -164.24 131.98 2.56 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 129.831 3.253 . . . . 0.0 107.15 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -96.59 174.27 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.974 2.449 . . . . 0.0 115.466 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -98.88 160.35 14.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.42 2.288 . . . . 0.0 107.516 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -53.39 -38.81 66.03 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -69.09 -32.53 21.15 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.21 1.94 . . . . 0.0 113.593 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.26 -37.32 61.02 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 111.037 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.74 -40.18 91.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.877 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -53.8 -42.61 68.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.706 1.202 . . . . 0.0 113.329 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -64.18 -50.11 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.565 1.546 . . . . 0.0 109.937 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.36 -37.39 80.41 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.645 -0.659 . . . . 0.0 111.167 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -71.37 -30.63 66.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.886 -1.134 . . . . 0.0 113.404 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.33 -22.7 54.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.495 0.718 . . . . 0.0 112.874 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.14 25.37 11.08 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.959 1.704 . . . . 0.0 113.563 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.48 17.33 79.82 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.36 -161.2 0.3 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.947 1.299 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -132.67 48.65 2.39 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.022 1.729 . . . . 0.0 110.746 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.16 -119.6 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.178 0.894 . . . . 0.0 112.66 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -141.39 19.62 2.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.891 1.677 . . . . 0.0 112.624 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -77.64 47.55 0.61 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.1 1.36 . . . . 0.0 112.783 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -168.73 174.47 6.6 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.417 1.887 . . . . 0.0 113.157 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.62 164.97 10.94 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.783 2.433 . . . . 0.0 113.91 -171.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.21 -42.42 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 126.017 1.727 . . . . 0.0 111.874 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.7 -30.19 71.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -79.18 -48.23 14.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.965 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.94 -47.01 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 119.699 1.136 . . . . 0.0 112.066 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -71.49 -23.84 61.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.06 -59.64 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.35 0.977 . . . . 0.0 110.659 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -55.99 -40.72 73.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.873 1.269 . . . . 0.0 113.298 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 tt -73.29 -32.29 64.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.365 1.066 . . . . 0.0 111.515 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.9 -47.31 89.88 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.696 -1.253 . . . . 0.0 112.736 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.01 -31.59 72.24 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.414 -1.05 . . . . 0.0 112.375 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.85 -54.44 47.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.838 1.199 . . . . 0.0 111.077 169.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -52.89 -42.96 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.342 0.974 . . . . 0.0 110.292 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.2 tpp -70.45 -35.27 73.24 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.26 -47.57 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.505 1.122 . . . . 0.0 111.341 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -65.0 -12.1 46.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.502 1.121 . . . . 0.0 112.745 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.33 3.9 pt20 47.92 46.13 18.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 129.407 3.083 . . . . 0.0 113.149 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.22 56.79 4.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.368 1.467 . . . . 0.0 110.887 -171.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.86 166.97 24.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.843 1.257 . . . . 0.0 112.747 -173.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -73.52 148.63 42.89 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.146 0.974 . . . . 0.0 113.279 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.541 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.43 -35.99 76.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.974 1.71 . . . . 0.0 111.716 -176.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -93.1 -20.75 20.2 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.554 1.542 . . . . 0.0 112.335 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -145.95 94.96 2.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.195 0.998 . . . . 0.0 112.69 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -59.01 -17.96 29.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.815 1.246 . . . . 0.0 112.896 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -22.26 66.57 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.339 1.055 . . . . 0.0 112.913 174.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.4 tpt -102.12 128.77 48.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.578 1.551 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.9 t -108.92 134.48 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.876 1.671 . . . . 0.0 110.6 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -136.67 96.93 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 110.468 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.5 m -89.55 27.51 1.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 128.35 2.66 . . . . 0.0 113.686 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.39 118.89 14.9 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.486 -0.759 . . . . 0.0 113.064 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.69 8.97 82.38 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.285 1.421 . . . . 0.0 115.719 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.32 149.2 21.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.132 1.966 . . . . 0.0 112.025 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.3 tp -59.18 -27.8 66.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.529 1.131 . . . . 0.0 111.291 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.1 tp -63.95 -48.98 74.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.326 1.05 . . . . 0.0 111.895 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.48 -37.46 93.77 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 118.621 0.646 . . . . 0.0 112.376 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -64.15 -37.34 87.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.85 0.86 . . . . 0.0 112.006 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.13 -45.96 53.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.876 0.871 . . . . 0.0 112.019 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.43 -28.68 69.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.046 0.938 . . . . 0.0 112.639 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 0.46 89.0 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.559 1.076 . . . . 0.0 114.024 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.66 147.81 32.39 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.847 1.659 . . . . 0.0 111.768 170.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -100.19 5.66 44.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.763 1.225 . . . . 0.0 113.06 -171.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -147.59 145.51 29.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -164.29 -177.37 4.9 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.17 2.588 . . . . 0.0 109.308 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 p -137.36 170.72 15.61 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.682 -1.261 . . . . 0.0 112.331 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.26 -15.69 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -94.37 -18.91 21.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -131.34 63.89 71.4 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.48 1.512 . . . . 0.0 112.587 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.78 13.98 1.99 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 125.11 3.873 . . . . 0.0 114.564 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.1 p -50.67 -27.62 1.61 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 117.648 2.462 . . . . 0.0 117.648 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -60.81 -27.84 85.46 Favored 'Trans proline' 0 C--N 1.357 1.012 0 CA-C-N 123.898 2.428 . . . . 0.0 114.437 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.41 -48.72 66.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.609 0.719 . . . . 0.0 110.297 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -66.85 -30.74 71.0 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.557 -0.714 . . . . 0.0 112.02 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -68.13 -31.63 71.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.293 1.037 . . . . 0.0 112.988 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -35.68 75.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.353 1.461 . . . . 0.0 111.197 169.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -88.33 -36.44 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -58.67 -27.34 64.71 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.071 1.749 . . . . 0.0 114.351 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -71.15 -26.17 62.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.465 1.906 . . . . 0.0 112.593 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -97.27 -71.17 0.69 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.442 1.497 . . . . 0.0 112.915 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -96.55 159.04 15.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.814 1.188 . . . . 0.0 112.072 171.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.98 106.98 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.45 -0.781 . . . . 0.0 109.054 172.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.8 t -150.46 173.3 14.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.609 1.164 . . . . 0.0 112.525 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -79.67 147.28 32.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.67 1.588 . . . . 0.0 111.568 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.15 5.9 0.76 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.239 0.526 0 C-N-CA 125.542 1.537 . . . . 0.0 113.771 179.539 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.432 ' H31' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 121.132 0.492 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.1 pt -73.72 162.96 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.408 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.7 m120 -83.31 36.7 0.53 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.763 1.625 . . . . 0.0 114.398 -169.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.408 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -129.2 -174.88 3.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.492 2.317 . . . . 0.0 112.697 -167.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.14 172.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 0.0 109.102 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -165.08 131.3 2.15 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 128.766 2.826 . . . . 0.0 108.24 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -104.11 174.57 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.995 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -106.79 167.7 9.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.782 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -42.15 -53.79 8.21 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.67 -27.56 45.05 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.494 2.129 . . . . 0.0 114.293 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.8 mt -84.39 -34.29 23.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.511 0.725 . . . . 0.0 112.101 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.29 -35.39 77.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.132 0.973 . . . . 0.0 110.957 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -39.35 73.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.9 1.28 . . . . 0.0 112.627 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -63.41 -54.37 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.464 1.505 . . . . 0.0 109.251 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.282 4.7 mp -70.77 -30.36 66.83 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.332 -0.855 . . . . 0.0 113.156 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -35.49 78.33 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.434 -1.416 . . . . 0.0 112.901 169.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.13 -21.15 64.8 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.175 0.898 . . . . 0.0 112.853 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.68 18.72 19.66 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.402 1.881 . . . . 0.0 113.715 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.11 15.5 76.6 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.71 -165.55 1.08 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.795 1.238 . . . . 0.0 112.734 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -131.5 56.73 1.79 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.968 1.707 . . . . 0.0 111.318 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.78 -126.17 7.32 Favored Glycine 0 C--O 1.218 -0.86 0 C-N-CA 124.32 0.962 . . . . 0.0 112.134 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -141.62 11.26 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.825 2.05 . . . . 0.0 111.716 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.5 ttt -76.12 54.56 0.87 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.39 1.476 . . . . 0.0 113.445 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -170.65 171.42 6.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.582 1.953 . . . . 0.0 113.037 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 164.84 7.4 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.176 2.19 . . . . 0.0 114.309 -169.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -51.52 -45.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 126.089 1.756 . . . . 0.0 111.929 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.88 -30.11 71.23 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.23 -47.82 15.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.02 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.0 -45.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 120.027 1.285 . . . . 0.0 112.688 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.7 ptm -70.64 -25.28 62.94 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -64.97 -57.85 7.66 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.969 1.307 . . . . 0.0 110.809 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -55.94 -35.85 67.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.918 0.887 . . . . 0.0 113.071 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tt -71.34 -38.58 71.64 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.245 -0.91 . . . . 0.0 112.155 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.57 -47.47 88.1 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 120.848 -1.158 . . . . 0.0 112.589 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.302 11.2 pt20 -70.24 -31.45 68.86 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.997 . . . . 0.0 112.719 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -55.68 -50.43 70.3 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.558 1.526 . . . . 0.0 111.6 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -57.11 -47.23 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.605 0.762 . . . . 0.0 109.762 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.63 71.65 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -73.48 -50.19 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.142 1.377 . . . . 0.0 111.312 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.31 -15.94 63.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.895 0.878 . . . . 0.0 112.9 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.288 6.2 pt20 43.55 43.53 4.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.72 2.808 . . . . 0.0 113.348 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -103.77 33.23 3.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 112.656 -169.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -99.87 165.44 11.56 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.188 1.795 . . . . 0.0 111.821 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.81 135.76 50.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.341 -0.85 . . . . 0.0 111.967 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.51 -45.54 62.91 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.304 1.042 . . . . 0.0 113.186 169.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -80.85 -13.94 58.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 112.497 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.17 98.28 1.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 112.282 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -59.28 -17.56 29.84 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.541 1.137 . . . . 0.0 112.867 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -20.4 62.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.254 1.421 . . . . 0.0 110.456 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.23 140.41 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.384 1.474 . . . . 0.0 111.489 -169.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.35 165.72 14.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.973 2.109 . . . . 0.0 111.178 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.4 m -139.51 -29.57 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.745 1.218 . . . . 0.0 114.15 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 52.72 -126.02 31.19 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.154 0.888 . . . . 0.0 111.878 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.05 14.2 50.46 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.78 150.71 45.59 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.676 2.238 . . . . 0.0 112.475 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.09 -27.85 35.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.452 1.101 . . . . 0.0 112.086 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 tp -65.69 -44.88 84.84 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.661 0.784 . . . . 0.0 112.256 173.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 118.773 0.715 . . . . 0.0 111.932 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -64.51 -37.69 88.41 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 117.683 0.742 . . . . 0.0 112.069 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.8 tp -70.63 -46.13 63.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.741 1.216 . . . . 0.0 112.484 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.85 -28.72 64.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.217 1.007 . . . . 0.0 113.06 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.13 -0.45 73.47 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 123.903 0.763 . . . . 0.0 113.396 -169.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -135.05 137.34 42.83 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 128.245 2.618 . . . . 0.0 109.624 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -103.52 11.83 35.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.783 0.833 . . . . 0.0 113.011 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.5 p -153.84 140.66 19.11 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.683 1.193 . . . . 0.0 111.624 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -162.61 175.34 11.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.41 1.884 . . . . 0.0 110.15 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.4 p -143.89 173.83 11.36 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.899 -1.125 . . . . 0.0 113.342 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.02 -20.84 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.107 0.963 . . . . 0.0 112.132 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.2 -19.39 21.49 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.88 1.272 . . . . 0.0 113.644 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -128.59 63.38 64.61 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.976 1.71 . . . . 0.0 112.402 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.56 -2.05 11.3 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.171 3.248 . . . . 0.0 113.783 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.1 m -41.91 -43.36 6.65 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -23.31 70.7 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 122.925 2.08 . . . . 0.0 114.465 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.67 -51.95 50.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.518 1.054 . . . . 0.0 110.147 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -62.87 -37.7 87.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.442 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.01 -31.54 72.83 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 173.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.3 -47.91 80.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.873 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.29 -21.86 21.87 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -63.75 -25.04 68.01 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.8 1.182 . . . . 0.0 113.27 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -70.05 -25.94 63.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.467 2.307 . . . . 0.0 112.549 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -97.77 -44.89 6.55 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.66 156.74 41.85 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.343 1.428 . . . . 0.0 112.441 172.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.75 100.91 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.796 0.808 . . . . 0.0 111.123 -176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.0 t -151.99 176.93 10.99 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.583 1.153 . . . . 0.0 112.715 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 pp -107.87 174.91 5.67 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.911 2.085 . . . . 0.0 113.648 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.07 162.58 35.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.756 1.222 . . . . 0.0 112.616 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -174.028 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 pt -123.7 152.49 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.589 1.556 . . . . 0.0 113.153 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -90.87 62.04 4.87 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.641 1.177 . . . . 0.0 112.511 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.38 -176.91 5.0 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.006 2.922 . . . . 0.0 109.818 -171.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.33 172.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.888 0.875 . . . . 0.0 111.869 -169.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -162.14 134.12 4.09 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 128.903 2.881 . . . . 0.0 107.588 172.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -98.66 -178.61 0.27 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.212 2.608 . . . . 0.0 114.574 -169.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -120.65 165.77 14.6 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.301 2.24 . . . . 0.0 108.651 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -39.59 -57.81 2.3 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.467 1.907 . . . . 0.0 116.136 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.83 -25.23 33.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.467 2.111 . . . . 0.0 114.109 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.08 -39.15 23.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.813 0.845 . . . . 0.0 111.065 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.22 -31.58 70.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.678 1.191 . . . . 0.0 111.662 170.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -58.86 -37.62 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.121 1.368 . . . . 0.0 112.787 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.25 -42.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.484 1.514 . . . . 0.0 110.14 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.59 -30.82 67.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.797 -0.564 . . . . 0.0 111.964 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -65.85 -37.13 85.37 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.964 -1.71 . . . . 0.0 112.164 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.65 -22.56 67.01 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.883 0.765 . . . . 0.0 112.435 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.4 2.58 39.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.144 1.378 . . . . 0.0 114.183 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.78 17.31 79.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.492 1.044 . . . . 0.0 114.998 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.27 -166.72 1.65 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.602 1.561 . . . . 0.0 112.792 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.38 65.67 1.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.911 1.684 . . . . 0.0 111.101 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.12 -138.81 23.27 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.732 0.682 . . . . 0.0 112.83 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -131.79 18.06 4.69 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.393 1.877 . . . . 0.0 112.29 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.94 52.64 1.28 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.466 1.506 . . . . 0.0 112.345 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -169.62 170.16 8.25 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.368 1.867 . . . . 0.0 113.209 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.38 165.49 14.09 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.358 2.263 . . . . 0.0 114.663 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -50.83 -44.54 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 126.243 1.817 . . . . 0.0 112.152 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.76 -30.08 71.08 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.09 -48.62 14.01 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.022 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -55.34 -44.96 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 120.194 1.361 . . . . 0.0 112.506 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 14.4 ptm -72.27 -24.95 61.43 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.07 10.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.713 1.205 . . . . 0.0 110.313 169.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -55.56 -42.31 74.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.077 0.951 . . . . 0.0 112.907 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.13 -38.0 89.49 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.04 1.291 . . . . 0.0 112.609 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.25 -47.43 89.5 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 119.487 1.04 . . . . 0.0 112.894 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.44 -31.67 67.47 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.548 -0.972 . . . . 0.0 112.873 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.08 -53.63 55.88 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.928 1.24 . . . . 0.0 110.29 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.7 mt -57.72 -42.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.677 0.791 . . . . 0.0 110.192 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.75 -32.22 73.64 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.13 -50.38 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.661 1.185 . . . . 0.0 111.495 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.08 -15.89 64.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.072 1.349 . . . . 0.0 113.11 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.304 6.1 pt20 46.77 43.44 13.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.625 2.77 . . . . 0.0 114.117 172.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.99 3.63 33.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.914 1.285 . . . . 0.0 113.423 -176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -78.73 164.58 24.45 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.666 -1.271 . . . . 0.0 113.413 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -73.14 139.35 46.34 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.682 -0.636 . . . . 0.0 111.986 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -40.38 65.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.376 1.47 . . . . 0.0 112.893 172.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -89.41 -20.35 24.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 112.932 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.21 96.49 2.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.463 1.105 . . . . 0.0 111.538 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -61.24 -14.64 27.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.955 0.902 . . . . 0.0 112.821 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -21.29 66.19 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.996 0.918 . . . . 0.0 112.97 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.8 tpt -104.87 136.01 45.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.662 1.985 . . . . 0.0 110.999 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.56 131.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.686 1.594 . . . . 0.0 110.764 -170.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -99.34 170.54 8.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.369 1.467 . . . . 0.0 111.317 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.03 24.71 0.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 113.457 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.3 113.45 5.45 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.43 -0.794 . . . . 0.0 112.638 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.74 12.81 71.15 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.095 1.331 . . . . 0.0 115.884 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.21 148.28 22.27 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.631 2.216 . . . . 0.0 111.18 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -27.72 63.05 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.53 0.732 . . . . 0.0 112.248 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.13 -40.7 90.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.626 0.77 . . . . 0.0 112.558 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.15 92.64 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 119.101 0.864 . . . . 0.0 112.286 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.24 -40.47 96.1 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.271 1.036 . . . . 0.0 111.539 171.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.25 -44.87 82.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.568 1.147 . . . . 0.0 112.621 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.26 -23.0 43.96 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 113.449 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.91 84.12 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.232 0.92 . . . . 0.0 114.015 -171.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -136.65 137.86 40.51 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.338 1.855 . . . . 0.0 112.526 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -98.64 7.98 45.47 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.601 1.161 . . . . 0.0 113.415 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.4 p -157.09 140.9 16.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 168.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -159.51 176.41 12.1 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.504 1.922 . . . . 0.0 110.506 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 p -143.41 173.33 11.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.764 -1.21 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.67 -20.87 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -94.97 -16.33 22.86 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -125.05 65.39 47.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.85 1.66 . . . . 0.0 112.062 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.03 4.69 5.95 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.364 3.376 . . . . 0.0 113.309 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.6 m -38.88 -45.89 3.08 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 127.717 2.407 . . . . 0.0 116.616 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.42 -20.5 66.25 Favored 'Trans proline' 0 C--N 1.355 0.909 0 CA-C-N 122.521 1.936 . . . . 0.0 115.073 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.52 -49.66 62.37 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.264 1.031 . . . . 0.0 109.722 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -66.77 -30.52 70.75 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.043 -1.035 . . . . 0.0 112.043 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.64 -32.52 74.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.091 -1.006 . . . . 0.0 112.935 170.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -34.15 72.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.235 1.414 . . . . 0.0 111.629 170.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.82 -26.26 21.77 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -26.2 68.61 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.215 1.371 . . . . 0.0 114.394 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.29 -28.84 69.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.389 1.075 . . . . 0.0 111.952 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -87.28 -68.2 0.77 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 171.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -130.87 140.86 50.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.663 1.185 . . . . 0.0 113.301 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.81 125.51 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 169.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.3 t -151.32 173.73 14.14 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.79 148.88 44.13 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.994 1.718 . . . . 0.0 111.26 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.33 171.98 13.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.332 1.453 . . . . 0.0 112.183 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -173.446 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 pt -125.0 169.41 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 127.498 2.319 . . . . 0.0 111.936 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -77.36 27.84 0.15 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.965 1.306 . . . . 0.0 114.279 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -124.28 -175.88 3.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.238 2.615 . . . . 0.0 113.857 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.49 172.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.563 1.145 . . . . 0.0 111.393 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -164.34 132.28 2.59 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 129.799 3.24 . . . . 0.0 106.889 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -100.24 174.9 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.024 2.483 . . . . 0.0 115.024 -169.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.88 160.23 14.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.949 2.1 . . . . 0.0 107.03 166.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -44.91 -46.28 28.01 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -68.85 -28.2 30.14 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 122.317 1.863 . . . . 0.0 114.037 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.68 -37.02 28.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.39 1.076 . . . . 0.0 111.011 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -57.72 -40.24 79.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 0.0 110.362 170.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -51.62 -41.62 61.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.692 1.597 . . . . 0.0 113.438 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.89 -51.68 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.297 1.039 . . . . 0.0 110.102 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.69 -31.67 68.64 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 111.925 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -31.87 69.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.793 -1.192 . . . . 0.0 112.86 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.05 -20.98 58.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.201 0.6 . . . . 0.0 112.605 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.46 21.65 17.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.381 1.872 . . . . 0.0 113.796 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.42 17.48 78.97 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.89 -161.12 0.32 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.993 1.317 . . . . 0.0 112.86 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -136.76 59.22 1.7 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.36 -130.85 10.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.859 1.219 . . . . 0.0 113.175 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -138.89 19.37 2.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.882 2.073 . . . . 0.0 111.589 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.6 ttt -77.7 50.34 0.83 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.698 1.199 . . . . 0.0 112.953 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -168.07 171.05 9.89 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.885 1.674 . . . . 0.0 113.876 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -65.38 167.68 8.23 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.555 2.342 . . . . 0.0 114.222 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.05 -42.24 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.801 2.041 . . . . 0.0 111.802 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -65.15 -33.91 77.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -79.01 -45.94 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.504 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.04 -47.16 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.875 1.216 . . . . 0.0 112.453 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.2 ptm -71.66 -24.01 61.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.69 -59.7 4.25 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.529 1.132 . . . . 0.0 110.744 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -55.25 -37.34 67.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.411 1.084 . . . . 0.0 113.214 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.06 -34.2 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.209 -0.932 . . . . 0.0 112.062 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.06 -47.37 91.11 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.711 -1.243 . . . . 0.0 112.154 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.291 13.9 pt20 -68.48 -31.44 70.72 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.147 -1.207 . . . . 0.0 112.925 172.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -54.6 -53.23 57.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 120.544 1.52 . . . . 0.0 110.467 169.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.4 -43.26 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.753 0.821 . . . . 0.0 110.399 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -34.78 78.51 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -78.13 -49.81 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.987 1.315 . . . . 0.0 111.847 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.04 -15.81 62.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.551 1.141 . . . . 0.0 112.858 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 6.4 pt20 47.72 43.49 16.82 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.003 2.521 . . . . 0.0 113.385 172.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.64 11.69 32.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.983 1.713 . . . . 0.0 112.902 -169.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -86.23 164.85 16.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.725 1.61 . . . . 0.0 112.222 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -71.76 146.69 47.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.135 0.969 . . . . 0.0 113.216 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.549 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -67.93 -34.84 77.38 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.004 1.722 . . . . 0.0 111.819 -175.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.54 -20.61 18.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.629 1.572 . . . . 0.0 112.483 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -144.79 93.29 2.39 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.851 0.834 . . . . 0.0 112.352 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -56.79 -21.25 27.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.27 1.428 . . . . 0.0 112.881 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -31.46 65.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.294 1.437 . . . . 0.0 113.018 171.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -98.7 130.08 45.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.117 1.367 . . . . 0.0 111.101 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -122.57 128.01 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.42 1.488 . . . . 0.0 110.258 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.42 166.59 10.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.069 1.348 . . . . 0.0 111.076 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.98 24.87 0.93 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 112.594 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.56 114.35 6.44 Favored Glycine 0 CA--C 1.533 1.169 0 O-C-N 121.531 -0.731 . . . . 0.0 112.741 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.73 11.67 66.21 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.063 1.316 . . . . 0.0 115.778 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -91.8 149.32 21.65 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 120.491 2.146 . . . . 0.0 111.44 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.23 -27.43 63.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.89 0.876 . . . . 0.0 111.991 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 tp -67.14 -40.33 86.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.796 0.838 . . . . 0.0 112.891 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.73 -36.25 92.9 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 119.132 0.878 . . . . 0.0 111.968 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -66.35 -37.43 85.31 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 112.095 171.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.2 tp -66.96 -46.96 73.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.709 0.803 . . . . 0.0 112.176 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.7 mt -77.96 -24.04 48.27 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.485 1.114 . . . . 0.0 113.101 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.73 8.85 87.19 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.253 0.93 . . . . 0.0 113.925 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -140.37 145.89 37.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.035 1.734 . . . . 0.0 113.091 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -104.29 8.29 35.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.364 1.065 . . . . 0.0 113.606 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -157.09 145.3 19.41 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -161.32 -177.42 6.0 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.544 2.338 . . . . 0.0 109.88 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.6 p -141.01 170.5 15.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.419 -1.426 . . . . 0.0 112.965 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.48 -11.24 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -88.24 -32.68 18.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.883 1.273 . . . . 0.0 111.873 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -127.19 71.47 76.23 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.926 1.69 . . . . 0.0 112.232 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.31 8.2 3.02 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.586 3.524 . . . . 0.0 113.734 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -46.13 -34.08 2.86 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 127.334 2.254 . . . . 0.0 116.772 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -59.81 -29.32 89.29 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 122.349 1.875 . . . . 0.0 114.318 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.79 -47.87 73.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.931 0.787 . . . . 0.0 110.579 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -65.52 -32.97 74.85 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.775 -0.578 . . . . 0.0 111.463 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.87 -31.62 68.35 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.174 0.897 . . . . 0.0 113.363 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -35.73 81.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.768 1.227 . . . . 0.0 110.768 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.84 -41.05 12.71 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.89 1.276 . . . . 0.0 114.14 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -27.61 64.84 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.671 1.588 . . . . 0.0 115.183 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.02 -24.63 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.491 1.517 . . . . 0.0 113.085 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -106.07 -45.13 4.41 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -167.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.8 170.1 8.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.54 1.536 . . . . 0.0 112.814 169.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 m -102.68 -21.51 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . 0.282 6.3 t 46.82 -168.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 129.449 3.1 . . . . 0.0 114.673 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.7 mt -76.31 149.47 37.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.167 1.387 . . . . 0.0 111.9 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.02 172.25 15.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.077 1.351 . . . . 0.0 112.656 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.242 0.663 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.782 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.466 ' H31' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 CA--C 1.545 0.768 0 CA-C-O 120.95 0.405 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.7 pt -67.15 156.06 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.43 57.2 2.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.192 1.397 . . . . 0.0 111.983 -171.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.12 -178.68 6.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.481 2.712 . . . . 0.0 109.829 -168.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.5 172.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.107 0.963 . . . . 0.0 111.303 -169.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -163.42 136.54 4.28 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 128.719 2.808 . . . . 0.0 108.006 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -101.36 174.21 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.311 2.674 . . . . 0.0 114.956 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -98.95 159.52 14.9 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.416 1.886 . . . . 0.0 107.798 167.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.1 tp -47.2 -43.8 46.97 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -66.76 -29.57 42.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.304 2.003 . . . . 0.0 114.119 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.4 mt -84.91 -33.03 22.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.627 0.771 . . . . 0.0 111.839 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.68 -35.77 77.09 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.901 0.881 . . . . 0.0 110.974 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -40.16 68.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.771 1.228 . . . . 0.0 112.717 177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -65.43 -51.92 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.859 1.664 . . . . 0.0 109.409 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.67 -30.3 66.86 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.433 -0.792 . . . . 0.0 112.932 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -34.3 76.67 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.396 -1.44 . . . . 0.0 112.878 169.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.81 -20.23 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 119.288 0.949 . . . . 0.0 112.997 170.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.74 17.51 24.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.343 1.857 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 17.52 75.62 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.98 -165.4 1.19 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.114 1.366 . . . . 0.0 112.616 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.65 52.82 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.231 1.412 . . . . 0.0 110.99 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.79 -124.26 7.39 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.303 -0.873 . . . . 0.0 112.145 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -140.27 20.26 2.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.933 1.693 . . . . 0.0 111.902 -176.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -77.63 42.48 0.37 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.199 1.8 . . . . 0.0 114.361 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -166.29 174.6 8.97 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 -167.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.74 165.89 11.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.051 2.14 . . . . 0.0 114.297 -169.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.36 -44.55 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.848 1.659 . . . . 0.0 112.012 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -64.52 -30.12 71.15 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.46 -48.58 13.69 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.35 -0.834 . . . . 0.0 111.157 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.59 -44.88 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 120.425 1.466 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.5 ptm -71.71 -28.81 63.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.72 -59.14 5.86 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.162 . . . . 0.0 110.501 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -57.62 -33.17 67.97 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -34.7 70.19 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.159 1.345 . . . . 0.0 113.92 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.36 88.15 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 120.151 1.342 . . . . 0.0 111.769 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.261 13.5 pt20 -70.56 -31.63 68.74 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 118.071 -0.966 . . . . 0.0 113.18 173.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -55.66 -53.56 55.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.847 1.658 . . . . 0.0 110.945 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.18 -42.34 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.321 1.048 . . . . 0.0 110.071 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 31.8 tpp -67.18 -30.39 70.32 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.674 0.991 . . . . 0.0 113.674 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.66 -50.59 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.754 1.221 . . . . 0.0 111.489 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -15.99 63.25 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.496 1.118 . . . . 0.0 112.951 175.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.3 pt20 45.55 42.64 8.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.261 2.624 . . . . 0.0 113.448 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.4 19.5 16.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.843 1.657 . . . . 0.0 112.552 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -88.92 166.59 13.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.951 1.701 . . . . 0.0 111.86 171.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -76.33 135.22 39.55 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.234 -0.916 . . . . 0.0 112.07 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -38.84 42.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.263 1.425 . . . . 0.0 113.208 171.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -89.79 -18.26 26.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.214 1.406 . . . . 0.0 113.067 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.91 92.33 1.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.518 1.127 . . . . 0.0 111.257 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -57.51 -18.74 20.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 112.484 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -24.81 67.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.646 1.178 . . . . 0.0 112.957 175.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -102.01 132.66 47.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.444 1.898 . . . . 0.0 110.843 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.3 t -126.8 130.18 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.67 1.588 . . . . 0.0 110.333 -170.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -101.88 165.1 11.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.057 1.343 . . . . 0.0 111.381 172.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.5 m -150.44 23.62 0.81 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.225 1.81 . . . . 0.0 112.75 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.17 114.79 7.03 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 121.409 -0.807 . . . . 0.0 112.645 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.95 12.74 65.51 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.107 1.337 . . . . 0.0 115.528 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.36 149.49 21.19 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.087 1.944 . . . . 0.0 111.452 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -58.04 -27.72 63.84 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.683 -0.635 . . . . 0.0 111.666 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.7 tp -67.19 -39.15 86.33 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.358 -0.839 . . . . 0.0 112.598 172.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.57 90.54 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 118.659 0.663 . . . . 0.0 112.211 171.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.9 -38.0 85.43 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.398 1.099 . . . . 0.0 112.189 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.44 -46.14 70.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.479 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.41 -20.67 43.41 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.457 1.103 . . . . 0.0 113.074 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.16 -9.66 52.81 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.747 1.642 . . . . 0.0 114.407 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -124.84 142.5 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.419 1.888 . . . . 0.0 111.518 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -97.58 12.48 33.37 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.5 p -157.14 148.44 22.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.586 1.154 . . . . 0.0 112.549 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.3 173.92 15.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.392 1.877 . . . . 0.0 110.401 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.0 p -141.4 171.35 14.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.659 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -71.73 -8.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.0 -24.32 16.98 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.346 1.459 . . . . 0.0 112.854 169.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -128.82 63.42 66.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.204 1.802 . . . . 0.0 112.217 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.64 6.18 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.075 3.183 . . . . 0.0 114.077 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.8 m -44.97 -37.96 5.59 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -172.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -56.58 -30.17 82.02 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.634 2.223 . . . . 0.0 115.38 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.53 -53.04 62.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.301 1.524 . . . . 0.0 110.663 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.63 -29.23 63.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.719 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.12 -31.6 72.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.884 0.873 . . . . 0.0 112.582 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.15 -40.08 82.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.515 1.126 . . . . 0.0 110.812 169.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.26 -36.13 35.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.723 1.209 . . . . 0.0 113.842 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -25.38 65.52 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.365 1.439 . . . . 0.0 114.312 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -67.5 -31.84 72.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.644 1.977 . . . . 0.0 112.27 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -109.91 -50.32 2.99 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.14 141.68 31.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.556 1.943 . . . . 0.0 109.837 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.1 m -75.21 41.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 125.087 1.355 . . . . 0.0 113.178 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.4 t -91.23 170.5 9.95 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.661 1.584 . . . . 0.0 113.661 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.64 164.56 16.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.468 1.907 . . . . 0.0 111.483 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.73 158.39 40.22 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.579 1.152 . . . . 0.0 113.767 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.468 0.465 0 C-N-CA 124.103 0.961 . . . . 0.0 113.065 -174.506 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.483 ' H32' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 121.704 0.764 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 pt -139.84 167.99 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 127.337 2.255 . . . . 0.0 112.578 -170.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.18 35.32 0.38 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.746 1.619 . . . . 0.0 114.327 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -126.09 -174.94 3.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.261 2.624 . . . . 0.0 113.01 -167.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.47 171.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.077 0.951 . . . . 0.0 110.321 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -164.73 130.43 2.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 127.964 2.505 . . . . 0.0 107.786 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -96.45 172.95 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.886 2.391 . . . . 0.0 114.254 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.1 159.3 15.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.654 1.981 . . . . 0.0 108.192 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.05 -52.9 14.54 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 -22.12 37.23 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.552 2.168 . . . . 0.0 114.008 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.3 mt -84.34 -36.75 22.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.901 0.88 . . . . 0.0 111.979 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.9 -35.95 78.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 111.166 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -51.74 -38.17 54.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.455 1.502 . . . . 0.0 112.77 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -67.49 -51.52 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.74 -30.64 67.21 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -35.14 79.47 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.477 -1.389 . . . . 0.0 112.789 171.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.41 -21.52 62.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.31 21.5 17.05 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.32 1.848 . . . . 0.0 113.661 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.43 78.01 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.981 1.152 . . . . 0.0 115.981 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.08 -164.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.0 1.32 . . . . 0.0 113.035 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -129.19 50.1 2.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.997 1.719 . . . . 0.0 111.674 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.3 -122.49 5.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.425 1.012 . . . . 0.0 113.046 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -143.59 14.8 1.78 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.041 1.736 . . . . 0.0 112.684 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -79.17 52.29 1.29 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.084 1.354 . . . . 0.0 112.549 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -168.89 169.73 9.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.176 1.79 . . . . 0.0 112.532 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 164.78 6.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 127.34 2.256 . . . . 0.0 114.109 -170.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -52.72 -44.13 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.317 1.847 . . . . 0.0 111.786 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.22 -30.08 71.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.65 -47.77 14.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.106 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.25 -46.84 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 120.183 1.356 . . . . 0.0 112.499 173.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.6 ptm -69.46 -24.81 63.85 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.05 -59.66 3.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.822 1.249 . . . . 0.0 110.751 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -56.05 -36.34 67.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.945 0.898 . . . . 0.0 113.05 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -70.88 -38.91 73.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.061 0.944 . . . . 0.0 112.01 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.22 -47.43 89.49 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.865 -1.147 . . . . 0.0 112.54 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.265 13.2 pt20 -68.71 -31.6 70.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.504 -0.997 . . . . 0.0 112.755 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -57.52 -51.08 70.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.123 1.329 . . . . 0.0 111.027 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.16 -41.96 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.198 0.908 . . . . 0.0 110.08 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.25 -34.43 78.08 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.1 -52.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.598 1.159 . . . . 0.0 111.594 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -67.23 -15.76 63.89 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.323 1.049 . . . . 0.0 113.335 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.3 5.6 pt20 46.13 47.14 13.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.445 2.698 . . . . 0.0 113.912 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.8 4.49 32.73 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.75 1.22 . . . . 0.0 113.624 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -78.53 163.3 25.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 112.706 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.57 150.11 41.68 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.952 0.882 . . . . 0.0 112.682 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.533 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -64.14 -31.84 73.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.964 1.306 . . . . 0.0 112.65 -174.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -102.66 -30.04 11.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.674 1.59 . . . . 0.0 110.461 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -110.35 80.07 1.27 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.247 1.019 . . . . 0.0 111.789 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -57.3 -22.42 41.63 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.028 -0.42 . . . . 0.0 111.605 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -26.19 54.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.9 tpt -88.62 127.55 35.57 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.087 1.312 . . . . 0.0 110.854 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 t -120.07 125.69 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.394 1.078 . . . . 0.0 110.98 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.86 167.38 10.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.914 1.285 . . . . 0.0 111.065 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.1 m -148.62 29.24 0.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.916 1.686 . . . . 0.0 112.082 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.74 113.85 6.15 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.35 -0.844 . . . . 0.0 112.542 -170.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.37 12.05 72.39 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.08 1.324 . . . . 0.0 115.576 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.21 150.8 19.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.161 1.98 . . . . 0.0 111.4 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -58.06 -27.74 63.9 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.82 -37.64 84.9 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.377 -0.827 . . . . 0.0 112.482 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.43 -38.21 94.63 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.504 -0.748 . . . . 0.0 112.008 170.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -65.8 -37.61 86.74 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.229 1.014 . . . . 0.0 112.262 172.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.87 -44.64 76.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 112.248 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -79.22 -25.0 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.391 0.676 . . . . 0.0 112.626 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.16 4.55 83.87 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.423 1.011 . . . . 0.0 113.437 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -138.24 141.72 39.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.618 1.967 . . . . 0.0 111.492 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -101.97 10.1 39.95 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 -172.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.0 p -154.52 148.87 26.1 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.54 179.05 8.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.957 2.503 . . . . 0.0 109.57 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 p -144.78 172.73 12.6 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.184 -1.572 . . . . 0.0 113.286 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.05 -21.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.422 0.689 . . . . 0.0 112.096 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.72 -21.64 19.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.12 77.21 67.94 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 111.541 174.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.84 3.62 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.394 3.396 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 m -46.68 -37.6 9.4 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.874 1.67 . . . . 0.0 115.343 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.58 -27.25 68.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.407 2.738 . . . . 0.0 116.661 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.96 -49.5 57.45 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 123.021 1.391 . . . . 0.0 110.136 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -67.94 -29.15 68.15 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 121.22 -0.925 . . . . 0.0 112.157 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.56 -31.33 72.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.356 1.062 . . . . 0.0 112.179 169.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -40.52 72.26 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.256 1.022 . . . . 0.0 111.484 169.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.45 -30.78 26.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -59.74 -26.54 65.74 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.627 1.571 . . . . 0.0 113.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -69.6 -31.04 68.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.588 1.955 . . . . 0.0 112.252 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -82.87 -71.31 0.5 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -109.77 151.22 27.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.632 1.173 . . . . 0.0 112.411 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.57 115.06 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.4 t -153.74 177.58 10.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.759 1.224 . . . . 0.0 112.32 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.98 151.33 46.2 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.572 1.549 . . . . 0.0 111.412 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.01 2.41 0.9 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 117.303 2.334 . . . . 0.0 117.303 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.322 -0.595 0 C-N-CA 124.898 1.279 . . . . 0.0 114.044 173.585 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.524 ' H32' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 CA--C 1.546 0.82 0 CA-C-O 121.593 0.711 . . . . 0.0 112.801 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 pt -68.42 159.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.68 1.192 . . . . 0.0 112.822 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -82.47 32.52 0.4 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.99 -177.2 4.19 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.969 2.507 . . . . 0.0 112.054 -168.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.99 172.31 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.362 1.065 . . . . 0.0 109.621 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.18 135.9 4.79 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 129.31 3.044 . . . . 0.0 107.344 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 24.1 Cg_endo -93.72 175.74 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.995 2.463 . . . . 0.0 115.468 -168.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -107.67 160.55 15.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.975 2.51 . . . . 0.0 107.65 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.3 tp -40.27 -55.76 3.89 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 126.271 1.828 . . . . 0.0 115.822 -175.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.94 -25.06 28.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.223 1.949 . . . . 0.0 113.452 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.34 -35.47 35.54 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.452 -0.78 . . . . 0.0 111.582 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.53 -32.73 73.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.706 0.802 . . . . 0.0 110.93 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -59.23 -40.22 85.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.919 1.288 . . . . 0.0 112.759 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -65.76 -46.08 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.196 1.398 . . . . 0.0 109.98 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.6 -30.81 67.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.081 0.552 . . . . 0.0 112.225 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -66.37 -37.2 84.74 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.095 -1.628 . . . . 0.0 112.178 169.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.89 -24.07 67.42 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.952 0.796 . . . . 0.0 112.033 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.51 4.81 30.14 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.65 1.58 . . . . 0.0 114.339 169.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.56 78.43 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.529 1.061 . . . . 0.0 115.364 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.01 -160.93 0.78 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.899 1.68 . . . . 0.0 113.092 -174.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -137.28 68.84 1.41 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.63 -146.09 32.28 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.903 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 48.2 mt-10 -129.48 19.06 5.77 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.235 2.214 . . . . 0.0 112.092 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.1 ttt -79.71 52.73 1.49 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.928 1.291 . . . . 0.0 112.38 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -166.35 175.87 7.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.41 1.884 . . . . 0.0 114.179 -169.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -78.13 170.19 17.02 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.782 2.433 . . . . 0.0 114.379 -169.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.4 t -52.77 -42.84 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 126.866 2.066 . . . . 0.0 111.773 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -65.98 -30.11 70.61 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.33 -47.87 13.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.022 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -55.21 -45.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 120.193 1.36 . . . . 0.0 112.697 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.7 ptm -70.75 -25.65 63.01 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.49 -59.8 3.61 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -55.73 -39.97 71.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.038 0.935 . . . . 0.0 112.849 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.84 -43.03 90.65 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.299 -0.876 . . . . 0.0 112.898 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.12 -46.86 84.32 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.259 0.936 . . . . 0.0 112.595 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 14.2 pt20 -71.8 -31.62 66.76 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.741 -0.858 . . . . 0.0 113.312 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -59.09 -51.7 68.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.622 1.556 . . . . 0.0 111.253 169.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.55 -43.34 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.22 1.008 . . . . 0.0 110.081 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.6 tpp -67.48 -32.52 73.42 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.9 t -75.45 -51.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.728 1.211 . . . . 0.0 111.446 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -66.75 -16.02 63.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.895 0.878 . . . . 0.0 112.88 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.296 6.2 pt20 44.25 43.7 6.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 128.36 2.664 . . . . 0.0 113.635 175.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -102.08 21.96 13.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.713 1.605 . . . . 0.0 112.848 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -87.54 169.74 11.92 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.414 1.886 . . . . 0.0 111.895 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.38 144.24 44.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.255 -0.903 . . . . 0.0 112.678 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.495 ' NE2' ' H ' ' A' ' 68' ' ' GLN . 0.6 OUTLIER -64.14 -39.89 94.99 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.543 1.937 . . . . 0.0 112.417 -177.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -92.38 -21.84 20.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.3 1.44 . . . . 0.0 112.362 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -138.99 88.27 2.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.393 1.092 . . . . 0.0 112.93 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -56.17 -17.84 8.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.418 1.087 . . . . 0.0 112.918 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -25.43 68.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.452 1.101 . . . . 0.0 112.978 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -103.11 134.32 46.74 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.884 1.674 . . . . 0.0 111.241 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -126.42 132.48 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.442 1.497 . . . . 0.0 110.778 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -112.9 162.47 15.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.915 1.686 . . . . 0.0 111.35 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.6 m -146.19 28.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.309 1.443 . . . . 0.0 111.864 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.99 106.43 0.23 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.464 1.031 . . . . 0.0 114.642 -169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.86 14.76 65.96 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.994 1.283 . . . . 0.0 115.493 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.35 153.95 20.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.2 1.5 . . . . 0.0 112.365 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -57.55 -27.93 63.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.564 0.746 . . . . 0.0 111.994 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.58 -41.32 88.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.1 0.864 . . . . 0.0 112.213 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.42 -37.79 94.93 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.724 -0.61 . . . . 0.0 111.825 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -66.53 -38.4 87.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.024 0.929 . . . . 0.0 112.274 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 tp -65.6 -46.06 80.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.054 1.342 . . . . 0.0 112.102 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -76.48 -26.81 55.74 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.29 2.01 71.84 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.009 0.814 . . . . 0.0 112.862 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -142.01 136.02 29.86 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 129.807 3.243 . . . . 0.0 108.058 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.284 9.0 pt20 -112.16 17.67 19.33 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.8 p -153.4 145.33 23.6 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.089 -1.007 . . . . 0.0 113.07 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -161.0 170.47 20.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.836 1.655 . . . . 0.0 111.208 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.0 p -137.32 170.88 15.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.671 0.788 . . . . 0.0 111.753 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -7.58 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -95.11 -27.13 15.73 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.133 1.373 . . . . 0.0 112.73 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -131.4 78.67 71.38 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.648 1.579 . . . . 0.0 111.199 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.15 5.44 6.24 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.273 3.315 . . . . 0.0 113.799 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -44.53 -38.0 4.98 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -173.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -59.07 -28.83 88.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.966 2.444 . . . . 0.0 115.932 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 tp -58.87 -53.3 59.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 123.158 1.456 . . . . 0.0 109.929 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.56 -29.17 62.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.296 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -64.38 -31.34 72.51 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.441 1.019 . . . . 0.0 112.529 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.5 ttp -72.2 -42.72 65.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.053 0.941 . . . . 0.0 110.335 169.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.14 -32.25 44.34 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -59.24 -28.1 66.39 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.772 1.629 . . . . 0.0 114.026 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.4 -26.57 58.52 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.629 1.971 . . . . 0.0 112.837 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -101.06 -47.87 4.61 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.58 1.152 . . . . 0.0 113.839 -174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.24 159.65 29.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.478 1.511 . . . . 0.0 112.09 169.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.85 39.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 125.302 1.441 . . . . 0.0 113.862 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 t -82.88 174.86 10.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.648 1.179 . . . . 0.0 112.862 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.79 153.38 41.12 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.342 1.457 . . . . 0.0 112.29 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.37 166.78 26.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 112.5 172.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.064 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.463 ' H32' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 CA--C 1.546 0.803 0 CA-C-O 121.012 0.434 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.8 pt -68.17 168.36 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.208 1.403 . . . . 0.0 113.115 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.51 33.75 0.21 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.948 1.699 . . . . 0.0 114.19 -175.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -127.61 -175.54 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 129.216 3.007 . . . . 0.0 112.032 -167.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -92.5 172.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.862 1.265 . . . . 0.0 109.9 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.3 ttp85 -164.77 142.66 5.32 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 130.108 3.363 . . . . 0.0 107.722 168.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -105.67 170.86 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.198 2.599 . . . . 0.0 114.111 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -83.44 158.76 21.95 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.727 1.211 . . . . 0.0 108.149 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.44 -50.43 22.85 Favored Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.43 -25.53 35.5 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.168 1.912 . . . . 0.0 114.274 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -81.19 -37.79 28.12 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.518 0.727 . . . . 0.0 111.436 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.67 -42.57 98.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.091 1.356 . . . . 0.0 111.719 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 40.2 pttt -68.49 -22.95 64.52 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -62.12 -52.79 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 109.347 169.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.69 -30.58 67.2 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -32.16 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.818 -1.176 . . . . 0.0 113.271 170.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.27 -22.64 63.34 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.136 0.88 . . . . 0.0 112.955 170.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.5 23.65 13.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.089 1.756 . . . . 0.0 113.462 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.73 15.6 79.4 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.43 -163.55 0.58 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.384 1.092 . . . . 0.0 113.173 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -132.32 49.2 2.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.019 2.128 . . . . 0.0 109.842 168.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.99 -115.73 4.77 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.737 1.16 . . . . 0.0 112.721 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.86 17.39 3.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.142 1.777 . . . . 0.0 111.241 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.5 ttt -74.52 50.73 0.43 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.314 1.846 . . . . 0.0 113.482 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -173.5 170.92 4.04 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.66 1.984 . . . . 0.0 112.666 -169.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.25 165.74 11.05 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.277 2.231 . . . . 0.0 113.594 -172.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -51.55 -44.68 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 126.581 1.952 . . . . 0.0 112.043 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -65.15 -30.18 71.08 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -80.38 -45.39 17.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.124 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -57.35 -45.04 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 120.075 1.307 . . . . 0.0 112.506 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.9 ptm -70.05 -24.16 63.21 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -66.78 -57.72 6.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.127 1.371 . . . . 0.0 110.983 170.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -56.48 -36.84 69.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.026 0.93 . . . . 0.0 113.145 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tt -71.79 -40.36 69.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.483 -0.761 . . . . 0.0 111.742 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.51 -47.43 89.97 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.9 -1.125 . . . . 0.0 112.807 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -69.59 -31.54 69.75 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.212 -1.17 . . . . 0.0 112.641 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.11 -50.61 72.27 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.957 1.253 . . . . 0.0 110.942 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mt -57.89 -43.74 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.706 0.684 . . . . 0.0 110.242 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.16 -32.97 74.72 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.53 -50.9 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.412 1.085 . . . . 0.0 111.518 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -15.87 63.66 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.376 1.07 . . . . 0.0 113.181 176.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.2 pt20 45.44 43.43 8.68 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.331 2.652 . . . . 0.0 113.62 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.03 8.39 43.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.668 1.587 . . . . 0.0 112.936 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -74.39 162.96 28.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.693 1.197 . . . . 0.0 112.268 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.48 147.77 41.61 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -47.1 78.56 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -76.77 -19.92 57.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.41 94.92 2.28 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.462 1.125 . . . . 0.0 113.311 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.84 -17.96 28.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.299 1.44 . . . . 0.0 112.876 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -25.17 65.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.943 0.897 . . . . 0.0 113.104 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.8 tpp -93.95 129.18 40.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 109.742 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.12 113.03 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.812 1.645 . . . . 0.0 109.806 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -86.91 165.12 16.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.783 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.74 25.28 1.18 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.584 1.553 . . . . 0.0 112.596 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.54 114.82 6.64 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.561 -0.712 . . . . 0.0 112.948 -169.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.74 10.93 72.72 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.144 1.354 . . . . 0.0 115.853 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.38 150.01 21.06 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.404 2.102 . . . . 0.0 111.437 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.01 -27.66 63.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.535 -0.728 . . . . 0.0 112.735 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.45 -39.74 94.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.383 0.992 . . . . 0.0 112.068 171.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.61 95.78 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.501 0.572 . . . . 0.0 112.146 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.98 -43.13 95.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.122 0.961 . . . . 0.0 111.995 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -70.65 -46.16 63.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.242 1.017 . . . . 0.0 111.892 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -71.82 -27.76 63.13 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.072 0.949 . . . . 0.0 112.563 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.03 7.24 83.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.345 1.45 . . . . 0.0 114.499 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.54 147.94 30.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.072 1.749 . . . . 0.0 111.721 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -101.98 9.87 40.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 113.448 -173.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -153.25 144.08 22.79 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.82 170.82 20.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.955 2.102 . . . . 0.0 110.67 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -136.58 154.4 50.7 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.701 0.8 . . . . 0.0 112.023 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.29 -14.89 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.87 -7.12 57.63 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.424 1.49 . . . . 0.0 113.731 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -145.24 64.27 10.69 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.707 1.603 . . . . 0.0 111.48 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.73 2.77 7.89 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.206 3.271 . . . . 0.0 114.714 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.9 m -48.5 -33.1 4.48 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -54.5 -31.0 67.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.115 2.543 . . . . 0.0 115.812 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.5 -48.76 46.93 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.621 1.169 . . . . 0.0 110.379 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -67.02 -29.24 69.0 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.011 -1.056 . . . . 0.0 112.177 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.95 -31.56 72.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.708 1.203 . . . . 0.0 112.526 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -32.5 70.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.866 1.267 . . . . 0.0 112.236 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.5 -31.62 16.69 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -62.73 -27.86 69.56 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.855 1.262 . . . . 0.0 113.935 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -62.44 -29.04 70.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.948 0.899 . . . . 0.0 112.109 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -87.65 -92.97 0.1 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.51 169.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.91 143.81 25.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.391 1.076 . . . . 0.0 112.922 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 m -81.13 62.91 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.732 1.213 . . . . 0.0 111.87 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -66.54 163.64 18.25 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.378 1.071 . . . . 0.0 113.467 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.1 mt -91.04 -0.56 57.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.955 1.702 . . . . 0.0 114.565 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.09 157.03 27.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.402 1.481 . . . . 0.0 112.73 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -171.376 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.498 ' H32' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 pt -143.54 164.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.645 1.978 . . . . 0.0 111.911 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -86.39 45.99 1.3 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.905 1.282 . . . . 0.0 112.776 -173.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.55 -173.06 3.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 130.389 3.476 . . . . 0.0 108.457 -169.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.08 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.983 -1.073 . . . . 0.0 111.55 -172.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -158.19 139.18 9.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 131.329 3.852 . . . . 0.0 106.729 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -96.72 167.01 1.04 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.242 2.628 . . . . 0.0 113.681 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -79.93 161.48 25.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.399 1.08 . . . . 0.0 108.597 167.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.92 -42.03 66.92 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -68.61 -29.32 30.26 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.264 1.976 . . . . 0.0 114.246 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.89 -31.2 25.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.955 0.902 . . . . 0.0 112.108 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.25 -43.23 87.76 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.943 0.897 . . . . 0.0 111.056 173.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.309 16.9 pttp -72.76 -24.84 61.0 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.67 -52.08 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 109.475 170.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.54 -30.72 70.44 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.483 -0.761 . . . . 0.0 112.463 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -29.9 69.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.678 -1.264 . . . . 0.0 113.378 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.33 59.78 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.4 21.81 16.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.157 1.783 . . . . 0.0 113.684 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.25 17.03 78.63 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.24 -156.23 0.16 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.859 1.264 . . . . 0.0 112.731 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -141.24 60.15 1.51 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.569 1.948 . . . . 0.0 109.624 168.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.29 18.02 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.584 -172.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -135.64 20.4 3.33 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.699 2.0 . . . . 0.0 110.923 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -76.07 54.74 0.88 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.876 1.67 . . . . 0.0 112.955 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -173.29 172.21 3.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.286 1.834 . . . . 0.0 112.384 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 167.07 13.76 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.814 2.045 . . . . 0.0 114.084 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -49.45 -45.88 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.455 1.902 . . . . 0.0 112.169 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -65.09 -30.07 70.99 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.79 -46.72 16.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.137 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -55.71 -46.72 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 120.477 1.489 . . . . 0.0 112.337 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 23.1 ptm -69.51 -27.44 65.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -62.47 -58.07 8.93 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.558 1.143 . . . . 0.0 110.758 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -58.31 -32.56 68.58 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.13 -41.27 81.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.559 1.072 . . . . 0.0 112.82 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.44 -47.42 88.2 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.963 0.801 . . . . 0.0 112.093 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.252 11.5 pt20 -70.72 -31.7 68.63 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.554 -0.968 . . . . 0.0 113.08 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.45 -51.93 66.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.454 1.479 . . . . 0.0 111.014 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.5 mt -60.59 -41.61 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.068 0.947 . . . . 0.0 110.272 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 37.7 tpp -67.78 -31.97 72.23 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.08 -50.4 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.357 1.063 . . . . 0.0 111.347 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -16.03 63.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.968 0.907 . . . . 0.0 113.125 175.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.4 pt20 43.49 43.07 4.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.455 2.702 . . . . 0.0 113.647 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 tp -99.51 20.21 14.28 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.523 1.529 . . . . 0.0 112.689 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -83.88 165.71 18.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 111.883 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.46 148.52 45.04 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.169 0.985 . . . . 0.0 113.026 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.536 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.7 -38.41 76.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.833 1.653 . . . . 0.0 111.43 -176.343 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -90.94 -20.39 22.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.585 1.554 . . . . 0.0 112.295 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -144.04 93.18 2.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.415 1.103 . . . . 0.0 112.414 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -57.69 -18.51 21.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.152 1.381 . . . . 0.0 112.821 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.78 63.64 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.24 1.016 . . . . 0.0 113.133 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -97.86 129.81 44.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.063 1.745 . . . . 0.0 110.302 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.03 131.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.114 1.366 . . . . 0.0 110.65 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -105.62 165.71 10.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.297 1.439 . . . . 0.0 111.6 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.02 24.24 1.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.151 1.781 . . . . 0.0 112.771 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.38 113.68 5.71 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.603 -0.685 . . . . 0.0 112.647 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.98 13.03 66.07 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.12 1.343 . . . . 0.0 115.676 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -95.25 148.42 22.43 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.39 2.095 . . . . 0.0 111.382 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.88 -27.8 63.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.47 0.708 . . . . 0.0 111.943 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.11 -39.95 90.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.4 -0.812 . . . . 0.0 112.465 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.93 92.59 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 118.543 0.61 . . . . 0.0 112.223 172.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -65.11 -36.68 85.07 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 117.893 0.846 . . . . 0.0 112.19 171.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.27 -50.51 53.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.606 1.162 . . . . 0.0 111.2 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.67 -24.02 58.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.123 0.969 . . . . 0.0 113.082 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.47 7.78 85.87 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.161 1.362 . . . . 0.0 114.634 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 150.19 33.84 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.886 1.674 . . . . 0.0 111.854 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -99.1 11.49 38.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.118 0.967 . . . . 0.0 113.434 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -155.32 149.73 26.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.86 177.84 10.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.65 1.98 . . . . 0.0 111.129 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 t -140.2 154.55 46.96 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.011 -1.056 . . . . 0.0 111.892 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.2 m -66.22 -12.92 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 169.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -83.18 -17.2 43.69 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.65 1.18 . . . . 0.0 113.026 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -140.38 69.87 32.92 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 111.478 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.75 3.95 4.5 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.21 3.273 . . . . 0.0 114.564 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -45.4 -35.45 3.22 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 126.364 1.866 . . . . 0.0 115.736 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -56.69 -30.09 82.56 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.95 2.433 . . . . 0.0 115.73 173.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.74 -45.56 61.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.177 0.899 . . . . 0.0 110.142 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.45 -30.25 69.92 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.621 -0.674 . . . . 0.0 112.275 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -66.72 -31.31 71.88 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.858 1.263 . . . . 0.0 112.872 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -33.33 67.44 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.292 1.437 . . . . 0.0 112.207 170.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.98 -27.02 18.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.959 1.704 . . . . 0.0 114.545 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -61.46 -23.37 65.82 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.4 1.48 . . . . 0.0 113.963 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -65.69 -27.31 68.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.546 1.938 . . . . 0.0 112.344 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -101.96 -71.7 0.71 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.147 0.979 . . . . 0.0 113.331 172.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.96 163.23 21.17 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.115 1.366 . . . . 0.0 113.345 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.5 m -100.36 33.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.89 1.676 . . . . 0.0 111.492 169.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 t -82.01 173.78 11.86 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.33 1.452 . . . . 0.0 114.075 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.0 mt -102.99 165.58 10.94 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.866 2.066 . . . . 0.0 111.95 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.94 161.63 27.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.084 1.354 . . . . 0.0 113.047 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.747 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.409 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 . . . . . 0 CA--C 1.545 0.75 0 CA-C-O 120.754 0.311 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.5 pt -92.92 166.32 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.315 1.446 . . . . 0.0 113.072 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -81.26 35.14 0.38 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.586 1.554 . . . . 0.0 113.912 -174.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -129.64 -177.66 4.36 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 128.42 2.688 . . . . 0.0 113.114 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.68 172.23 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.851 1.661 . . . . 0.0 111.677 -176.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -163.35 143.42 6.91 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 130.173 3.389 . . . . 0.0 108.22 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -102.65 169.37 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.783 2.989 . . . . 0.0 113.843 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -87.4 164.45 16.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 109.792 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.5 tp -42.82 -56.32 6.22 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.926 1.69 . . . . 0.0 115.377 -172.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.89 -26.8 37.67 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.215 1.943 . . . . 0.0 113.821 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.7 mt -80.83 -34.59 33.78 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.363 -0.836 . . . . 0.0 112.243 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.39 -32.16 73.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.795 1.238 . . . . 0.0 110.988 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -58.57 -41.69 86.28 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.42 1.488 . . . . 0.0 112.861 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.86 -51.31 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.187 1.395 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.32 13.6 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -61.43 -33.96 74.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.613 -1.304 . . . . 0.0 112.399 169.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.05 62.35 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.247 0.93 . . . . 0.0 113.317 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 23.52 13.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.008 1.723 . . . . 0.0 113.434 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.26 79.62 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.676 1.131 . . . . 0.0 115.687 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.0 -169.58 2.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.466 1.106 . . . . 0.0 113.247 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -123.39 44.74 2.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.678 1.991 . . . . 0.0 110.841 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.74 -115.33 4.12 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.983 1.278 . . . . 0.0 112.646 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -139.51 15.77 2.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.741 2.016 . . . . 0.0 110.769 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 56.6 ttp -77.0 52.39 0.87 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.609 1.564 . . . . 0.0 112.772 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -171.61 171.48 5.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.521 1.929 . . . . 0.0 112.693 -168.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -65.63 165.63 12.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.501 1.92 . . . . 0.0 112.214 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.86 -37.92 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.16 0.984 . . . . 0.0 112.185 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.33 -30.04 69.26 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -80.52 -43.48 20.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.512 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 m -54.96 -50.01 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 120.551 1.523 . . . . 0.0 113.016 175.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -68.49 -23.98 64.63 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.043 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.18 -59.17 3.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.989 1.316 . . . . 0.0 111.033 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -56.19 -36.83 68.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.133 0.973 . . . . 0.0 113.119 174.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.86 -42.53 73.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.939 0.895 . . . . 0.0 112.707 174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.49 -47.36 76.92 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.398 -0.814 . . . . 0.0 111.813 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.93 -31.55 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.543 -0.974 . . . . 0.0 113.555 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -55.34 -50.41 69.72 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.727 1.603 . . . . 0.0 111.06 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.8 mt -63.45 -42.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.151 0.98 . . . . 0.0 110.531 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -45.36 92.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.634 1.174 . . . . 0.0 111.467 177.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.62 -48.39 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.079 0.952 . . . . 0.0 111.72 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -67.1 -16.11 64.13 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.284 6.3 pt20 41.93 42.88 2.44 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.868 2.467 . . . . 0.0 113.462 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -98.32 16.28 22.0 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.511 1.524 . . . . 0.0 113.309 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -81.71 160.4 23.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.985 1.314 . . . . 0.0 111.178 169.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -74.45 133.46 42.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.038 -1.039 . . . . 0.0 112.048 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.46 -33.66 60.04 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.876 1.67 . . . . 0.0 113.579 171.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -83.82 -27.38 28.8 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.012 1.325 . . . . 0.0 112.422 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.33 95.63 1.95 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.546 1.138 . . . . 0.0 111.655 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -60.51 -14.92 22.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.737 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.38 69.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.629 0.772 . . . . 0.0 112.743 173.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.5 tpp -91.84 130.6 37.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.021 1.729 . . . . 0.0 110.356 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.06 118.09 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.041 1.737 . . . . 0.0 109.764 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.41 162.06 14.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.538 1.135 . . . . 0.0 111.736 171.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -153.88 27.12 0.48 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.065 2.146 . . . . 0.0 112.21 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 118.6 13.08 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.33 -0.856 . . . . 0.0 113.349 -169.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.52 8.61 67.25 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.005 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -98.53 156.1 16.95 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 120.573 2.187 . . . . 0.0 112.272 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.56 -27.62 66.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.713 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 tp -66.84 -44.29 81.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.224 -0.922 . . . . 0.0 112.9 173.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.02 86.12 Favored Glycine 0 N--CA 1.477 1.424 0 CA-C-O 118.151 -1.361 . . . . 0.0 112.411 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.48 -40.03 92.63 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.014 1.907 . . . . 0.0 112.334 170.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -70.32 -51.73 28.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.082 0.953 . . . . 0.0 111.144 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.9 -20.14 61.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 112.198 176.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.73 13.04 82.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.749 1.642 . . . . 0.0 114.686 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -129.31 -25.17 2.73 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 121.63 3.937 . . . . 0.0 121.63 -169.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 55.05 2.85 0.05 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.3 p -157.22 138.3 13.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.837 1.255 . . . . 0.0 112.68 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.89 176.11 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.121 1.768 . . . . 0.0 110.681 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 t -140.5 156.93 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.135 -0.978 . . . . 0.0 111.363 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.08 -18.03 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.668 -0.645 . . . . 0.0 112.446 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.15 -1.89 50.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 113.897 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -137.81 60.58 25.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.889 1.676 . . . . 0.0 111.803 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -79.15 -0.11 10.48 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.946 3.097 . . . . 0.0 113.908 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.2 m -46.82 -32.45 2.11 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.72 -24.57 68.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.157 1.904 . . . . 0.0 114.132 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.82 -47.4 53.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.853 0.861 . . . . 0.0 110.11 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -68.22 -30.52 69.61 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.518 -0.739 . . . . 0.0 112.462 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.54 -31.52 72.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.471 1.032 . . . . 0.0 112.917 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -34.2 73.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.39 1.476 . . . . 0.0 112.099 171.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.65 -33.8 15.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 114.443 -175.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -58.25 -28.36 64.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.206 1.403 . . . . 0.0 113.689 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.15 -27.14 68.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.847 2.059 . . . . 0.0 112.556 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -98.37 -70.0 0.74 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.72 1.208 . . . . 0.0 113.177 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.84 155.29 39.68 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.932 1.693 . . . . 0.0 113.272 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.37 -26.21 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 t 51.07 -178.02 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 129.737 3.215 . . . . 0.0 116.63 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.38 156.91 31.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.96 2.504 . . . . 0.0 109.381 169.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.67 164.77 26.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.098 0.959 . . . . 0.0 113.192 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.241 0.638 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.011 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.2 pt -76.53 162.52 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.408 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.9 m120 -85.23 38.41 0.72 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.658 1.583 . . . . 0.0 114.384 -169.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.408 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -131.37 -177.65 4.49 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.432 2.293 . . . . 0.0 112.558 -167.475 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 m -94.55 172.13 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.528 1.131 . . . . 0.0 110.289 -175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -162.21 144.14 8.39 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 128.089 2.555 . . . . 0.0 109.001 -172.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 8.5 Cg_endo -98.52 176.27 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.143 2.562 . . . . 0.0 114.705 -169.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -105.83 157.37 17.51 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.674 1.99 . . . . 0.0 107.507 167.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.8 mt -47.37 -46.01 56.93 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.87 -21.74 20.86 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.922 1.748 . . . . 0.0 114.015 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.24 -34.15 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.934 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.5 -41.62 81.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 111.629 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.269 18.3 pttp -72.52 -21.84 61.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.6 mt -69.69 -45.8 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.648 1.179 . . . . 0.0 110.083 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.67 -37.21 86.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.466 -0.771 . . . . 0.0 111.233 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.829 -1.169 . . . . 0.0 113.436 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.43 -22.26 61.22 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 112.99 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.13 22.12 14.59 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.074 1.75 . . . . 0.0 113.543 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 17.55 78.66 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.75 -156.07 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.89 1.276 . . . . 0.0 112.996 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -148.41 67.28 1.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.312 1.845 . . . . 0.0 110.489 169.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.13 -146.62 36.6 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.749 -172.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 45.4 mt-10 -122.19 15.39 10.62 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.868 2.067 . . . . 0.0 111.958 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.6 ttt -79.45 59.15 2.84 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.874 1.27 . . . . 0.0 113.705 -168.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -170.41 177.75 3.96 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.296 1.838 . . . . 0.0 113.719 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.35 165.64 13.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.521 2.328 . . . . 0.0 114.387 -172.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.4 t -52.12 -47.01 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 125.958 1.703 . . . . 0.0 111.843 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -62.52 -30.08 71.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -78.83 -47.93 15.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.067 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -55.88 -45.42 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 120.463 1.483 . . . . 0.0 112.376 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.5 ptm -70.26 -26.28 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -64.61 -59.43 4.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.162 1.385 . . . . 0.0 110.868 171.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -56.41 -36.25 68.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.784 0.834 . . . . 0.0 113.189 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.99 -44.64 88.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.054 0.941 . . . . 0.0 112.343 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.831 0.741 . . . . 0.0 112.249 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.28 11.2 pt20 -70.67 -31.54 68.48 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.392 -1.063 . . . . 0.0 113.087 176.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -55.97 -54.48 44.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.247 1.385 . . . . 0.0 110.496 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.34 -42.25 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.809 0.843 . . . . 0.0 110.146 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -34.93 79.49 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.9 t -78.24 -50.28 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 111.174 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.3 64.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.963 0.905 . . . . 0.0 112.665 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.333 5.8 pt20 46.44 39.44 6.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.667 2.787 . . . . 0.0 114.523 176.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -91.6 51.44 1.87 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.249 1.42 . . . . 0.0 111.42 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -124.97 162.51 24.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.787 2.035 . . . . 0.0 111.376 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.25 138.5 47.52 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.349 -0.844 . . . . 0.0 111.837 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -48.51 79.0 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.06 -1.025 . . . . 0.0 112.864 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -80.93 -6.39 58.64 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.128 0.876 . . . . 0.0 113.031 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.7 86.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.573 1.177 . . . . 0.0 111.365 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.07 -15.42 32.46 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.145 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -22.2 65.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.84 1.256 . . . . 0.0 113.146 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 43.2 tpp -107.24 134.6 50.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.073 2.149 . . . . 0.0 111.143 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.02 133.24 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.996 1.718 . . . . 0.0 110.275 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.41 84.88 2.11 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.301 2.241 . . . . 0.0 110.603 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -80.39 38.59 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.187 2.595 . . . . 0.0 113.451 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 113.03 2.49 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.305 -0.872 . . . . 0.0 114.609 -168.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.59 11.61 77.15 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.057 1.313 . . . . 0.0 116.187 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.93 156.8 20.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.944 1.872 . . . . 0.0 112.366 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.56 -28.06 59.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 112.755 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.23 -37.62 81.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.17 -0.956 . . . . 0.0 112.21 171.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.66 -39.93 98.06 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.415 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -64.83 -38.48 91.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.841 1.321 . . . . 0.0 112.07 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -69.56 -46.48 66.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.258 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.08 -18.64 45.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.816 1.246 . . . . 0.0 113.297 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.01 73.93 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.84 1.686 . . . . 0.0 114.937 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.39 -36.89 0.71 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -169.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 5.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.5 p -145.78 135.53 23.4 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.468 1.485 . . . . 0.0 114.586 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -169.94 168.28 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.717 2.407 . . . . 0.0 109.521 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 p -132.86 171.48 13.86 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.424 -0.797 . . . . 0.0 111.282 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.81 -9.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.261 -0.899 . . . . 0.0 113.378 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -95.05 -25.58 16.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.238 1.415 . . . . 0.0 112.984 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -130.63 70.92 82.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 125.973 1.709 . . . . 0.0 111.907 174.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -88.09 16.31 1.92 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 125.02 3.813 . . . . 0.0 114.853 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.1 p -50.85 -31.01 4.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.3 -31.72 52.37 Favored 'Trans proline' 0 C--N 1.357 0.987 0 CA-C-N 123.959 2.449 . . . . 0.0 114.108 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.4 -49.21 72.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.174 1.39 . . . . 0.0 110.531 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.05 -29.19 57.95 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.366 -0.834 . . . . 0.0 112.452 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.06 -32.96 72.81 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.295 -0.878 . . . . 0.0 113.241 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.3 ttp -68.52 -41.36 80.04 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.267 1.427 . . . . 0.0 110.617 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.04 -48.68 56.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.315 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -58.13 -31.92 67.66 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.92 -26.42 64.14 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.738 2.015 . . . . 0.0 112.917 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -99.36 -93.69 0.26 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 110.55 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.2 tp -78.0 114.76 17.18 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 119.92 1.236 . . . . 0.0 110.213 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -60.08 115.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.604 -0.685 . . . . 0.0 109.749 169.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.8 t -151.85 175.55 12.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.83 0.852 . . . . 0.0 113.087 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.52 158.17 31.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.605 1.562 . . . . 0.0 112.234 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.54 167.44 22.08 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.766 1.226 . . . . 0.0 113.228 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -176.465 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.459 ' H31' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.32 158.22 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.718 2.007 . . . . 0.0 113.243 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -91.58 53.33 2.23 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.184 1.394 . . . . 0.0 112.102 -171.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.18 -176.62 4.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.055 2.942 . . . . 0.0 109.159 -168.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.46 171.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 120.987 -1.071 . . . . 0.0 111.818 -169.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -162.67 140.48 6.38 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 129.527 3.131 . . . . 0.0 107.279 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 1.1 Cg_endo -103.57 179.37 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.048 2.499 . . . . 0.0 115.28 -169.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -108.73 158.47 17.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.784 2.433 . . . . 0.0 107.213 167.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -45.24 -47.05 33.51 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 -23.13 30.89 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.058 1.839 . . . . 0.0 114.694 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.19 -35.47 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.376 0.67 . . . . 0.0 111.865 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.47 -41.88 81.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.329 1.052 . . . . 0.0 111.601 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -71.38 -20.44 62.14 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.55 -51.68 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 109.285 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.97 -34.2 76.09 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.605 -0.685 . . . . 0.0 111.753 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -30.7 68.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.892 -1.13 . . . . 0.0 113.188 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.98 60.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.519 0.727 . . . . 0.0 112.869 169.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.77 22.35 15.3 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.195 1.798 . . . . 0.0 113.533 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.64 16.98 78.99 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.644 1.018 . . . . 0.0 115.644 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.73 -156.7 0.16 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.97 1.308 . . . . 0.0 112.729 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.27 59.94 1.55 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.559 1.544 . . . . 0.0 110.364 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.64 -141.7 27.88 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.848 -172.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.445 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.3 mt-10 -121.72 21.33 10.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.799 2.04 . . . . 0.0 112.138 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.5 ptm -74.72 41.17 0.15 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -169.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -166.62 174.48 8.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.707 1.603 . . . . 0.0 113.979 -168.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.66 167.66 16.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.32 2.248 . . . . 0.0 114.236 -169.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -49.15 -43.43 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 126.317 1.847 . . . . 0.0 112.75 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -31.28 70.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -77.76 -46.43 21.74 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.098 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.45 -46.24 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 120.319 1.418 . . . . 0.0 112.586 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.2 ptm -69.46 -28.21 65.9 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.52 -59.04 6.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.618 1.167 . . . . 0.0 110.851 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -55.81 -36.77 67.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 113.386 173.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.17 -36.98 80.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.839 1.199 . . . . 0.0 113.129 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.74 -47.42 90.41 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.927 1.24 . . . . 0.0 112.232 173.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.272 13.4 pt20 -70.22 -31.5 68.95 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.451 -1.029 . . . . 0.0 113.081 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -55.89 -54.5 43.95 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.207 1.367 . . . . 0.0 110.07 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.3 mt -59.03 -39.98 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.931 0.892 . . . . 0.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.8 tpp -69.11 -32.35 71.7 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.23 -51.35 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.028 -1.045 . . . . 0.0 111.344 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -68.08 -12.96 61.79 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.307 1.443 . . . . 0.0 113.064 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.31 5.8 pt20 48.76 50.18 17.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.37 3.068 . . . . 0.0 114.023 169.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.6 mt -88.4 3.91 48.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.531 1.133 . . . . 0.0 113.741 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -89.11 162.2 16.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.455 1.102 . . . . 0.0 113.015 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -78.9 152.3 31.25 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.79 -47.34 63.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -77.7 -17.33 57.76 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -149.61 87.07 1.48 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.059 0.933 . . . . 0.0 111.787 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -55.94 -22.81 28.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.763 1.625 . . . . 0.0 112.44 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.09 -34.35 56.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.301 1.84 . . . . 0.0 112.987 170.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tpt -99.51 135.33 41.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.002 1.721 . . . . 0.0 111.158 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -132.08 136.73 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.025 1.73 . . . . 0.0 110.487 -170.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -105.94 175.0 5.64 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.187 1.795 . . . . 0.0 112.194 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.88 20.24 0.32 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.714 1.606 . . . . 0.0 113.733 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.3 115.75 5.01 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.845 0.736 . . . . 0.0 114.115 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.34 6.97 71.38 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.305 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -96.6 158.81 15.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 121.089 2.445 . . . . 0.0 112.506 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -27.69 68.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.996 0.918 . . . . 0.0 112.13 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.38 -41.57 96.62 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.38 -0.825 . . . . 0.0 111.994 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.22 96.94 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 119.339 0.972 . . . . 0.0 112.654 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -43.89 95.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.479 1.14 . . . . 0.0 111.722 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.73 -46.38 66.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.326 1.05 . . . . 0.0 112.245 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.28 -25.71 63.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.804 1.241 . . . . 0.0 113.035 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 4.67 75.5 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.394 0.997 . . . . 0.0 113.796 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -138.39 141.25 39.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 112.393 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -102.99 7.76 39.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.719 1.208 . . . . 0.0 113.27 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.0 p -155.92 143.42 19.41 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.498 1.119 . . . . 0.0 112.462 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.73 178.7 8.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.117 2.167 . . . . 0.0 110.262 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.7 p -142.98 170.38 15.81 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.649 -1.282 . . . . 0.0 112.969 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.51 -19.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.898 0.879 . . . . 0.0 112.943 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.08 -10.74 29.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.037 1.335 . . . . 0.0 113.803 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -132.61 62.73 64.41 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.832 1.653 . . . . 0.0 112.639 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.08 0.17 9.63 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.106 3.204 . . . . 0.0 114.09 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.6 m -42.77 -39.32 3.55 Favored Pre-proline 0 N--CA 1.472 0.663 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.42 -24.19 71.14 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 123.242 2.194 . . . . 0.0 114.89 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.44 -47.47 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.233 1.378 . . . . 0.0 109.802 170.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.11 -33.0 74.77 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.686 -0.633 . . . . 0.0 111.941 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.34 -31.47 69.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.457 1.026 . . . . 0.0 113.401 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.38 77.63 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.986 1.314 . . . . 0.0 111.234 169.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.6 mt -91.16 -34.92 14.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.357 1.463 . . . . 0.0 114.483 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -28.08 62.92 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.562 1.545 . . . . 0.0 113.692 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.69 -28.14 69.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.743 2.017 . . . . 0.0 112.847 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -108.19 -48.34 3.38 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -122.33 144.85 48.76 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.372 1.469 . . . . 0.0 111.638 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.5 t -81.87 67.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 122.176 0.988 . . . . 0.0 110.691 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.24 -9.68 20.21 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -175.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.3 mt 43.53 -133.2 0.59 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.275 3.03 . . . . 0.0 110.076 -172.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.75 170.39 16.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.949 0.9 . . . . 0.0 113.206 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 124.121 0.969 . . . . 0.0 113.588 -171.948 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.416 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.3 pt -96.28 167.96 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.478 1.511 . . . . 0.0 112.76 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -79.34 33.47 0.24 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.671 1.588 . . . . 0.0 114.007 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -128.31 -176.44 3.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.846 2.858 . . . . 0.0 113.085 -167.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.2 172.4 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.269 1.427 . . . . 0.0 109.163 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -164.25 139.93 4.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 130.459 3.503 . . . . 0.0 108.145 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -102.15 164.04 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.123 3.215 . . . . 0.0 113.744 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -82.13 158.78 23.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.585 1.154 . . . . 0.0 108.89 168.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.8 tp -41.79 -49.92 10.26 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.35 -21.55 35.26 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.092 1.862 . . . . 0.0 114.629 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.66 -32.59 16.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.196 0.999 . . . . 0.0 112.422 173.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.8 tt -61.73 -39.02 90.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.28 1.832 . . . . 0.0 112.032 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -72.42 -22.51 61.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -59.14 -52.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.929 1.292 . . . . 0.0 108.978 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.272 0.2 OUTLIER -70.72 -30.49 67.05 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.178 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -60.91 -32.76 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.569 1.532 . . . . 0.0 112.642 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.64 56.43 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.549 1.068 . . . . 0.0 113.434 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.52 19.16 21.04 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.218 1.807 . . . . 0.0 113.807 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 14.27 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.543 1.068 . . . . 0.0 115.495 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.98 -163.51 0.93 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.019 1.328 . . . . 0.0 112.547 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.84 58.1 1.78 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.002 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 -118.79 5.86 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.089 1.328 . . . . 0.0 112.956 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -143.72 17.64 1.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.513 1.925 . . . . 0.0 110.987 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.6 ttp -76.3 49.13 0.56 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.113 1.765 . . . . 0.0 113.128 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -170.02 173.87 5.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.272 1.829 . . . . 0.0 113.42 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 166.11 10.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.103 2.561 . . . . 0.0 113.983 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.1 t -50.95 -46.95 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.414 1.886 . . . . 0.0 112.078 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.57 -30.08 71.1 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -79.0 -46.3 18.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.6 -0.714 . . . . 0.0 110.885 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.69 -45.45 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.257 1.389 . . . . 0.0 112.883 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.4 ptm -68.89 -27.91 66.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -64.37 -59.8 3.93 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 110.987 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -56.79 -35.06 68.27 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.917 0.887 . . . . 0.0 113.216 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.13 -39.43 72.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.086 0.857 . . . . 0.0 112.987 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -47.35 89.04 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 119.316 0.962 . . . . 0.0 111.799 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 12.7 pt20 -69.85 -31.5 69.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.114 -0.945 . . . . 0.0 113.031 174.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.18 -54.08 49.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.822 1.646 . . . . 0.0 110.837 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.13 -44.37 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.595 0.758 . . . . 0.0 110.246 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -33.99 77.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.18 -51.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.339 1.455 . . . . 0.0 111.746 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -66.42 -15.99 63.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.447 0.699 . . . . 0.0 112.423 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.6 pt20 46.97 43.27 13.52 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 128.085 2.554 . . . . 0.0 113.287 172.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.18 18.04 15.86 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.893 1.677 . . . . 0.0 112.847 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -85.91 166.36 16.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.253 1.421 . . . . 0.0 112.799 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.26 135.72 49.23 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.446 -0.784 . . . . 0.0 112.301 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -36.52 44.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.167 1.387 . . . . 0.0 113.365 172.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -91.73 -20.37 21.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.915 1.286 . . . . 0.0 113.021 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -153.55 102.63 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.336 1.054 . . . . 0.0 111.976 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -59.81 -17.42 35.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.924 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -21.55 62.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.67 0.788 . . . . 0.0 113.026 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.6 tpt -96.79 125.57 41.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 109.787 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.7 120.99 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.987 1.315 . . . . 0.0 110.345 -169.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -88.59 165.87 14.52 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.35 1.06 . . . . 0.0 111.422 172.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -151.62 23.85 0.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.478 1.511 . . . . 0.0 113.058 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.2 108.58 2.11 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.311 -0.868 . . . . 0.0 112.732 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 14.13 72.59 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.452 1.025 . . . . 0.0 115.127 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.16 147.64 22.92 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.751 1.775 . . . . 0.0 110.571 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.1 mt -58.51 -27.52 64.57 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.363 -0.836 . . . . 0.0 112.06 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.82 -37.23 85.68 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.303 -0.873 . . . . 0.0 112.525 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.13 -39.03 94.46 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.558 0.617 . . . . 0.0 112.346 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 117.975 0.887 . . . . 0.0 111.607 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.83 -45.77 67.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.519 1.128 . . . . 0.0 113.062 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.25 -19.72 39.05 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 113.494 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.04 8.61 87.22 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.422 1.011 . . . . 0.0 114.754 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.4 154.73 41.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.348 1.459 . . . . 0.0 112.849 172.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.2 11.9 32.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.8 p -157.17 144.59 18.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -155.74 175.82 13.42 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.787 2.035 . . . . 0.0 109.565 172.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 p -149.16 175.29 11.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.347 -1.471 . . . . 0.0 113.226 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.08 -19.95 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.592 0.757 . . . . 0.0 112.098 170.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -90.36 -21.0 22.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.272 1.429 . . . . 0.0 113.495 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -122.33 61.07 14.12 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 126.405 1.882 . . . . 0.0 112.149 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.49 -4.54 10.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.575 2.85 . . . . 0.0 113.84 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -46.53 -35.5 4.96 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.3 -31.79 95.68 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.33 2.02 . . . . 0.0 114.665 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 tt -66.76 -54.87 18.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.202 1.401 . . . . 0.0 109.904 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -61.84 -36.61 81.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.482 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.83 -45.12 91.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.957 0.799 . . . . 0.0 112.411 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ttp -56.15 -39.18 71.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.623 1.569 . . . . 0.0 111.288 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . 0.286 4.5 pp -85.79 -40.79 15.66 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -64.11 -30.57 71.63 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 120.484 1.493 . . . . 0.0 113.485 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -68.32 -22.61 64.69 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.578 0.751 . . . . 0.0 112.525 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -91.15 -75.63 0.47 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -90.61 154.29 19.7 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.88 1.218 . . . . 0.0 113.129 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.07 109.95 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -155.76 -176.95 6.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.312 1.045 . . . . 0.0 112.782 -175.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.5 mt -110.46 159.24 17.67 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.623 1.969 . . . . 0.0 111.663 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.56 169.81 16.96 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.289 1.436 . . . . 0.0 112.441 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -170.582 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.43 ' H32' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 pt -134.42 163.23 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.953 1.701 . . . . 0.0 112.714 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -88.07 32.06 0.77 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.317 1.447 . . . . 0.0 114.753 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -178.7 4.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.639 2.776 . . . . 0.0 111.351 -168.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.74 172.66 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.536 1.534 . . . . 0.0 110.077 -170.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -162.26 144.6 8.54 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 130.211 3.404 . . . . 0.0 108.308 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -104.61 170.47 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -83.26 156.98 22.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.848 1.259 . . . . 0.0 107.895 167.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -50.87 -40.82 67.98 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.84 -23.55 47.71 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.579 2.186 . . . . 0.0 115.08 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.5 mt -92.45 -34.76 13.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.294 1.037 . . . . 0.0 112.027 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.55 -38.26 89.35 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.822 1.649 . . . . 0.0 112.074 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.278 44.3 pttt -70.09 -24.47 63.22 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.68 -53.56 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.439 1.496 . . . . 0.0 109.225 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.3 12.9 mt -70.88 -30.94 67.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -64.4 -32.33 73.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.374 -1.454 . . . . 0.0 112.844 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.43 63.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.447 1.021 . . . . 0.0 113.025 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 25.57 10.78 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.026 1.731 . . . . 0.0 113.375 172.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.15 12.22 81.63 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.75 1.167 . . . . 0.0 115.884 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.17 -169.72 2.67 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 118.714 1.257 . . . . 0.0 113.272 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -125.95 47.95 2.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.787 2.035 . . . . 0.0 110.985 169.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.49 -119.78 5.22 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.98 1.276 . . . . 0.0 112.561 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.02 18.96 3.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.516 1.927 . . . . 0.0 110.853 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 58.7 ttp -75.22 47.1 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.903 2.081 . . . . 0.0 113.067 -170.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -171.82 175.92 3.77 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.312 2.245 . . . . 0.0 112.788 -168.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -74.37 170.31 15.89 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.932 2.093 . . . . 0.0 113.564 -171.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -47.87 -46.55 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 127.01 2.124 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -66.95 -30.13 70.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.31 -45.24 18.19 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.859 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -58.09 -46.1 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.442 1.474 . . . . 0.0 112.763 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.8 ptm -70.02 -26.97 64.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.93 -58.57 6.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.074 1.35 . . . . 0.0 110.766 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -56.73 -36.9 70.26 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.78 -42.86 81.01 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.163 0.892 . . . . 0.0 112.166 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.79 -47.28 89.75 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.843 0.735 . . . . 0.0 112.414 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.254 12.5 pt20 -70.67 -31.65 68.63 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.65 -0.912 . . . . 0.0 112.998 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.11 -51.5 69.44 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.515 1.507 . . . . 0.0 110.833 169.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -57.87 -42.99 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.671 0.789 . . . . 0.0 110.326 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.3 tpp -68.84 -32.0 71.37 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.57 -50.33 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.481 1.112 . . . . 0.0 111.352 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -66.4 -16.08 63.81 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.784 0.834 . . . . 0.0 112.876 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.295 6.5 pt20 45.15 42.86 7.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.191 2.597 . . . . 0.0 113.427 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -99.46 19.87 14.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.653 1.581 . . . . 0.0 112.758 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -84.28 165.45 18.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.61 1.564 . . . . 0.0 111.916 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.91 135.54 48.03 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.243 -0.91 . . . . 0.0 111.913 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -45.28 63.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.244 1.017 . . . . 0.0 113.17 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -81.42 -12.35 58.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.769 0.828 . . . . 0.0 112.488 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.7 93.92 1.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.553 1.141 . . . . 0.0 112.126 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -58.63 -17.62 23.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.721 1.208 . . . . 0.0 112.843 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -26.06 67.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.502 1.121 . . . . 0.0 112.862 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -101.28 130.19 47.38 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.993 1.717 . . . . 0.0 110.918 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.82 133.37 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 110.805 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -111.81 158.46 19.36 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.567 1.547 . . . . 0.0 111.377 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 66.7 m -146.67 28.09 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.33 115.17 7.29 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 121.672 -0.642 . . . . 0.0 112.612 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.97 12.82 65.68 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.062 1.315 . . . . 0.0 115.36 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.63 150.06 21.09 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 119.793 1.797 . . . . 0.0 112.014 -175.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.51 -27.74 64.76 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.606 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.46 -39.19 91.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.705 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.68 -37.67 89.31 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.786 -0.571 . . . . 0.0 111.702 173.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -65.63 -37.36 86.35 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 117.984 0.892 . . . . 0.0 112.279 171.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.16 -44.72 79.06 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.008 1.323 . . . . 0.0 112.305 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.65 -18.41 31.38 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.72 5.05 89.53 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.57 1.081 . . . . 0.0 114.38 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -138.76 144.27 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.22 1.808 . . . . 0.0 111.555 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -94.59 6.92 47.41 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.9 p -154.23 149.88 27.46 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 169.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -161.14 176.84 10.86 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.066 2.146 . . . . 0.0 109.734 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.5 p -142.44 171.58 13.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.72 -1.238 . . . . 0.0 112.226 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 m -72.35 -7.24 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.45 -24.82 17.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.195 1.398 . . . . 0.0 112.45 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -129.35 64.56 71.72 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.312 1.845 . . . . 0.0 111.985 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.3 0.04 10.2 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.165 3.243 . . . . 0.0 113.836 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 m -46.29 -34.79 3.64 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -59.47 -28.05 86.53 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.306 2.004 . . . . 0.0 114.941 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tt -68.2 -52.41 34.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.794 1.238 . . . . 0.0 110.405 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -64.92 -36.21 83.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.734 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.76 -31.53 72.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.634 0.773 . . . . 0.0 112.925 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -47.03 83.51 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.247 1.019 . . . . 0.0 111.19 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -92.5 -20.3 21.1 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -62.22 -27.15 68.79 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.943 1.247 . . . . 0.0 112.948 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -65.4 -27.25 68.41 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.051 2.54 . . . . 0.0 112.741 171.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -97.51 -49.37 4.92 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -128.38 144.04 51.08 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.496 1.118 . . . . 0.0 112.654 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -76.68 118.18 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 t -159.67 -177.31 6.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.894 0.877 . . . . 0.0 113.102 -169.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.15 157.39 32.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.268 1.827 . . . . 0.0 112.871 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.33 174.64 12.63 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.635 1.574 . . . . 0.0 112.014 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.595 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' 49H . . . . . 0.477 ' H32' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 CA--C 1.546 0.793 0 CA-C-O 122.577 1.179 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -163.26 -172.57 3.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.823 3.249 . . . . 0.0 108.434 -168.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.56 169.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 -168.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -164.75 141.03 4.84 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 130.443 3.497 . . . . 0.0 108.82 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 11.5 Cg_endo -102.7 175.3 0.19 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.897 3.064 . . . . 0.0 113.944 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -97.05 163.44 12.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.524 1.53 . . . . 0.0 110.287 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -42.59 -55.68 6.73 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.95 -21.13 50.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.721 2.281 . . . . 0.0 114.339 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.4 mt -90.63 -33.38 15.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.484 1.114 . . . . 0.0 111.914 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.03 -34.97 72.51 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.978 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -54.84 -35.2 63.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.908 2.083 . . . . 0.0 112.964 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -73.99 -47.5 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.515 1.526 . . . . 0.0 109.675 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.267 2.2 mp -70.75 -30.56 67.1 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.533 -0.729 . . . . 0.0 112.486 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -60.65 -35.95 77.47 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.692 -1.255 . . . . 0.0 112.78 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.16 -21.96 64.26 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.028 0.831 . . . . 0.0 113.218 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.08 17.0 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.057 1.743 . . . . 0.0 113.616 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.19 15.15 76.69 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -85.43 -157.75 0.34 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.869 1.268 . . . . 0.0 112.282 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -136.32 54.21 1.9 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.82 1.648 . . . . 0.0 111.902 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.8 -170.39 40.25 Favored Glycine 0 C--O 1.216 -0.979 0 C-N-CA 124.466 1.032 . . . . 0.0 112.184 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' ' 29' ' ' PRO . 45.9 mt-10 -79.16 18.97 0.59 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.016 1.727 . . . . 0.0 113.808 173.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.9 ttp -74.26 48.65 0.33 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.296 2.238 . . . . 0.0 115.036 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' CZ ' ' CD2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -170.75 177.15 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.971 2.108 . . . . 0.0 112.597 -175.59 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 164.32 10.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.173 2.189 . . . . 0.0 113.737 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.9 -45.34 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 126.026 1.73 . . . . 0.0 112.533 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -66.96 -30.29 70.38 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -46.2 17.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.361 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 m -58.02 -43.63 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 120.415 1.461 . . . . 0.0 113.348 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.2 ptm -68.08 -25.25 65.24 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.47 -59.65 3.46 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.866 1.267 . . . . 0.0 110.911 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 82.2 m-85 -58.09 -33.55 69.21 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.1 tp -69.17 -41.32 77.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.135 0.879 . . . . 0.0 112.212 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.41 86.14 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 119.237 0.926 . . . . 0.0 112.038 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.259 8.0 pt20 -70.93 -31.6 68.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.483 -1.01 . . . . 0.0 112.969 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -56.9 -54.54 45.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.68 1.127 . . . . 0.0 110.157 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.9 mt -59.83 -39.23 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 118.868 0.758 . . . . 0.0 110.119 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 tpt -65.42 -35.84 82.13 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.38 -50.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.502 1.046 . . . . 0.0 111.17 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -67.46 -15.77 63.85 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.576 1.55 . . . . 0.0 113.179 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 5.0 pt20 46.92 41.88 11.42 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.657 2.783 . . . . 0.0 113.767 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -83.43 54.15 2.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.859 1.664 . . . . 0.0 111.15 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -139.36 167.72 21.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.182 1.393 . . . . 0.0 112.937 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.37 144.01 40.36 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.704 -0.622 . . . . 0.0 111.933 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.15 -46.04 79.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.252 1.021 . . . . 0.0 113.374 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -80.75 -8.85 59.8 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.582 0.753 . . . . 0.0 112.937 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -157.4 86.59 0.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.486 1.136 . . . . 0.0 112.546 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -55.72 -20.47 14.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.198 1.399 . . . . 0.0 112.396 170.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -25.52 67.82 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.067 1.347 . . . . 0.0 113.031 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 tpt -104.72 127.16 52.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.328 1.451 . . . . 0.0 110.798 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 t -110.4 134.38 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.446 1.498 . . . . 0.0 110.456 -170.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -132.72 102.53 5.71 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.111 2.564 . . . . 0.0 110.307 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 98.6 m -97.78 28.88 3.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.496 2.319 . . . . 0.0 113.781 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.83 115.16 6.45 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 121.681 -0.637 . . . . 0.0 112.99 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.22 10.99 75.06 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.288 1.423 . . . . 0.0 115.969 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.2 151.62 19.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 120.241 2.021 . . . . 0.0 112.395 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 mp -57.24 -27.89 62.44 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.824 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.76 -40.15 88.16 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.219 0.918 . . . . 0.0 112.671 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.97 -39.16 96.27 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -65.62 -37.7 87.31 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.889 -0.771 . . . . 0.0 112.464 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.0 tp -66.6 -45.56 78.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.141 1.376 . . . . 0.0 112.296 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.5 -23.04 34.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 113.222 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.35 7.46 86.53 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.856 1.217 . . . . 0.0 114.403 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 147.11 30.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.446 1.899 . . . . 0.0 110.836 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -97.18 9.79 41.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.7 p -152.47 148.38 27.35 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -162.43 176.27 10.66 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.582 2.353 . . . . 0.0 109.764 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.5 p -140.2 168.7 19.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.821 -1.174 . . . . 0.0 112.528 174.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.71 -9.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -95.01 -26.06 16.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.338 1.455 . . . . 0.0 112.456 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -124.06 67.19 42.96 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.434 1.893 . . . . 0.0 112.095 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.05 6.43 5.58 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.287 3.325 . . . . 0.0 114.708 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.5 m -47.41 -34.32 4.69 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -57.75 -26.21 72.29 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.163 2.575 . . . . 0.0 115.884 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.46 -50.55 36.99 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.518 1.054 . . . . 0.0 110.081 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.08 -29.15 68.84 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.332 -0.855 . . . . 0.0 112.561 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.6 -31.35 72.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.152 0.981 . . . . 0.0 112.733 169.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.64 71.57 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.057 1.343 . . . . 0.0 111.835 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.4 mt -83.61 -39.72 19.95 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.096 1.359 . . . . 0.0 113.551 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -56.55 -29.53 62.08 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.6 1.56 . . . . 0.0 113.681 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.53 -28.33 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.347 1.859 . . . . 0.0 112.543 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 123.779 0.832 . . . . 0.0 113.089 175.509 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.39 -178.85 5.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.729 2.812 . . . . 0.0 110.743 -168.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 169.2 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.795 0.438 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -164.72 135.46 3.2 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 128.266 2.626 . . . . 0.0 107.789 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.538 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 10.9 Cg_endo -99.18 176.23 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.9 2.4 . . . . 0.0 114.934 -169.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -104.57 159.72 15.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.595 2.358 . . . . 0.0 106.815 166.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.49 -40.62 77.04 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -67.33 -25.46 42.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.623 2.215 . . . . 0.0 114.246 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.29 -37.17 20.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.215 1.006 . . . . 0.0 111.267 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.72 -31.9 70.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.102 0.961 . . . . 0.0 111.431 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.56 -38.76 72.36 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.61 1.564 . . . . 0.0 112.596 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.6 mt -70.78 -46.73 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.17 1.788 . . . . 0.0 109.552 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.69 -31.41 68.29 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.75 -0.594 . . . . 0.0 112.026 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -65.36 -34.92 79.45 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.468 -1.395 . . . . 0.0 112.979 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.99 64.6 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.19 0.904 . . . . 0.0 112.926 171.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.19 16.78 24.35 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.985 1.714 . . . . 0.0 114.035 172.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.73 15.64 73.69 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.434 1.016 . . . . 0.0 115.549 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -84.4 -162.92 0.72 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.905 1.282 . . . . 0.0 112.311 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -133.47 68.63 1.49 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.724 1.61 . . . . 0.0 111.074 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.37 -144.22 37.04 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.482 0.563 . . . . 0.0 112.583 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.7 mt-10 -125.06 16.45 8.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.55 1.94 . . . . 0.0 112.266 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.8 ttt -79.51 58.28 2.64 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.493 1.117 . . . . 0.0 112.963 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -170.37 175.07 4.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.338 1.855 . . . . 0.0 113.413 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.05 165.23 16.17 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.261 2.224 . . . . 0.0 114.308 -172.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.9 t -47.85 -45.27 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.27 1.828 . . . . 0.0 112.359 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -66.29 -30.57 71.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.62 -47.6 16.79 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.635 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.41 -46.17 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 120.373 1.442 . . . . 0.0 112.676 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -70.63 -27.83 64.36 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.95 -59.7 4.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 110.703 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 54.3 m-85 -55.85 -37.21 68.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.149 0.979 . . . . 0.0 113.548 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.28 -36.72 79.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.844 1.202 . . . . 0.0 113.008 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 -47.37 88.41 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.882 1.219 . . . . 0.0 112.256 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.274 13.3 pt20 -70.91 -31.61 68.29 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.474 -1.015 . . . . 0.0 113.09 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.61 -53.82 49.54 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.562 1.528 . . . . 0.0 110.346 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.25 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.532 1.133 . . . . 0.0 110.382 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttm -69.04 -30.51 68.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.33 -50.84 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.12 0.968 . . . . 0.0 111.239 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.02 -15.94 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.947 0.899 . . . . 0.0 113.239 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.29 6.4 pt20 43.97 44.22 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 128.152 2.581 . . . . 0.0 113.582 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.63 16.53 23.12 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.863 1.665 . . . . 0.0 112.843 -169.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -81.96 165.64 20.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.378 1.471 . . . . 0.0 112.269 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.73 147.98 45.09 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 122.196 0.998 . . . . 0.0 112.989 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.608 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.8 -37.86 76.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.92 1.688 . . . . 0.0 111.483 -176.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -91.33 -20.94 21.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.698 1.599 . . . . 0.0 112.38 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.25 92.02 2.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.365 1.079 . . . . 0.0 112.268 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -57.21 -18.79 17.37 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.419 1.488 . . . . 0.0 112.776 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -24.72 66.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.377 1.071 . . . . 0.0 113.041 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -99.9 133.13 44.73 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.424 1.889 . . . . 0.0 110.776 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.61 132.62 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.543 1.537 . . . . 0.0 110.489 -171.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -113.69 165.71 12.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.871 1.668 . . . . 0.0 110.989 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.7 m -134.8 -25.51 1.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.431 1.093 . . . . 0.0 113.824 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 53.4 31.65 43.54 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.19 13.61 65.74 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.784 1.183 . . . . 0.0 115.758 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -69.3 167.24 16.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.511 1.656 . . . . 0.0 111.904 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.34 -27.99 64.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.648 1.179 . . . . 0.0 112.514 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.11 -41.56 86.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.516 -0.74 . . . . 0.0 112.109 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.73 96.65 Favored Glycine 0 N--CA 1.472 1.04 0 O-C-N 121.696 -0.627 . . . . 0.0 112.215 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.71 -36.86 84.83 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.554 -0.968 . . . . 0.0 112.066 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.41 -43.36 81.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.808 1.243 . . . . 0.0 112.497 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.79 -18.89 42.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.383 1.073 . . . . 0.0 112.975 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.63 -14.22 25.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.985 1.755 . . . . 0.0 113.963 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -125.98 138.74 53.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.762 2.425 . . . . 0.0 108.954 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -98.53 16.3 22.27 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -153.29 146.38 24.62 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.269 -0.894 . . . . 0.0 112.663 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -164.14 174.42 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.528 1.931 . . . . 0.0 110.12 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 p -139.1 171.7 13.92 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.752 -1.218 . . . . 0.0 111.996 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.56 -8.32 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.07 -23.8 17.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.216 1.406 . . . . 0.0 112.574 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -130.38 65.4 75.81 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.49 1.916 . . . . 0.0 111.965 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.1 0.44 9.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.409 3.406 . . . . 0.0 113.888 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.0 m -46.1 -35.35 4.1 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -54.36 -31.21 66.65 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.741 2.294 . . . . 0.0 115.758 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.54 -50.8 33.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.692 1.197 . . . . 0.0 110.488 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -62.89 -37.46 87.04 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.666 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.22 -31.78 72.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 0.0 112.92 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -45.91 90.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.475 1.11 . . . . 0.0 111.117 170.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -93.82 -19.69 20.77 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -27.08 69.09 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.996 1.271 . . . . 0.0 112.904 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.9 -29.94 71.16 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.778 2.431 . . . . 0.0 112.259 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 123.607 0.763 . . . . 0.0 112.826 169.976 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 CA--C 1.546 0.814 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.67 -178.79 3.91 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.719 2.408 . . . . 0.0 113.981 -167.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 46' ' ' MET . 7.8 t -93.59 172.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.467 1.907 . . . . 0.0 108.941 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -162.44 139.12 6.0 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 129.908 3.283 . . . . 0.0 107.474 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -99.73 168.37 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.514 2.809 . . . . 0.0 113.997 -171.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -86.62 162.81 17.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.014 1.326 . . . . 0.0 110.444 168.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.8 mt -49.18 -48.19 74.19 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.14 -28.61 34.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.2 1.822 . . . . 0.0 113.856 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.23 -37.74 37.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.842 0.747 . . . . 0.0 111.266 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.75 -34.81 73.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.826 1.25 . . . . 0.0 111.169 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -59.28 -40.77 87.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.762 1.225 . . . . 0.0 113.182 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.5 -50.91 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.238 1.415 . . . . 0.0 109.595 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.354 12.5 mt -70.94 -30.37 66.66 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -63.18 -37.91 89.11 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 119.885 -1.76 . . . . 0.0 111.921 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.94 -18.42 65.23 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.794 0.725 . . . . 0.0 112.745 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.03 5.03 46.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.586 1.555 . . . . 0.0 114.332 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.46 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.564 1.078 . . . . 0.0 114.94 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.68 -164.0 1.09 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.432 1.493 . . . . 0.0 112.716 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -124.58 43.18 3.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 110.88 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.19 -113.87 3.76 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.879 -1.138 . . . . 0.0 112.446 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.25 19.29 2.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.555 1.942 . . . . 0.0 111.431 -174.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 28.2 ptm -71.54 38.82 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.585 1.554 . . . . 0.0 115.192 -175.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -166.27 174.78 8.83 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.441 1.897 . . . . 0.0 113.967 -167.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -68.4 168.1 13.32 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.656 2.382 . . . . 0.0 113.628 -172.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -53.01 -43.52 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 126.29 1.836 . . . . 0.0 111.804 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -65.79 -30.06 70.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.47 -46.93 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.014 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.42 -44.8 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 119.929 1.241 . . . . 0.0 112.752 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.9 ptm -71.47 -27.47 63.26 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -61.44 -58.77 6.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.558 1.143 . . . . 0.0 110.395 170.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -56.34 -39.21 72.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.094 0.958 . . . . 0.0 113.253 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.09 -35.02 69.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.624 1.102 . . . . 0.0 112.702 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -47.48 90.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.157 0.89 . . . . 0.0 112.219 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.45 -31.56 71.82 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.419 -1.047 . . . . 0.0 112.378 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -58.53 -53.57 56.81 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.558 1.072 . . . . 0.0 111.654 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -56.25 -42.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.534 0.734 . . . . 0.0 109.983 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.38 -36.14 83.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.25 -48.94 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.06 0.944 . . . . 0.0 111.122 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -66.84 -15.92 63.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.982 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.313 5.3 pt20 46.23 39.63 6.42 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.389 2.676 . . . . 0.0 113.803 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt -84.86 58.23 4.86 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.586 1.554 . . . . 0.0 110.579 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -136.98 168.03 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.172 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.4 135.32 48.64 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.498 -0.751 . . . . 0.0 111.742 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -48.79 -39.38 25.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.923 1.689 . . . . 0.0 113.867 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -90.18 -15.95 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.984 1.313 . . . . 0.0 113.407 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.66 95.03 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.713 1.244 . . . . 0.0 112.396 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -57.75 -18.66 22.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.625 1.57 . . . . 0.0 112.72 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -14.56 61.42 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -110.74 119.86 40.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.602 1.561 . . . . 0.0 110.357 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -96.8 135.01 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.453 1.501 . . . . 0.0 110.555 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -135.75 95.81 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.95 2.5 . . . . 0.0 109.699 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 97.6 m -79.52 -24.03 42.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.104 1.761 . . . . 0.0 114.671 -169.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 50.97 35.74 32.98 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.7 1.143 . . . . 0.0 115.87 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.46 62.54 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.84 158.18 25.8 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.731 1.766 . . . . 0.0 111.441 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.18 -27.84 48.63 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.463 -0.773 . . . . 0.0 112.832 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.1 tp -57.09 -47.98 79.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.899 1.28 . . . . 0.0 111.643 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.79 94.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.834 0.73 . . . . 0.0 112.417 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -65.21 -37.73 88.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.135 0.968 . . . . 0.0 111.992 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.95 -46.87 79.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.17 1.388 . . . . 0.0 111.815 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -79.07 -17.37 55.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.69 -2.3 83.38 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.963 1.268 . . . . 0.0 114.47 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -146.66 142.23 27.66 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 128.084 2.554 . . . . 0.0 109.123 172.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -96.43 12.97 29.42 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.564 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.2 p -147.1 141.33 26.2 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.95 -1.094 . . . . 0.0 112.929 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -164.63 173.38 12.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.214 2.205 . . . . 0.0 109.873 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 p -142.95 175.18 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.087 -1.008 . . . . 0.0 112.624 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.5 m -67.68 -13.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -93.06 -21.94 19.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.713 1.205 . . . . 0.0 113.0 172.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -126.14 60.58 36.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.911 1.684 . . . . 0.0 112.58 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.94 0.3 9.98 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.195 3.263 . . . . 0.0 113.652 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.0 m -45.91 -33.55 2.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 127.079 2.152 . . . . 0.0 116.322 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.24 -29.47 90.42 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.227 1.831 . . . . 0.0 114.769 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.48 -49.34 63.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.263 0.938 . . . . 0.0 110.531 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.54 -34.07 77.38 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.674 -0.641 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -68.52 -31.59 70.95 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -34.46 77.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.341 1.456 . . . . 0.0 111.314 170.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.3 mt -92.89 -37.23 12.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.114 1.366 . . . . 0.0 114.243 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -56.45 -25.92 52.17 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.726 1.611 . . . . 0.0 113.845 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.17 -26.55 63.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.506 1.923 . . . . 0.0 112.636 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 175.221 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m120 . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 122.388 1.09 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -163.31 -174.68 3.89 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.782 2.833 . . . . 0.0 109.637 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.73 172.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.456 1.502 . . . . 0.0 112.259 -169.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -161.38 145.4 9.88 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 130.652 3.581 . . . . 0.0 108.165 168.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -103.72 172.15 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.834 3.023 . . . . 0.0 114.181 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -86.51 158.57 19.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 108.062 167.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.7 -46.09 71.59 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -66.03 -24.96 51.97 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.711 2.274 . . . . 0.0 114.643 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.37 -35.86 16.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.243 1.017 . . . . 0.0 111.952 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.26 -31.9 72.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.636 1.575 . . . . 0.0 111.36 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -56.17 -38.68 71.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.459 1.504 . . . . 0.0 112.607 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -66.85 -50.9 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.068 1.747 . . . . 0.0 109.417 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.324 12.3 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.748 -0.595 . . . . 0.0 112.571 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -61.81 -33.19 73.68 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.643 -1.285 . . . . 0.0 112.576 169.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.82 -22.61 62.47 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.379 0.99 . . . . 0.0 113.263 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.67 24.45 12.64 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.012 1.725 . . . . 0.0 113.334 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.94 14.02 80.46 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.785 1.183 . . . . 0.0 115.824 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.9 -169.27 2.42 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.46 1.13 . . . . 0.0 113.438 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.53 45.22 2.5 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.69 1.996 . . . . 0.0 110.917 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.71 -119.95 5.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.093 1.33 . . . . 0.0 112.637 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.4 17.04 3.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.557 1.943 . . . . 0.0 110.589 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 58.1 ttp -76.52 50.52 0.67 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.116 1.767 . . . . 0.0 112.889 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -174.37 171.16 3.47 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.438 2.295 . . . . 0.0 112.208 -168.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 168.76 10.83 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.47 1.908 . . . . 0.0 114.092 -171.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.3 t -47.78 -44.14 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.518 1.927 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -67.64 -30.59 70.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -80.46 -44.29 19.46 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.961 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.47 -46.24 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.252 1.387 . . . . 0.0 112.622 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.2 ptm -69.86 -23.96 63.35 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.89 -59.75 3.54 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.975 1.31 . . . . 0.0 110.961 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -56.14 -37.14 69.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.258 1.023 . . . . 0.0 113.281 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tt -72.57 -38.07 68.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.897 0.879 . . . . 0.0 111.623 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.09 -47.4 87.83 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.898 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.257 13.7 pt20 -69.91 -31.54 69.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.416 -1.049 . . . . 0.0 112.873 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CD1' HD22 ' A' ' 81' ' ' LEU . 12.5 t80 -55.66 -51.51 67.01 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.442 1.473 . . . . 0.0 110.457 169.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.2 mt -58.12 -44.89 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.999 0.92 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.0 ttm -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.62 -51.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.36 1.064 . . . . 0.0 111.355 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 -15.97 64.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.92 0.888 . . . . 0.0 113.282 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.3 pt20 43.79 43.51 5.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 128.164 2.585 . . . . 0.0 113.483 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -99.67 23.19 9.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.818 1.647 . . . . 0.0 112.9 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -87.01 163.69 16.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.707 1.603 . . . . 0.0 111.337 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -75.13 134.55 41.25 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.157 -0.964 . . . . 0.0 111.904 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -53.78 -35.72 61.64 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.637 1.575 . . . . 0.0 113.515 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -82.2 -26.6 33.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 112.398 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.7 93.9 1.92 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 122.425 1.107 . . . . 0.0 111.558 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -58.87 -17.68 26.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 112.606 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.06 69.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.249 1.02 . . . . 0.0 112.913 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.3 tpt -98.4 133.06 43.32 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.981 1.712 . . . . 0.0 110.962 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.0 t -125.83 131.83 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.073 1.349 . . . . 0.0 110.957 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -108.51 163.51 13.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.575 1.55 . . . . 0.0 111.795 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 m -145.24 29.69 1.16 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.872 2.069 . . . . 0.0 111.489 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.47 113.44 3.81 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 121.612 -0.68 . . . . 0.0 114.048 -169.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.74 11.76 66.4 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.07 -1.406 . . . . 0.0 115.775 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -100.04 159.18 15.29 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 120.421 2.111 . . . . 0.0 111.99 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.34 -28.04 68.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.093 0.957 . . . . 0.0 111.863 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.4 HD22 ' CD1' ' A' ' 59' ' ' TYR . 46.9 tp -67.2 -37.88 84.39 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.339 -0.85 . . . . 0.0 112.38 171.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.43 -39.24 94.06 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.839 -0.538 . . . . 0.0 111.891 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -65.0 -36.95 86.04 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.795 -0.827 . . . . 0.0 112.138 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.04 -43.57 82.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.665 1.186 . . . . 0.0 112.395 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.78 -21.51 37.73 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.2 -0.31 89.39 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.629 1.109 . . . . 0.0 114.583 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -145.75 156.11 43.39 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.128 1.771 . . . . 0.0 111.897 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -99.55 16.32 23.71 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.0 p -153.57 152.93 31.47 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 169.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -163.12 179.54 7.41 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.62 2.368 . . . . 0.0 109.58 170.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 p -145.26 171.2 14.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.294 -1.504 . . . . 0.0 112.705 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.0 m -73.49 -6.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -95.11 -28.39 15.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.331 . . . . 0.0 112.345 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -128.71 70.62 80.7 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.287 1.835 . . . . 0.0 111.498 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.82 1.62 8.69 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.334 3.356 . . . . 0.0 113.527 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -45.47 -34.46 2.45 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.935 2.094 . . . . 0.0 115.924 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.59 -26.41 80.45 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.362 2.041 . . . . 0.0 114.876 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.34 -46.03 57.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.191 0.905 . . . . 0.0 110.424 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -67.15 -31.68 72.28 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.518 -0.739 . . . . 0.0 112.404 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.68 -31.59 71.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.177 0.899 . . . . 0.0 112.798 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -36.38 81.9 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.076 1.35 . . . . 0.0 111.6 169.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.7 -39.77 15.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.002 1.321 . . . . 0.0 114.233 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -57.71 -28.36 63.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.416 1.486 . . . . 0.0 113.787 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -71.0 -26.69 63.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.855 2.062 . . . . 0.0 112.735 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 m120 . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.604 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.8 -178.23 4.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.427 2.691 . . . . 0.0 113.647 -167.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -92.29 172.16 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.448 1.499 . . . . 0.0 109.99 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -159.94 141.83 9.58 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 130.723 3.609 . . . . 0.0 108.708 169.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 28.0 Cg_endo -99.38 169.58 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.892 3.062 . . . . 0.0 113.858 -175.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -82.88 160.44 22.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.983 1.313 . . . . 0.0 109.177 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.36 -47.75 67.57 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.42 -28.1 33.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 CA-C-N 122.299 1.857 . . . . 0.0 113.339 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.35 -35.66 54.43 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.282 -0.886 . . . . 0.0 111.568 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.3 -35.03 76.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.994 1.318 . . . . 0.0 110.951 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -59.73 -43.22 94.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.547 1.539 . . . . 0.0 112.648 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.0 mt -59.25 -52.87 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 109.492 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.347 11.1 mt -70.79 -30.5 66.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -61.45 -33.82 74.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.689 -1.257 . . . . 0.0 112.417 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.88 -21.78 61.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.299 0.954 . . . . 0.0 113.456 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.54 24.02 13.67 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.773 1.629 . . . . 0.0 113.517 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.87 15.03 78.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.552 1.072 . . . . 0.0 115.743 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.16 -166.86 1.46 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.672 1.189 . . . . 0.0 112.932 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -125.44 48.29 2.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.621 1.969 . . . . 0.0 110.587 169.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.29 -116.55 5.26 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.086 1.327 . . . . 0.0 113.107 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 40.7 mt-10 -139.08 19.95 2.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.066 2.146 . . . . 0.0 110.954 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 58.0 ttp -78.08 47.59 0.67 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.4 1.48 . . . . 0.0 112.924 -172.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -170.58 175.6 4.62 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.111 1.764 . . . . 0.0 113.635 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.55 167.08 11.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.508 2.323 . . . . 0.0 113.721 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.4 -43.27 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.245 1.818 . . . . 0.0 111.804 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -64.34 -30.07 71.13 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -79.97 -48.17 13.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.932 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -55.34 -44.44 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.025 1.284 . . . . 0.0 112.788 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -71.31 -28.65 64.25 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.74 -59.37 5.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 110.874 170.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -55.51 -36.05 66.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.233 1.013 . . . . 0.0 113.592 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.52 -39.07 74.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.63 1.104 . . . . 0.0 113.383 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.71 -47.27 79.18 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 119.697 1.135 . . . . 0.0 112.134 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.01 -31.61 66.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.457 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.1 -51.53 68.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.887 1.676 . . . . 0.0 110.78 169.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -58.52 -44.25 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.952 0.901 . . . . 0.0 110.379 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 36.5 tpp -66.67 -31.6 72.38 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -74.39 -49.38 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.693 1.197 . . . . 0.0 111.414 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -66.02 -16.13 63.64 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.5 pt20 43.35 42.72 3.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.153 2.581 . . . . 0.0 113.259 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -100.65 22.04 12.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.895 1.678 . . . . 0.0 112.66 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -88.29 165.53 14.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.644 1.578 . . . . 0.0 112.069 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -71.21 138.36 49.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.228 -0.92 . . . . 0.0 112.13 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -38.4 51.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.244 1.418 . . . . 0.0 113.482 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -98.69 -16.56 18.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.0 1.32 . . . . 0.0 113.709 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.11 94.34 2.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.786 1.234 . . . . 0.0 109.768 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -63.89 -14.12 50.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.165 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.09 -19.74 61.1 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -96.77 128.08 43.37 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.254 1.822 . . . . 0.0 109.858 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.77 131.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.676 1.59 . . . . 0.0 110.921 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -104.45 161.87 13.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.258 1.423 . . . . 0.0 110.992 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.5 m -145.95 29.57 1.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.515 1.926 . . . . 0.0 111.812 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.89 114.31 6.64 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.357 -0.839 . . . . 0.0 112.339 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.11 72.02 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.001 1.286 . . . . 0.0 115.435 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -96.41 146.45 24.75 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.01 1.905 . . . . 0.0 110.826 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.12 -27.66 62.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.419 0.688 . . . . 0.0 112.477 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.6 tp -65.69 -38.83 90.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.679 0.792 . . . . 0.0 112.581 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.87 -39.56 93.43 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 121.409 -0.807 . . . . 0.0 111.781 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -63.54 -37.32 86.87 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 117.714 0.757 . . . . 0.0 112.005 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.92 -46.02 63.22 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.091 1.357 . . . . 0.0 112.695 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.21 -21.4 53.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.068 0.947 . . . . 0.0 113.052 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 1.07 90.37 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.701 1.143 . . . . 0.0 114.394 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -144.76 148.66 34.37 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.337 1.855 . . . . 0.0 111.458 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.82 12.24 32.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.457 1.103 . . . . 0.0 113.423 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -151.98 146.43 25.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -160.31 176.82 11.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.042 2.137 . . . . 0.0 110.15 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 p -147.59 173.86 12.31 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.543 -1.348 . . . . 0.0 113.166 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.62 -21.12 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.872 0.869 . . . . 0.0 111.732 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -88.88 -28.89 20.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.101 1.36 . . . . 0.0 113.008 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -121.02 65.55 13.64 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.298 1.839 . . . . 0.0 112.207 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.0 -0.9 10.22 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.969 3.113 . . . . 0.0 113.725 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -47.31 -34.37 4.56 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -58.84 -32.15 96.67 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.369 2.046 . . . . 0.0 114.645 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -64.95 -48.32 74.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.176 0.99 . . . . 0.0 110.623 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -69.12 -31.35 69.98 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.427 -0.796 . . . . 0.0 111.922 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.83 -33.05 71.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.097 0.862 . . . . 0.0 113.08 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -64.51 -39.69 94.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.892 1.277 . . . . 0.0 110.271 169.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.0 mt -82.65 -42.43 18.17 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -56.53 -28.48 60.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.686 1.194 . . . . 0.0 113.868 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.99 -26.58 63.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.91 2.084 . . . . 0.0 112.977 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 CA--C 1.551 0.982 0 C-N-CA 124.561 1.145 . . . . 0.0 112.762 173.845 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 122.432 1.11 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -163.23 -160.14 0.58 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 129.229 3.012 . . . . 0.0 108.656 -168.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.29 172.33 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.497 1.519 . . . . 0.0 110.512 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -160.7 137.97 6.79 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 131.177 3.791 . . . . 0.0 106.867 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 29.4 Cg_endo -101.05 168.71 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.197 2.598 . . . . 0.0 114.432 -170.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.41 159.14 23.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.085 1.354 . . . . 0.0 108.2 167.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -53.11 -39.58 72.09 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -65.3 -29.97 54.38 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.42 2.08 . . . . 0.0 114.109 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.86 -36.65 27.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.508 1.123 . . . . 0.0 111.333 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.87 -45.77 93.26 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.077 1.351 . . . . 0.0 111.207 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 38.0 pttt -70.54 -26.15 63.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.41 -54.39 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.478 1.111 . . . . 0.0 108.765 169.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.251 35.0 mt -70.93 -30.77 67.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.77 0.828 . . . . 0.0 112.32 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -34.1 77.54 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.702 -1.249 . . . . 0.0 113.017 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.49 64.45 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -102.84 22.92 12.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.01 1.724 . . . . 0.0 113.549 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.35 80.85 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.512 1.053 . . . . 0.0 115.721 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.89 -164.61 0.76 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.449 1.125 . . . . 0.0 113.074 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -130.44 48.65 2.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 127.194 2.197 . . . . 0.0 109.193 168.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 -111.77 3.79 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.361 1.458 . . . . 0.0 113.276 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 38.5 mt-10 -139.07 16.78 2.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.588 1.955 . . . . 0.0 111.594 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -75.97 49.83 0.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.515 1.526 . . . . 0.0 113.235 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -173.2 172.12 3.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.461 2.305 . . . . 0.0 112.481 -169.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.38 167.35 16.7 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.121 2.168 . . . . 0.0 114.139 -171.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.78 -43.29 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.779 2.032 . . . . 0.0 112.31 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.54 -30.14 70.38 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -80.54 -46.41 15.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.4 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.17 -44.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 120.03 1.287 . . . . 0.0 112.684 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.04 -28.51 66.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.46 -58.25 7.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.964 171.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -56.69 -37.0 70.27 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.57 -41.73 75.45 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.15 0.886 . . . . 0.0 111.46 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.92 -47.48 88.64 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 112.907 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -70.51 -31.58 68.73 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.527 -0.984 . . . . 0.0 112.598 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -58.19 -52.1 66.96 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.887 1.222 . . . . 0.0 110.964 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -53.68 -46.29 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.045 0.839 . . . . 0.0 109.711 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -33.88 76.06 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.18 -47.42 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.302 1.041 . . . . 0.0 110.883 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -66.69 -11.24 53.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.046 0.938 . . . . 0.0 112.944 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.336 3.0 pt20 46.66 45.55 14.46 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 129.655 3.182 . . . . 0.0 113.311 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.08 58.21 4.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.245 1.418 . . . . 0.0 110.982 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -143.55 164.84 29.25 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.003 1.321 . . . . 0.0 112.574 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -72.86 135.58 45.18 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.649 -0.657 . . . . 0.0 111.721 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -40.23 36.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.162 1.385 . . . . 0.0 113.037 171.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -89.14 -19.16 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.227 1.411 . . . . 0.0 113.094 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -152.69 94.83 1.93 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.404 1.097 . . . . 0.0 111.742 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.92 -17.84 28.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.131 1.372 . . . . 0.0 112.636 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -21.57 65.45 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.091 0.957 . . . . 0.0 112.973 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.5 tpt -104.65 124.1 48.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.303 1.841 . . . . 0.0 110.73 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.96 138.17 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.127 1.771 . . . . 0.0 110.282 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -135.14 94.72 3.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.288 2.235 . . . . 0.0 110.535 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -88.53 30.69 0.88 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.67 2.788 . . . . 0.0 113.472 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.88 116.52 9.15 Favored Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 112.671 -170.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.86 11.3 78.19 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.364 1.459 . . . . 0.0 115.737 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.06 147.93 22.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.363 2.081 . . . . 0.0 111.792 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.99 -27.59 63.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.5 tp -65.93 -43.24 88.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.998 0.919 . . . . 0.0 112.694 171.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.24 -38.31 95.0 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 118.993 0.815 . . . . 0.0 111.719 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -65.07 -38.0 89.36 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.925 -0.75 . . . . 0.0 111.793 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.33 -48.87 63.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.071 0.948 . . . . 0.0 112.399 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.35 -20.35 61.48 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 112.701 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.93 -0.21 89.85 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.732 1.158 . . . . 0.0 114.075 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -145.6 145.29 30.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.38 1.872 . . . . 0.0 111.316 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.99 2.69 55.38 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.413 1.085 . . . . 0.0 113.086 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.5 p -147.39 140.23 24.94 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -160.65 176.48 11.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.959 2.503 . . . . 0.0 109.155 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.6 p -144.19 174.98 10.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.852 -1.155 . . . . 0.0 112.164 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.97 -8.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 169.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.04 -22.84 17.65 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.323 1.449 . . . . 0.0 113.139 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -124.22 62.14 28.87 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 126.116 1.766 . . . . 0.0 112.012 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.2 2.5 7.95 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.053 3.169 . . . . 0.0 114.258 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 m -46.85 -34.68 4.19 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -33.58 97.02 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 122.989 2.103 . . . . 0.0 114.679 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tp -57.78 -56.88 16.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 123.022 1.392 . . . . 0.0 110.219 171.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -70.49 -29.2 65.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.455 -0.778 . . . . 0.0 112.035 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.04 -31.51 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.6 1.091 . . . . 0.0 113.193 173.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.6 ttp -68.41 -37.11 80.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.363 1.065 . . . . 0.0 110.773 169.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.07 -31.48 18.02 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -29.3 65.16 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.463 1.505 . . . . 0.0 113.361 175.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.83 -29.0 70.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.273 1.829 . . . . 0.0 112.473 172.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.18 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -125.94 -175.64 3.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.304 2.642 . . . . 0.0 113.671 -166.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 28' ' ' ARG . 6.3 t -92.2 172.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.813 1.645 . . . . 0.0 109.298 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 27' ' ' VAL . 1.1 tmt_? -164.24 131.98 2.56 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 129.831 3.253 . . . . 0.0 107.15 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -96.59 174.27 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.974 2.449 . . . . 0.0 115.466 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -98.88 160.35 14.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.42 2.288 . . . . 0.0 107.516 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -53.39 -38.81 66.03 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -69.09 -32.53 21.15 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.21 1.94 . . . . 0.0 113.593 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.26 -37.32 61.02 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 111.037 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.74 -40.18 91.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.877 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -53.8 -42.61 68.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.706 1.202 . . . . 0.0 113.329 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -64.18 -50.11 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.565 1.546 . . . . 0.0 109.937 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.36 -37.39 80.41 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.645 -0.659 . . . . 0.0 111.167 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -71.37 -30.63 66.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.886 -1.134 . . . . 0.0 113.404 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.33 -22.7 54.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.495 0.718 . . . . 0.0 112.874 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.14 25.37 11.08 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.959 1.704 . . . . 0.0 113.563 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.48 17.33 79.82 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.36 -161.2 0.3 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.947 1.299 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -132.67 48.65 2.39 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.022 1.729 . . . . 0.0 110.746 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.16 -119.6 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.178 0.894 . . . . 0.0 112.66 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -141.39 19.62 2.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.891 1.677 . . . . 0.0 112.624 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 27.3 ttt -77.64 47.55 0.61 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.1 1.36 . . . . 0.0 112.783 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -168.73 174.47 6.6 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.417 1.887 . . . . 0.0 113.157 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.62 164.97 10.94 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.783 2.433 . . . . 0.0 113.91 -171.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.21 -42.42 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 126.017 1.727 . . . . 0.0 111.874 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.7 -30.19 71.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -79.18 -48.23 14.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.965 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.94 -47.01 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 119.699 1.136 . . . . 0.0 112.066 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -71.49 -23.84 61.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.06 -59.64 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.35 0.977 . . . . 0.0 110.659 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -55.99 -40.72 73.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.873 1.269 . . . . 0.0 113.298 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 tt -73.29 -32.29 64.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.365 1.066 . . . . 0.0 111.515 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.9 -47.31 89.88 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.696 -1.253 . . . . 0.0 112.736 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.01 -31.59 72.24 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.414 -1.05 . . . . 0.0 112.375 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.85 -54.44 47.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.838 1.199 . . . . 0.0 111.077 169.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -52.89 -42.96 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.342 0.974 . . . . 0.0 110.292 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.2 tpp -70.45 -35.27 73.24 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.26 -47.57 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.505 1.122 . . . . 0.0 111.341 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -65.0 -12.1 46.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.502 1.121 . . . . 0.0 112.745 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.33 3.9 pt20 47.92 46.13 18.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 129.407 3.083 . . . . 0.0 113.149 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.22 56.79 4.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.368 1.467 . . . . 0.0 110.887 -171.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.86 166.97 24.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.843 1.257 . . . . 0.0 112.747 -173.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -73.52 148.63 42.89 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.146 0.974 . . . . 0.0 113.279 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.43 -35.99 76.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.974 1.71 . . . . 0.0 111.716 -176.364 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -93.1 -20.75 20.2 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.554 1.542 . . . . 0.0 112.335 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -145.95 94.96 2.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.195 0.998 . . . . 0.0 112.69 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -59.01 -17.96 29.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.815 1.246 . . . . 0.0 112.896 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -22.26 66.57 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.339 1.055 . . . . 0.0 112.913 174.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.4 tpt -102.12 128.77 48.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.578 1.551 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.9 t -108.92 134.48 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.876 1.671 . . . . 0.0 110.6 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -136.67 96.93 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 110.468 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.5 m -89.55 27.51 1.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 128.35 2.66 . . . . 0.0 113.686 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.39 118.89 14.9 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.486 -0.759 . . . . 0.0 113.064 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.69 8.97 82.38 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.285 1.421 . . . . 0.0 115.719 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.32 149.2 21.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.132 1.966 . . . . 0.0 112.025 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.3 tp -59.18 -27.8 66.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.529 1.131 . . . . 0.0 111.291 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.1 tp -63.95 -48.98 74.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.326 1.05 . . . . 0.0 111.895 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.48 -37.46 93.77 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 118.621 0.646 . . . . 0.0 112.376 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -64.15 -37.34 87.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.85 0.86 . . . . 0.0 112.006 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.13 -45.96 53.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.876 0.871 . . . . 0.0 112.019 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.43 -28.68 69.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.046 0.938 . . . . 0.0 112.639 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 0.46 89.0 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.559 1.076 . . . . 0.0 114.024 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.66 147.81 32.39 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.847 1.659 . . . . 0.0 111.768 170.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -100.19 5.66 44.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.763 1.225 . . . . 0.0 113.06 -171.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -147.59 145.51 29.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -164.29 -177.37 4.9 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.17 2.588 . . . . 0.0 109.308 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 p -137.36 170.72 15.61 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.682 -1.261 . . . . 0.0 112.331 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.26 -15.69 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -94.37 -18.91 21.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -131.34 63.89 71.4 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.48 1.512 . . . . 0.0 112.587 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.78 13.98 1.99 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 125.11 3.873 . . . . 0.0 114.564 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.1 p -50.67 -27.62 1.61 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 117.648 2.462 . . . . 0.0 117.648 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -60.81 -27.84 85.46 Favored 'Trans proline' 0 C--N 1.357 1.012 0 CA-C-N 123.898 2.428 . . . . 0.0 114.437 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.41 -48.72 66.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.609 0.719 . . . . 0.0 110.297 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -66.85 -30.74 71.0 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.557 -0.714 . . . . 0.0 112.02 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -68.13 -31.63 71.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.293 1.037 . . . . 0.0 112.988 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -35.68 75.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.353 1.461 . . . . 0.0 111.197 169.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -88.33 -36.44 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -58.67 -27.34 64.71 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.071 1.749 . . . . 0.0 114.351 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -71.15 -26.17 62.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.465 1.906 . . . . 0.0 112.593 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 125.442 1.497 . . . . 0.0 112.915 -179.472 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.7 m120 . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -129.2 -174.88 3.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.492 2.317 . . . . 0.0 112.697 -167.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.14 172.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 0.0 109.102 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -165.08 131.3 2.15 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 128.766 2.826 . . . . 0.0 108.24 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -104.11 174.57 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.995 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -106.79 167.7 9.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.782 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -42.15 -53.79 8.21 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.67 -27.56 45.05 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.494 2.129 . . . . 0.0 114.293 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.8 mt -84.39 -34.29 23.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.511 0.725 . . . . 0.0 112.101 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.29 -35.39 77.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.132 0.973 . . . . 0.0 110.957 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -39.35 73.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.9 1.28 . . . . 0.0 112.627 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -63.41 -54.37 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.464 1.505 . . . . 0.0 109.251 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.282 4.7 mp -70.77 -30.36 66.83 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.332 -0.855 . . . . 0.0 113.156 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -35.49 78.33 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.434 -1.416 . . . . 0.0 112.901 169.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.13 -21.15 64.8 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.175 0.898 . . . . 0.0 112.853 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.68 18.72 19.66 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.402 1.881 . . . . 0.0 113.715 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.11 15.5 76.6 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -82.71 -165.55 1.08 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.795 1.238 . . . . 0.0 112.734 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -131.5 56.73 1.79 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.968 1.707 . . . . 0.0 111.318 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.78 -126.17 7.32 Favored Glycine 0 C--O 1.218 -0.86 0 C-N-CA 124.32 0.962 . . . . 0.0 112.134 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -141.62 11.26 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.825 2.05 . . . . 0.0 111.716 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.5 ttt -76.12 54.56 0.87 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.39 1.476 . . . . 0.0 113.445 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -170.65 171.42 6.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.582 1.953 . . . . 0.0 113.037 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 164.84 7.4 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.176 2.19 . . . . 0.0 114.309 -169.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -51.52 -45.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 126.089 1.756 . . . . 0.0 111.929 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.88 -30.11 71.23 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.23 -47.82 15.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.02 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.0 -45.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 120.027 1.285 . . . . 0.0 112.688 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.7 ptm -70.64 -25.28 62.94 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -64.97 -57.85 7.66 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.969 1.307 . . . . 0.0 110.809 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 61.2 m-85 -55.94 -35.85 67.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.918 0.887 . . . . 0.0 113.071 173.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tt -71.34 -38.58 71.64 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.245 -0.91 . . . . 0.0 112.155 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.57 -47.47 88.1 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 120.848 -1.158 . . . . 0.0 112.589 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.302 11.2 pt20 -70.24 -31.45 68.86 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.997 . . . . 0.0 112.719 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -55.68 -50.43 70.3 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.558 1.526 . . . . 0.0 111.6 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -57.11 -47.23 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.605 0.762 . . . . 0.0 109.762 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.63 71.65 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -73.48 -50.19 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.142 1.377 . . . . 0.0 111.312 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.31 -15.94 63.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.895 0.878 . . . . 0.0 112.9 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.288 6.2 pt20 43.55 43.53 4.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.72 2.808 . . . . 0.0 113.348 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -103.77 33.23 3.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 112.656 -169.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -99.87 165.44 11.56 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.188 1.795 . . . . 0.0 111.821 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.81 135.76 50.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.341 -0.85 . . . . 0.0 111.967 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.51 -45.54 62.91 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.304 1.042 . . . . 0.0 113.186 169.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -80.85 -13.94 58.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 112.497 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.17 98.28 1.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 112.282 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -59.28 -17.56 29.84 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.541 1.137 . . . . 0.0 112.867 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -20.4 62.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.254 1.421 . . . . 0.0 110.456 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.23 140.41 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.384 1.474 . . . . 0.0 111.489 -169.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.35 165.72 14.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.973 2.109 . . . . 0.0 111.178 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.4 m -139.51 -29.57 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.745 1.218 . . . . 0.0 114.15 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 52.72 -126.02 31.19 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.154 0.888 . . . . 0.0 111.878 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.05 14.2 50.46 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.78 150.71 45.59 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.676 2.238 . . . . 0.0 112.475 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.09 -27.85 35.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.452 1.101 . . . . 0.0 112.086 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 tp -65.69 -44.88 84.84 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.661 0.784 . . . . 0.0 112.256 173.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 118.773 0.715 . . . . 0.0 111.932 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -64.51 -37.69 88.41 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 117.683 0.742 . . . . 0.0 112.069 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.8 tp -70.63 -46.13 63.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.741 1.216 . . . . 0.0 112.484 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.85 -28.72 64.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.217 1.007 . . . . 0.0 113.06 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.13 -0.45 73.47 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 123.903 0.763 . . . . 0.0 113.396 -169.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -135.05 137.34 42.83 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 128.245 2.618 . . . . 0.0 109.624 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -103.52 11.83 35.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.783 0.833 . . . . 0.0 113.011 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.5 p -153.84 140.66 19.11 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.683 1.193 . . . . 0.0 111.624 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -162.61 175.34 11.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.41 1.884 . . . . 0.0 110.15 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.4 p -143.89 173.83 11.36 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.899 -1.125 . . . . 0.0 113.342 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.02 -20.84 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.107 0.963 . . . . 0.0 112.132 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.2 -19.39 21.49 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.88 1.272 . . . . 0.0 113.644 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -128.59 63.38 64.61 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.976 1.71 . . . . 0.0 112.402 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.56 -2.05 11.3 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.171 3.248 . . . . 0.0 113.783 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.1 m -41.91 -43.36 6.65 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -23.31 70.7 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 122.925 2.08 . . . . 0.0 114.465 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.67 -51.95 50.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.518 1.054 . . . . 0.0 110.147 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -62.87 -37.7 87.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.442 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.01 -31.54 72.83 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 173.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.3 -47.91 80.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.873 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.29 -21.86 21.87 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -63.75 -25.04 68.01 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.8 1.182 . . . . 0.0 113.27 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -70.05 -25.94 63.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.467 2.307 . . . . 0.0 112.549 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.571 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 N--CA 1.475 0.804 0 CA-C-O 122.344 1.068 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -163.38 -176.91 5.0 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.006 2.922 . . . . 0.0 109.818 -171.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.33 172.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.888 0.875 . . . . 0.0 111.869 -169.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -162.14 134.12 4.09 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 128.903 2.881 . . . . 0.0 107.588 172.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 8.8 Cg_endo -98.66 -178.61 0.27 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.212 2.608 . . . . 0.0 114.574 -169.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -120.65 165.77 14.6 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.301 2.24 . . . . 0.0 108.651 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -39.59 -57.81 2.3 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.467 1.907 . . . . 0.0 116.136 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.83 -25.23 33.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.467 2.111 . . . . 0.0 114.109 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.08 -39.15 23.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.813 0.845 . . . . 0.0 111.065 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.22 -31.58 70.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.678 1.191 . . . . 0.0 111.662 170.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -58.86 -37.62 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.121 1.368 . . . . 0.0 112.787 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.25 -42.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.484 1.514 . . . . 0.0 110.14 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.59 -30.82 67.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.797 -0.564 . . . . 0.0 111.964 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -65.85 -37.13 85.37 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.964 -1.71 . . . . 0.0 112.164 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.65 -22.56 67.01 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.883 0.765 . . . . 0.0 112.435 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.4 2.58 39.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.144 1.378 . . . . 0.0 114.183 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.78 17.31 79.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.492 1.044 . . . . 0.0 114.998 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -90.27 -166.72 1.65 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.602 1.561 . . . . 0.0 112.792 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.38 65.67 1.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.911 1.684 . . . . 0.0 111.101 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.12 -138.81 23.27 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.732 0.682 . . . . 0.0 112.83 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 45.6 mt-10 -131.79 18.06 4.69 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.393 1.877 . . . . 0.0 112.29 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.94 52.64 1.28 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.466 1.506 . . . . 0.0 112.345 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -169.62 170.16 8.25 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.368 1.867 . . . . 0.0 113.209 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.38 165.49 14.09 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.358 2.263 . . . . 0.0 114.663 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -50.83 -44.54 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 126.243 1.817 . . . . 0.0 112.152 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.76 -30.08 71.08 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.09 -48.62 14.01 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.022 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -55.34 -44.96 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 120.194 1.361 . . . . 0.0 112.506 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 14.4 ptm -72.27 -24.95 61.43 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.07 10.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.713 1.205 . . . . 0.0 110.313 169.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 62.7 m-85 -55.56 -42.31 74.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.077 0.951 . . . . 0.0 112.907 173.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.13 -38.0 89.49 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.04 1.291 . . . . 0.0 112.609 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.25 -47.43 89.5 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 119.487 1.04 . . . . 0.0 112.894 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.44 -31.67 67.47 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.548 -0.972 . . . . 0.0 112.873 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.08 -53.63 55.88 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.928 1.24 . . . . 0.0 110.29 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.7 mt -57.72 -42.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.677 0.791 . . . . 0.0 110.192 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.75 -32.22 73.64 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.13 -50.38 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.661 1.185 . . . . 0.0 111.495 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.08 -15.89 64.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.072 1.349 . . . . 0.0 113.11 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.304 6.1 pt20 46.77 43.44 13.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.625 2.77 . . . . 0.0 114.117 172.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.99 3.63 33.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.914 1.285 . . . . 0.0 113.423 -176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -78.73 164.58 24.45 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.666 -1.271 . . . . 0.0 113.413 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -73.14 139.35 46.34 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.682 -0.636 . . . . 0.0 111.986 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -40.38 65.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.376 1.47 . . . . 0.0 112.893 172.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -89.41 -20.35 24.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 112.932 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.21 96.49 2.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.463 1.105 . . . . 0.0 111.538 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -61.24 -14.64 27.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.955 0.902 . . . . 0.0 112.821 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -21.29 66.19 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.996 0.918 . . . . 0.0 112.97 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.8 tpt -104.87 136.01 45.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.662 1.985 . . . . 0.0 110.999 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.56 131.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.686 1.594 . . . . 0.0 110.764 -170.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -99.34 170.54 8.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.369 1.467 . . . . 0.0 111.317 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.03 24.71 0.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 113.457 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.3 113.45 5.45 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.43 -0.794 . . . . 0.0 112.638 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.74 12.81 71.15 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.095 1.331 . . . . 0.0 115.884 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.21 148.28 22.27 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.631 2.216 . . . . 0.0 111.18 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -27.72 63.05 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.53 0.732 . . . . 0.0 112.248 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.13 -40.7 90.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.626 0.77 . . . . 0.0 112.558 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.15 92.64 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 119.101 0.864 . . . . 0.0 112.286 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.24 -40.47 96.1 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.271 1.036 . . . . 0.0 111.539 171.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.25 -44.87 82.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.568 1.147 . . . . 0.0 112.621 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.26 -23.0 43.96 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 113.449 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.91 84.12 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.232 0.92 . . . . 0.0 114.015 -171.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -136.65 137.86 40.51 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.338 1.855 . . . . 0.0 112.526 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -98.64 7.98 45.47 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.601 1.161 . . . . 0.0 113.415 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.4 p -157.09 140.9 16.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 168.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -159.51 176.41 12.1 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.504 1.922 . . . . 0.0 110.506 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 p -143.41 173.33 11.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.764 -1.21 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.67 -20.87 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -94.97 -16.33 22.86 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -125.05 65.39 47.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.85 1.66 . . . . 0.0 112.062 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.03 4.69 5.95 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.364 3.376 . . . . 0.0 113.309 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.6 m -38.88 -45.89 3.08 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 127.717 2.407 . . . . 0.0 116.616 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.42 -20.5 66.25 Favored 'Trans proline' 0 C--N 1.355 0.909 0 CA-C-N 122.521 1.936 . . . . 0.0 115.073 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.52 -49.66 62.37 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.264 1.031 . . . . 0.0 109.722 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -66.77 -30.52 70.75 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.043 -1.035 . . . . 0.0 112.043 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.64 -32.52 74.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.091 -1.006 . . . . 0.0 112.935 170.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -34.15 72.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.235 1.414 . . . . 0.0 111.629 170.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.82 -26.26 21.77 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -26.2 68.61 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.215 1.371 . . . . 0.0 114.394 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.29 -28.84 69.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.389 1.075 . . . . 0.0 111.952 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 171.347 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 CA--C 1.552 1.036 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -124.28 -175.88 3.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.238 2.615 . . . . 0.0 113.857 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.49 172.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.563 1.145 . . . . 0.0 111.393 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -164.34 132.28 2.59 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 129.799 3.24 . . . . 0.0 106.889 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 13.2 Cg_endo -100.24 174.9 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.024 2.483 . . . . 0.0 115.024 -169.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.88 160.23 14.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.949 2.1 . . . . 0.0 107.03 166.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -44.91 -46.28 28.01 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -68.85 -28.2 30.14 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 122.317 1.863 . . . . 0.0 114.037 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.68 -37.02 28.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.39 1.076 . . . . 0.0 111.011 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -57.72 -40.24 79.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 0.0 110.362 170.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -51.62 -41.62 61.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.692 1.597 . . . . 0.0 113.438 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.89 -51.68 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.297 1.039 . . . . 0.0 110.102 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.69 -31.67 68.64 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 111.925 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -31.87 69.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.793 -1.192 . . . . 0.0 112.86 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.05 -20.98 58.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.201 0.6 . . . . 0.0 112.605 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.46 21.65 17.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.381 1.872 . . . . 0.0 113.796 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.42 17.48 78.97 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.89 -161.12 0.32 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.993 1.317 . . . . 0.0 112.86 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -136.76 59.22 1.7 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.36 -130.85 10.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.859 1.219 . . . . 0.0 113.175 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 46.7 mt-10 -138.89 19.37 2.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.882 2.073 . . . . 0.0 111.589 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.6 ttt -77.7 50.34 0.83 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.698 1.199 . . . . 0.0 112.953 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -168.07 171.05 9.89 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.885 1.674 . . . . 0.0 113.876 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -65.38 167.68 8.23 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.555 2.342 . . . . 0.0 114.222 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.05 -42.24 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.801 2.041 . . . . 0.0 111.802 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -65.15 -33.91 77.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -79.01 -45.94 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.504 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.04 -47.16 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.875 1.216 . . . . 0.0 112.453 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.2 ptm -71.66 -24.01 61.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.69 -59.7 4.25 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.529 1.132 . . . . 0.0 110.744 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -55.25 -37.34 67.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.411 1.084 . . . . 0.0 113.214 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.06 -34.2 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.209 -0.932 . . . . 0.0 112.062 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.06 -47.37 91.11 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.711 -1.243 . . . . 0.0 112.154 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.291 13.9 pt20 -68.48 -31.44 70.72 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.147 -1.207 . . . . 0.0 112.925 172.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -54.6 -53.23 57.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 120.544 1.52 . . . . 0.0 110.467 169.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.4 -43.26 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.753 0.821 . . . . 0.0 110.399 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -34.78 78.51 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -78.13 -49.81 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.987 1.315 . . . . 0.0 111.847 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.04 -15.81 62.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.551 1.141 . . . . 0.0 112.858 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 6.4 pt20 47.72 43.49 16.82 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.003 2.521 . . . . 0.0 113.385 172.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.64 11.69 32.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.983 1.713 . . . . 0.0 112.902 -169.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -86.23 164.85 16.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.725 1.61 . . . . 0.0 112.222 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -71.76 146.69 47.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.135 0.969 . . . . 0.0 113.216 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.628 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -67.93 -34.84 77.38 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.004 1.722 . . . . 0.0 111.819 -175.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.54 -20.61 18.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.629 1.572 . . . . 0.0 112.483 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -144.79 93.29 2.39 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.851 0.834 . . . . 0.0 112.352 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -56.79 -21.25 27.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.27 1.428 . . . . 0.0 112.881 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -31.46 65.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.294 1.437 . . . . 0.0 113.018 171.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -98.7 130.08 45.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.117 1.367 . . . . 0.0 111.101 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -122.57 128.01 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.42 1.488 . . . . 0.0 110.258 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.42 166.59 10.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.069 1.348 . . . . 0.0 111.076 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.98 24.87 0.93 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 112.594 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.56 114.35 6.44 Favored Glycine 0 CA--C 1.533 1.169 0 O-C-N 121.531 -0.731 . . . . 0.0 112.741 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.73 11.67 66.21 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.063 1.316 . . . . 0.0 115.778 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -91.8 149.32 21.65 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 120.491 2.146 . . . . 0.0 111.44 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.23 -27.43 63.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.89 0.876 . . . . 0.0 111.991 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 tp -67.14 -40.33 86.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.796 0.838 . . . . 0.0 112.891 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.73 -36.25 92.9 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 119.132 0.878 . . . . 0.0 111.968 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -66.35 -37.43 85.31 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 112.095 171.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.2 tp -66.96 -46.96 73.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.709 0.803 . . . . 0.0 112.176 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.7 mt -77.96 -24.04 48.27 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.485 1.114 . . . . 0.0 113.101 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.73 8.85 87.19 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.253 0.93 . . . . 0.0 113.925 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -140.37 145.89 37.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.035 1.734 . . . . 0.0 113.091 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -104.29 8.29 35.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.364 1.065 . . . . 0.0 113.606 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -157.09 145.3 19.41 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -161.32 -177.42 6.0 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.544 2.338 . . . . 0.0 109.88 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.6 p -141.01 170.5 15.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.419 -1.426 . . . . 0.0 112.965 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.48 -11.24 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -88.24 -32.68 18.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.883 1.273 . . . . 0.0 111.873 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -127.19 71.47 76.23 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.926 1.69 . . . . 0.0 112.232 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.31 8.2 3.02 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.586 3.524 . . . . 0.0 113.734 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -46.13 -34.08 2.86 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 127.334 2.254 . . . . 0.0 116.772 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -59.81 -29.32 89.29 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 122.349 1.875 . . . . 0.0 114.318 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.79 -47.87 73.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.931 0.787 . . . . 0.0 110.579 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -65.52 -32.97 74.85 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.775 -0.578 . . . . 0.0 111.463 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.87 -31.62 68.35 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.174 0.897 . . . . 0.0 113.363 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -35.73 81.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.768 1.227 . . . . 0.0 110.768 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.84 -41.05 12.71 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.89 1.276 . . . . 0.0 114.14 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -27.61 64.84 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.671 1.588 . . . . 0.0 115.183 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.02 -24.63 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.491 1.517 . . . . 0.0 113.085 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -167.938 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 122.264 1.031 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -163.12 -178.68 6.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.481 2.712 . . . . 0.0 109.829 -168.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.5 172.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.107 0.963 . . . . 0.0 111.303 -169.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -163.42 136.54 4.28 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 128.719 2.808 . . . . 0.0 108.006 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -101.36 174.21 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.311 2.674 . . . . 0.0 114.956 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -98.95 159.52 14.9 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.416 1.886 . . . . 0.0 107.798 167.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.1 tp -47.2 -43.8 46.97 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -66.76 -29.57 42.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.304 2.003 . . . . 0.0 114.119 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.4 mt -84.91 -33.03 22.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.627 0.771 . . . . 0.0 111.839 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.68 -35.77 77.09 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.901 0.881 . . . . 0.0 110.974 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -40.16 68.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.771 1.228 . . . . 0.0 112.717 177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -65.43 -51.92 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.859 1.664 . . . . 0.0 109.409 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.67 -30.3 66.86 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.433 -0.792 . . . . 0.0 112.932 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -34.3 76.67 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.396 -1.44 . . . . 0.0 112.878 169.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.81 -20.23 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 119.288 0.949 . . . . 0.0 112.997 170.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.74 17.51 24.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.343 1.857 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 17.52 75.62 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.98 -165.4 1.19 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.114 1.366 . . . . 0.0 112.616 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.65 52.82 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.231 1.412 . . . . 0.0 110.99 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.79 -124.26 7.39 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.303 -0.873 . . . . 0.0 112.145 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -140.27 20.26 2.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.933 1.693 . . . . 0.0 111.902 -176.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -77.63 42.48 0.37 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.199 1.8 . . . . 0.0 114.361 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -166.29 174.6 8.97 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 -167.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.74 165.89 11.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.051 2.14 . . . . 0.0 114.297 -169.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.36 -44.55 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.848 1.659 . . . . 0.0 112.012 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -64.52 -30.12 71.15 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.46 -48.58 13.69 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.35 -0.834 . . . . 0.0 111.157 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.59 -44.88 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 120.425 1.466 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.5 ptm -71.71 -28.81 63.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.72 -59.14 5.86 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.162 . . . . 0.0 110.501 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -57.62 -33.17 67.97 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -34.7 70.19 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.159 1.345 . . . . 0.0 113.92 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.36 88.15 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 120.151 1.342 . . . . 0.0 111.769 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.261 13.5 pt20 -70.56 -31.63 68.74 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 118.071 -0.966 . . . . 0.0 113.18 173.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -55.66 -53.56 55.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.847 1.658 . . . . 0.0 110.945 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.18 -42.34 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.321 1.048 . . . . 0.0 110.071 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 31.8 tpp -67.18 -30.39 70.32 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.674 0.991 . . . . 0.0 113.674 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.66 -50.59 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.754 1.221 . . . . 0.0 111.489 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -15.99 63.25 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.496 1.118 . . . . 0.0 112.951 175.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.3 pt20 45.55 42.64 8.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.261 2.624 . . . . 0.0 113.448 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.4 19.5 16.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.843 1.657 . . . . 0.0 112.552 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -88.92 166.59 13.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.951 1.701 . . . . 0.0 111.86 171.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -76.33 135.22 39.55 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.234 -0.916 . . . . 0.0 112.07 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -38.84 42.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.263 1.425 . . . . 0.0 113.208 171.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -89.79 -18.26 26.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.214 1.406 . . . . 0.0 113.067 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.91 92.33 1.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.518 1.127 . . . . 0.0 111.257 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -57.51 -18.74 20.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 112.484 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -24.81 67.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.646 1.178 . . . . 0.0 112.957 175.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -102.01 132.66 47.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.444 1.898 . . . . 0.0 110.843 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.3 t -126.8 130.18 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.67 1.588 . . . . 0.0 110.333 -170.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -101.88 165.1 11.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.057 1.343 . . . . 0.0 111.381 172.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.5 m -150.44 23.62 0.81 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.225 1.81 . . . . 0.0 112.75 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.17 114.79 7.03 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 121.409 -0.807 . . . . 0.0 112.645 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.95 12.74 65.51 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.107 1.337 . . . . 0.0 115.528 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.36 149.49 21.19 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.087 1.944 . . . . 0.0 111.452 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -58.04 -27.72 63.84 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.683 -0.635 . . . . 0.0 111.666 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.7 tp -67.19 -39.15 86.33 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.358 -0.839 . . . . 0.0 112.598 172.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.57 90.54 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 118.659 0.663 . . . . 0.0 112.211 171.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.9 -38.0 85.43 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.398 1.099 . . . . 0.0 112.189 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.44 -46.14 70.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.479 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.41 -20.67 43.41 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.457 1.103 . . . . 0.0 113.074 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.16 -9.66 52.81 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.747 1.642 . . . . 0.0 114.407 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -124.84 142.5 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.419 1.888 . . . . 0.0 111.518 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -97.58 12.48 33.37 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.5 p -157.14 148.44 22.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.586 1.154 . . . . 0.0 112.549 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.3 173.92 15.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.392 1.877 . . . . 0.0 110.401 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.0 p -141.4 171.35 14.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.659 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -71.73 -8.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.0 -24.32 16.98 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.346 1.459 . . . . 0.0 112.854 169.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -128.82 63.42 66.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.204 1.802 . . . . 0.0 112.217 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.64 6.18 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.075 3.183 . . . . 0.0 114.077 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.8 m -44.97 -37.96 5.59 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -172.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -56.58 -30.17 82.02 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.634 2.223 . . . . 0.0 115.38 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.53 -53.04 62.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.301 1.524 . . . . 0.0 110.663 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.63 -29.23 63.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.719 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.12 -31.6 72.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.884 0.873 . . . . 0.0 112.582 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.15 -40.08 82.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.515 1.126 . . . . 0.0 110.812 169.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.26 -36.13 35.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.723 1.209 . . . . 0.0 113.842 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -25.38 65.52 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.365 1.439 . . . . 0.0 114.312 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -67.5 -31.84 72.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.644 1.977 . . . . 0.0 112.27 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.7 m120 . . . . . 0 CA--C 1.544 0.748 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.789 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -126.09 -174.94 3.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.261 2.624 . . . . 0.0 113.01 -167.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.47 171.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.077 0.951 . . . . 0.0 110.321 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -164.73 130.43 2.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 127.964 2.505 . . . . 0.0 107.786 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -96.45 172.95 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.886 2.391 . . . . 0.0 114.254 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.1 159.3 15.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.654 1.981 . . . . 0.0 108.192 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.05 -52.9 14.54 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 -22.12 37.23 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.552 2.168 . . . . 0.0 114.008 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.3 mt -84.34 -36.75 22.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.901 0.88 . . . . 0.0 111.979 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.9 -35.95 78.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 111.166 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -51.74 -38.17 54.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.455 1.502 . . . . 0.0 112.77 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -67.49 -51.52 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.74 -30.64 67.21 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -35.14 79.47 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.477 -1.389 . . . . 0.0 112.789 171.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.41 -21.52 62.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.31 21.5 17.05 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.32 1.848 . . . . 0.0 113.661 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.43 78.01 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.981 1.152 . . . . 0.0 115.981 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.08 -164.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.0 1.32 . . . . 0.0 113.035 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -129.19 50.1 2.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.997 1.719 . . . . 0.0 111.674 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.3 -122.49 5.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.425 1.012 . . . . 0.0 113.046 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -143.59 14.8 1.78 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.041 1.736 . . . . 0.0 112.684 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -79.17 52.29 1.29 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.084 1.354 . . . . 0.0 112.549 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -168.89 169.73 9.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.176 1.79 . . . . 0.0 112.532 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 164.78 6.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 127.34 2.256 . . . . 0.0 114.109 -170.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -52.72 -44.13 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.317 1.847 . . . . 0.0 111.786 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.22 -30.08 71.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.65 -47.77 14.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.106 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.25 -46.84 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 120.183 1.356 . . . . 0.0 112.499 173.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.6 ptm -69.46 -24.81 63.85 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.05 -59.66 3.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.822 1.249 . . . . 0.0 110.751 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -56.05 -36.34 67.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.945 0.898 . . . . 0.0 113.05 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -70.88 -38.91 73.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.061 0.944 . . . . 0.0 112.01 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.22 -47.43 89.49 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.865 -1.147 . . . . 0.0 112.54 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.265 13.2 pt20 -68.71 -31.6 70.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.504 -0.997 . . . . 0.0 112.755 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -57.52 -51.08 70.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.123 1.329 . . . . 0.0 111.027 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.16 -41.96 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.198 0.908 . . . . 0.0 110.08 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.25 -34.43 78.08 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.1 -52.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.598 1.159 . . . . 0.0 111.594 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -67.23 -15.76 63.89 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.323 1.049 . . . . 0.0 113.335 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.3 5.6 pt20 46.13 47.14 13.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.445 2.698 . . . . 0.0 113.912 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.8 4.49 32.73 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.75 1.22 . . . . 0.0 113.624 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -78.53 163.3 25.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 112.706 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.57 150.11 41.68 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.952 0.882 . . . . 0.0 112.682 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.599 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -64.14 -31.84 73.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.964 1.306 . . . . 0.0 112.65 -174.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -102.66 -30.04 11.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.674 1.59 . . . . 0.0 110.461 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -110.35 80.07 1.27 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.247 1.019 . . . . 0.0 111.789 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -57.3 -22.42 41.63 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.028 -0.42 . . . . 0.0 111.605 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -26.19 54.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.9 tpt -88.62 127.55 35.57 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.087 1.312 . . . . 0.0 110.854 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 t -120.07 125.69 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.394 1.078 . . . . 0.0 110.98 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.86 167.38 10.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.914 1.285 . . . . 0.0 111.065 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.1 m -148.62 29.24 0.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.916 1.686 . . . . 0.0 112.082 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.74 113.85 6.15 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.35 -0.844 . . . . 0.0 112.542 -170.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.37 12.05 72.39 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.08 1.324 . . . . 0.0 115.576 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.21 150.8 19.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.161 1.98 . . . . 0.0 111.4 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -58.06 -27.74 63.9 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.82 -37.64 84.9 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.377 -0.827 . . . . 0.0 112.482 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.43 -38.21 94.63 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.504 -0.748 . . . . 0.0 112.008 170.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -65.8 -37.61 86.74 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.229 1.014 . . . . 0.0 112.262 172.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.87 -44.64 76.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 112.248 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -79.22 -25.0 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.391 0.676 . . . . 0.0 112.626 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.16 4.55 83.87 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.423 1.011 . . . . 0.0 113.437 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -138.24 141.72 39.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.618 1.967 . . . . 0.0 111.492 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -101.97 10.1 39.95 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 -172.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.0 p -154.52 148.87 26.1 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.54 179.05 8.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.957 2.503 . . . . 0.0 109.57 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 p -144.78 172.73 12.6 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.184 -1.572 . . . . 0.0 113.286 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.05 -21.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.422 0.689 . . . . 0.0 112.096 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.72 -21.64 19.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.12 77.21 67.94 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 111.541 174.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.84 3.62 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.394 3.396 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 m -46.68 -37.6 9.4 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.874 1.67 . . . . 0.0 115.343 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.58 -27.25 68.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.407 2.738 . . . . 0.0 116.661 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.96 -49.5 57.45 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 123.021 1.391 . . . . 0.0 110.136 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -67.94 -29.15 68.15 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 121.22 -0.925 . . . . 0.0 112.157 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.56 -31.33 72.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.356 1.062 . . . . 0.0 112.179 169.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -40.52 72.26 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.256 1.022 . . . . 0.0 111.484 169.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.45 -30.78 26.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -59.74 -26.54 65.74 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.627 1.571 . . . . 0.0 113.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -69.6 -31.04 68.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.588 1.955 . . . . 0.0 112.252 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 t30 . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 171.85 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.99 -177.2 4.19 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.969 2.507 . . . . 0.0 112.054 -168.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 28' ' ' ARG . 2.9 t -81.99 172.31 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.362 1.065 . . . . 0.0 109.621 -174.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -162.18 135.9 4.79 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 129.31 3.044 . . . . 0.0 107.344 173.42 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.544 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 24.1 Cg_endo -93.72 175.74 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.995 2.463 . . . . 0.0 115.468 -168.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -107.67 160.55 15.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.975 2.51 . . . . 0.0 107.65 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.3 tp -40.27 -55.76 3.89 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 126.271 1.828 . . . . 0.0 115.822 -175.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.94 -25.06 28.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.223 1.949 . . . . 0.0 113.452 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.34 -35.47 35.54 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.452 -0.78 . . . . 0.0 111.582 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.53 -32.73 73.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.706 0.802 . . . . 0.0 110.93 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -59.23 -40.22 85.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.919 1.288 . . . . 0.0 112.759 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -65.76 -46.08 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.196 1.398 . . . . 0.0 109.98 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.6 -30.81 67.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.081 0.552 . . . . 0.0 112.225 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -66.37 -37.2 84.74 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.095 -1.628 . . . . 0.0 112.178 169.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.89 -24.07 67.42 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.952 0.796 . . . . 0.0 112.033 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . . . -84.51 4.81 30.14 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.65 1.58 . . . . 0.0 114.339 169.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.56 78.43 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.529 1.061 . . . . 0.0 115.364 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -92.01 -160.93 0.78 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.899 1.68 . . . . 0.0 113.092 -174.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -137.28 68.84 1.41 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.63 -146.09 32.28 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.903 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 48.2 mt-10 -129.48 19.06 5.77 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.235 2.214 . . . . 0.0 112.092 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.1 ttt -79.71 52.73 1.49 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.928 1.291 . . . . 0.0 112.38 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -166.35 175.87 7.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.41 1.884 . . . . 0.0 114.179 -169.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 49' ' ' VAL . 1.6 m -78.13 170.19 17.02 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.782 2.433 . . . . 0.0 114.379 -169.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 48' ' ' THR . 60.4 t -52.77 -42.84 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 126.866 2.066 . . . . 0.0 111.773 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -65.98 -30.11 70.61 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.33 -47.87 13.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.022 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -55.21 -45.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 120.193 1.36 . . . . 0.0 112.697 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.7 ptm -70.75 -25.65 63.01 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.49 -59.8 3.61 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.429 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 52.1 m-85 -55.73 -39.97 71.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.038 0.935 . . . . 0.0 112.849 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.84 -43.03 90.65 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.299 -0.876 . . . . 0.0 112.898 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.12 -46.86 84.32 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.259 0.936 . . . . 0.0 112.595 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 14.2 pt20 -71.8 -31.62 66.76 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.741 -0.858 . . . . 0.0 113.312 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CE2' ' HE3' ' A' ' 63' ' ' LYS . 60.5 t80 -59.09 -51.7 68.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.622 1.556 . . . . 0.0 111.253 169.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.55 -43.34 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.22 1.008 . . . . 0.0 110.081 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.6 tpp -67.48 -32.52 73.42 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.9 t -75.45 -51.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.728 1.211 . . . . 0.0 111.446 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 21.2 mmtp -66.75 -16.02 63.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.895 0.878 . . . . 0.0 112.88 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.296 6.2 pt20 44.25 43.7 6.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 128.36 2.664 . . . . 0.0 113.635 175.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -102.08 21.96 13.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.713 1.605 . . . . 0.0 112.848 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -87.54 169.74 11.92 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.414 1.886 . . . . 0.0 111.895 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.38 144.24 44.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.255 -0.903 . . . . 0.0 112.678 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.518 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 9.9 mp0 -64.14 -39.89 94.99 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.543 1.937 . . . . 0.0 112.417 -177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -92.38 -21.84 20.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.3 1.44 . . . . 0.0 112.362 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -138.99 88.27 2.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.393 1.092 . . . . 0.0 112.93 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -56.17 -17.84 8.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.418 1.087 . . . . 0.0 112.918 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -25.43 68.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.452 1.101 . . . . 0.0 112.978 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -103.11 134.32 46.74 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.884 1.674 . . . . 0.0 111.241 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -126.42 132.48 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.442 1.497 . . . . 0.0 110.778 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -112.9 162.47 15.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.915 1.686 . . . . 0.0 111.35 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.6 m -146.19 28.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.309 1.443 . . . . 0.0 111.864 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.99 106.43 0.23 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.464 1.031 . . . . 0.0 114.642 -169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.86 14.76 65.96 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.994 1.283 . . . . 0.0 115.493 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.35 153.95 20.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.2 1.5 . . . . 0.0 112.365 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -57.55 -27.93 63.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.564 0.746 . . . . 0.0 111.994 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.58 -41.32 88.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.1 0.864 . . . . 0.0 112.213 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.42 -37.79 94.93 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.724 -0.61 . . . . 0.0 111.825 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -66.53 -38.4 87.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.024 0.929 . . . . 0.0 112.274 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 tp -65.6 -46.06 80.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.054 1.342 . . . . 0.0 112.102 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -76.48 -26.81 55.74 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.29 2.01 71.84 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.009 0.814 . . . . 0.0 112.862 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -142.01 136.02 29.86 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 129.807 3.243 . . . . 0.0 108.058 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.284 9.0 pt20 -112.16 17.67 19.33 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.8 p -153.4 145.33 23.6 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.089 -1.007 . . . . 0.0 113.07 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -161.0 170.47 20.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.836 1.655 . . . . 0.0 111.208 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.0 p -137.32 170.88 15.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.671 0.788 . . . . 0.0 111.753 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -7.58 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -95.11 -27.13 15.73 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.133 1.373 . . . . 0.0 112.73 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -131.4 78.67 71.38 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.648 1.579 . . . . 0.0 111.199 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.15 5.44 6.24 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.273 3.315 . . . . 0.0 113.799 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -44.53 -38.0 4.98 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -173.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -59.07 -28.83 88.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.966 2.444 . . . . 0.0 115.932 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 tp -58.87 -53.3 59.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 123.158 1.456 . . . . 0.0 109.929 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.56 -29.17 62.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.296 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -64.38 -31.34 72.51 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.441 1.019 . . . . 0.0 112.529 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.5 ttp -72.2 -42.72 65.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.053 0.941 . . . . 0.0 110.335 169.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.14 -32.25 44.34 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -59.24 -28.1 66.39 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.772 1.629 . . . . 0.0 114.026 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.4 -26.57 58.52 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.629 1.971 . . . . 0.0 112.837 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 124.58 1.152 . . . . 0.0 113.839 -174.698 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -127.61 -175.54 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 129.216 3.007 . . . . 0.0 112.032 -167.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' MET . 2.0 t -92.5 172.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.862 1.265 . . . . 0.0 109.9 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.3 ttp85 -164.77 142.66 5.32 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 130.108 3.363 . . . . 0.0 107.722 168.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -105.67 170.86 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.198 2.599 . . . . 0.0 114.111 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -83.44 158.76 21.95 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.727 1.211 . . . . 0.0 108.149 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.44 -50.43 22.85 Favored Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.43 -25.53 35.5 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.168 1.912 . . . . 0.0 114.274 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -81.19 -37.79 28.12 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.518 0.727 . . . . 0.0 111.436 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.67 -42.57 98.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.091 1.356 . . . . 0.0 111.719 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 40.2 pttt -68.49 -22.95 64.52 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -62.12 -52.79 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 109.347 169.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.69 -30.58 67.2 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -32.16 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.818 -1.176 . . . . 0.0 113.271 170.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.27 -22.64 63.34 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.136 0.88 . . . . 0.0 112.955 170.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.5 23.65 13.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.089 1.756 . . . . 0.0 113.462 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.73 15.6 79.4 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.43 -163.55 0.58 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.384 1.092 . . . . 0.0 113.173 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -132.32 49.2 2.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.019 2.128 . . . . 0.0 109.842 168.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.99 -115.73 4.77 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.737 1.16 . . . . 0.0 112.721 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.86 17.39 3.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.142 1.777 . . . . 0.0 111.241 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 24.5 ttt -74.52 50.73 0.43 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.314 1.846 . . . . 0.0 113.482 -172.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -173.5 170.92 4.04 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.66 1.984 . . . . 0.0 112.666 -169.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.25 165.74 11.05 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.277 2.231 . . . . 0.0 113.594 -172.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -51.55 -44.68 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 126.581 1.952 . . . . 0.0 112.043 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -65.15 -30.18 71.08 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -80.38 -45.39 17.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.124 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -57.35 -45.04 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 120.075 1.307 . . . . 0.0 112.506 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.9 ptm -70.05 -24.16 63.21 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -66.78 -57.72 6.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.127 1.371 . . . . 0.0 110.983 170.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -56.48 -36.84 69.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.026 0.93 . . . . 0.0 113.145 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tt -71.79 -40.36 69.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.483 -0.761 . . . . 0.0 111.742 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.51 -47.43 89.97 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.9 -1.125 . . . . 0.0 112.807 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -69.59 -31.54 69.75 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.212 -1.17 . . . . 0.0 112.641 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.11 -50.61 72.27 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.957 1.253 . . . . 0.0 110.942 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mt -57.89 -43.74 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.706 0.684 . . . . 0.0 110.242 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.16 -32.97 74.72 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.53 -50.9 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.412 1.085 . . . . 0.0 111.518 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -15.87 63.66 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.376 1.07 . . . . 0.0 113.181 176.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.2 pt20 45.44 43.43 8.68 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.331 2.652 . . . . 0.0 113.62 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.03 8.39 43.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.668 1.587 . . . . 0.0 112.936 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -74.39 162.96 28.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.693 1.197 . . . . 0.0 112.268 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.48 147.77 41.61 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -47.1 78.56 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -76.77 -19.92 57.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.41 94.92 2.28 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.462 1.125 . . . . 0.0 113.311 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.84 -17.96 28.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.299 1.44 . . . . 0.0 112.876 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -25.17 65.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.943 0.897 . . . . 0.0 113.104 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.8 tpp -93.95 129.18 40.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 109.742 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.12 113.03 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.812 1.645 . . . . 0.0 109.806 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -86.91 165.12 16.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.783 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.74 25.28 1.18 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.584 1.553 . . . . 0.0 112.596 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.54 114.82 6.64 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.561 -0.712 . . . . 0.0 112.948 -169.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.74 10.93 72.72 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.144 1.354 . . . . 0.0 115.853 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.38 150.01 21.06 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.404 2.102 . . . . 0.0 111.437 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.01 -27.66 63.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.535 -0.728 . . . . 0.0 112.735 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.45 -39.74 94.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.383 0.992 . . . . 0.0 112.068 171.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.61 95.78 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.501 0.572 . . . . 0.0 112.146 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.98 -43.13 95.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.122 0.961 . . . . 0.0 111.995 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -70.65 -46.16 63.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.242 1.017 . . . . 0.0 111.892 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -71.82 -27.76 63.13 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.072 0.949 . . . . 0.0 112.563 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.03 7.24 83.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.345 1.45 . . . . 0.0 114.499 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.54 147.94 30.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.072 1.749 . . . . 0.0 111.721 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -101.98 9.87 40.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 113.448 -173.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -153.25 144.08 22.79 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.82 170.82 20.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.955 2.102 . . . . 0.0 110.67 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -136.58 154.4 50.7 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.701 0.8 . . . . 0.0 112.023 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.29 -14.89 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.87 -7.12 57.63 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.424 1.49 . . . . 0.0 113.731 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -145.24 64.27 10.69 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.707 1.603 . . . . 0.0 111.48 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.73 2.77 7.89 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.206 3.271 . . . . 0.0 114.714 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.9 m -48.5 -33.1 4.48 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -54.5 -31.0 67.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.115 2.543 . . . . 0.0 115.812 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.5 -48.76 46.93 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.621 1.169 . . . . 0.0 110.379 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -67.02 -29.24 69.0 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.011 -1.056 . . . . 0.0 112.177 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.95 -31.56 72.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.708 1.203 . . . . 0.0 112.526 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -32.5 70.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.866 1.267 . . . . 0.0 112.236 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.5 -31.62 16.69 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -62.73 -27.86 69.56 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.855 1.262 . . . . 0.0 113.935 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -62.44 -29.04 70.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.948 0.899 . . . . 0.0 112.109 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 . . . . . 0 CA--C 1.547 0.852 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.51 169.588 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 122.337 1.065 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -163.55 -173.06 3.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 130.389 3.476 . . . . 0.0 108.457 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.08 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.983 -1.073 . . . . 0.0 111.55 -172.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -158.19 139.18 9.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 131.329 3.852 . . . . 0.0 106.729 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 35.6 Cg_endo -96.72 167.01 1.04 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.242 2.628 . . . . 0.0 113.681 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -79.93 161.48 25.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.399 1.08 . . . . 0.0 108.597 167.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.92 -42.03 66.92 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -68.61 -29.32 30.26 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.264 1.976 . . . . 0.0 114.246 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.89 -31.2 25.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.955 0.902 . . . . 0.0 112.108 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.25 -43.23 87.76 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.943 0.897 . . . . 0.0 111.056 173.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.309 16.9 pttp -72.76 -24.84 61.0 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.67 -52.08 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 109.475 170.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 37' ' ' LEU . 1.2 mm? -67.54 -30.72 70.44 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.483 -0.761 . . . . 0.0 112.463 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -29.9 69.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.678 -1.264 . . . . 0.0 113.378 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.33 59.78 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.4 21.81 16.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.157 1.783 . . . . 0.0 113.684 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.25 17.03 78.63 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.24 -156.23 0.16 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.859 1.264 . . . . 0.0 112.731 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -141.24 60.15 1.51 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.569 1.948 . . . . 0.0 109.624 168.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.29 18.02 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.584 -172.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 40.3 mt-10 -135.64 20.4 3.33 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.699 2.0 . . . . 0.0 110.923 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -76.07 54.74 0.88 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.876 1.67 . . . . 0.0 112.955 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -173.29 172.21 3.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.286 1.834 . . . . 0.0 112.384 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 167.07 13.76 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.814 2.045 . . . . 0.0 114.084 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -49.45 -45.88 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.455 1.902 . . . . 0.0 112.169 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -65.09 -30.07 70.99 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.79 -46.72 16.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.137 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -55.71 -46.72 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 120.477 1.489 . . . . 0.0 112.337 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 23.1 ptm -69.51 -27.44 65.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -62.47 -58.07 8.93 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.558 1.143 . . . . 0.0 110.758 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -58.31 -32.56 68.58 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.13 -41.27 81.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.559 1.072 . . . . 0.0 112.82 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.44 -47.42 88.2 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.963 0.801 . . . . 0.0 112.093 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.252 11.5 pt20 -70.72 -31.7 68.63 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.554 -0.968 . . . . 0.0 113.08 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.45 -51.93 66.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.454 1.479 . . . . 0.0 111.014 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.5 mt -60.59 -41.61 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.068 0.947 . . . . 0.0 110.272 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 37.7 tpp -67.78 -31.97 72.23 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.08 -50.4 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.357 1.063 . . . . 0.0 111.347 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -16.03 63.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.968 0.907 . . . . 0.0 113.125 175.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.4 pt20 43.49 43.07 4.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.455 2.702 . . . . 0.0 113.647 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 tp -99.51 20.21 14.28 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.523 1.529 . . . . 0.0 112.689 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -83.88 165.71 18.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 111.883 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.46 148.52 45.04 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.169 0.985 . . . . 0.0 113.026 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.606 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.7 -38.41 76.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.833 1.653 . . . . 0.0 111.43 -176.343 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -90.94 -20.39 22.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.585 1.554 . . . . 0.0 112.295 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -144.04 93.18 2.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.415 1.103 . . . . 0.0 112.414 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -57.69 -18.51 21.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.152 1.381 . . . . 0.0 112.821 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.78 63.64 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.24 1.016 . . . . 0.0 113.133 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -97.86 129.81 44.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.063 1.745 . . . . 0.0 110.302 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.03 131.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.114 1.366 . . . . 0.0 110.65 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -105.62 165.71 10.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.297 1.439 . . . . 0.0 111.6 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.02 24.24 1.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.151 1.781 . . . . 0.0 112.771 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.38 113.68 5.71 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.603 -0.685 . . . . 0.0 112.647 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.98 13.03 66.07 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.12 1.343 . . . . 0.0 115.676 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -95.25 148.42 22.43 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.39 2.095 . . . . 0.0 111.382 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.88 -27.8 63.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.47 0.708 . . . . 0.0 111.943 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.11 -39.95 90.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.4 -0.812 . . . . 0.0 112.465 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.93 92.59 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 118.543 0.61 . . . . 0.0 112.223 172.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -65.11 -36.68 85.07 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 117.893 0.846 . . . . 0.0 112.19 171.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.27 -50.51 53.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.606 1.162 . . . . 0.0 111.2 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.67 -24.02 58.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.123 0.969 . . . . 0.0 113.082 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.47 7.78 85.87 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.161 1.362 . . . . 0.0 114.634 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 150.19 33.84 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.886 1.674 . . . . 0.0 111.854 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -99.1 11.49 38.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.118 0.967 . . . . 0.0 113.434 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -155.32 149.73 26.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.86 177.84 10.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.65 1.98 . . . . 0.0 111.129 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 t -140.2 154.55 46.96 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.011 -1.056 . . . . 0.0 111.892 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.2 m -66.22 -12.92 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 169.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -83.18 -17.2 43.69 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.65 1.18 . . . . 0.0 113.026 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -140.38 69.87 32.92 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 111.478 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.75 3.95 4.5 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.21 3.273 . . . . 0.0 114.564 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -45.4 -35.45 3.22 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 126.364 1.866 . . . . 0.0 115.736 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -56.69 -30.09 82.56 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.95 2.433 . . . . 0.0 115.73 173.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.74 -45.56 61.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.177 0.899 . . . . 0.0 110.142 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.45 -30.25 69.92 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.621 -0.674 . . . . 0.0 112.275 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -66.72 -31.31 71.88 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.858 1.263 . . . . 0.0 112.872 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -33.33 67.44 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.292 1.437 . . . . 0.0 112.207 170.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.98 -27.02 18.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.959 1.704 . . . . 0.0 114.545 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -61.46 -23.37 65.82 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.4 1.48 . . . . 0.0 113.963 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -65.69 -27.31 68.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.546 1.938 . . . . 0.0 112.344 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 CA--C 1.548 0.882 0 C-N-CA 124.147 0.979 . . . . 0.0 113.331 172.428 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -129.64 -177.66 4.36 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 128.42 2.688 . . . . 0.0 113.114 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.68 172.23 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.851 1.661 . . . . 0.0 111.677 -176.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -163.35 143.42 6.91 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 130.173 3.389 . . . . 0.0 108.22 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -102.65 169.37 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.783 2.989 . . . . 0.0 113.843 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -87.4 164.45 16.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 109.792 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.5 tp -42.82 -56.32 6.22 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.926 1.69 . . . . 0.0 115.377 -172.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.89 -26.8 37.67 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.215 1.943 . . . . 0.0 113.821 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.7 mt -80.83 -34.59 33.78 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.363 -0.836 . . . . 0.0 112.243 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.39 -32.16 73.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.795 1.238 . . . . 0.0 110.988 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -58.57 -41.69 86.28 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.42 1.488 . . . . 0.0 112.861 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.86 -51.31 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.187 1.395 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.32 13.6 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -61.43 -33.96 74.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.613 -1.304 . . . . 0.0 112.399 169.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.05 62.35 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.247 0.93 . . . . 0.0 113.317 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 23.52 13.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.008 1.723 . . . . 0.0 113.434 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.26 79.62 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.676 1.131 . . . . 0.0 115.687 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.0 -169.58 2.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.466 1.106 . . . . 0.0 113.247 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -123.39 44.74 2.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.678 1.991 . . . . 0.0 110.841 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.74 -115.33 4.12 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.983 1.278 . . . . 0.0 112.646 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -139.51 15.77 2.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.741 2.016 . . . . 0.0 110.769 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 56.6 ttp -77.0 52.39 0.87 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.609 1.564 . . . . 0.0 112.772 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -171.61 171.48 5.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.521 1.929 . . . . 0.0 112.693 -168.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -65.63 165.63 12.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.501 1.92 . . . . 0.0 112.214 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.86 -37.92 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.16 0.984 . . . . 0.0 112.185 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.33 -30.04 69.26 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -80.52 -43.48 20.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.512 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 m -54.96 -50.01 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 120.551 1.523 . . . . 0.0 113.016 175.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -68.49 -23.98 64.63 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.043 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.18 -59.17 3.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.989 1.316 . . . . 0.0 111.033 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -56.19 -36.83 68.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.133 0.973 . . . . 0.0 113.119 174.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.86 -42.53 73.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.939 0.895 . . . . 0.0 112.707 174.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.49 -47.36 76.92 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.398 -0.814 . . . . 0.0 111.813 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.93 -31.55 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.543 -0.974 . . . . 0.0 113.555 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -55.34 -50.41 69.72 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.727 1.603 . . . . 0.0 111.06 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.8 mt -63.45 -42.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.151 0.98 . . . . 0.0 110.531 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -45.36 92.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.634 1.174 . . . . 0.0 111.467 177.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.62 -48.39 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.079 0.952 . . . . 0.0 111.72 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -67.1 -16.11 64.13 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.284 6.3 pt20 41.93 42.88 2.44 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.868 2.467 . . . . 0.0 113.462 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -98.32 16.28 22.0 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.511 1.524 . . . . 0.0 113.309 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -81.71 160.4 23.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.985 1.314 . . . . 0.0 111.178 169.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -74.45 133.46 42.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.038 -1.039 . . . . 0.0 112.048 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -54.46 -33.66 60.04 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.876 1.67 . . . . 0.0 113.579 171.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -83.82 -27.38 28.8 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.012 1.325 . . . . 0.0 112.422 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.33 95.63 1.95 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.546 1.138 . . . . 0.0 111.655 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -60.51 -14.92 22.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.737 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.38 69.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.629 0.772 . . . . 0.0 112.743 173.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.5 tpp -91.84 130.6 37.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.021 1.729 . . . . 0.0 110.356 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.06 118.09 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.041 1.737 . . . . 0.0 109.764 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.41 162.06 14.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.538 1.135 . . . . 0.0 111.736 171.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -153.88 27.12 0.48 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.065 2.146 . . . . 0.0 112.21 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 118.6 13.08 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.33 -0.856 . . . . 0.0 113.349 -169.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.52 8.61 67.25 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.005 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -98.53 156.1 16.95 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 120.573 2.187 . . . . 0.0 112.272 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.56 -27.62 66.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.713 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 tp -66.84 -44.29 81.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.224 -0.922 . . . . 0.0 112.9 173.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.02 86.12 Favored Glycine 0 N--CA 1.477 1.424 0 CA-C-O 118.151 -1.361 . . . . 0.0 112.411 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.48 -40.03 92.63 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.014 1.907 . . . . 0.0 112.334 170.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -70.32 -51.73 28.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.082 0.953 . . . . 0.0 111.144 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.9 -20.14 61.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 112.198 176.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.73 13.04 82.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.749 1.642 . . . . 0.0 114.686 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -129.31 -25.17 2.73 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 121.63 3.937 . . . . 0.0 121.63 -169.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 55.05 2.85 0.05 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.3 p -157.22 138.3 13.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.837 1.255 . . . . 0.0 112.68 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.89 176.11 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.121 1.768 . . . . 0.0 110.681 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 t -140.5 156.93 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.135 -0.978 . . . . 0.0 111.363 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.08 -18.03 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.668 -0.645 . . . . 0.0 112.446 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.15 -1.89 50.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 113.897 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -137.81 60.58 25.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.889 1.676 . . . . 0.0 111.803 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -79.15 -0.11 10.48 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.946 3.097 . . . . 0.0 113.908 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.2 m -46.82 -32.45 2.11 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.72 -24.57 68.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.157 1.904 . . . . 0.0 114.132 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.82 -47.4 53.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.853 0.861 . . . . 0.0 110.11 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -68.22 -30.52 69.61 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.518 -0.739 . . . . 0.0 112.462 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.54 -31.52 72.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.471 1.032 . . . . 0.0 112.917 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -34.2 73.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.39 1.476 . . . . 0.0 112.099 171.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.65 -33.8 15.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 114.443 -175.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -58.25 -28.36 64.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.206 1.403 . . . . 0.0 113.689 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.15 -27.14 68.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.847 2.059 . . . . 0.0 112.556 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 . . . . . 0 CA--C 1.548 0.894 0 C-N-CA 124.72 1.208 . . . . 0.0 113.177 173.234 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.9 m120 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -131.37 -177.65 4.49 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.432 2.293 . . . . 0.0 112.558 -167.475 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' MET . 15.4 m -94.55 172.13 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.528 1.131 . . . . 0.0 110.289 -175.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -162.21 144.14 8.39 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 128.089 2.555 . . . . 0.0 109.001 -172.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 8.5 Cg_endo -98.52 176.27 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.143 2.562 . . . . 0.0 114.705 -169.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -105.83 157.37 17.51 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.674 1.99 . . . . 0.0 107.507 167.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.8 mt -47.37 -46.01 56.93 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.87 -21.74 20.86 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.922 1.748 . . . . 0.0 114.015 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.24 -34.15 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.934 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.5 -41.62 81.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 111.629 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.269 18.3 pttp -72.52 -21.84 61.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.6 mt -69.69 -45.8 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.648 1.179 . . . . 0.0 110.083 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.67 -37.21 86.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.466 -0.771 . . . . 0.0 111.233 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.829 -1.169 . . . . 0.0 113.436 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.43 -22.26 61.22 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 112.99 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.13 22.12 14.59 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.074 1.75 . . . . 0.0 113.543 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 17.55 78.66 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.75 -156.07 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.89 1.276 . . . . 0.0 112.996 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -148.41 67.28 1.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.312 1.845 . . . . 0.0 110.489 169.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.13 -146.62 36.6 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.749 -172.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.48 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 45.4 mt-10 -122.19 15.39 10.62 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.868 2.067 . . . . 0.0 111.958 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 27.6 ttt -79.45 59.15 2.84 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.874 1.27 . . . . 0.0 113.705 -168.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -170.41 177.75 3.96 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.296 1.838 . . . . 0.0 113.719 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.35 165.64 13.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.521 2.328 . . . . 0.0 114.387 -172.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.4 t -52.12 -47.01 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 125.958 1.703 . . . . 0.0 111.843 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -62.52 -30.08 71.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -78.83 -47.93 15.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.067 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -55.88 -45.42 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 120.463 1.483 . . . . 0.0 112.376 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.5 ptm -70.26 -26.28 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -64.61 -59.43 4.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.162 1.385 . . . . 0.0 110.868 171.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -56.41 -36.25 68.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.784 0.834 . . . . 0.0 113.189 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.99 -44.64 88.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.054 0.941 . . . . 0.0 112.343 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.831 0.741 . . . . 0.0 112.249 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.28 11.2 pt20 -70.67 -31.54 68.48 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.392 -1.063 . . . . 0.0 113.087 176.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -55.97 -54.48 44.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.247 1.385 . . . . 0.0 110.496 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.34 -42.25 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.809 0.843 . . . . 0.0 110.146 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -34.93 79.49 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.9 t -78.24 -50.28 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 111.174 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.3 64.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.963 0.905 . . . . 0.0 112.665 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.333 5.8 pt20 46.44 39.44 6.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.667 2.787 . . . . 0.0 114.523 176.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -91.6 51.44 1.87 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.249 1.42 . . . . 0.0 111.42 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -124.97 162.51 24.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.787 2.035 . . . . 0.0 111.376 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.25 138.5 47.52 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.349 -0.844 . . . . 0.0 111.837 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -48.51 79.0 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.06 -1.025 . . . . 0.0 112.864 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -80.93 -6.39 58.64 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.128 0.876 . . . . 0.0 113.031 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.7 86.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.573 1.177 . . . . 0.0 111.365 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.07 -15.42 32.46 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.145 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -22.2 65.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.84 1.256 . . . . 0.0 113.146 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 43.2 tpp -107.24 134.6 50.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.073 2.149 . . . . 0.0 111.143 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.02 133.24 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.996 1.718 . . . . 0.0 110.275 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.41 84.88 2.11 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.301 2.241 . . . . 0.0 110.603 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -80.39 38.59 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.187 2.595 . . . . 0.0 113.451 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 113.03 2.49 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.305 -0.872 . . . . 0.0 114.609 -168.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.59 11.61 77.15 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.057 1.313 . . . . 0.0 116.187 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.93 156.8 20.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.944 1.872 . . . . 0.0 112.366 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.56 -28.06 59.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 112.755 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.23 -37.62 81.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.17 -0.956 . . . . 0.0 112.21 171.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.66 -39.93 98.06 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.415 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -64.83 -38.48 91.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.841 1.321 . . . . 0.0 112.07 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -69.56 -46.48 66.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.258 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.08 -18.64 45.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.816 1.246 . . . . 0.0 113.297 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.01 73.93 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.84 1.686 . . . . 0.0 114.937 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.39 -36.89 0.71 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -169.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 5.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.5 p -145.78 135.53 23.4 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.468 1.485 . . . . 0.0 114.586 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -169.94 168.28 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.717 2.407 . . . . 0.0 109.521 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 p -132.86 171.48 13.86 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.424 -0.797 . . . . 0.0 111.282 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.81 -9.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.261 -0.899 . . . . 0.0 113.378 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -95.05 -25.58 16.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.238 1.415 . . . . 0.0 112.984 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -130.63 70.92 82.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 125.973 1.709 . . . . 0.0 111.907 174.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -88.09 16.31 1.92 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 125.02 3.813 . . . . 0.0 114.853 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.1 p -50.85 -31.01 4.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.3 -31.72 52.37 Favored 'Trans proline' 0 C--N 1.357 0.987 0 CA-C-N 123.959 2.449 . . . . 0.0 114.108 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.4 -49.21 72.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.174 1.39 . . . . 0.0 110.531 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.05 -29.19 57.95 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.366 -0.834 . . . . 0.0 112.452 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.06 -32.96 72.81 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.295 -0.878 . . . . 0.0 113.241 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.3 ttp -68.52 -41.36 80.04 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.267 1.427 . . . . 0.0 110.617 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.04 -48.68 56.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.315 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -58.13 -31.92 67.66 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.92 -26.42 64.14 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.738 2.015 . . . . 0.0 112.917 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 110.55 174.011 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 CA--C 1.544 0.737 0 CA-C-O 122.544 1.164 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -163.18 -176.62 4.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.055 2.942 . . . . 0.0 109.159 -168.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.46 171.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 120.987 -1.071 . . . . 0.0 111.818 -169.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -162.67 140.48 6.38 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 129.527 3.131 . . . . 0.0 107.279 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 1.1 Cg_endo -103.57 179.37 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.048 2.499 . . . . 0.0 115.28 -169.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -108.73 158.47 17.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.784 2.433 . . . . 0.0 107.213 167.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -45.24 -47.05 33.51 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 -23.13 30.89 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.058 1.839 . . . . 0.0 114.694 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.19 -35.47 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.376 0.67 . . . . 0.0 111.865 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.47 -41.88 81.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.329 1.052 . . . . 0.0 111.601 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -71.38 -20.44 62.14 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.55 -51.68 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 109.285 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.97 -34.2 76.09 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.605 -0.685 . . . . 0.0 111.753 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -30.7 68.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.892 -1.13 . . . . 0.0 113.188 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.98 60.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.519 0.727 . . . . 0.0 112.869 169.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.77 22.35 15.3 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.195 1.798 . . . . 0.0 113.533 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.64 16.98 78.99 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.644 1.018 . . . . 0.0 115.644 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.73 -156.7 0.16 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.97 1.308 . . . . 0.0 112.729 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.27 59.94 1.55 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.559 1.544 . . . . 0.0 110.364 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.64 -141.7 27.88 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.848 -172.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.491 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.3 mt-10 -121.72 21.33 10.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.799 2.04 . . . . 0.0 112.138 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.5 ptm -74.72 41.17 0.15 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -169.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -166.62 174.48 8.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.707 1.603 . . . . 0.0 113.979 -168.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.66 167.66 16.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.32 2.248 . . . . 0.0 114.236 -169.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -49.15 -43.43 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 126.317 1.847 . . . . 0.0 112.75 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -31.28 70.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -77.76 -46.43 21.74 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.098 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.45 -46.24 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 120.319 1.418 . . . . 0.0 112.586 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.2 ptm -69.46 -28.21 65.9 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.52 -59.04 6.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.618 1.167 . . . . 0.0 110.851 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -55.81 -36.77 67.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 113.386 173.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.17 -36.98 80.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.839 1.199 . . . . 0.0 113.129 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.74 -47.42 90.41 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.927 1.24 . . . . 0.0 112.232 173.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.272 13.4 pt20 -70.22 -31.5 68.95 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.451 -1.029 . . . . 0.0 113.081 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -55.89 -54.5 43.95 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.207 1.367 . . . . 0.0 110.07 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.3 mt -59.03 -39.98 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.931 0.892 . . . . 0.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.8 tpp -69.11 -32.35 71.7 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.23 -51.35 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.028 -1.045 . . . . 0.0 111.344 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -68.08 -12.96 61.79 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.307 1.443 . . . . 0.0 113.064 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.31 5.8 pt20 48.76 50.18 17.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.37 3.068 . . . . 0.0 114.023 169.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.6 mt -88.4 3.91 48.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.531 1.133 . . . . 0.0 113.741 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -89.11 162.2 16.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.455 1.102 . . . . 0.0 113.015 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -78.9 152.3 31.25 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.79 -47.34 63.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -77.7 -17.33 57.76 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -149.61 87.07 1.48 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.059 0.933 . . . . 0.0 111.787 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -55.94 -22.81 28.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.763 1.625 . . . . 0.0 112.44 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.09 -34.35 56.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.301 1.84 . . . . 0.0 112.987 170.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tpt -99.51 135.33 41.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.002 1.721 . . . . 0.0 111.158 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -132.08 136.73 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.025 1.73 . . . . 0.0 110.487 -170.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -105.94 175.0 5.64 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.187 1.795 . . . . 0.0 112.194 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.88 20.24 0.32 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.714 1.606 . . . . 0.0 113.733 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.3 115.75 5.01 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.845 0.736 . . . . 0.0 114.115 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.34 6.97 71.38 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.305 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -96.6 158.81 15.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 121.089 2.445 . . . . 0.0 112.506 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -27.69 68.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.996 0.918 . . . . 0.0 112.13 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.38 -41.57 96.62 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.38 -0.825 . . . . 0.0 111.994 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.22 96.94 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 119.339 0.972 . . . . 0.0 112.654 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -43.89 95.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.479 1.14 . . . . 0.0 111.722 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.73 -46.38 66.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.326 1.05 . . . . 0.0 112.245 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.28 -25.71 63.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.804 1.241 . . . . 0.0 113.035 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 4.67 75.5 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.394 0.997 . . . . 0.0 113.796 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -138.39 141.25 39.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 112.393 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -102.99 7.76 39.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.719 1.208 . . . . 0.0 113.27 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.0 p -155.92 143.42 19.41 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.498 1.119 . . . . 0.0 112.462 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.73 178.7 8.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.117 2.167 . . . . 0.0 110.262 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.7 p -142.98 170.38 15.81 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.649 -1.282 . . . . 0.0 112.969 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.51 -19.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.898 0.879 . . . . 0.0 112.943 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.08 -10.74 29.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.037 1.335 . . . . 0.0 113.803 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -132.61 62.73 64.41 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.832 1.653 . . . . 0.0 112.639 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.08 0.17 9.63 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.106 3.204 . . . . 0.0 114.09 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.6 m -42.77 -39.32 3.55 Favored Pre-proline 0 N--CA 1.472 0.663 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.42 -24.19 71.14 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 123.242 2.194 . . . . 0.0 114.89 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.44 -47.47 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.233 1.378 . . . . 0.0 109.802 170.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.11 -33.0 74.77 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.686 -0.633 . . . . 0.0 111.941 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.34 -31.47 69.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.457 1.026 . . . . 0.0 113.401 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.38 77.63 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.986 1.314 . . . . 0.0 111.234 169.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.6 mt -91.16 -34.92 14.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.357 1.463 . . . . 0.0 114.483 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -28.08 62.92 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.562 1.545 . . . . 0.0 113.692 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.69 -28.14 69.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.743 2.017 . . . . 0.0 112.847 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.382 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -128.31 -176.44 3.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.846 2.858 . . . . 0.0 113.085 -167.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.2 172.4 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.269 1.427 . . . . 0.0 109.163 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -164.25 139.93 4.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 130.459 3.503 . . . . 0.0 108.145 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -102.15 164.04 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.123 3.215 . . . . 0.0 113.744 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -82.13 158.78 23.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.585 1.154 . . . . 0.0 108.89 168.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.8 tp -41.79 -49.92 10.26 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.35 -21.55 35.26 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.092 1.862 . . . . 0.0 114.629 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.66 -32.59 16.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.196 0.999 . . . . 0.0 112.422 173.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.8 tt -61.73 -39.02 90.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.28 1.832 . . . . 0.0 112.032 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -72.42 -22.51 61.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -59.14 -52.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.929 1.292 . . . . 0.0 108.978 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 37' ' ' LEU 0.272 0.2 OUTLIER -70.72 -30.49 67.05 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.178 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -60.91 -32.76 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.569 1.532 . . . . 0.0 112.642 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.64 56.43 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.549 1.068 . . . . 0.0 113.434 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.52 19.16 21.04 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.218 1.807 . . . . 0.0 113.807 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 14.27 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.543 1.068 . . . . 0.0 115.495 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.98 -163.51 0.93 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.019 1.328 . . . . 0.0 112.547 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.84 58.1 1.78 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.002 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 -118.79 5.86 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.089 1.328 . . . . 0.0 112.956 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -143.72 17.64 1.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.513 1.925 . . . . 0.0 110.987 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.6 ttp -76.3 49.13 0.56 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.113 1.765 . . . . 0.0 113.128 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -170.02 173.87 5.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.272 1.829 . . . . 0.0 113.42 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 166.11 10.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.103 2.561 . . . . 0.0 113.983 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.1 t -50.95 -46.95 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.414 1.886 . . . . 0.0 112.078 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.57 -30.08 71.1 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -79.0 -46.3 18.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.6 -0.714 . . . . 0.0 110.885 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.69 -45.45 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.257 1.389 . . . . 0.0 112.883 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.4 ptm -68.89 -27.91 66.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -64.37 -59.8 3.93 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 110.987 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -56.79 -35.06 68.27 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.917 0.887 . . . . 0.0 113.216 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.13 -39.43 72.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.086 0.857 . . . . 0.0 112.987 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -47.35 89.04 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 119.316 0.962 . . . . 0.0 111.799 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 12.7 pt20 -69.85 -31.5 69.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.114 -0.945 . . . . 0.0 113.031 174.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.18 -54.08 49.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.822 1.646 . . . . 0.0 110.837 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.13 -44.37 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.595 0.758 . . . . 0.0 110.246 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -33.99 77.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.18 -51.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.339 1.455 . . . . 0.0 111.746 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -66.42 -15.99 63.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.447 0.699 . . . . 0.0 112.423 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.6 pt20 46.97 43.27 13.52 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 128.085 2.554 . . . . 0.0 113.287 172.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.18 18.04 15.86 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.893 1.677 . . . . 0.0 112.847 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -85.91 166.36 16.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.253 1.421 . . . . 0.0 112.799 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.26 135.72 49.23 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.446 -0.784 . . . . 0.0 112.301 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -36.52 44.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.167 1.387 . . . . 0.0 113.365 172.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -91.73 -20.37 21.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.915 1.286 . . . . 0.0 113.021 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -153.55 102.63 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.336 1.054 . . . . 0.0 111.976 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -59.81 -17.42 35.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.924 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -21.55 62.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.67 0.788 . . . . 0.0 113.026 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.6 tpt -96.79 125.57 41.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 109.787 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.7 120.99 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.987 1.315 . . . . 0.0 110.345 -169.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -88.59 165.87 14.52 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.35 1.06 . . . . 0.0 111.422 172.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -151.62 23.85 0.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.478 1.511 . . . . 0.0 113.058 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.2 108.58 2.11 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.311 -0.868 . . . . 0.0 112.732 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 14.13 72.59 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.452 1.025 . . . . 0.0 115.127 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.16 147.64 22.92 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.751 1.775 . . . . 0.0 110.571 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.1 mt -58.51 -27.52 64.57 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.363 -0.836 . . . . 0.0 112.06 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.82 -37.23 85.68 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.303 -0.873 . . . . 0.0 112.525 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.13 -39.03 94.46 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.558 0.617 . . . . 0.0 112.346 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 117.975 0.887 . . . . 0.0 111.607 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.83 -45.77 67.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.519 1.128 . . . . 0.0 113.062 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.25 -19.72 39.05 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 113.494 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.04 8.61 87.22 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.422 1.011 . . . . 0.0 114.754 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.4 154.73 41.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.348 1.459 . . . . 0.0 112.849 172.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.2 11.9 32.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.8 p -157.17 144.59 18.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -155.74 175.82 13.42 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.787 2.035 . . . . 0.0 109.565 172.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 p -149.16 175.29 11.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.347 -1.471 . . . . 0.0 113.226 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.08 -19.95 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.592 0.757 . . . . 0.0 112.098 170.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -90.36 -21.0 22.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.272 1.429 . . . . 0.0 113.495 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -122.33 61.07 14.12 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 126.405 1.882 . . . . 0.0 112.149 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.49 -4.54 10.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.575 2.85 . . . . 0.0 113.84 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -46.53 -35.5 4.96 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.3 -31.79 95.68 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.33 2.02 . . . . 0.0 114.665 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 tt -66.76 -54.87 18.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.202 1.401 . . . . 0.0 109.904 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -61.84 -36.61 81.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.482 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.83 -45.12 91.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.957 0.799 . . . . 0.0 112.411 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ttp -56.15 -39.18 71.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.623 1.569 . . . . 0.0 111.288 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . 0.286 4.5 pp -85.79 -40.79 15.66 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -64.11 -30.57 71.63 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 120.484 1.493 . . . . 0.0 113.485 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -68.32 -22.61 64.69 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.578 0.751 . . . . 0.0 112.525 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 173.027 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -178.7 4.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.639 2.776 . . . . 0.0 111.351 -168.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 46' ' ' MET . 2.2 t -87.74 172.66 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.536 1.534 . . . . 0.0 110.077 -170.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -162.26 144.6 8.54 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 130.211 3.404 . . . . 0.0 108.308 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -104.61 170.47 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -83.26 156.98 22.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.848 1.259 . . . . 0.0 107.895 167.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -50.87 -40.82 67.98 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.84 -23.55 47.71 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.579 2.186 . . . . 0.0 115.08 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.5 mt -92.45 -34.76 13.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.294 1.037 . . . . 0.0 112.027 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.55 -38.26 89.35 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.822 1.649 . . . . 0.0 112.074 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.278 44.3 pttt -70.09 -24.47 63.22 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.68 -53.56 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.439 1.496 . . . . 0.0 109.225 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.3 12.9 mt -70.88 -30.94 67.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -64.4 -32.33 73.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.374 -1.454 . . . . 0.0 112.844 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.43 63.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.447 1.021 . . . . 0.0 113.025 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 25.57 10.78 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.026 1.731 . . . . 0.0 113.375 172.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.15 12.22 81.63 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.75 1.167 . . . . 0.0 115.884 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.17 -169.72 2.67 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 118.714 1.257 . . . . 0.0 113.272 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -125.95 47.95 2.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.787 2.035 . . . . 0.0 110.985 169.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.49 -119.78 5.22 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.98 1.276 . . . . 0.0 112.561 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.02 18.96 3.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.516 1.927 . . . . 0.0 110.853 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 58.7 ttp -75.22 47.1 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.903 2.081 . . . . 0.0 113.067 -170.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -171.82 175.92 3.77 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.312 2.245 . . . . 0.0 112.788 -168.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -74.37 170.31 15.89 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.932 2.093 . . . . 0.0 113.564 -171.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -47.87 -46.55 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 127.01 2.124 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -66.95 -30.13 70.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.31 -45.24 18.19 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.859 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -58.09 -46.1 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.442 1.474 . . . . 0.0 112.763 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.8 ptm -70.02 -26.97 64.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.93 -58.57 6.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.074 1.35 . . . . 0.0 110.766 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -56.73 -36.9 70.26 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.78 -42.86 81.01 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.163 0.892 . . . . 0.0 112.166 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.79 -47.28 89.75 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.843 0.735 . . . . 0.0 112.414 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.254 12.5 pt20 -70.67 -31.65 68.63 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.65 -0.912 . . . . 0.0 112.998 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.11 -51.5 69.44 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.515 1.507 . . . . 0.0 110.833 169.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -57.87 -42.99 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.671 0.789 . . . . 0.0 110.326 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.3 tpp -68.84 -32.0 71.37 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.57 -50.33 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.481 1.112 . . . . 0.0 111.352 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -66.4 -16.08 63.81 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.784 0.834 . . . . 0.0 112.876 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.295 6.5 pt20 45.15 42.86 7.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.191 2.597 . . . . 0.0 113.427 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -99.46 19.87 14.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.653 1.581 . . . . 0.0 112.758 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -84.28 165.45 18.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.61 1.564 . . . . 0.0 111.916 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.91 135.54 48.03 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.243 -0.91 . . . . 0.0 111.913 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -45.28 63.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.244 1.017 . . . . 0.0 113.17 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -81.42 -12.35 58.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.769 0.828 . . . . 0.0 112.488 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.7 93.92 1.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.553 1.141 . . . . 0.0 112.126 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -58.63 -17.62 23.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.721 1.208 . . . . 0.0 112.843 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -26.06 67.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.502 1.121 . . . . 0.0 112.862 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -101.28 130.19 47.38 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.993 1.717 . . . . 0.0 110.918 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.82 133.37 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 110.805 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -111.81 158.46 19.36 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.567 1.547 . . . . 0.0 111.377 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 88' ' ' GLN . 66.7 m -146.67 28.09 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.33 115.17 7.29 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 121.672 -0.642 . . . . 0.0 112.612 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.97 12.82 65.68 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.062 1.315 . . . . 0.0 115.36 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.63 150.06 21.09 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 119.793 1.797 . . . . 0.0 112.014 -175.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.51 -27.74 64.76 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.606 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.46 -39.19 91.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.705 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.68 -37.67 89.31 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.786 -0.571 . . . . 0.0 111.702 173.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -65.63 -37.36 86.35 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 117.984 0.892 . . . . 0.0 112.279 171.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.16 -44.72 79.06 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.008 1.323 . . . . 0.0 112.305 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.65 -18.41 31.38 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.72 5.05 89.53 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.57 1.081 . . . . 0.0 114.38 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -138.76 144.27 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.22 1.808 . . . . 0.0 111.555 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 76' ' ' CYS . 38.5 mt-30 -94.59 6.92 47.41 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.9 p -154.23 149.88 27.46 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 169.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -161.14 176.84 10.86 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.066 2.146 . . . . 0.0 109.734 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.5 p -142.44 171.58 13.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.72 -1.238 . . . . 0.0 112.226 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 m -72.35 -7.24 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.45 -24.82 17.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.195 1.398 . . . . 0.0 112.45 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -129.35 64.56 71.72 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.312 1.845 . . . . 0.0 111.985 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.3 0.04 10.2 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.165 3.243 . . . . 0.0 113.836 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 m -46.29 -34.79 3.64 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -59.47 -28.05 86.53 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.306 2.004 . . . . 0.0 114.941 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tt -68.2 -52.41 34.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.794 1.238 . . . . 0.0 110.405 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -64.92 -36.21 83.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.734 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.76 -31.53 72.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.634 0.773 . . . . 0.0 112.925 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -47.03 83.51 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.247 1.019 . . . . 0.0 111.19 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -92.5 -20.3 21.1 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -62.22 -27.15 68.79 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.943 1.247 . . . . 0.0 112.948 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -65.4 -27.25 68.41 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.051 2.54 . . . . 0.0 112.741 171.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m120 . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.042 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 . . . . . 0 CA--C 1.546 0.811 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.8 pt -60.13 158.99 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.008 1.323 . . . . 0.0 114.21 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.27 48.04 1.56 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.304 1.442 . . . . 0.0 112.674 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -163.26 -172.57 3.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.823 3.249 . . . . 0.0 108.434 -168.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.56 169.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 -168.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -164.75 141.03 4.84 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 130.443 3.497 . . . . 0.0 108.82 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 11.5 Cg_endo -102.7 175.3 0.19 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.897 3.064 . . . . 0.0 113.944 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -97.05 163.44 12.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.524 1.53 . . . . 0.0 110.287 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -42.59 -55.68 6.73 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.95 -21.13 50.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.721 2.281 . . . . 0.0 114.339 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.4 mt -90.63 -33.38 15.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.484 1.114 . . . . 0.0 111.914 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.03 -34.97 72.51 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.978 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -54.84 -35.2 63.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.908 2.083 . . . . 0.0 112.964 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -73.99 -47.5 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.515 1.526 . . . . 0.0 109.675 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.267 2.2 mp -70.75 -30.56 67.1 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.533 -0.729 . . . . 0.0 112.486 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -60.65 -35.95 77.47 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.692 -1.255 . . . . 0.0 112.78 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.16 -21.96 64.26 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.028 0.831 . . . . 0.0 113.218 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.08 17.0 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.057 1.743 . . . . 0.0 113.616 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.19 15.15 76.69 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -85.43 -157.75 0.34 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.869 1.268 . . . . 0.0 112.282 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -136.32 54.21 1.9 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.82 1.648 . . . . 0.0 111.902 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.8 -170.39 40.25 Favored Glycine 0 C--O 1.216 -0.979 0 C-N-CA 124.466 1.032 . . . . 0.0 112.184 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' ' 29' ' ' PRO . 45.9 mt-10 -79.16 18.97 0.59 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.016 1.727 . . . . 0.0 113.808 173.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.9 ttp -74.26 48.65 0.33 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.296 2.238 . . . . 0.0 115.036 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' CZ ' ' CD2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -170.75 177.15 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.971 2.108 . . . . 0.0 112.597 -175.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 164.32 10.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.173 2.189 . . . . 0.0 113.737 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.9 -45.34 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 126.026 1.73 . . . . 0.0 112.533 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -66.96 -30.29 70.38 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -46.2 17.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.361 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 m -58.02 -43.63 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 120.415 1.461 . . . . 0.0 113.348 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.2 ptm -68.08 -25.25 65.24 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.47 -59.65 3.46 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.866 1.267 . . . . 0.0 110.911 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 82.2 m-85 -58.09 -33.55 69.21 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.1 tp -69.17 -41.32 77.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.135 0.879 . . . . 0.0 112.212 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.41 86.14 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 119.237 0.926 . . . . 0.0 112.038 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.259 8.0 pt20 -70.93 -31.6 68.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.483 -1.01 . . . . 0.0 112.969 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -56.9 -54.54 45.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.68 1.127 . . . . 0.0 110.157 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.9 mt -59.83 -39.23 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 118.868 0.758 . . . . 0.0 110.119 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 tpt -65.42 -35.84 82.13 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.38 -50.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.502 1.046 . . . . 0.0 111.17 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -67.46 -15.77 63.85 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.576 1.55 . . . . 0.0 113.179 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 5.0 pt20 46.92 41.88 11.42 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.657 2.783 . . . . 0.0 113.767 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -83.43 54.15 2.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.859 1.664 . . . . 0.0 111.15 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -139.36 167.72 21.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.182 1.393 . . . . 0.0 112.937 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.37 144.01 40.36 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.704 -0.622 . . . . 0.0 111.933 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.15 -46.04 79.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.252 1.021 . . . . 0.0 113.374 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -80.75 -8.85 59.8 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.582 0.753 . . . . 0.0 112.937 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -157.4 86.59 0.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.486 1.136 . . . . 0.0 112.546 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -55.72 -20.47 14.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.198 1.399 . . . . 0.0 112.396 170.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -25.52 67.82 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.067 1.347 . . . . 0.0 113.031 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 tpt -104.72 127.16 52.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.328 1.451 . . . . 0.0 110.798 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 t -110.4 134.38 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.446 1.498 . . . . 0.0 110.456 -170.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -132.72 102.53 5.71 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.111 2.564 . . . . 0.0 110.307 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 98.6 m -97.78 28.88 3.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.496 2.319 . . . . 0.0 113.781 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.83 115.16 6.45 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 121.681 -0.637 . . . . 0.0 112.99 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.22 10.99 75.06 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.288 1.423 . . . . 0.0 115.969 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.2 151.62 19.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 120.241 2.021 . . . . 0.0 112.395 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 mp -57.24 -27.89 62.44 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.824 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.76 -40.15 88.16 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.219 0.918 . . . . 0.0 112.671 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.97 -39.16 96.27 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -65.62 -37.7 87.31 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.889 -0.771 . . . . 0.0 112.464 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.0 tp -66.6 -45.56 78.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.141 1.376 . . . . 0.0 112.296 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.5 -23.04 34.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 113.222 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.35 7.46 86.53 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.856 1.217 . . . . 0.0 114.403 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 147.11 30.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.446 1.899 . . . . 0.0 110.836 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -97.18 9.79 41.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.7 p -152.47 148.38 27.35 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -162.43 176.27 10.66 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.582 2.353 . . . . 0.0 109.764 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.5 p -140.2 168.7 19.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.821 -1.174 . . . . 0.0 112.528 174.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.71 -9.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -95.01 -26.06 16.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.338 1.455 . . . . 0.0 112.456 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -124.06 67.19 42.96 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.434 1.893 . . . . 0.0 112.095 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.05 6.43 5.58 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.287 3.325 . . . . 0.0 114.708 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.5 m -47.41 -34.32 4.69 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -57.75 -26.21 72.29 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.163 2.575 . . . . 0.0 115.884 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.46 -50.55 36.99 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.518 1.054 . . . . 0.0 110.081 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.08 -29.15 68.84 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.332 -0.855 . . . . 0.0 112.561 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.6 -31.35 72.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.152 0.981 . . . . 0.0 112.733 169.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.64 71.57 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.057 1.343 . . . . 0.0 111.835 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.4 mt -83.61 -39.72 19.95 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.096 1.359 . . . . 0.0 113.551 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -56.55 -29.53 62.08 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.6 1.56 . . . . 0.0 113.681 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.53 -28.33 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.347 1.859 . . . . 0.0 112.543 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -93.14 -62.97 1.27 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.779 0.832 . . . . 0.0 113.089 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -123.44 150.96 43.18 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.845 1.258 . . . . 0.0 112.717 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.04 117.24 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.4 t -150.31 -176.78 5.61 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.911 1.284 . . . . 0.0 111.663 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.63 160.55 16.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.594 1.558 . . . . 0.0 112.696 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -153.27 176.43 11.97 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.405 1.482 . . . . 0.0 111.818 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.119 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 200' ' ' 49H . . . . . 0.413 ' C6 ' ' C4 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.6 pt -134.78 167.71 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 127.36 2.264 . . . . 0.0 112.679 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -82.15 29.37 0.41 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.476 1.51 . . . . 0.0 114.45 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.39 -178.85 5.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.729 2.812 . . . . 0.0 110.743 -168.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 169.2 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.795 0.438 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -164.72 135.46 3.2 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 128.266 2.626 . . . . 0.0 107.789 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.538 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 10.9 Cg_endo -99.18 176.23 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.9 2.4 . . . . 0.0 114.934 -169.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -104.57 159.72 15.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.595 2.358 . . . . 0.0 106.815 166.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.49 -40.62 77.04 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -67.33 -25.46 42.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.623 2.215 . . . . 0.0 114.246 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.29 -37.17 20.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.215 1.006 . . . . 0.0 111.267 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.72 -31.9 70.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.102 0.961 . . . . 0.0 111.431 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.56 -38.76 72.36 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.61 1.564 . . . . 0.0 112.596 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.6 mt -70.78 -46.73 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.17 1.788 . . . . 0.0 109.552 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.69 -31.41 68.29 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.75 -0.594 . . . . 0.0 112.026 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -65.36 -34.92 79.45 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.468 -1.395 . . . . 0.0 112.979 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.99 64.6 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.19 0.904 . . . . 0.0 112.926 171.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.19 16.78 24.35 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.985 1.714 . . . . 0.0 114.035 172.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.73 15.64 73.69 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.434 1.016 . . . . 0.0 115.549 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -84.4 -162.92 0.72 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.905 1.282 . . . . 0.0 112.311 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -133.47 68.63 1.49 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.724 1.61 . . . . 0.0 111.074 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.37 -144.22 37.04 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.482 0.563 . . . . 0.0 112.583 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.7 mt-10 -125.06 16.45 8.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.55 1.94 . . . . 0.0 112.266 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.8 ttt -79.51 58.28 2.64 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.493 1.117 . . . . 0.0 112.963 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -170.37 175.07 4.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.338 1.855 . . . . 0.0 113.413 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.05 165.23 16.17 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.261 2.224 . . . . 0.0 114.308 -172.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.9 t -47.85 -45.27 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.27 1.828 . . . . 0.0 112.359 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -66.29 -30.57 71.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.62 -47.6 16.79 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.635 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.41 -46.17 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 120.373 1.442 . . . . 0.0 112.676 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -70.63 -27.83 64.36 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.95 -59.7 4.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 110.703 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 54.3 m-85 -55.85 -37.21 68.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.149 0.979 . . . . 0.0 113.548 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.28 -36.72 79.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.844 1.202 . . . . 0.0 113.008 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 -47.37 88.41 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.882 1.219 . . . . 0.0 112.256 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.274 13.3 pt20 -70.91 -31.61 68.29 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.474 -1.015 . . . . 0.0 113.09 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.61 -53.82 49.54 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.562 1.528 . . . . 0.0 110.346 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.25 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.532 1.133 . . . . 0.0 110.382 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttm -69.04 -30.51 68.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.33 -50.84 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.12 0.968 . . . . 0.0 111.239 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.02 -15.94 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.947 0.899 . . . . 0.0 113.239 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.29 6.4 pt20 43.97 44.22 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 128.152 2.581 . . . . 0.0 113.582 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.63 16.53 23.12 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.863 1.665 . . . . 0.0 112.843 -169.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -81.96 165.64 20.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.378 1.471 . . . . 0.0 112.269 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.73 147.98 45.09 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 122.196 0.998 . . . . 0.0 112.989 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.608 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.8 -37.86 76.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.92 1.688 . . . . 0.0 111.483 -176.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -91.33 -20.94 21.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.698 1.599 . . . . 0.0 112.38 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.25 92.02 2.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.365 1.079 . . . . 0.0 112.268 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -57.21 -18.79 17.37 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.419 1.488 . . . . 0.0 112.776 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -24.72 66.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.377 1.071 . . . . 0.0 113.041 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -99.9 133.13 44.73 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.424 1.889 . . . . 0.0 110.776 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.61 132.62 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.543 1.537 . . . . 0.0 110.489 -171.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -113.69 165.71 12.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.871 1.668 . . . . 0.0 110.989 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.7 m -134.8 -25.51 1.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.431 1.093 . . . . 0.0 113.824 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 53.4 31.65 43.54 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.19 13.61 65.74 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.784 1.183 . . . . 0.0 115.758 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -69.3 167.24 16.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.511 1.656 . . . . 0.0 111.904 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.34 -27.99 64.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.648 1.179 . . . . 0.0 112.514 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.11 -41.56 86.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.516 -0.74 . . . . 0.0 112.109 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.73 96.65 Favored Glycine 0 N--CA 1.472 1.04 0 O-C-N 121.696 -0.627 . . . . 0.0 112.215 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.71 -36.86 84.83 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.554 -0.968 . . . . 0.0 112.066 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.41 -43.36 81.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.808 1.243 . . . . 0.0 112.497 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.79 -18.89 42.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.383 1.073 . . . . 0.0 112.975 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.63 -14.22 25.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.985 1.755 . . . . 0.0 113.963 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -125.98 138.74 53.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.762 2.425 . . . . 0.0 108.954 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -98.53 16.3 22.27 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -153.29 146.38 24.62 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.269 -0.894 . . . . 0.0 112.663 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -164.14 174.42 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.528 1.931 . . . . 0.0 110.12 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 p -139.1 171.7 13.92 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.752 -1.218 . . . . 0.0 111.996 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.56 -8.32 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.07 -23.8 17.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.216 1.406 . . . . 0.0 112.574 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -130.38 65.4 75.81 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.49 1.916 . . . . 0.0 111.965 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.1 0.44 9.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.409 3.406 . . . . 0.0 113.888 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.0 m -46.1 -35.35 4.1 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -54.36 -31.21 66.65 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.741 2.294 . . . . 0.0 115.758 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.54 -50.8 33.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.692 1.197 . . . . 0.0 110.488 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -62.89 -37.46 87.04 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.666 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.22 -31.78 72.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 0.0 112.92 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -45.91 90.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.475 1.11 . . . . 0.0 111.117 170.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -93.82 -19.69 20.77 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -27.08 69.09 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.996 1.271 . . . . 0.0 112.904 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.9 -29.94 71.16 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.778 2.431 . . . . 0.0 112.259 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -84.68 -67.63 0.78 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.607 0.763 . . . . 0.0 112.826 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -113.32 143.06 45.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.668 1.187 . . . . 0.0 113.086 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.51 112.26 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 t -153.76 175.98 12.66 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.013 0.925 . . . . 0.0 112.997 -171.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.49 157.05 20.54 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.064 1.746 . . . . 0.0 112.373 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.8 172.55 13.48 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.446 1.499 . . . . 0.0 112.22 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.359 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 200' ' ' 49H . . . . . 0.41 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.963 0.411 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 pt -135.23 166.14 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.874 1.67 . . . . 0.0 113.055 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.4 36.52 0.48 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.863 1.665 . . . . 0.0 114.218 -172.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.67 -178.79 3.91 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.719 2.408 . . . . 0.0 113.981 -167.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 46' ' ' MET . 7.8 t -93.59 172.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.467 1.907 . . . . 0.0 108.941 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -162.44 139.12 6.0 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 129.908 3.283 . . . . 0.0 107.474 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -99.73 168.37 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.514 2.809 . . . . 0.0 113.997 -171.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -86.62 162.81 17.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.014 1.326 . . . . 0.0 110.444 168.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.8 mt -49.18 -48.19 74.19 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.14 -28.61 34.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.2 1.822 . . . . 0.0 113.856 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.23 -37.74 37.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.842 0.747 . . . . 0.0 111.266 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.75 -34.81 73.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.826 1.25 . . . . 0.0 111.169 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -59.28 -40.77 87.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.762 1.225 . . . . 0.0 113.182 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.5 -50.91 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.238 1.415 . . . . 0.0 109.595 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.354 12.5 mt -70.94 -30.37 66.66 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -63.18 -37.91 89.11 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 119.885 -1.76 . . . . 0.0 111.921 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.94 -18.42 65.23 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.794 0.725 . . . . 0.0 112.745 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.03 5.03 46.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.586 1.555 . . . . 0.0 114.332 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.46 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.564 1.078 . . . . 0.0 114.94 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.68 -164.0 1.09 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.432 1.493 . . . . 0.0 112.716 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -124.58 43.18 3.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 110.88 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.19 -113.87 3.76 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.879 -1.138 . . . . 0.0 112.446 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.25 19.29 2.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.555 1.942 . . . . 0.0 111.431 -174.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 28.2 ptm -71.54 38.82 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.585 1.554 . . . . 0.0 115.192 -175.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -166.27 174.78 8.83 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.441 1.897 . . . . 0.0 113.967 -167.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -68.4 168.1 13.32 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.656 2.382 . . . . 0.0 113.628 -172.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -53.01 -43.52 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 126.29 1.836 . . . . 0.0 111.804 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -65.79 -30.06 70.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.47 -46.93 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.014 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.42 -44.8 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 119.929 1.241 . . . . 0.0 112.752 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.9 ptm -71.47 -27.47 63.26 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -61.44 -58.77 6.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.558 1.143 . . . . 0.0 110.395 170.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -56.34 -39.21 72.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.094 0.958 . . . . 0.0 113.253 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.09 -35.02 69.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.624 1.102 . . . . 0.0 112.702 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -47.48 90.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.157 0.89 . . . . 0.0 112.219 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.45 -31.56 71.82 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.419 -1.047 . . . . 0.0 112.378 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -58.53 -53.57 56.81 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.558 1.072 . . . . 0.0 111.654 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -56.25 -42.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.534 0.734 . . . . 0.0 109.983 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.38 -36.14 83.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.25 -48.94 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.06 0.944 . . . . 0.0 111.122 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -66.84 -15.92 63.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.982 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.313 5.3 pt20 46.23 39.63 6.42 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.389 2.676 . . . . 0.0 113.803 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt -84.86 58.23 4.86 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.586 1.554 . . . . 0.0 110.579 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -136.98 168.03 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.172 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.4 135.32 48.64 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.498 -0.751 . . . . 0.0 111.742 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -48.79 -39.38 25.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.923 1.689 . . . . 0.0 113.867 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -90.18 -15.95 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.984 1.313 . . . . 0.0 113.407 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.66 95.03 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.713 1.244 . . . . 0.0 112.396 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -57.75 -18.66 22.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.625 1.57 . . . . 0.0 112.72 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -14.56 61.42 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -110.74 119.86 40.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.602 1.561 . . . . 0.0 110.357 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -96.8 135.01 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.453 1.501 . . . . 0.0 110.555 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -135.75 95.81 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.95 2.5 . . . . 0.0 109.699 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 97.6 m -79.52 -24.03 42.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.104 1.761 . . . . 0.0 114.671 -169.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 50.97 35.74 32.98 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.7 1.143 . . . . 0.0 115.87 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.46 62.54 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.84 158.18 25.8 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.731 1.766 . . . . 0.0 111.441 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.18 -27.84 48.63 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.463 -0.773 . . . . 0.0 112.832 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.1 tp -57.09 -47.98 79.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.899 1.28 . . . . 0.0 111.643 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.79 94.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.834 0.73 . . . . 0.0 112.417 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -65.21 -37.73 88.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.135 0.968 . . . . 0.0 111.992 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.95 -46.87 79.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.17 1.388 . . . . 0.0 111.815 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -79.07 -17.37 55.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.69 -2.3 83.38 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.963 1.268 . . . . 0.0 114.47 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -146.66 142.23 27.66 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 128.084 2.554 . . . . 0.0 109.123 172.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -96.43 12.97 29.42 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.564 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.2 p -147.1 141.33 26.2 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.95 -1.094 . . . . 0.0 112.929 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -164.63 173.38 12.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.214 2.205 . . . . 0.0 109.873 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 p -142.95 175.18 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.087 -1.008 . . . . 0.0 112.624 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.5 m -67.68 -13.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -93.06 -21.94 19.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.713 1.205 . . . . 0.0 113.0 172.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -126.14 60.58 36.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.911 1.684 . . . . 0.0 112.58 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.94 0.3 9.98 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.195 3.263 . . . . 0.0 113.652 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.0 m -45.91 -33.55 2.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 127.079 2.152 . . . . 0.0 116.322 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.24 -29.47 90.42 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.227 1.831 . . . . 0.0 114.769 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.48 -49.34 63.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.263 0.938 . . . . 0.0 110.531 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.54 -34.07 77.38 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.674 -0.641 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -68.52 -31.59 70.95 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -34.46 77.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.341 1.456 . . . . 0.0 111.314 170.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.3 mt -92.89 -37.23 12.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.114 1.366 . . . . 0.0 114.243 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -56.45 -25.92 52.17 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.726 1.611 . . . . 0.0 113.845 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.17 -26.55 63.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.506 1.923 . . . . 0.0 112.636 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -112.2 -64.93 1.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.88 140.86 57.8 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.828 1.251 . . . . 0.0 109.571 171.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.22 74.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.434 -0.791 . . . . 0.0 109.12 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.3 t -129.52 171.15 12.87 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.689 1.596 . . . . 0.0 113.007 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.52 148.45 24.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.786 1.634 . . . . 0.0 111.993 -173.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.24 175.6 11.63 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.718 1.607 . . . . 0.0 111.778 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.11 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.0 pt -136.58 158.57 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.771 1.629 . . . . 0.0 113.049 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -91.83 54.42 2.43 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.186 1.395 . . . . 0.0 112.185 -171.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -163.31 -174.68 3.89 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.782 2.833 . . . . 0.0 109.637 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.73 172.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.456 1.502 . . . . 0.0 112.259 -169.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -161.38 145.4 9.88 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 130.652 3.581 . . . . 0.0 108.165 168.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -103.72 172.15 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.834 3.023 . . . . 0.0 114.181 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -86.51 158.57 19.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 108.062 167.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.7 -46.09 71.59 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -66.03 -24.96 51.97 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.711 2.274 . . . . 0.0 114.643 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.37 -35.86 16.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.243 1.017 . . . . 0.0 111.952 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.26 -31.9 72.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.636 1.575 . . . . 0.0 111.36 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -56.17 -38.68 71.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.459 1.504 . . . . 0.0 112.607 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -66.85 -50.9 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.068 1.747 . . . . 0.0 109.417 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.324 12.3 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.748 -0.595 . . . . 0.0 112.571 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -61.81 -33.19 73.68 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.643 -1.285 . . . . 0.0 112.576 169.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.82 -22.61 62.47 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.379 0.99 . . . . 0.0 113.263 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.67 24.45 12.64 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.012 1.725 . . . . 0.0 113.334 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.94 14.02 80.46 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.785 1.183 . . . . 0.0 115.824 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.9 -169.27 2.42 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.46 1.13 . . . . 0.0 113.438 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.53 45.22 2.5 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.69 1.996 . . . . 0.0 110.917 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.71 -119.95 5.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.093 1.33 . . . . 0.0 112.637 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.4 17.04 3.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.557 1.943 . . . . 0.0 110.589 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 58.1 ttp -76.52 50.52 0.67 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.116 1.767 . . . . 0.0 112.889 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -174.37 171.16 3.47 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.438 2.295 . . . . 0.0 112.208 -168.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 168.76 10.83 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.47 1.908 . . . . 0.0 114.092 -171.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.3 t -47.78 -44.14 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.518 1.927 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -67.64 -30.59 70.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -80.46 -44.29 19.46 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.961 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.47 -46.24 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.252 1.387 . . . . 0.0 112.622 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.2 ptm -69.86 -23.96 63.35 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.89 -59.75 3.54 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.975 1.31 . . . . 0.0 110.961 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -56.14 -37.14 69.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.258 1.023 . . . . 0.0 113.281 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tt -72.57 -38.07 68.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.897 0.879 . . . . 0.0 111.623 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.09 -47.4 87.83 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.898 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.257 13.7 pt20 -69.91 -31.54 69.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.416 -1.049 . . . . 0.0 112.873 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CD1' HD22 ' A' ' 81' ' ' LEU . 12.5 t80 -55.66 -51.51 67.01 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.442 1.473 . . . . 0.0 110.457 169.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.2 mt -58.12 -44.89 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.999 0.92 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.0 ttm -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.62 -51.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.36 1.064 . . . . 0.0 111.355 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 -15.97 64.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.92 0.888 . . . . 0.0 113.282 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.3 pt20 43.79 43.51 5.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 128.164 2.585 . . . . 0.0 113.483 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -99.67 23.19 9.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.818 1.647 . . . . 0.0 112.9 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -87.01 163.69 16.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.707 1.603 . . . . 0.0 111.337 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -75.13 134.55 41.25 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.157 -0.964 . . . . 0.0 111.904 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -53.78 -35.72 61.64 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.637 1.575 . . . . 0.0 113.515 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -82.2 -26.6 33.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 112.398 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.7 93.9 1.92 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 122.425 1.107 . . . . 0.0 111.558 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -58.87 -17.68 26.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 112.606 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.06 69.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.249 1.02 . . . . 0.0 112.913 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.3 tpt -98.4 133.06 43.32 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.981 1.712 . . . . 0.0 110.962 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.0 t -125.83 131.83 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.073 1.349 . . . . 0.0 110.957 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -108.51 163.51 13.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.575 1.55 . . . . 0.0 111.795 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 m -145.24 29.69 1.16 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.872 2.069 . . . . 0.0 111.489 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.47 113.44 3.81 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 121.612 -0.68 . . . . 0.0 114.048 -169.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.74 11.76 66.4 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.07 -1.406 . . . . 0.0 115.775 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -100.04 159.18 15.29 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 120.421 2.111 . . . . 0.0 111.99 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.34 -28.04 68.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.093 0.957 . . . . 0.0 111.863 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.4 HD22 ' CD1' ' A' ' 59' ' ' TYR . 46.9 tp -67.2 -37.88 84.39 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.339 -0.85 . . . . 0.0 112.38 171.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.43 -39.24 94.06 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.839 -0.538 . . . . 0.0 111.891 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -65.0 -36.95 86.04 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.795 -0.827 . . . . 0.0 112.138 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.04 -43.57 82.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.665 1.186 . . . . 0.0 112.395 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.78 -21.51 37.73 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.2 -0.31 89.39 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.629 1.109 . . . . 0.0 114.583 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -145.75 156.11 43.39 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.128 1.771 . . . . 0.0 111.897 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -99.55 16.32 23.71 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.0 p -153.57 152.93 31.47 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 169.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -163.12 179.54 7.41 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.62 2.368 . . . . 0.0 109.58 170.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 p -145.26 171.2 14.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.294 -1.504 . . . . 0.0 112.705 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.0 m -73.49 -6.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -95.11 -28.39 15.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.331 . . . . 0.0 112.345 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -128.71 70.62 80.7 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.287 1.835 . . . . 0.0 111.498 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.82 1.62 8.69 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.334 3.356 . . . . 0.0 113.527 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -45.47 -34.46 2.45 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.935 2.094 . . . . 0.0 115.924 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.59 -26.41 80.45 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.362 2.041 . . . . 0.0 114.876 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.34 -46.03 57.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.191 0.905 . . . . 0.0 110.424 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -67.15 -31.68 72.28 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.518 -0.739 . . . . 0.0 112.404 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.68 -31.59 71.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.177 0.899 . . . . 0.0 112.798 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -36.38 81.9 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.076 1.35 . . . . 0.0 111.6 169.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.7 -39.77 15.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.002 1.321 . . . . 0.0 114.233 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -57.71 -28.36 63.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.416 1.486 . . . . 0.0 113.787 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -71.0 -26.69 63.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.855 2.062 . . . . 0.0 112.735 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -105.0 -42.1 5.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -128.11 147.52 50.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.793 1.237 . . . . 0.0 112.087 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -76.06 114.09 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 170.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.6 t -152.86 172.88 16.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.081 0.952 . . . . 0.0 112.869 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.1 mt -81.48 158.45 24.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.738 1.615 . . . . 0.0 111.921 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.11 169.17 19.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.816 1.246 . . . . 0.0 113.145 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.717 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 200' ' ' 49H . . . . . 0.419 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 pt -83.05 167.74 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.98 1.312 . . . . 0.0 112.656 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -80.05 32.62 0.27 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.577 1.551 . . . . 0.0 113.964 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.8 -178.23 4.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.427 2.691 . . . . 0.0 113.647 -167.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -92.29 172.16 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.448 1.499 . . . . 0.0 109.99 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -159.94 141.83 9.58 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 130.723 3.609 . . . . 0.0 108.708 169.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 28.0 Cg_endo -99.38 169.58 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.892 3.062 . . . . 0.0 113.858 -175.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -82.88 160.44 22.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.983 1.313 . . . . 0.0 109.177 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.36 -47.75 67.57 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.42 -28.1 33.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 CA-C-N 122.299 1.857 . . . . 0.0 113.339 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.35 -35.66 54.43 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.282 -0.886 . . . . 0.0 111.568 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.3 -35.03 76.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.994 1.318 . . . . 0.0 110.951 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -59.73 -43.22 94.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.547 1.539 . . . . 0.0 112.648 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.0 mt -59.25 -52.87 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 109.492 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.347 11.1 mt -70.79 -30.5 66.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -61.45 -33.82 74.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.689 -1.257 . . . . 0.0 112.417 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.88 -21.78 61.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.299 0.954 . . . . 0.0 113.456 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.54 24.02 13.67 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.773 1.629 . . . . 0.0 113.517 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.87 15.03 78.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.552 1.072 . . . . 0.0 115.743 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.16 -166.86 1.46 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.672 1.189 . . . . 0.0 112.932 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -125.44 48.29 2.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.621 1.969 . . . . 0.0 110.587 169.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.29 -116.55 5.26 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.086 1.327 . . . . 0.0 113.107 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 40.7 mt-10 -139.08 19.95 2.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.066 2.146 . . . . 0.0 110.954 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 58.0 ttp -78.08 47.59 0.67 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.4 1.48 . . . . 0.0 112.924 -172.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -170.58 175.6 4.62 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.111 1.764 . . . . 0.0 113.635 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.55 167.08 11.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.508 2.323 . . . . 0.0 113.721 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.4 -43.27 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.245 1.818 . . . . 0.0 111.804 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -64.34 -30.07 71.13 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -79.97 -48.17 13.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.932 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -55.34 -44.44 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.025 1.284 . . . . 0.0 112.788 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -71.31 -28.65 64.25 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.74 -59.37 5.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 110.874 170.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -55.51 -36.05 66.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.233 1.013 . . . . 0.0 113.592 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.52 -39.07 74.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.63 1.104 . . . . 0.0 113.383 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.71 -47.27 79.18 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 119.697 1.135 . . . . 0.0 112.134 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.01 -31.61 66.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.457 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.1 -51.53 68.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.887 1.676 . . . . 0.0 110.78 169.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -58.52 -44.25 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.952 0.901 . . . . 0.0 110.379 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 36.5 tpp -66.67 -31.6 72.38 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -74.39 -49.38 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.693 1.197 . . . . 0.0 111.414 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -66.02 -16.13 63.64 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.5 pt20 43.35 42.72 3.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.153 2.581 . . . . 0.0 113.259 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -100.65 22.04 12.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.895 1.678 . . . . 0.0 112.66 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -88.29 165.53 14.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.644 1.578 . . . . 0.0 112.069 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -71.21 138.36 49.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.228 -0.92 . . . . 0.0 112.13 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -38.4 51.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.244 1.418 . . . . 0.0 113.482 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -98.69 -16.56 18.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.0 1.32 . . . . 0.0 113.709 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.11 94.34 2.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.786 1.234 . . . . 0.0 109.768 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -63.89 -14.12 50.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.165 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.09 -19.74 61.1 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -96.77 128.08 43.37 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.254 1.822 . . . . 0.0 109.858 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.77 131.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.676 1.59 . . . . 0.0 110.921 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -104.45 161.87 13.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.258 1.423 . . . . 0.0 110.992 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.5 m -145.95 29.57 1.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.515 1.926 . . . . 0.0 111.812 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.89 114.31 6.64 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.357 -0.839 . . . . 0.0 112.339 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.11 72.02 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.001 1.286 . . . . 0.0 115.435 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -96.41 146.45 24.75 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.01 1.905 . . . . 0.0 110.826 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.12 -27.66 62.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.419 0.688 . . . . 0.0 112.477 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.6 tp -65.69 -38.83 90.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.679 0.792 . . . . 0.0 112.581 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.87 -39.56 93.43 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 121.409 -0.807 . . . . 0.0 111.781 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -63.54 -37.32 86.87 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 117.714 0.757 . . . . 0.0 112.005 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.92 -46.02 63.22 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.091 1.357 . . . . 0.0 112.695 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.21 -21.4 53.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.068 0.947 . . . . 0.0 113.052 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 1.07 90.37 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.701 1.143 . . . . 0.0 114.394 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -144.76 148.66 34.37 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.337 1.855 . . . . 0.0 111.458 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.82 12.24 32.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.457 1.103 . . . . 0.0 113.423 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -151.98 146.43 25.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -160.31 176.82 11.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.042 2.137 . . . . 0.0 110.15 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 p -147.59 173.86 12.31 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.543 -1.348 . . . . 0.0 113.166 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.62 -21.12 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.872 0.869 . . . . 0.0 111.732 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -88.88 -28.89 20.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.101 1.36 . . . . 0.0 113.008 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -121.02 65.55 13.64 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.298 1.839 . . . . 0.0 112.207 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.0 -0.9 10.22 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.969 3.113 . . . . 0.0 113.725 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -47.31 -34.37 4.56 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -58.84 -32.15 96.67 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.369 2.046 . . . . 0.0 114.645 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -64.95 -48.32 74.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.176 0.99 . . . . 0.0 110.623 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -69.12 -31.35 69.98 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.427 -0.796 . . . . 0.0 111.922 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.83 -33.05 71.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.097 0.862 . . . . 0.0 113.08 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -64.51 -39.69 94.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.892 1.277 . . . . 0.0 110.271 169.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.0 mt -82.65 -42.43 18.17 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -56.53 -28.48 60.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.686 1.194 . . . . 0.0 113.868 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.99 -26.58 63.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.91 2.084 . . . . 0.0 112.977 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -96.7 -88.87 0.28 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.561 1.145 . . . . 0.0 112.762 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -80.58 149.76 29.79 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 120.135 1.334 . . . . 0.0 112.098 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.31 112.87 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 t -155.75 -177.63 6.7 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.96 0.904 . . . . 0.0 112.977 -172.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.11 158.03 36.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.425 1.89 . . . . 0.0 112.172 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.55 176.18 11.58 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.151 1.38 . . . . 0.0 112.124 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -174.659 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 200' ' ' 49H . . . . . 0.401 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 pt -66.0 156.37 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -89.07 52.63 2.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.225 1.41 . . . . 0.0 112.287 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -163.23 -160.14 0.58 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 129.229 3.012 . . . . 0.0 108.656 -168.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.29 172.33 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.497 1.519 . . . . 0.0 110.512 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -160.7 137.97 6.79 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 131.177 3.791 . . . . 0.0 106.867 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 29.4 Cg_endo -101.05 168.71 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.197 2.598 . . . . 0.0 114.432 -170.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.41 159.14 23.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.085 1.354 . . . . 0.0 108.2 167.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -53.11 -39.58 72.09 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -65.3 -29.97 54.38 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.42 2.08 . . . . 0.0 114.109 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.86 -36.65 27.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.508 1.123 . . . . 0.0 111.333 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.87 -45.77 93.26 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.077 1.351 . . . . 0.0 111.207 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 38.0 pttt -70.54 -26.15 63.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.41 -54.39 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.478 1.111 . . . . 0.0 108.765 169.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.251 35.0 mt -70.93 -30.77 67.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.77 0.828 . . . . 0.0 112.32 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -34.1 77.54 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.702 -1.249 . . . . 0.0 113.017 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.49 64.45 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -102.84 22.92 12.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.01 1.724 . . . . 0.0 113.549 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.35 80.85 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.512 1.053 . . . . 0.0 115.721 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.89 -164.61 0.76 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.449 1.125 . . . . 0.0 113.074 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -130.44 48.65 2.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 127.194 2.197 . . . . 0.0 109.193 168.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 -111.77 3.79 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.361 1.458 . . . . 0.0 113.276 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 38.5 mt-10 -139.07 16.78 2.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.588 1.955 . . . . 0.0 111.594 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -75.97 49.83 0.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.515 1.526 . . . . 0.0 113.235 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -173.2 172.12 3.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.461 2.305 . . . . 0.0 112.481 -169.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.38 167.35 16.7 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.121 2.168 . . . . 0.0 114.139 -171.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.78 -43.29 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.779 2.032 . . . . 0.0 112.31 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.54 -30.14 70.38 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -80.54 -46.41 15.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.4 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.17 -44.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 120.03 1.287 . . . . 0.0 112.684 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.04 -28.51 66.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.46 -58.25 7.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.964 171.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -56.69 -37.0 70.27 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.57 -41.73 75.45 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.15 0.886 . . . . 0.0 111.46 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.92 -47.48 88.64 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 112.907 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -70.51 -31.58 68.73 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.527 -0.984 . . . . 0.0 112.598 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -58.19 -52.1 66.96 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.887 1.222 . . . . 0.0 110.964 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -53.68 -46.29 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.045 0.839 . . . . 0.0 109.711 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -33.88 76.06 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.18 -47.42 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.302 1.041 . . . . 0.0 110.883 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -66.69 -11.24 53.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.046 0.938 . . . . 0.0 112.944 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.336 3.0 pt20 46.66 45.55 14.46 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 129.655 3.182 . . . . 0.0 113.311 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.08 58.21 4.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.245 1.418 . . . . 0.0 110.982 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -143.55 164.84 29.25 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.003 1.321 . . . . 0.0 112.574 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -72.86 135.58 45.18 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.649 -0.657 . . . . 0.0 111.721 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -40.23 36.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.162 1.385 . . . . 0.0 113.037 171.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -89.14 -19.16 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.227 1.411 . . . . 0.0 113.094 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -152.69 94.83 1.93 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.404 1.097 . . . . 0.0 111.742 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.92 -17.84 28.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.131 1.372 . . . . 0.0 112.636 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -21.57 65.45 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.091 0.957 . . . . 0.0 112.973 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.5 tpt -104.65 124.1 48.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.303 1.841 . . . . 0.0 110.73 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.96 138.17 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.127 1.771 . . . . 0.0 110.282 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -135.14 94.72 3.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.288 2.235 . . . . 0.0 110.535 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -88.53 30.69 0.88 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.67 2.788 . . . . 0.0 113.472 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.88 116.52 9.15 Favored Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 112.671 -170.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.86 11.3 78.19 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.364 1.459 . . . . 0.0 115.737 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.06 147.93 22.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.363 2.081 . . . . 0.0 111.792 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.99 -27.59 63.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.5 tp -65.93 -43.24 88.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.998 0.919 . . . . 0.0 112.694 171.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.24 -38.31 95.0 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 118.993 0.815 . . . . 0.0 111.719 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -65.07 -38.0 89.36 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.925 -0.75 . . . . 0.0 111.793 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.33 -48.87 63.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.071 0.948 . . . . 0.0 112.399 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.35 -20.35 61.48 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 112.701 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.93 -0.21 89.85 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.732 1.158 . . . . 0.0 114.075 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -145.6 145.29 30.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.38 1.872 . . . . 0.0 111.316 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.99 2.69 55.38 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.413 1.085 . . . . 0.0 113.086 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.5 p -147.39 140.23 24.94 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -160.65 176.48 11.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.959 2.503 . . . . 0.0 109.155 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.6 p -144.19 174.98 10.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.852 -1.155 . . . . 0.0 112.164 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.97 -8.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 169.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.04 -22.84 17.65 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.323 1.449 . . . . 0.0 113.139 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -124.22 62.14 28.87 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 126.116 1.766 . . . . 0.0 112.012 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.2 2.5 7.95 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.053 3.169 . . . . 0.0 114.258 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 m -46.85 -34.68 4.19 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -33.58 97.02 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 122.989 2.103 . . . . 0.0 114.679 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tp -57.78 -56.88 16.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 123.022 1.392 . . . . 0.0 110.219 171.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -70.49 -29.2 65.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.455 -0.778 . . . . 0.0 112.035 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.04 -31.51 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.6 1.091 . . . . 0.0 113.193 173.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.6 ttp -68.41 -37.11 80.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.363 1.065 . . . . 0.0 110.773 169.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.07 -31.48 18.02 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -29.3 65.16 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.463 1.505 . . . . 0.0 113.361 175.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.83 -29.0 70.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.273 1.829 . . . . 0.0 112.473 172.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -91.94 -65.57 1.0 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -120.89 148.25 44.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.688 1.195 . . . . 0.0 112.901 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.42 126.18 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.5 t -149.12 177.92 9.18 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.544 1.137 . . . . 0.0 112.159 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.33 151.53 46.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.627 1.571 . . . . 0.0 112.802 -175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.51 174.75 12.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.641 1.576 . . . . 0.0 112.01 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -174.765 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.72 167.04 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.083 1.753 . . . . 0.0 112.097 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -82.15 35.43 0.43 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.56 1.544 . . . . 0.0 114.034 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -125.94 -175.64 3.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.304 2.642 . . . . 0.0 113.671 -166.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 28' ' ' ARG . 6.3 t -92.2 172.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.813 1.645 . . . . 0.0 109.298 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 27' ' ' VAL . 1.1 tmt_? -164.24 131.98 2.56 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 129.831 3.253 . . . . 0.0 107.15 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -96.59 174.27 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.974 2.449 . . . . 0.0 115.466 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -98.88 160.35 14.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.42 2.288 . . . . 0.0 107.516 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -53.39 -38.81 66.03 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -69.09 -32.53 21.15 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.21 1.94 . . . . 0.0 113.593 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.26 -37.32 61.02 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 111.037 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.74 -40.18 91.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.877 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -53.8 -42.61 68.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.706 1.202 . . . . 0.0 113.329 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -64.18 -50.11 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.565 1.546 . . . . 0.0 109.937 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.36 -37.39 80.41 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.645 -0.659 . . . . 0.0 111.167 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -71.37 -30.63 66.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.886 -1.134 . . . . 0.0 113.404 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.33 -22.7 54.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.495 0.718 . . . . 0.0 112.874 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.14 25.37 11.08 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.959 1.704 . . . . 0.0 113.563 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.48 17.33 79.82 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.36 -161.2 0.3 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.947 1.299 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -132.67 48.65 2.39 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.022 1.729 . . . . 0.0 110.746 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.16 -119.6 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.178 0.894 . . . . 0.0 112.66 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -141.39 19.62 2.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.891 1.677 . . . . 0.0 112.624 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 27.3 ttt -77.64 47.55 0.61 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.1 1.36 . . . . 0.0 112.783 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -168.73 174.47 6.6 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.417 1.887 . . . . 0.0 113.157 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.62 164.97 10.94 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.783 2.433 . . . . 0.0 113.91 -171.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.21 -42.42 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 126.017 1.727 . . . . 0.0 111.874 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.7 -30.19 71.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -79.18 -48.23 14.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.965 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.94 -47.01 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 119.699 1.136 . . . . 0.0 112.066 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -71.49 -23.84 61.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.06 -59.64 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.35 0.977 . . . . 0.0 110.659 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -55.99 -40.72 73.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.873 1.269 . . . . 0.0 113.298 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 tt -73.29 -32.29 64.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.365 1.066 . . . . 0.0 111.515 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.9 -47.31 89.88 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.696 -1.253 . . . . 0.0 112.736 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.01 -31.59 72.24 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.414 -1.05 . . . . 0.0 112.375 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.85 -54.44 47.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.838 1.199 . . . . 0.0 111.077 169.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -52.89 -42.96 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.342 0.974 . . . . 0.0 110.292 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.2 tpp -70.45 -35.27 73.24 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.26 -47.57 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.505 1.122 . . . . 0.0 111.341 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -65.0 -12.1 46.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.502 1.121 . . . . 0.0 112.745 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.33 3.9 pt20 47.92 46.13 18.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 129.407 3.083 . . . . 0.0 113.149 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.22 56.79 4.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.368 1.467 . . . . 0.0 110.887 -171.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.86 166.97 24.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.843 1.257 . . . . 0.0 112.747 -173.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -73.52 148.63 42.89 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.146 0.974 . . . . 0.0 113.279 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.43 -35.99 76.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.974 1.71 . . . . 0.0 111.716 -176.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -93.1 -20.75 20.2 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.554 1.542 . . . . 0.0 112.335 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -145.95 94.96 2.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.195 0.998 . . . . 0.0 112.69 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -59.01 -17.96 29.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.815 1.246 . . . . 0.0 112.896 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -22.26 66.57 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.339 1.055 . . . . 0.0 112.913 174.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.4 tpt -102.12 128.77 48.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.578 1.551 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.9 t -108.92 134.48 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.876 1.671 . . . . 0.0 110.6 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -136.67 96.93 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 110.468 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.5 m -89.55 27.51 1.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 128.35 2.66 . . . . 0.0 113.686 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.39 118.89 14.9 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.486 -0.759 . . . . 0.0 113.064 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.69 8.97 82.38 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.285 1.421 . . . . 0.0 115.719 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.32 149.2 21.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.132 1.966 . . . . 0.0 112.025 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.3 tp -59.18 -27.8 66.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.529 1.131 . . . . 0.0 111.291 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.1 tp -63.95 -48.98 74.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.326 1.05 . . . . 0.0 111.895 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.48 -37.46 93.77 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 118.621 0.646 . . . . 0.0 112.376 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -64.15 -37.34 87.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.85 0.86 . . . . 0.0 112.006 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.13 -45.96 53.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.876 0.871 . . . . 0.0 112.019 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.43 -28.68 69.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.046 0.938 . . . . 0.0 112.639 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 0.46 89.0 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.559 1.076 . . . . 0.0 114.024 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.66 147.81 32.39 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.847 1.659 . . . . 0.0 111.768 170.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -100.19 5.66 44.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.763 1.225 . . . . 0.0 113.06 -171.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -147.59 145.51 29.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -164.29 -177.37 4.9 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.17 2.588 . . . . 0.0 109.308 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 p -137.36 170.72 15.61 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.682 -1.261 . . . . 0.0 112.331 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.26 -15.69 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -94.37 -18.91 21.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -131.34 63.89 71.4 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.48 1.512 . . . . 0.0 112.587 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.78 13.98 1.99 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 125.11 3.873 . . . . 0.0 114.564 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.1 p -50.67 -27.62 1.61 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 117.648 2.462 . . . . 0.0 117.648 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -60.81 -27.84 85.46 Favored 'Trans proline' 0 C--N 1.357 1.012 0 CA-C-N 123.898 2.428 . . . . 0.0 114.437 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.41 -48.72 66.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.609 0.719 . . . . 0.0 110.297 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -66.85 -30.74 71.0 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.557 -0.714 . . . . 0.0 112.02 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -68.13 -31.63 71.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.293 1.037 . . . . 0.0 112.988 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -35.68 75.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.353 1.461 . . . . 0.0 111.197 169.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -88.33 -36.44 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -58.67 -27.34 64.71 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.071 1.749 . . . . 0.0 114.351 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -71.15 -26.17 62.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.465 1.906 . . . . 0.0 112.593 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -97.27 -71.17 0.69 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.442 1.497 . . . . 0.0 112.915 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -96.55 159.04 15.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.814 1.188 . . . . 0.0 112.072 171.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.98 106.98 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.45 -0.781 . . . . 0.0 109.054 172.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.8 t -150.46 173.3 14.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.609 1.164 . . . . 0.0 112.525 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -79.67 147.28 32.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.67 1.588 . . . . 0.0 111.568 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.15 5.9 0.76 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.239 0.526 0 C-N-CA 125.542 1.537 . . . . 0.0 113.771 179.539 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 121.132 0.492 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.1 pt -73.72 162.96 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.7 m120 -83.31 36.7 0.53 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.763 1.625 . . . . 0.0 114.398 -169.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -129.2 -174.88 3.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.492 2.317 . . . . 0.0 112.697 -167.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.14 172.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 0.0 109.102 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -165.08 131.3 2.15 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 128.766 2.826 . . . . 0.0 108.24 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -104.11 174.57 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.995 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -106.79 167.7 9.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.782 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -42.15 -53.79 8.21 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.67 -27.56 45.05 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.494 2.129 . . . . 0.0 114.293 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.8 mt -84.39 -34.29 23.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.511 0.725 . . . . 0.0 112.101 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.29 -35.39 77.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.132 0.973 . . . . 0.0 110.957 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -39.35 73.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.9 1.28 . . . . 0.0 112.627 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -63.41 -54.37 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.464 1.505 . . . . 0.0 109.251 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.282 4.7 mp -70.77 -30.36 66.83 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.332 -0.855 . . . . 0.0 113.156 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -35.49 78.33 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.434 -1.416 . . . . 0.0 112.901 169.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.13 -21.15 64.8 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.175 0.898 . . . . 0.0 112.853 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.68 18.72 19.66 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.402 1.881 . . . . 0.0 113.715 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.11 15.5 76.6 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -82.71 -165.55 1.08 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.795 1.238 . . . . 0.0 112.734 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -131.5 56.73 1.79 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.968 1.707 . . . . 0.0 111.318 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.78 -126.17 7.32 Favored Glycine 0 C--O 1.218 -0.86 0 C-N-CA 124.32 0.962 . . . . 0.0 112.134 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -141.62 11.26 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.825 2.05 . . . . 0.0 111.716 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.5 ttt -76.12 54.56 0.87 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.39 1.476 . . . . 0.0 113.445 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -170.65 171.42 6.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.582 1.953 . . . . 0.0 113.037 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 164.84 7.4 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.176 2.19 . . . . 0.0 114.309 -169.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -51.52 -45.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 126.089 1.756 . . . . 0.0 111.929 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.88 -30.11 71.23 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.23 -47.82 15.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.02 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.0 -45.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 120.027 1.285 . . . . 0.0 112.688 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.7 ptm -70.64 -25.28 62.94 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -64.97 -57.85 7.66 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.969 1.307 . . . . 0.0 110.809 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 61.2 m-85 -55.94 -35.85 67.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.918 0.887 . . . . 0.0 113.071 173.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tt -71.34 -38.58 71.64 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.245 -0.91 . . . . 0.0 112.155 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.57 -47.47 88.1 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 120.848 -1.158 . . . . 0.0 112.589 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.302 11.2 pt20 -70.24 -31.45 68.86 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.997 . . . . 0.0 112.719 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -55.68 -50.43 70.3 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.558 1.526 . . . . 0.0 111.6 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -57.11 -47.23 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.605 0.762 . . . . 0.0 109.762 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.63 71.65 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -73.48 -50.19 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.142 1.377 . . . . 0.0 111.312 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.31 -15.94 63.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.895 0.878 . . . . 0.0 112.9 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.288 6.2 pt20 43.55 43.53 4.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.72 2.808 . . . . 0.0 113.348 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -103.77 33.23 3.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 112.656 -169.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -99.87 165.44 11.56 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.188 1.795 . . . . 0.0 111.821 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.81 135.76 50.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.341 -0.85 . . . . 0.0 111.967 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.51 -45.54 62.91 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.304 1.042 . . . . 0.0 113.186 169.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -80.85 -13.94 58.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 112.497 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.17 98.28 1.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 112.282 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -59.28 -17.56 29.84 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.541 1.137 . . . . 0.0 112.867 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -20.4 62.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.254 1.421 . . . . 0.0 110.456 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.23 140.41 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.384 1.474 . . . . 0.0 111.489 -169.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.35 165.72 14.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.973 2.109 . . . . 0.0 111.178 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.4 m -139.51 -29.57 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.745 1.218 . . . . 0.0 114.15 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 52.72 -126.02 31.19 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.154 0.888 . . . . 0.0 111.878 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.05 14.2 50.46 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.78 150.71 45.59 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.676 2.238 . . . . 0.0 112.475 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.09 -27.85 35.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.452 1.101 . . . . 0.0 112.086 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 tp -65.69 -44.88 84.84 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.661 0.784 . . . . 0.0 112.256 173.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 118.773 0.715 . . . . 0.0 111.932 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -64.51 -37.69 88.41 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 117.683 0.742 . . . . 0.0 112.069 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.8 tp -70.63 -46.13 63.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.741 1.216 . . . . 0.0 112.484 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.85 -28.72 64.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.217 1.007 . . . . 0.0 113.06 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.13 -0.45 73.47 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 123.903 0.763 . . . . 0.0 113.396 -169.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -135.05 137.34 42.83 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 128.245 2.618 . . . . 0.0 109.624 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -103.52 11.83 35.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.783 0.833 . . . . 0.0 113.011 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.5 p -153.84 140.66 19.11 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.683 1.193 . . . . 0.0 111.624 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -162.61 175.34 11.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.41 1.884 . . . . 0.0 110.15 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.4 p -143.89 173.83 11.36 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.899 -1.125 . . . . 0.0 113.342 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.02 -20.84 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.107 0.963 . . . . 0.0 112.132 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.2 -19.39 21.49 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.88 1.272 . . . . 0.0 113.644 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -128.59 63.38 64.61 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.976 1.71 . . . . 0.0 112.402 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.56 -2.05 11.3 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.171 3.248 . . . . 0.0 113.783 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.1 m -41.91 -43.36 6.65 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -23.31 70.7 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 122.925 2.08 . . . . 0.0 114.465 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.67 -51.95 50.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.518 1.054 . . . . 0.0 110.147 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -62.87 -37.7 87.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.442 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.01 -31.54 72.83 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 173.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.3 -47.91 80.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.873 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.29 -21.86 21.87 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -63.75 -25.04 68.01 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.8 1.182 . . . . 0.0 113.27 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -70.05 -25.94 63.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.467 2.307 . . . . 0.0 112.549 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -97.77 -44.89 6.55 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.66 156.74 41.85 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.343 1.428 . . . . 0.0 112.441 172.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.75 100.91 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.796 0.808 . . . . 0.0 111.123 -176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.0 t -151.99 176.93 10.99 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.583 1.153 . . . . 0.0 112.715 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 pp -107.87 174.91 5.67 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.911 2.085 . . . . 0.0 113.648 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.07 162.58 35.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.756 1.222 . . . . 0.0 112.616 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -174.028 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 pt -123.7 152.49 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.589 1.556 . . . . 0.0 113.153 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -90.87 62.04 4.87 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.641 1.177 . . . . 0.0 112.511 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -163.38 -176.91 5.0 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.006 2.922 . . . . 0.0 109.818 -171.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.33 172.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.888 0.875 . . . . 0.0 111.869 -169.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -162.14 134.12 4.09 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 128.903 2.881 . . . . 0.0 107.588 172.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 8.8 Cg_endo -98.66 -178.61 0.27 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.212 2.608 . . . . 0.0 114.574 -169.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -120.65 165.77 14.6 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.301 2.24 . . . . 0.0 108.651 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -39.59 -57.81 2.3 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.467 1.907 . . . . 0.0 116.136 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.83 -25.23 33.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.467 2.111 . . . . 0.0 114.109 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.08 -39.15 23.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.813 0.845 . . . . 0.0 111.065 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.22 -31.58 70.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.678 1.191 . . . . 0.0 111.662 170.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -58.86 -37.62 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.121 1.368 . . . . 0.0 112.787 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.25 -42.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.484 1.514 . . . . 0.0 110.14 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.59 -30.82 67.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.797 -0.564 . . . . 0.0 111.964 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -65.85 -37.13 85.37 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.964 -1.71 . . . . 0.0 112.164 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.65 -22.56 67.01 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.883 0.765 . . . . 0.0 112.435 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.4 2.58 39.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.144 1.378 . . . . 0.0 114.183 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.78 17.31 79.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.492 1.044 . . . . 0.0 114.998 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -90.27 -166.72 1.65 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.602 1.561 . . . . 0.0 112.792 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.38 65.67 1.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.911 1.684 . . . . 0.0 111.101 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.12 -138.81 23.27 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.732 0.682 . . . . 0.0 112.83 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 45.6 mt-10 -131.79 18.06 4.69 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.393 1.877 . . . . 0.0 112.29 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.94 52.64 1.28 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.466 1.506 . . . . 0.0 112.345 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -169.62 170.16 8.25 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.368 1.867 . . . . 0.0 113.209 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.38 165.49 14.09 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.358 2.263 . . . . 0.0 114.663 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -50.83 -44.54 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 126.243 1.817 . . . . 0.0 112.152 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.76 -30.08 71.08 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.09 -48.62 14.01 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.022 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -55.34 -44.96 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 120.194 1.361 . . . . 0.0 112.506 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 14.4 ptm -72.27 -24.95 61.43 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.07 10.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.713 1.205 . . . . 0.0 110.313 169.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 62.7 m-85 -55.56 -42.31 74.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.077 0.951 . . . . 0.0 112.907 173.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.13 -38.0 89.49 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.04 1.291 . . . . 0.0 112.609 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.25 -47.43 89.5 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 119.487 1.04 . . . . 0.0 112.894 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.44 -31.67 67.47 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.548 -0.972 . . . . 0.0 112.873 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.08 -53.63 55.88 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.928 1.24 . . . . 0.0 110.29 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.7 mt -57.72 -42.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.677 0.791 . . . . 0.0 110.192 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.75 -32.22 73.64 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.13 -50.38 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.661 1.185 . . . . 0.0 111.495 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.08 -15.89 64.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.072 1.349 . . . . 0.0 113.11 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.304 6.1 pt20 46.77 43.44 13.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.625 2.77 . . . . 0.0 114.117 172.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.99 3.63 33.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.914 1.285 . . . . 0.0 113.423 -176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -78.73 164.58 24.45 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.666 -1.271 . . . . 0.0 113.413 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -73.14 139.35 46.34 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.682 -0.636 . . . . 0.0 111.986 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -40.38 65.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.376 1.47 . . . . 0.0 112.893 172.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -89.41 -20.35 24.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 112.932 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.21 96.49 2.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.463 1.105 . . . . 0.0 111.538 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -61.24 -14.64 27.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.955 0.902 . . . . 0.0 112.821 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -21.29 66.19 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.996 0.918 . . . . 0.0 112.97 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.8 tpt -104.87 136.01 45.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.662 1.985 . . . . 0.0 110.999 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.56 131.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.686 1.594 . . . . 0.0 110.764 -170.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -99.34 170.54 8.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.369 1.467 . . . . 0.0 111.317 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.03 24.71 0.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 113.457 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.3 113.45 5.45 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.43 -0.794 . . . . 0.0 112.638 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.74 12.81 71.15 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.095 1.331 . . . . 0.0 115.884 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.21 148.28 22.27 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.631 2.216 . . . . 0.0 111.18 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -27.72 63.05 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.53 0.732 . . . . 0.0 112.248 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.13 -40.7 90.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.626 0.77 . . . . 0.0 112.558 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.15 92.64 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 119.101 0.864 . . . . 0.0 112.286 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.24 -40.47 96.1 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.271 1.036 . . . . 0.0 111.539 171.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.25 -44.87 82.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.568 1.147 . . . . 0.0 112.621 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.26 -23.0 43.96 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 113.449 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.91 84.12 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.232 0.92 . . . . 0.0 114.015 -171.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -136.65 137.86 40.51 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.338 1.855 . . . . 0.0 112.526 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -98.64 7.98 45.47 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.601 1.161 . . . . 0.0 113.415 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.4 p -157.09 140.9 16.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 168.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -159.51 176.41 12.1 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.504 1.922 . . . . 0.0 110.506 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 p -143.41 173.33 11.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.764 -1.21 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.67 -20.87 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -94.97 -16.33 22.86 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -125.05 65.39 47.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.85 1.66 . . . . 0.0 112.062 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.03 4.69 5.95 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.364 3.376 . . . . 0.0 113.309 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.6 m -38.88 -45.89 3.08 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 127.717 2.407 . . . . 0.0 116.616 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.42 -20.5 66.25 Favored 'Trans proline' 0 C--N 1.355 0.909 0 CA-C-N 122.521 1.936 . . . . 0.0 115.073 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.52 -49.66 62.37 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.264 1.031 . . . . 0.0 109.722 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -66.77 -30.52 70.75 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.043 -1.035 . . . . 0.0 112.043 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.64 -32.52 74.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.091 -1.006 . . . . 0.0 112.935 170.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -34.15 72.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.235 1.414 . . . . 0.0 111.629 170.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.82 -26.26 21.77 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -26.2 68.61 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.215 1.371 . . . . 0.0 114.394 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.29 -28.84 69.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.389 1.075 . . . . 0.0 111.952 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -87.28 -68.2 0.77 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 171.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -130.87 140.86 50.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.663 1.185 . . . . 0.0 113.301 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.81 125.51 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 169.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.3 t -151.32 173.73 14.14 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.79 148.88 44.13 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.994 1.718 . . . . 0.0 111.26 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.33 171.98 13.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.332 1.453 . . . . 0.0 112.183 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -173.446 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 pt -125.0 169.41 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 127.498 2.319 . . . . 0.0 111.936 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -77.36 27.84 0.15 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.965 1.306 . . . . 0.0 114.279 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -124.28 -175.88 3.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.238 2.615 . . . . 0.0 113.857 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.49 172.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.563 1.145 . . . . 0.0 111.393 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -164.34 132.28 2.59 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 129.799 3.24 . . . . 0.0 106.889 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 13.2 Cg_endo -100.24 174.9 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.024 2.483 . . . . 0.0 115.024 -169.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.88 160.23 14.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.949 2.1 . . . . 0.0 107.03 166.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -44.91 -46.28 28.01 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -68.85 -28.2 30.14 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 122.317 1.863 . . . . 0.0 114.037 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.68 -37.02 28.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.39 1.076 . . . . 0.0 111.011 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -57.72 -40.24 79.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 0.0 110.362 170.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -51.62 -41.62 61.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.692 1.597 . . . . 0.0 113.438 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.89 -51.68 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.297 1.039 . . . . 0.0 110.102 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.69 -31.67 68.64 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 111.925 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -31.87 69.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.793 -1.192 . . . . 0.0 112.86 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.05 -20.98 58.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.201 0.6 . . . . 0.0 112.605 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.46 21.65 17.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.381 1.872 . . . . 0.0 113.796 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.42 17.48 78.97 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.89 -161.12 0.32 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.993 1.317 . . . . 0.0 112.86 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -136.76 59.22 1.7 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.36 -130.85 10.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.859 1.219 . . . . 0.0 113.175 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 46.7 mt-10 -138.89 19.37 2.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.882 2.073 . . . . 0.0 111.589 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.6 ttt -77.7 50.34 0.83 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.698 1.199 . . . . 0.0 112.953 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -168.07 171.05 9.89 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.885 1.674 . . . . 0.0 113.876 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -65.38 167.68 8.23 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.555 2.342 . . . . 0.0 114.222 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.05 -42.24 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.801 2.041 . . . . 0.0 111.802 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -65.15 -33.91 77.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -79.01 -45.94 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.504 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.04 -47.16 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.875 1.216 . . . . 0.0 112.453 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.2 ptm -71.66 -24.01 61.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.69 -59.7 4.25 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.529 1.132 . . . . 0.0 110.744 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -55.25 -37.34 67.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.411 1.084 . . . . 0.0 113.214 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.06 -34.2 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.209 -0.932 . . . . 0.0 112.062 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.06 -47.37 91.11 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.711 -1.243 . . . . 0.0 112.154 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.291 13.9 pt20 -68.48 -31.44 70.72 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.147 -1.207 . . . . 0.0 112.925 172.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -54.6 -53.23 57.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 120.544 1.52 . . . . 0.0 110.467 169.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.4 -43.26 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.753 0.821 . . . . 0.0 110.399 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -34.78 78.51 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -78.13 -49.81 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.987 1.315 . . . . 0.0 111.847 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.04 -15.81 62.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.551 1.141 . . . . 0.0 112.858 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 6.4 pt20 47.72 43.49 16.82 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.003 2.521 . . . . 0.0 113.385 172.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.64 11.69 32.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.983 1.713 . . . . 0.0 112.902 -169.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -86.23 164.85 16.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.725 1.61 . . . . 0.0 112.222 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -71.76 146.69 47.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.135 0.969 . . . . 0.0 113.216 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.628 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -67.93 -34.84 77.38 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.004 1.722 . . . . 0.0 111.819 -175.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.54 -20.61 18.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.629 1.572 . . . . 0.0 112.483 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -144.79 93.29 2.39 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.851 0.834 . . . . 0.0 112.352 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -56.79 -21.25 27.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.27 1.428 . . . . 0.0 112.881 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -31.46 65.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.294 1.437 . . . . 0.0 113.018 171.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -98.7 130.08 45.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.117 1.367 . . . . 0.0 111.101 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -122.57 128.01 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.42 1.488 . . . . 0.0 110.258 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.42 166.59 10.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.069 1.348 . . . . 0.0 111.076 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.98 24.87 0.93 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 112.594 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.56 114.35 6.44 Favored Glycine 0 CA--C 1.533 1.169 0 O-C-N 121.531 -0.731 . . . . 0.0 112.741 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.73 11.67 66.21 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.063 1.316 . . . . 0.0 115.778 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -91.8 149.32 21.65 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 120.491 2.146 . . . . 0.0 111.44 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.23 -27.43 63.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.89 0.876 . . . . 0.0 111.991 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 tp -67.14 -40.33 86.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.796 0.838 . . . . 0.0 112.891 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.73 -36.25 92.9 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 119.132 0.878 . . . . 0.0 111.968 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -66.35 -37.43 85.31 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 112.095 171.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.2 tp -66.96 -46.96 73.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.709 0.803 . . . . 0.0 112.176 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.7 mt -77.96 -24.04 48.27 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.485 1.114 . . . . 0.0 113.101 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.73 8.85 87.19 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.253 0.93 . . . . 0.0 113.925 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -140.37 145.89 37.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.035 1.734 . . . . 0.0 113.091 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -104.29 8.29 35.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.364 1.065 . . . . 0.0 113.606 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -157.09 145.3 19.41 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -161.32 -177.42 6.0 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.544 2.338 . . . . 0.0 109.88 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.6 p -141.01 170.5 15.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.419 -1.426 . . . . 0.0 112.965 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.48 -11.24 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -88.24 -32.68 18.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.883 1.273 . . . . 0.0 111.873 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -127.19 71.47 76.23 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.926 1.69 . . . . 0.0 112.232 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.31 8.2 3.02 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.586 3.524 . . . . 0.0 113.734 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -46.13 -34.08 2.86 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 127.334 2.254 . . . . 0.0 116.772 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -59.81 -29.32 89.29 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 122.349 1.875 . . . . 0.0 114.318 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.79 -47.87 73.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.931 0.787 . . . . 0.0 110.579 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -65.52 -32.97 74.85 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.775 -0.578 . . . . 0.0 111.463 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.87 -31.62 68.35 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.174 0.897 . . . . 0.0 113.363 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -35.73 81.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.768 1.227 . . . . 0.0 110.768 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.84 -41.05 12.71 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.89 1.276 . . . . 0.0 114.14 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -27.61 64.84 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.671 1.588 . . . . 0.0 115.183 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.02 -24.63 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.491 1.517 . . . . 0.0 113.085 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -106.07 -45.13 4.41 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -167.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.626 HD13 ' HB ' ' A' ' 108' ' ' THR . 0.6 OUTLIER -105.8 170.1 8.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.54 1.536 . . . . 0.0 112.814 169.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 m -102.68 -21.51 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.626 ' HB ' HD13 ' A' ' 106' ' ' LEU 0.282 6.3 t 46.82 -168.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 129.449 3.1 . . . . 0.0 114.673 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.7 mt -76.31 149.47 37.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.167 1.387 . . . . 0.0 111.9 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.02 172.25 15.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.077 1.351 . . . . 0.0 112.656 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.242 0.663 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.782 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 CA--C 1.545 0.768 0 CA-C-O 120.95 0.405 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.7 pt -67.15 156.06 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.43 57.2 2.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.192 1.397 . . . . 0.0 111.983 -171.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -163.12 -178.68 6.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.481 2.712 . . . . 0.0 109.829 -168.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.5 172.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.107 0.963 . . . . 0.0 111.303 -169.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -163.42 136.54 4.28 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 128.719 2.808 . . . . 0.0 108.006 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -101.36 174.21 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.311 2.674 . . . . 0.0 114.956 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -98.95 159.52 14.9 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.416 1.886 . . . . 0.0 107.798 167.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.1 tp -47.2 -43.8 46.97 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -66.76 -29.57 42.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.304 2.003 . . . . 0.0 114.119 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.4 mt -84.91 -33.03 22.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.627 0.771 . . . . 0.0 111.839 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.68 -35.77 77.09 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.901 0.881 . . . . 0.0 110.974 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -40.16 68.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.771 1.228 . . . . 0.0 112.717 177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -65.43 -51.92 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.859 1.664 . . . . 0.0 109.409 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.67 -30.3 66.86 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.433 -0.792 . . . . 0.0 112.932 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -34.3 76.67 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.396 -1.44 . . . . 0.0 112.878 169.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.81 -20.23 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 119.288 0.949 . . . . 0.0 112.997 170.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.74 17.51 24.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.343 1.857 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 17.52 75.62 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.98 -165.4 1.19 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.114 1.366 . . . . 0.0 112.616 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.65 52.82 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.231 1.412 . . . . 0.0 110.99 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.79 -124.26 7.39 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.303 -0.873 . . . . 0.0 112.145 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -140.27 20.26 2.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.933 1.693 . . . . 0.0 111.902 -176.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -77.63 42.48 0.37 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.199 1.8 . . . . 0.0 114.361 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -166.29 174.6 8.97 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 -167.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.74 165.89 11.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.051 2.14 . . . . 0.0 114.297 -169.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.36 -44.55 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.848 1.659 . . . . 0.0 112.012 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -64.52 -30.12 71.15 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.46 -48.58 13.69 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.35 -0.834 . . . . 0.0 111.157 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.59 -44.88 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 120.425 1.466 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.5 ptm -71.71 -28.81 63.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.72 -59.14 5.86 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.162 . . . . 0.0 110.501 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -57.62 -33.17 67.97 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -34.7 70.19 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.159 1.345 . . . . 0.0 113.92 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.36 88.15 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 120.151 1.342 . . . . 0.0 111.769 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.261 13.5 pt20 -70.56 -31.63 68.74 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 118.071 -0.966 . . . . 0.0 113.18 173.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -55.66 -53.56 55.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.847 1.658 . . . . 0.0 110.945 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.18 -42.34 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.321 1.048 . . . . 0.0 110.071 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 31.8 tpp -67.18 -30.39 70.32 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.674 0.991 . . . . 0.0 113.674 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.66 -50.59 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.754 1.221 . . . . 0.0 111.489 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -15.99 63.25 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.496 1.118 . . . . 0.0 112.951 175.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.3 pt20 45.55 42.64 8.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.261 2.624 . . . . 0.0 113.448 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.4 19.5 16.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.843 1.657 . . . . 0.0 112.552 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -88.92 166.59 13.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.951 1.701 . . . . 0.0 111.86 171.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -76.33 135.22 39.55 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.234 -0.916 . . . . 0.0 112.07 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -38.84 42.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.263 1.425 . . . . 0.0 113.208 171.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -89.79 -18.26 26.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.214 1.406 . . . . 0.0 113.067 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.91 92.33 1.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.518 1.127 . . . . 0.0 111.257 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -57.51 -18.74 20.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 112.484 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -24.81 67.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.646 1.178 . . . . 0.0 112.957 175.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -102.01 132.66 47.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.444 1.898 . . . . 0.0 110.843 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.3 t -126.8 130.18 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.67 1.588 . . . . 0.0 110.333 -170.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -101.88 165.1 11.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.057 1.343 . . . . 0.0 111.381 172.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.5 m -150.44 23.62 0.81 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.225 1.81 . . . . 0.0 112.75 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.17 114.79 7.03 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 121.409 -0.807 . . . . 0.0 112.645 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.95 12.74 65.51 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.107 1.337 . . . . 0.0 115.528 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.36 149.49 21.19 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.087 1.944 . . . . 0.0 111.452 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -58.04 -27.72 63.84 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.683 -0.635 . . . . 0.0 111.666 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.7 tp -67.19 -39.15 86.33 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.358 -0.839 . . . . 0.0 112.598 172.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.57 90.54 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 118.659 0.663 . . . . 0.0 112.211 171.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.9 -38.0 85.43 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.398 1.099 . . . . 0.0 112.189 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.44 -46.14 70.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.479 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.41 -20.67 43.41 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.457 1.103 . . . . 0.0 113.074 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.16 -9.66 52.81 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.747 1.642 . . . . 0.0 114.407 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -124.84 142.5 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.419 1.888 . . . . 0.0 111.518 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -97.58 12.48 33.37 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.5 p -157.14 148.44 22.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.586 1.154 . . . . 0.0 112.549 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.3 173.92 15.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.392 1.877 . . . . 0.0 110.401 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.0 p -141.4 171.35 14.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.659 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -71.73 -8.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.0 -24.32 16.98 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.346 1.459 . . . . 0.0 112.854 169.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -128.82 63.42 66.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.204 1.802 . . . . 0.0 112.217 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.64 6.18 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.075 3.183 . . . . 0.0 114.077 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.8 m -44.97 -37.96 5.59 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -172.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -56.58 -30.17 82.02 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.634 2.223 . . . . 0.0 115.38 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.53 -53.04 62.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.301 1.524 . . . . 0.0 110.663 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.63 -29.23 63.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.719 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.12 -31.6 72.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.884 0.873 . . . . 0.0 112.582 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.15 -40.08 82.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.515 1.126 . . . . 0.0 110.812 169.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.26 -36.13 35.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.723 1.209 . . . . 0.0 113.842 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -25.38 65.52 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.365 1.439 . . . . 0.0 114.312 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -67.5 -31.84 72.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.644 1.977 . . . . 0.0 112.27 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -109.91 -50.32 2.99 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.14 141.68 31.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.556 1.943 . . . . 0.0 109.837 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.1 m -75.21 41.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 125.087 1.355 . . . . 0.0 113.178 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.4 t -91.23 170.5 9.95 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.661 1.584 . . . . 0.0 113.661 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.64 164.56 16.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.468 1.907 . . . . 0.0 111.483 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.73 158.39 40.22 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.579 1.152 . . . . 0.0 113.767 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.468 0.465 0 C-N-CA 124.103 0.961 . . . . 0.0 113.065 -174.506 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 121.704 0.764 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 pt -139.84 167.99 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 127.337 2.255 . . . . 0.0 112.578 -170.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.18 35.32 0.38 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.746 1.619 . . . . 0.0 114.327 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -126.09 -174.94 3.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.261 2.624 . . . . 0.0 113.01 -167.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.47 171.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.077 0.951 . . . . 0.0 110.321 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -164.73 130.43 2.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 127.964 2.505 . . . . 0.0 107.786 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -96.45 172.95 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.886 2.391 . . . . 0.0 114.254 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.1 159.3 15.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.654 1.981 . . . . 0.0 108.192 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.05 -52.9 14.54 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 -22.12 37.23 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.552 2.168 . . . . 0.0 114.008 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.3 mt -84.34 -36.75 22.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.901 0.88 . . . . 0.0 111.979 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.9 -35.95 78.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 111.166 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -51.74 -38.17 54.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.455 1.502 . . . . 0.0 112.77 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -67.49 -51.52 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.74 -30.64 67.21 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -35.14 79.47 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.477 -1.389 . . . . 0.0 112.789 171.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.41 -21.52 62.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.31 21.5 17.05 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.32 1.848 . . . . 0.0 113.661 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.43 78.01 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.981 1.152 . . . . 0.0 115.981 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.08 -164.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.0 1.32 . . . . 0.0 113.035 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -129.19 50.1 2.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.997 1.719 . . . . 0.0 111.674 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.3 -122.49 5.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.425 1.012 . . . . 0.0 113.046 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -143.59 14.8 1.78 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.041 1.736 . . . . 0.0 112.684 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -79.17 52.29 1.29 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.084 1.354 . . . . 0.0 112.549 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -168.89 169.73 9.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.176 1.79 . . . . 0.0 112.532 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 164.78 6.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 127.34 2.256 . . . . 0.0 114.109 -170.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -52.72 -44.13 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.317 1.847 . . . . 0.0 111.786 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.22 -30.08 71.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.65 -47.77 14.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.106 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.25 -46.84 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 120.183 1.356 . . . . 0.0 112.499 173.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.6 ptm -69.46 -24.81 63.85 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.05 -59.66 3.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.822 1.249 . . . . 0.0 110.751 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -56.05 -36.34 67.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.945 0.898 . . . . 0.0 113.05 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -70.88 -38.91 73.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.061 0.944 . . . . 0.0 112.01 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.22 -47.43 89.49 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.865 -1.147 . . . . 0.0 112.54 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.265 13.2 pt20 -68.71 -31.6 70.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.504 -0.997 . . . . 0.0 112.755 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -57.52 -51.08 70.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.123 1.329 . . . . 0.0 111.027 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.16 -41.96 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.198 0.908 . . . . 0.0 110.08 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.25 -34.43 78.08 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.1 -52.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.598 1.159 . . . . 0.0 111.594 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -67.23 -15.76 63.89 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.323 1.049 . . . . 0.0 113.335 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.3 5.6 pt20 46.13 47.14 13.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.445 2.698 . . . . 0.0 113.912 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.8 4.49 32.73 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.75 1.22 . . . . 0.0 113.624 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -78.53 163.3 25.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 112.706 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.57 150.11 41.68 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.952 0.882 . . . . 0.0 112.682 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.599 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -64.14 -31.84 73.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.964 1.306 . . . . 0.0 112.65 -174.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -102.66 -30.04 11.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.674 1.59 . . . . 0.0 110.461 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -110.35 80.07 1.27 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.247 1.019 . . . . 0.0 111.789 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -57.3 -22.42 41.63 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.028 -0.42 . . . . 0.0 111.605 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -26.19 54.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.9 tpt -88.62 127.55 35.57 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.087 1.312 . . . . 0.0 110.854 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 t -120.07 125.69 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.394 1.078 . . . . 0.0 110.98 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.86 167.38 10.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.914 1.285 . . . . 0.0 111.065 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.1 m -148.62 29.24 0.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.916 1.686 . . . . 0.0 112.082 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.74 113.85 6.15 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.35 -0.844 . . . . 0.0 112.542 -170.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.37 12.05 72.39 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.08 1.324 . . . . 0.0 115.576 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.21 150.8 19.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.161 1.98 . . . . 0.0 111.4 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -58.06 -27.74 63.9 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.82 -37.64 84.9 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.377 -0.827 . . . . 0.0 112.482 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.43 -38.21 94.63 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.504 -0.748 . . . . 0.0 112.008 170.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -65.8 -37.61 86.74 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.229 1.014 . . . . 0.0 112.262 172.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.87 -44.64 76.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 112.248 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -79.22 -25.0 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.391 0.676 . . . . 0.0 112.626 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.16 4.55 83.87 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.423 1.011 . . . . 0.0 113.437 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -138.24 141.72 39.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.618 1.967 . . . . 0.0 111.492 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -101.97 10.1 39.95 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 -172.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.0 p -154.52 148.87 26.1 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.54 179.05 8.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.957 2.503 . . . . 0.0 109.57 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 p -144.78 172.73 12.6 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.184 -1.572 . . . . 0.0 113.286 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.05 -21.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.422 0.689 . . . . 0.0 112.096 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.72 -21.64 19.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.12 77.21 67.94 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 111.541 174.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.84 3.62 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.394 3.396 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 m -46.68 -37.6 9.4 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.874 1.67 . . . . 0.0 115.343 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.58 -27.25 68.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.407 2.738 . . . . 0.0 116.661 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.96 -49.5 57.45 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 123.021 1.391 . . . . 0.0 110.136 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -67.94 -29.15 68.15 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 121.22 -0.925 . . . . 0.0 112.157 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.56 -31.33 72.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.356 1.062 . . . . 0.0 112.179 169.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -40.52 72.26 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.256 1.022 . . . . 0.0 111.484 169.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.45 -30.78 26.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -59.74 -26.54 65.74 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.627 1.571 . . . . 0.0 113.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -69.6 -31.04 68.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.588 1.955 . . . . 0.0 112.252 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -82.87 -71.31 0.5 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -109.77 151.22 27.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.632 1.173 . . . . 0.0 112.411 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.57 115.06 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.4 t -153.74 177.58 10.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.759 1.224 . . . . 0.0 112.32 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.98 151.33 46.2 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.572 1.549 . . . . 0.0 111.412 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.01 2.41 0.9 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 117.303 2.334 . . . . 0.0 117.303 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.322 -0.595 0 C-N-CA 124.898 1.279 . . . . 0.0 114.044 173.585 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 CA--C 1.546 0.82 0 CA-C-O 121.593 0.711 . . . . 0.0 112.801 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 pt -68.42 159.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.68 1.192 . . . . 0.0 112.822 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -82.47 32.52 0.4 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.99 -177.2 4.19 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.969 2.507 . . . . 0.0 112.054 -168.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 28' ' ' ARG . 2.9 t -81.99 172.31 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.362 1.065 . . . . 0.0 109.621 -174.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -162.18 135.9 4.79 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 129.31 3.044 . . . . 0.0 107.344 173.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.544 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 24.1 Cg_endo -93.72 175.74 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.995 2.463 . . . . 0.0 115.468 -168.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -107.67 160.55 15.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.975 2.51 . . . . 0.0 107.65 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.3 tp -40.27 -55.76 3.89 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 126.271 1.828 . . . . 0.0 115.822 -175.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.94 -25.06 28.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.223 1.949 . . . . 0.0 113.452 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.34 -35.47 35.54 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.452 -0.78 . . . . 0.0 111.582 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.53 -32.73 73.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.706 0.802 . . . . 0.0 110.93 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -59.23 -40.22 85.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.919 1.288 . . . . 0.0 112.759 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -65.76 -46.08 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.196 1.398 . . . . 0.0 109.98 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.6 -30.81 67.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.081 0.552 . . . . 0.0 112.225 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -66.37 -37.2 84.74 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.095 -1.628 . . . . 0.0 112.178 169.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.89 -24.07 67.42 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.952 0.796 . . . . 0.0 112.033 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . . . -84.51 4.81 30.14 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.65 1.58 . . . . 0.0 114.339 169.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.56 78.43 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.529 1.061 . . . . 0.0 115.364 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -92.01 -160.93 0.78 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.899 1.68 . . . . 0.0 113.092 -174.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -137.28 68.84 1.41 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.63 -146.09 32.28 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.903 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 48.2 mt-10 -129.48 19.06 5.77 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.235 2.214 . . . . 0.0 112.092 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.1 ttt -79.71 52.73 1.49 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.928 1.291 . . . . 0.0 112.38 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -166.35 175.87 7.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.41 1.884 . . . . 0.0 114.179 -169.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 49' ' ' VAL . 1.6 m -78.13 170.19 17.02 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.782 2.433 . . . . 0.0 114.379 -169.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 48' ' ' THR . 60.4 t -52.77 -42.84 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 126.866 2.066 . . . . 0.0 111.773 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -65.98 -30.11 70.61 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.33 -47.87 13.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.022 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -55.21 -45.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 120.193 1.36 . . . . 0.0 112.697 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.7 ptm -70.75 -25.65 63.01 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.49 -59.8 3.61 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.429 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 52.1 m-85 -55.73 -39.97 71.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.038 0.935 . . . . 0.0 112.849 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.84 -43.03 90.65 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.299 -0.876 . . . . 0.0 112.898 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.12 -46.86 84.32 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.259 0.936 . . . . 0.0 112.595 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 14.2 pt20 -71.8 -31.62 66.76 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.741 -0.858 . . . . 0.0 113.312 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CE2' ' HE3' ' A' ' 63' ' ' LYS . 60.5 t80 -59.09 -51.7 68.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.622 1.556 . . . . 0.0 111.253 169.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.55 -43.34 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.22 1.008 . . . . 0.0 110.081 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.6 tpp -67.48 -32.52 73.42 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.9 t -75.45 -51.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.728 1.211 . . . . 0.0 111.446 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 21.2 mmtp -66.75 -16.02 63.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.895 0.878 . . . . 0.0 112.88 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.296 6.2 pt20 44.25 43.7 6.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 128.36 2.664 . . . . 0.0 113.635 175.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -102.08 21.96 13.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.713 1.605 . . . . 0.0 112.848 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -87.54 169.74 11.92 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.414 1.886 . . . . 0.0 111.895 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.38 144.24 44.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.255 -0.903 . . . . 0.0 112.678 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.518 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 9.9 mp0 -64.14 -39.89 94.99 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.543 1.937 . . . . 0.0 112.417 -177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -92.38 -21.84 20.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.3 1.44 . . . . 0.0 112.362 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -138.99 88.27 2.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.393 1.092 . . . . 0.0 112.93 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -56.17 -17.84 8.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.418 1.087 . . . . 0.0 112.918 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -25.43 68.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.452 1.101 . . . . 0.0 112.978 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -103.11 134.32 46.74 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.884 1.674 . . . . 0.0 111.241 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -126.42 132.48 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.442 1.497 . . . . 0.0 110.778 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -112.9 162.47 15.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.915 1.686 . . . . 0.0 111.35 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.6 m -146.19 28.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.309 1.443 . . . . 0.0 111.864 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.99 106.43 0.23 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.464 1.031 . . . . 0.0 114.642 -169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.86 14.76 65.96 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.994 1.283 . . . . 0.0 115.493 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.35 153.95 20.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.2 1.5 . . . . 0.0 112.365 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -57.55 -27.93 63.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.564 0.746 . . . . 0.0 111.994 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.58 -41.32 88.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.1 0.864 . . . . 0.0 112.213 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.42 -37.79 94.93 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.724 -0.61 . . . . 0.0 111.825 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -66.53 -38.4 87.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.024 0.929 . . . . 0.0 112.274 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 tp -65.6 -46.06 80.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.054 1.342 . . . . 0.0 112.102 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -76.48 -26.81 55.74 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.29 2.01 71.84 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.009 0.814 . . . . 0.0 112.862 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -142.01 136.02 29.86 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 129.807 3.243 . . . . 0.0 108.058 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.284 9.0 pt20 -112.16 17.67 19.33 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.8 p -153.4 145.33 23.6 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.089 -1.007 . . . . 0.0 113.07 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -161.0 170.47 20.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.836 1.655 . . . . 0.0 111.208 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.0 p -137.32 170.88 15.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.671 0.788 . . . . 0.0 111.753 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -7.58 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -95.11 -27.13 15.73 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.133 1.373 . . . . 0.0 112.73 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -131.4 78.67 71.38 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.648 1.579 . . . . 0.0 111.199 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.15 5.44 6.24 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.273 3.315 . . . . 0.0 113.799 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -44.53 -38.0 4.98 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -173.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -59.07 -28.83 88.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.966 2.444 . . . . 0.0 115.932 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 tp -58.87 -53.3 59.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 123.158 1.456 . . . . 0.0 109.929 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.56 -29.17 62.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.296 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -64.38 -31.34 72.51 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.441 1.019 . . . . 0.0 112.529 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.5 ttp -72.2 -42.72 65.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.053 0.941 . . . . 0.0 110.335 169.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.14 -32.25 44.34 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -59.24 -28.1 66.39 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.772 1.629 . . . . 0.0 114.026 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.4 -26.57 58.52 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.629 1.971 . . . . 0.0 112.837 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -101.06 -47.87 4.61 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.58 1.152 . . . . 0.0 113.839 -174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.24 159.65 29.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.478 1.511 . . . . 0.0 112.09 169.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.85 39.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 125.302 1.441 . . . . 0.0 113.862 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 t -82.88 174.86 10.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.648 1.179 . . . . 0.0 112.862 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.79 153.38 41.12 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.342 1.457 . . . . 0.0 112.29 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.37 166.78 26.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 112.5 172.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.064 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 CA--C 1.546 0.803 0 CA-C-O 121.012 0.434 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.8 pt -68.17 168.36 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.208 1.403 . . . . 0.0 113.115 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.51 33.75 0.21 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.948 1.699 . . . . 0.0 114.19 -175.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -127.61 -175.54 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 129.216 3.007 . . . . 0.0 112.032 -167.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' MET . 2.0 t -92.5 172.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.862 1.265 . . . . 0.0 109.9 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.3 ttp85 -164.77 142.66 5.32 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 130.108 3.363 . . . . 0.0 107.722 168.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -105.67 170.86 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.198 2.599 . . . . 0.0 114.111 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -83.44 158.76 21.95 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.727 1.211 . . . . 0.0 108.149 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.44 -50.43 22.85 Favored Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.43 -25.53 35.5 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.168 1.912 . . . . 0.0 114.274 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -81.19 -37.79 28.12 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.518 0.727 . . . . 0.0 111.436 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.67 -42.57 98.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.091 1.356 . . . . 0.0 111.719 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 40.2 pttt -68.49 -22.95 64.52 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -62.12 -52.79 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 109.347 169.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.69 -30.58 67.2 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -32.16 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.818 -1.176 . . . . 0.0 113.271 170.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.27 -22.64 63.34 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.136 0.88 . . . . 0.0 112.955 170.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.5 23.65 13.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.089 1.756 . . . . 0.0 113.462 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.73 15.6 79.4 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.43 -163.55 0.58 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.384 1.092 . . . . 0.0 113.173 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -132.32 49.2 2.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.019 2.128 . . . . 0.0 109.842 168.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.99 -115.73 4.77 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.737 1.16 . . . . 0.0 112.721 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.86 17.39 3.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.142 1.777 . . . . 0.0 111.241 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 24.5 ttt -74.52 50.73 0.43 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.314 1.846 . . . . 0.0 113.482 -172.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -173.5 170.92 4.04 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.66 1.984 . . . . 0.0 112.666 -169.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.25 165.74 11.05 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.277 2.231 . . . . 0.0 113.594 -172.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -51.55 -44.68 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 126.581 1.952 . . . . 0.0 112.043 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -65.15 -30.18 71.08 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -80.38 -45.39 17.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.124 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -57.35 -45.04 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 120.075 1.307 . . . . 0.0 112.506 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.9 ptm -70.05 -24.16 63.21 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -66.78 -57.72 6.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.127 1.371 . . . . 0.0 110.983 170.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -56.48 -36.84 69.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.026 0.93 . . . . 0.0 113.145 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tt -71.79 -40.36 69.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.483 -0.761 . . . . 0.0 111.742 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.51 -47.43 89.97 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.9 -1.125 . . . . 0.0 112.807 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -69.59 -31.54 69.75 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.212 -1.17 . . . . 0.0 112.641 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.11 -50.61 72.27 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.957 1.253 . . . . 0.0 110.942 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mt -57.89 -43.74 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.706 0.684 . . . . 0.0 110.242 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.16 -32.97 74.72 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.53 -50.9 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.412 1.085 . . . . 0.0 111.518 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -15.87 63.66 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.376 1.07 . . . . 0.0 113.181 176.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.2 pt20 45.44 43.43 8.68 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.331 2.652 . . . . 0.0 113.62 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.03 8.39 43.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.668 1.587 . . . . 0.0 112.936 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -74.39 162.96 28.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.693 1.197 . . . . 0.0 112.268 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.48 147.77 41.61 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -47.1 78.56 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -76.77 -19.92 57.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.41 94.92 2.28 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.462 1.125 . . . . 0.0 113.311 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.84 -17.96 28.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.299 1.44 . . . . 0.0 112.876 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -25.17 65.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.943 0.897 . . . . 0.0 113.104 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.8 tpp -93.95 129.18 40.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 109.742 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.12 113.03 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.812 1.645 . . . . 0.0 109.806 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -86.91 165.12 16.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.783 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.74 25.28 1.18 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.584 1.553 . . . . 0.0 112.596 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.54 114.82 6.64 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.561 -0.712 . . . . 0.0 112.948 -169.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.74 10.93 72.72 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.144 1.354 . . . . 0.0 115.853 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.38 150.01 21.06 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.404 2.102 . . . . 0.0 111.437 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.01 -27.66 63.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.535 -0.728 . . . . 0.0 112.735 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.45 -39.74 94.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.383 0.992 . . . . 0.0 112.068 171.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.61 95.78 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.501 0.572 . . . . 0.0 112.146 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.98 -43.13 95.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.122 0.961 . . . . 0.0 111.995 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -70.65 -46.16 63.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.242 1.017 . . . . 0.0 111.892 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -71.82 -27.76 63.13 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.072 0.949 . . . . 0.0 112.563 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.03 7.24 83.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.345 1.45 . . . . 0.0 114.499 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.54 147.94 30.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.072 1.749 . . . . 0.0 111.721 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -101.98 9.87 40.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 113.448 -173.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -153.25 144.08 22.79 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.82 170.82 20.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.955 2.102 . . . . 0.0 110.67 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -136.58 154.4 50.7 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.701 0.8 . . . . 0.0 112.023 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.29 -14.89 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.87 -7.12 57.63 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.424 1.49 . . . . 0.0 113.731 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -145.24 64.27 10.69 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.707 1.603 . . . . 0.0 111.48 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.73 2.77 7.89 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.206 3.271 . . . . 0.0 114.714 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.9 m -48.5 -33.1 4.48 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -54.5 -31.0 67.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.115 2.543 . . . . 0.0 115.812 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.5 -48.76 46.93 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.621 1.169 . . . . 0.0 110.379 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -67.02 -29.24 69.0 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.011 -1.056 . . . . 0.0 112.177 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.95 -31.56 72.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.708 1.203 . . . . 0.0 112.526 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -32.5 70.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.866 1.267 . . . . 0.0 112.236 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.5 -31.62 16.69 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -62.73 -27.86 69.56 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.855 1.262 . . . . 0.0 113.935 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -62.44 -29.04 70.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.948 0.899 . . . . 0.0 112.109 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -87.65 -92.97 0.1 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.51 169.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.91 143.81 25.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.391 1.076 . . . . 0.0 112.922 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 m -81.13 62.91 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.732 1.213 . . . . 0.0 111.87 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -66.54 163.64 18.25 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.378 1.071 . . . . 0.0 113.467 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.1 mt -91.04 -0.56 57.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.955 1.702 . . . . 0.0 114.565 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.09 157.03 27.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.402 1.481 . . . . 0.0 112.73 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -171.376 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 pt -143.54 164.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.645 1.978 . . . . 0.0 111.911 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -86.39 45.99 1.3 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.905 1.282 . . . . 0.0 112.776 -173.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -163.55 -173.06 3.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 130.389 3.476 . . . . 0.0 108.457 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.08 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.983 -1.073 . . . . 0.0 111.55 -172.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -158.19 139.18 9.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 131.329 3.852 . . . . 0.0 106.729 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 35.6 Cg_endo -96.72 167.01 1.04 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.242 2.628 . . . . 0.0 113.681 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -79.93 161.48 25.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.399 1.08 . . . . 0.0 108.597 167.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.92 -42.03 66.92 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -68.61 -29.32 30.26 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.264 1.976 . . . . 0.0 114.246 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.89 -31.2 25.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.955 0.902 . . . . 0.0 112.108 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.25 -43.23 87.76 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.943 0.897 . . . . 0.0 111.056 173.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.309 16.9 pttp -72.76 -24.84 61.0 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.67 -52.08 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 109.475 170.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 37' ' ' LEU . 1.2 mm? -67.54 -30.72 70.44 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.483 -0.761 . . . . 0.0 112.463 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -29.9 69.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.678 -1.264 . . . . 0.0 113.378 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.33 59.78 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.4 21.81 16.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.157 1.783 . . . . 0.0 113.684 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.25 17.03 78.63 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.24 -156.23 0.16 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.859 1.264 . . . . 0.0 112.731 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -141.24 60.15 1.51 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.569 1.948 . . . . 0.0 109.624 168.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.29 18.02 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.584 -172.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 40.3 mt-10 -135.64 20.4 3.33 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.699 2.0 . . . . 0.0 110.923 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -76.07 54.74 0.88 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.876 1.67 . . . . 0.0 112.955 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -173.29 172.21 3.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.286 1.834 . . . . 0.0 112.384 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 167.07 13.76 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.814 2.045 . . . . 0.0 114.084 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -49.45 -45.88 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.455 1.902 . . . . 0.0 112.169 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -65.09 -30.07 70.99 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.79 -46.72 16.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.137 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -55.71 -46.72 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 120.477 1.489 . . . . 0.0 112.337 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 23.1 ptm -69.51 -27.44 65.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -62.47 -58.07 8.93 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.558 1.143 . . . . 0.0 110.758 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -58.31 -32.56 68.58 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.13 -41.27 81.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.559 1.072 . . . . 0.0 112.82 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.44 -47.42 88.2 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.963 0.801 . . . . 0.0 112.093 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.252 11.5 pt20 -70.72 -31.7 68.63 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.554 -0.968 . . . . 0.0 113.08 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.45 -51.93 66.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.454 1.479 . . . . 0.0 111.014 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.5 mt -60.59 -41.61 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.068 0.947 . . . . 0.0 110.272 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 37.7 tpp -67.78 -31.97 72.23 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.08 -50.4 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.357 1.063 . . . . 0.0 111.347 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -16.03 63.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.968 0.907 . . . . 0.0 113.125 175.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.4 pt20 43.49 43.07 4.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.455 2.702 . . . . 0.0 113.647 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 tp -99.51 20.21 14.28 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.523 1.529 . . . . 0.0 112.689 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -83.88 165.71 18.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 111.883 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.46 148.52 45.04 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.169 0.985 . . . . 0.0 113.026 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.606 ' H ' ' CD ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.7 -38.41 76.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.833 1.653 . . . . 0.0 111.43 -176.343 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -90.94 -20.39 22.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.585 1.554 . . . . 0.0 112.295 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -144.04 93.18 2.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.415 1.103 . . . . 0.0 112.414 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -57.69 -18.51 21.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.152 1.381 . . . . 0.0 112.821 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.78 63.64 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.24 1.016 . . . . 0.0 113.133 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -97.86 129.81 44.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.063 1.745 . . . . 0.0 110.302 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.03 131.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.114 1.366 . . . . 0.0 110.65 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -105.62 165.71 10.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.297 1.439 . . . . 0.0 111.6 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.02 24.24 1.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.151 1.781 . . . . 0.0 112.771 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.38 113.68 5.71 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.603 -0.685 . . . . 0.0 112.647 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.98 13.03 66.07 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.12 1.343 . . . . 0.0 115.676 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -95.25 148.42 22.43 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.39 2.095 . . . . 0.0 111.382 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.88 -27.8 63.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.47 0.708 . . . . 0.0 111.943 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.11 -39.95 90.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.4 -0.812 . . . . 0.0 112.465 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.93 92.59 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 118.543 0.61 . . . . 0.0 112.223 172.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -65.11 -36.68 85.07 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 117.893 0.846 . . . . 0.0 112.19 171.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.27 -50.51 53.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.606 1.162 . . . . 0.0 111.2 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.67 -24.02 58.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.123 0.969 . . . . 0.0 113.082 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.47 7.78 85.87 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.161 1.362 . . . . 0.0 114.634 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 150.19 33.84 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.886 1.674 . . . . 0.0 111.854 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -99.1 11.49 38.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.118 0.967 . . . . 0.0 113.434 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -155.32 149.73 26.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.86 177.84 10.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.65 1.98 . . . . 0.0 111.129 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 t -140.2 154.55 46.96 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.011 -1.056 . . . . 0.0 111.892 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.2 m -66.22 -12.92 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 169.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -83.18 -17.2 43.69 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.65 1.18 . . . . 0.0 113.026 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -140.38 69.87 32.92 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 111.478 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.75 3.95 4.5 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.21 3.273 . . . . 0.0 114.564 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -45.4 -35.45 3.22 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 126.364 1.866 . . . . 0.0 115.736 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -56.69 -30.09 82.56 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.95 2.433 . . . . 0.0 115.73 173.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.74 -45.56 61.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.177 0.899 . . . . 0.0 110.142 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.45 -30.25 69.92 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.621 -0.674 . . . . 0.0 112.275 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -66.72 -31.31 71.88 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.858 1.263 . . . . 0.0 112.872 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -33.33 67.44 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.292 1.437 . . . . 0.0 112.207 170.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.98 -27.02 18.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.959 1.704 . . . . 0.0 114.545 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -61.46 -23.37 65.82 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.4 1.48 . . . . 0.0 113.963 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -65.69 -27.31 68.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.546 1.938 . . . . 0.0 112.344 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -101.96 -71.7 0.71 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.147 0.979 . . . . 0.0 113.331 172.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.96 163.23 21.17 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.115 1.366 . . . . 0.0 113.345 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.5 m -100.36 33.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.89 1.676 . . . . 0.0 111.492 169.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 t -82.01 173.78 11.86 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.33 1.452 . . . . 0.0 114.075 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.0 mt -102.99 165.58 10.94 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.866 2.066 . . . . 0.0 111.95 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.94 161.63 27.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.084 1.354 . . . . 0.0 113.047 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.747 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 200' ' ' 49H . . . . . 0.409 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 . . . . . 0 CA--C 1.545 0.75 0 CA-C-O 120.754 0.311 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.5 pt -92.92 166.32 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.315 1.446 . . . . 0.0 113.072 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -81.26 35.14 0.38 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.586 1.554 . . . . 0.0 113.912 -174.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -129.64 -177.66 4.36 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 128.42 2.688 . . . . 0.0 113.114 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.68 172.23 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.851 1.661 . . . . 0.0 111.677 -176.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -163.35 143.42 6.91 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 130.173 3.389 . . . . 0.0 108.22 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -102.65 169.37 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.783 2.989 . . . . 0.0 113.843 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -87.4 164.45 16.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 109.792 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.5 tp -42.82 -56.32 6.22 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.926 1.69 . . . . 0.0 115.377 -172.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.89 -26.8 37.67 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.215 1.943 . . . . 0.0 113.821 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.7 mt -80.83 -34.59 33.78 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.363 -0.836 . . . . 0.0 112.243 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.39 -32.16 73.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.795 1.238 . . . . 0.0 110.988 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -58.57 -41.69 86.28 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.42 1.488 . . . . 0.0 112.861 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.86 -51.31 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.187 1.395 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.32 13.6 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -61.43 -33.96 74.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.613 -1.304 . . . . 0.0 112.399 169.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.05 62.35 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.247 0.93 . . . . 0.0 113.317 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 23.52 13.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.008 1.723 . . . . 0.0 113.434 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.26 79.62 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.676 1.131 . . . . 0.0 115.687 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.0 -169.58 2.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.466 1.106 . . . . 0.0 113.247 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -123.39 44.74 2.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.678 1.991 . . . . 0.0 110.841 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.74 -115.33 4.12 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.983 1.278 . . . . 0.0 112.646 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -139.51 15.77 2.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.741 2.016 . . . . 0.0 110.769 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 56.6 ttp -77.0 52.39 0.87 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.609 1.564 . . . . 0.0 112.772 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -171.61 171.48 5.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.521 1.929 . . . . 0.0 112.693 -168.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -65.63 165.63 12.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.501 1.92 . . . . 0.0 112.214 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.86 -37.92 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.16 0.984 . . . . 0.0 112.185 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.33 -30.04 69.26 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -80.52 -43.48 20.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.512 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 m -54.96 -50.01 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 120.551 1.523 . . . . 0.0 113.016 175.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -68.49 -23.98 64.63 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.043 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.18 -59.17 3.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.989 1.316 . . . . 0.0 111.033 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -56.19 -36.83 68.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.133 0.973 . . . . 0.0 113.119 174.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.86 -42.53 73.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.939 0.895 . . . . 0.0 112.707 174.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.49 -47.36 76.92 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.398 -0.814 . . . . 0.0 111.813 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.93 -31.55 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.543 -0.974 . . . . 0.0 113.555 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -55.34 -50.41 69.72 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.727 1.603 . . . . 0.0 111.06 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.8 mt -63.45 -42.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.151 0.98 . . . . 0.0 110.531 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -45.36 92.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.634 1.174 . . . . 0.0 111.467 177.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.62 -48.39 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.079 0.952 . . . . 0.0 111.72 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -67.1 -16.11 64.13 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.284 6.3 pt20 41.93 42.88 2.44 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.868 2.467 . . . . 0.0 113.462 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -98.32 16.28 22.0 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.511 1.524 . . . . 0.0 113.309 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -81.71 160.4 23.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.985 1.314 . . . . 0.0 111.178 169.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -74.45 133.46 42.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.038 -1.039 . . . . 0.0 112.048 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -54.46 -33.66 60.04 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.876 1.67 . . . . 0.0 113.579 171.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -83.82 -27.38 28.8 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.012 1.325 . . . . 0.0 112.422 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.33 95.63 1.95 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.546 1.138 . . . . 0.0 111.655 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -60.51 -14.92 22.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.737 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.38 69.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.629 0.772 . . . . 0.0 112.743 173.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.5 tpp -91.84 130.6 37.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.021 1.729 . . . . 0.0 110.356 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.06 118.09 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.041 1.737 . . . . 0.0 109.764 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.41 162.06 14.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.538 1.135 . . . . 0.0 111.736 171.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -153.88 27.12 0.48 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.065 2.146 . . . . 0.0 112.21 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 118.6 13.08 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.33 -0.856 . . . . 0.0 113.349 -169.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.52 8.61 67.25 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.005 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -98.53 156.1 16.95 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 120.573 2.187 . . . . 0.0 112.272 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.56 -27.62 66.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.713 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 tp -66.84 -44.29 81.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.224 -0.922 . . . . 0.0 112.9 173.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.02 86.12 Favored Glycine 0 N--CA 1.477 1.424 0 CA-C-O 118.151 -1.361 . . . . 0.0 112.411 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.48 -40.03 92.63 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.014 1.907 . . . . 0.0 112.334 170.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -70.32 -51.73 28.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.082 0.953 . . . . 0.0 111.144 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.9 -20.14 61.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 112.198 176.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.73 13.04 82.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.749 1.642 . . . . 0.0 114.686 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -129.31 -25.17 2.73 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 121.63 3.937 . . . . 0.0 121.63 -169.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 55.05 2.85 0.05 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.3 p -157.22 138.3 13.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.837 1.255 . . . . 0.0 112.68 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.89 176.11 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.121 1.768 . . . . 0.0 110.681 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 t -140.5 156.93 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.135 -0.978 . . . . 0.0 111.363 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.08 -18.03 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.668 -0.645 . . . . 0.0 112.446 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.15 -1.89 50.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 113.897 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -137.81 60.58 25.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.889 1.676 . . . . 0.0 111.803 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -79.15 -0.11 10.48 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.946 3.097 . . . . 0.0 113.908 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.2 m -46.82 -32.45 2.11 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.72 -24.57 68.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.157 1.904 . . . . 0.0 114.132 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.82 -47.4 53.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.853 0.861 . . . . 0.0 110.11 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -68.22 -30.52 69.61 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.518 -0.739 . . . . 0.0 112.462 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.54 -31.52 72.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.471 1.032 . . . . 0.0 112.917 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -34.2 73.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.39 1.476 . . . . 0.0 112.099 171.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.65 -33.8 15.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 114.443 -175.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -58.25 -28.36 64.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.206 1.403 . . . . 0.0 113.689 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.15 -27.14 68.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.847 2.059 . . . . 0.0 112.556 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -98.37 -70.0 0.74 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.72 1.208 . . . . 0.0 113.177 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.84 155.29 39.68 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.932 1.693 . . . . 0.0 113.272 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.37 -26.21 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 t 51.07 -178.02 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 129.737 3.215 . . . . 0.0 116.63 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.38 156.91 31.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.96 2.504 . . . . 0.0 109.381 169.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.67 164.77 26.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.098 0.959 . . . . 0.0 113.192 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.241 0.638 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.011 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.2 pt -76.53 162.52 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.9 m120 -85.23 38.41 0.72 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.658 1.583 . . . . 0.0 114.384 -169.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -131.37 -177.65 4.49 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.432 2.293 . . . . 0.0 112.558 -167.475 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' MET . 15.4 m -94.55 172.13 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.528 1.131 . . . . 0.0 110.289 -175.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -162.21 144.14 8.39 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 128.089 2.555 . . . . 0.0 109.001 -172.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 8.5 Cg_endo -98.52 176.27 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.143 2.562 . . . . 0.0 114.705 -169.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -105.83 157.37 17.51 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.674 1.99 . . . . 0.0 107.507 167.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.8 mt -47.37 -46.01 56.93 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.87 -21.74 20.86 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.922 1.748 . . . . 0.0 114.015 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.24 -34.15 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.934 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.5 -41.62 81.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 111.629 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.269 18.3 pttp -72.52 -21.84 61.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.6 mt -69.69 -45.8 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.648 1.179 . . . . 0.0 110.083 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.67 -37.21 86.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.466 -0.771 . . . . 0.0 111.233 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.829 -1.169 . . . . 0.0 113.436 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.43 -22.26 61.22 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 112.99 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.13 22.12 14.59 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.074 1.75 . . . . 0.0 113.543 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 17.55 78.66 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.75 -156.07 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.89 1.276 . . . . 0.0 112.996 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -148.41 67.28 1.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.312 1.845 . . . . 0.0 110.489 169.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.13 -146.62 36.6 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.749 -172.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.48 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 45.4 mt-10 -122.19 15.39 10.62 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.868 2.067 . . . . 0.0 111.958 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 27.6 ttt -79.45 59.15 2.84 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.874 1.27 . . . . 0.0 113.705 -168.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -170.41 177.75 3.96 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.296 1.838 . . . . 0.0 113.719 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.35 165.64 13.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.521 2.328 . . . . 0.0 114.387 -172.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.4 t -52.12 -47.01 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 125.958 1.703 . . . . 0.0 111.843 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -62.52 -30.08 71.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -78.83 -47.93 15.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.067 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -55.88 -45.42 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 120.463 1.483 . . . . 0.0 112.376 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.5 ptm -70.26 -26.28 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -64.61 -59.43 4.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.162 1.385 . . . . 0.0 110.868 171.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -56.41 -36.25 68.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.784 0.834 . . . . 0.0 113.189 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.99 -44.64 88.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.054 0.941 . . . . 0.0 112.343 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.831 0.741 . . . . 0.0 112.249 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.28 11.2 pt20 -70.67 -31.54 68.48 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.392 -1.063 . . . . 0.0 113.087 176.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -55.97 -54.48 44.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.247 1.385 . . . . 0.0 110.496 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.34 -42.25 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.809 0.843 . . . . 0.0 110.146 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -34.93 79.49 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.9 t -78.24 -50.28 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 111.174 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.3 64.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.963 0.905 . . . . 0.0 112.665 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.333 5.8 pt20 46.44 39.44 6.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.667 2.787 . . . . 0.0 114.523 176.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -91.6 51.44 1.87 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.249 1.42 . . . . 0.0 111.42 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -124.97 162.51 24.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.787 2.035 . . . . 0.0 111.376 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.25 138.5 47.52 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.349 -0.844 . . . . 0.0 111.837 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -48.51 79.0 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.06 -1.025 . . . . 0.0 112.864 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -80.93 -6.39 58.64 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.128 0.876 . . . . 0.0 113.031 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.7 86.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.573 1.177 . . . . 0.0 111.365 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.07 -15.42 32.46 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.145 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -22.2 65.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.84 1.256 . . . . 0.0 113.146 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 43.2 tpp -107.24 134.6 50.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.073 2.149 . . . . 0.0 111.143 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.02 133.24 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.996 1.718 . . . . 0.0 110.275 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.41 84.88 2.11 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.301 2.241 . . . . 0.0 110.603 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -80.39 38.59 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.187 2.595 . . . . 0.0 113.451 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 113.03 2.49 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.305 -0.872 . . . . 0.0 114.609 -168.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.59 11.61 77.15 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.057 1.313 . . . . 0.0 116.187 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.93 156.8 20.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.944 1.872 . . . . 0.0 112.366 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.56 -28.06 59.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 112.755 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.23 -37.62 81.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.17 -0.956 . . . . 0.0 112.21 171.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.66 -39.93 98.06 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.415 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -64.83 -38.48 91.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.841 1.321 . . . . 0.0 112.07 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -69.56 -46.48 66.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.258 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.08 -18.64 45.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.816 1.246 . . . . 0.0 113.297 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.01 73.93 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.84 1.686 . . . . 0.0 114.937 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.39 -36.89 0.71 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -169.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 5.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.5 p -145.78 135.53 23.4 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.468 1.485 . . . . 0.0 114.586 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -169.94 168.28 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.717 2.407 . . . . 0.0 109.521 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 p -132.86 171.48 13.86 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.424 -0.797 . . . . 0.0 111.282 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.81 -9.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.261 -0.899 . . . . 0.0 113.378 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -95.05 -25.58 16.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.238 1.415 . . . . 0.0 112.984 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -130.63 70.92 82.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 125.973 1.709 . . . . 0.0 111.907 174.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -88.09 16.31 1.92 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 125.02 3.813 . . . . 0.0 114.853 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.1 p -50.85 -31.01 4.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.3 -31.72 52.37 Favored 'Trans proline' 0 C--N 1.357 0.987 0 CA-C-N 123.959 2.449 . . . . 0.0 114.108 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.4 -49.21 72.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.174 1.39 . . . . 0.0 110.531 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.05 -29.19 57.95 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.366 -0.834 . . . . 0.0 112.452 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.06 -32.96 72.81 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.295 -0.878 . . . . 0.0 113.241 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.3 ttp -68.52 -41.36 80.04 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.267 1.427 . . . . 0.0 110.617 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.04 -48.68 56.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.315 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -58.13 -31.92 67.66 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.92 -26.42 64.14 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.738 2.015 . . . . 0.0 112.917 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -99.36 -93.69 0.26 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 110.55 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.2 tp -78.0 114.76 17.18 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 119.92 1.236 . . . . 0.0 110.213 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -60.08 115.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.604 -0.685 . . . . 0.0 109.749 169.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.8 t -151.85 175.55 12.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.83 0.852 . . . . 0.0 113.087 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.52 158.17 31.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.605 1.562 . . . . 0.0 112.234 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.54 167.44 22.08 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.766 1.226 . . . . 0.0 113.228 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -176.465 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.32 158.22 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.718 2.007 . . . . 0.0 113.243 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -91.58 53.33 2.23 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.184 1.394 . . . . 0.0 112.102 -171.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -163.18 -176.62 4.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.055 2.942 . . . . 0.0 109.159 -168.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.46 171.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 120.987 -1.071 . . . . 0.0 111.818 -169.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -162.67 140.48 6.38 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 129.527 3.131 . . . . 0.0 107.279 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 1.1 Cg_endo -103.57 179.37 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.048 2.499 . . . . 0.0 115.28 -169.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -108.73 158.47 17.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.784 2.433 . . . . 0.0 107.213 167.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -45.24 -47.05 33.51 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 -23.13 30.89 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.058 1.839 . . . . 0.0 114.694 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.19 -35.47 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.376 0.67 . . . . 0.0 111.865 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.47 -41.88 81.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.329 1.052 . . . . 0.0 111.601 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -71.38 -20.44 62.14 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.55 -51.68 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 109.285 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.97 -34.2 76.09 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.605 -0.685 . . . . 0.0 111.753 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -30.7 68.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.892 -1.13 . . . . 0.0 113.188 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.98 60.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.519 0.727 . . . . 0.0 112.869 169.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.77 22.35 15.3 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.195 1.798 . . . . 0.0 113.533 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.64 16.98 78.99 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.644 1.018 . . . . 0.0 115.644 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.73 -156.7 0.16 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.97 1.308 . . . . 0.0 112.729 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.27 59.94 1.55 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.559 1.544 . . . . 0.0 110.364 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.64 -141.7 27.88 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.848 -172.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.491 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.3 mt-10 -121.72 21.33 10.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.799 2.04 . . . . 0.0 112.138 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.5 ptm -74.72 41.17 0.15 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -169.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -166.62 174.48 8.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.707 1.603 . . . . 0.0 113.979 -168.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.66 167.66 16.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.32 2.248 . . . . 0.0 114.236 -169.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -49.15 -43.43 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 126.317 1.847 . . . . 0.0 112.75 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -31.28 70.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -77.76 -46.43 21.74 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.098 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.45 -46.24 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 120.319 1.418 . . . . 0.0 112.586 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.2 ptm -69.46 -28.21 65.9 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.52 -59.04 6.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.618 1.167 . . . . 0.0 110.851 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -55.81 -36.77 67.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 113.386 173.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.17 -36.98 80.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.839 1.199 . . . . 0.0 113.129 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.74 -47.42 90.41 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.927 1.24 . . . . 0.0 112.232 173.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.272 13.4 pt20 -70.22 -31.5 68.95 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.451 -1.029 . . . . 0.0 113.081 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -55.89 -54.5 43.95 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.207 1.367 . . . . 0.0 110.07 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.3 mt -59.03 -39.98 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.931 0.892 . . . . 0.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.8 tpp -69.11 -32.35 71.7 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.23 -51.35 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.028 -1.045 . . . . 0.0 111.344 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -68.08 -12.96 61.79 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.307 1.443 . . . . 0.0 113.064 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.31 5.8 pt20 48.76 50.18 17.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.37 3.068 . . . . 0.0 114.023 169.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.6 mt -88.4 3.91 48.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.531 1.133 . . . . 0.0 113.741 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -89.11 162.2 16.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.455 1.102 . . . . 0.0 113.015 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -78.9 152.3 31.25 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.79 -47.34 63.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -77.7 -17.33 57.76 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -149.61 87.07 1.48 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.059 0.933 . . . . 0.0 111.787 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -55.94 -22.81 28.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.763 1.625 . . . . 0.0 112.44 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.09 -34.35 56.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.301 1.84 . . . . 0.0 112.987 170.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tpt -99.51 135.33 41.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.002 1.721 . . . . 0.0 111.158 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -132.08 136.73 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.025 1.73 . . . . 0.0 110.487 -170.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -105.94 175.0 5.64 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.187 1.795 . . . . 0.0 112.194 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.88 20.24 0.32 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.714 1.606 . . . . 0.0 113.733 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.3 115.75 5.01 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.845 0.736 . . . . 0.0 114.115 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.34 6.97 71.38 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.305 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -96.6 158.81 15.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 121.089 2.445 . . . . 0.0 112.506 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -27.69 68.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.996 0.918 . . . . 0.0 112.13 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.38 -41.57 96.62 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.38 -0.825 . . . . 0.0 111.994 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.22 96.94 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 119.339 0.972 . . . . 0.0 112.654 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -43.89 95.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.479 1.14 . . . . 0.0 111.722 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.73 -46.38 66.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.326 1.05 . . . . 0.0 112.245 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.28 -25.71 63.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.804 1.241 . . . . 0.0 113.035 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 4.67 75.5 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.394 0.997 . . . . 0.0 113.796 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -138.39 141.25 39.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 112.393 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -102.99 7.76 39.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.719 1.208 . . . . 0.0 113.27 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.0 p -155.92 143.42 19.41 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.498 1.119 . . . . 0.0 112.462 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.73 178.7 8.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.117 2.167 . . . . 0.0 110.262 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.7 p -142.98 170.38 15.81 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.649 -1.282 . . . . 0.0 112.969 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.51 -19.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.898 0.879 . . . . 0.0 112.943 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.08 -10.74 29.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.037 1.335 . . . . 0.0 113.803 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -132.61 62.73 64.41 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.832 1.653 . . . . 0.0 112.639 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.08 0.17 9.63 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.106 3.204 . . . . 0.0 114.09 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.6 m -42.77 -39.32 3.55 Favored Pre-proline 0 N--CA 1.472 0.663 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.42 -24.19 71.14 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 123.242 2.194 . . . . 0.0 114.89 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.44 -47.47 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.233 1.378 . . . . 0.0 109.802 170.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.11 -33.0 74.77 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.686 -0.633 . . . . 0.0 111.941 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.34 -31.47 69.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.457 1.026 . . . . 0.0 113.401 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.38 77.63 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.986 1.314 . . . . 0.0 111.234 169.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.6 mt -91.16 -34.92 14.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.357 1.463 . . . . 0.0 114.483 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -28.08 62.92 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.562 1.545 . . . . 0.0 113.692 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.69 -28.14 69.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.743 2.017 . . . . 0.0 112.847 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -108.19 -48.34 3.38 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -122.33 144.85 48.76 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.372 1.469 . . . . 0.0 111.638 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.5 t -81.87 67.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 122.176 0.988 . . . . 0.0 110.691 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.24 -9.68 20.21 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -175.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.3 mt 43.53 -133.2 0.59 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.275 3.03 . . . . 0.0 110.076 -172.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.75 170.39 16.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.949 0.9 . . . . 0.0 113.206 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 124.121 0.969 . . . . 0.0 113.588 -171.948 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 200' ' ' 49H . . . . . 0.416 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.3 pt -96.28 167.96 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.478 1.511 . . . . 0.0 112.76 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -79.34 33.47 0.24 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.671 1.588 . . . . 0.0 114.007 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -128.31 -176.44 3.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.846 2.858 . . . . 0.0 113.085 -167.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.2 172.4 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.269 1.427 . . . . 0.0 109.163 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -164.25 139.93 4.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 130.459 3.503 . . . . 0.0 108.145 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -102.15 164.04 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.123 3.215 . . . . 0.0 113.744 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -82.13 158.78 23.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.585 1.154 . . . . 0.0 108.89 168.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.8 tp -41.79 -49.92 10.26 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.35 -21.55 35.26 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.092 1.862 . . . . 0.0 114.629 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.66 -32.59 16.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.196 0.999 . . . . 0.0 112.422 173.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.8 tt -61.73 -39.02 90.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.28 1.832 . . . . 0.0 112.032 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -72.42 -22.51 61.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -59.14 -52.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.929 1.292 . . . . 0.0 108.978 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 37' ' ' LEU 0.272 0.2 OUTLIER -70.72 -30.49 67.05 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.178 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -60.91 -32.76 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.569 1.532 . . . . 0.0 112.642 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.64 56.43 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.549 1.068 . . . . 0.0 113.434 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.52 19.16 21.04 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.218 1.807 . . . . 0.0 113.807 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 14.27 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.543 1.068 . . . . 0.0 115.495 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.98 -163.51 0.93 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.019 1.328 . . . . 0.0 112.547 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.84 58.1 1.78 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.002 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 -118.79 5.86 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.089 1.328 . . . . 0.0 112.956 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -143.72 17.64 1.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.513 1.925 . . . . 0.0 110.987 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.6 ttp -76.3 49.13 0.56 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.113 1.765 . . . . 0.0 113.128 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -170.02 173.87 5.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.272 1.829 . . . . 0.0 113.42 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 166.11 10.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.103 2.561 . . . . 0.0 113.983 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.1 t -50.95 -46.95 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.414 1.886 . . . . 0.0 112.078 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.57 -30.08 71.1 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -79.0 -46.3 18.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.6 -0.714 . . . . 0.0 110.885 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.69 -45.45 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.257 1.389 . . . . 0.0 112.883 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.4 ptm -68.89 -27.91 66.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -64.37 -59.8 3.93 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 110.987 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -56.79 -35.06 68.27 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.917 0.887 . . . . 0.0 113.216 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.13 -39.43 72.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.086 0.857 . . . . 0.0 112.987 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -47.35 89.04 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 119.316 0.962 . . . . 0.0 111.799 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 12.7 pt20 -69.85 -31.5 69.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.114 -0.945 . . . . 0.0 113.031 174.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.18 -54.08 49.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.822 1.646 . . . . 0.0 110.837 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.13 -44.37 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.595 0.758 . . . . 0.0 110.246 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -33.99 77.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.18 -51.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.339 1.455 . . . . 0.0 111.746 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -66.42 -15.99 63.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.447 0.699 . . . . 0.0 112.423 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.6 pt20 46.97 43.27 13.52 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 128.085 2.554 . . . . 0.0 113.287 172.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.18 18.04 15.86 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.893 1.677 . . . . 0.0 112.847 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -85.91 166.36 16.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.253 1.421 . . . . 0.0 112.799 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.26 135.72 49.23 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.446 -0.784 . . . . 0.0 112.301 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -36.52 44.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.167 1.387 . . . . 0.0 113.365 172.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -91.73 -20.37 21.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.915 1.286 . . . . 0.0 113.021 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -153.55 102.63 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.336 1.054 . . . . 0.0 111.976 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -59.81 -17.42 35.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.924 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -21.55 62.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.67 0.788 . . . . 0.0 113.026 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.6 tpt -96.79 125.57 41.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 109.787 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.7 120.99 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.987 1.315 . . . . 0.0 110.345 -169.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -88.59 165.87 14.52 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.35 1.06 . . . . 0.0 111.422 172.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -151.62 23.85 0.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.478 1.511 . . . . 0.0 113.058 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.2 108.58 2.11 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.311 -0.868 . . . . 0.0 112.732 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 14.13 72.59 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.452 1.025 . . . . 0.0 115.127 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.16 147.64 22.92 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.751 1.775 . . . . 0.0 110.571 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.1 mt -58.51 -27.52 64.57 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.363 -0.836 . . . . 0.0 112.06 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.82 -37.23 85.68 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.303 -0.873 . . . . 0.0 112.525 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.13 -39.03 94.46 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.558 0.617 . . . . 0.0 112.346 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 117.975 0.887 . . . . 0.0 111.607 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.83 -45.77 67.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.519 1.128 . . . . 0.0 113.062 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.25 -19.72 39.05 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 113.494 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.04 8.61 87.22 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.422 1.011 . . . . 0.0 114.754 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.4 154.73 41.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.348 1.459 . . . . 0.0 112.849 172.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.2 11.9 32.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.8 p -157.17 144.59 18.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -155.74 175.82 13.42 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.787 2.035 . . . . 0.0 109.565 172.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 p -149.16 175.29 11.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.347 -1.471 . . . . 0.0 113.226 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.08 -19.95 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.592 0.757 . . . . 0.0 112.098 170.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -90.36 -21.0 22.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.272 1.429 . . . . 0.0 113.495 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -122.33 61.07 14.12 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 126.405 1.882 . . . . 0.0 112.149 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.49 -4.54 10.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.575 2.85 . . . . 0.0 113.84 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -46.53 -35.5 4.96 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.3 -31.79 95.68 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.33 2.02 . . . . 0.0 114.665 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 tt -66.76 -54.87 18.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.202 1.401 . . . . 0.0 109.904 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -61.84 -36.61 81.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.482 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.83 -45.12 91.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.957 0.799 . . . . 0.0 112.411 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ttp -56.15 -39.18 71.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.623 1.569 . . . . 0.0 111.288 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . 0.286 4.5 pp -85.79 -40.79 15.66 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -64.11 -30.57 71.63 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 120.484 1.493 . . . . 0.0 113.485 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -68.32 -22.61 64.69 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.578 0.751 . . . . 0.0 112.525 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -91.15 -75.63 0.47 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -90.61 154.29 19.7 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.88 1.218 . . . . 0.0 113.129 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.07 109.95 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -155.76 -176.95 6.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.312 1.045 . . . . 0.0 112.782 -175.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.5 mt -110.46 159.24 17.67 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.623 1.969 . . . . 0.0 111.663 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.56 169.81 16.96 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.289 1.436 . . . . 0.0 112.441 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -170.582 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 pt -134.42 163.23 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.953 1.701 . . . . 0.0 112.714 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -88.07 32.06 0.77 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.317 1.447 . . . . 0.0 114.753 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -178.7 4.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.639 2.776 . . . . 0.0 111.351 -168.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 46' ' ' MET . 2.2 t -87.74 172.66 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.536 1.534 . . . . 0.0 110.077 -170.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -162.26 144.6 8.54 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 130.211 3.404 . . . . 0.0 108.308 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -104.61 170.47 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -83.26 156.98 22.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.848 1.259 . . . . 0.0 107.895 167.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -50.87 -40.82 67.98 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.84 -23.55 47.71 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.579 2.186 . . . . 0.0 115.08 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.5 mt -92.45 -34.76 13.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.294 1.037 . . . . 0.0 112.027 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.55 -38.26 89.35 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.822 1.649 . . . . 0.0 112.074 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.278 44.3 pttt -70.09 -24.47 63.22 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.68 -53.56 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.439 1.496 . . . . 0.0 109.225 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.3 12.9 mt -70.88 -30.94 67.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -64.4 -32.33 73.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.374 -1.454 . . . . 0.0 112.844 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.43 63.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.447 1.021 . . . . 0.0 113.025 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 25.57 10.78 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.026 1.731 . . . . 0.0 113.375 172.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.15 12.22 81.63 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.75 1.167 . . . . 0.0 115.884 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.17 -169.72 2.67 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 118.714 1.257 . . . . 0.0 113.272 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -125.95 47.95 2.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.787 2.035 . . . . 0.0 110.985 169.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.49 -119.78 5.22 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.98 1.276 . . . . 0.0 112.561 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.02 18.96 3.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.516 1.927 . . . . 0.0 110.853 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 58.7 ttp -75.22 47.1 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.903 2.081 . . . . 0.0 113.067 -170.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -171.82 175.92 3.77 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.312 2.245 . . . . 0.0 112.788 -168.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -74.37 170.31 15.89 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.932 2.093 . . . . 0.0 113.564 -171.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -47.87 -46.55 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 127.01 2.124 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -66.95 -30.13 70.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.31 -45.24 18.19 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.859 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -58.09 -46.1 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.442 1.474 . . . . 0.0 112.763 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.8 ptm -70.02 -26.97 64.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.93 -58.57 6.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.074 1.35 . . . . 0.0 110.766 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -56.73 -36.9 70.26 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.78 -42.86 81.01 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.163 0.892 . . . . 0.0 112.166 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.79 -47.28 89.75 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.843 0.735 . . . . 0.0 112.414 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.254 12.5 pt20 -70.67 -31.65 68.63 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.65 -0.912 . . . . 0.0 112.998 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.11 -51.5 69.44 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.515 1.507 . . . . 0.0 110.833 169.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -57.87 -42.99 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.671 0.789 . . . . 0.0 110.326 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.3 tpp -68.84 -32.0 71.37 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.57 -50.33 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.481 1.112 . . . . 0.0 111.352 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -66.4 -16.08 63.81 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.784 0.834 . . . . 0.0 112.876 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.295 6.5 pt20 45.15 42.86 7.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.191 2.597 . . . . 0.0 113.427 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -99.46 19.87 14.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.653 1.581 . . . . 0.0 112.758 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -84.28 165.45 18.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.61 1.564 . . . . 0.0 111.916 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.91 135.54 48.03 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.243 -0.91 . . . . 0.0 111.913 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -45.28 63.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.244 1.017 . . . . 0.0 113.17 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -81.42 -12.35 58.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.769 0.828 . . . . 0.0 112.488 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.7 93.92 1.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.553 1.141 . . . . 0.0 112.126 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -58.63 -17.62 23.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.721 1.208 . . . . 0.0 112.843 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -26.06 67.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.502 1.121 . . . . 0.0 112.862 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -101.28 130.19 47.38 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.993 1.717 . . . . 0.0 110.918 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.82 133.37 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 110.805 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -111.81 158.46 19.36 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.567 1.547 . . . . 0.0 111.377 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 88' ' ' GLN . 66.7 m -146.67 28.09 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.33 115.17 7.29 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 121.672 -0.642 . . . . 0.0 112.612 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.97 12.82 65.68 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.062 1.315 . . . . 0.0 115.36 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.63 150.06 21.09 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 119.793 1.797 . . . . 0.0 112.014 -175.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.51 -27.74 64.76 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.606 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.46 -39.19 91.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.705 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.68 -37.67 89.31 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.786 -0.571 . . . . 0.0 111.702 173.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -65.63 -37.36 86.35 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 117.984 0.892 . . . . 0.0 112.279 171.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.16 -44.72 79.06 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.008 1.323 . . . . 0.0 112.305 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.65 -18.41 31.38 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.72 5.05 89.53 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.57 1.081 . . . . 0.0 114.38 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -138.76 144.27 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.22 1.808 . . . . 0.0 111.555 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 76' ' ' CYS . 38.5 mt-30 -94.59 6.92 47.41 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.9 p -154.23 149.88 27.46 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 169.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -161.14 176.84 10.86 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.066 2.146 . . . . 0.0 109.734 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.5 p -142.44 171.58 13.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.72 -1.238 . . . . 0.0 112.226 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 m -72.35 -7.24 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.45 -24.82 17.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.195 1.398 . . . . 0.0 112.45 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -129.35 64.56 71.72 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.312 1.845 . . . . 0.0 111.985 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.3 0.04 10.2 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.165 3.243 . . . . 0.0 113.836 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 m -46.29 -34.79 3.64 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -59.47 -28.05 86.53 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.306 2.004 . . . . 0.0 114.941 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tt -68.2 -52.41 34.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.794 1.238 . . . . 0.0 110.405 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -64.92 -36.21 83.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.734 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.76 -31.53 72.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.634 0.773 . . . . 0.0 112.925 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -47.03 83.51 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.247 1.019 . . . . 0.0 111.19 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -92.5 -20.3 21.1 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -62.22 -27.15 68.79 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.943 1.247 . . . . 0.0 112.948 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -65.4 -27.25 68.41 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.051 2.54 . . . . 0.0 112.741 171.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -97.51 -49.37 4.92 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -128.38 144.04 51.08 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.496 1.118 . . . . 0.0 112.654 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -76.68 118.18 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 t -159.67 -177.31 6.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.894 0.877 . . . . 0.0 113.102 -169.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.15 157.39 32.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.268 1.827 . . . . 0.0 112.871 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.33 174.64 12.63 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.635 1.574 . . . . 0.0 112.014 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.595 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 CA--C 1.546 0.793 0 CA-C-O 122.577 1.179 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -172.57 3.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.823 3.249 . . . . 0.0 108.434 -168.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.56 169.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 -168.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -164.75 141.03 4.84 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 130.443 3.497 . . . . 0.0 108.82 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 11.5 Cg_endo -102.7 175.3 0.19 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.897 3.064 . . . . 0.0 113.944 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -97.05 163.44 12.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.524 1.53 . . . . 0.0 110.287 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -42.59 -55.68 6.73 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.95 -21.13 50.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.721 2.281 . . . . 0.0 114.339 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.4 mt -90.63 -33.38 15.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.484 1.114 . . . . 0.0 111.914 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.03 -34.97 72.51 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.978 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -54.84 -35.2 63.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.908 2.083 . . . . 0.0 112.964 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -73.99 -47.5 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.515 1.526 . . . . 0.0 109.675 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.267 2.2 mp -70.75 -30.56 67.1 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.533 -0.729 . . . . 0.0 112.486 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -60.65 -35.95 77.47 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.692 -1.255 . . . . 0.0 112.78 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.16 -21.96 64.26 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.028 0.831 . . . . 0.0 113.218 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.08 17.0 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.057 1.743 . . . . 0.0 113.616 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.19 15.15 76.69 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -85.43 -157.75 0.34 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.869 1.268 . . . . 0.0 112.282 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -136.32 54.21 1.9 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.82 1.648 . . . . 0.0 111.902 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.8 -170.39 40.25 Favored Glycine 0 C--O 1.216 -0.979 0 C-N-CA 124.466 1.032 . . . . 0.0 112.184 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' ' 29' ' ' PRO . 45.9 mt-10 -79.16 18.97 0.59 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.016 1.727 . . . . 0.0 113.808 173.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.9 ttp -74.26 48.65 0.33 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.296 2.238 . . . . 0.0 115.036 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' CZ ' ' CD2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -170.75 177.15 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.971 2.108 . . . . 0.0 112.597 -175.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 164.32 10.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.173 2.189 . . . . 0.0 113.737 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.9 -45.34 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 126.026 1.73 . . . . 0.0 112.533 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -66.96 -30.29 70.38 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -46.2 17.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.361 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 m -58.02 -43.63 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 120.415 1.461 . . . . 0.0 113.348 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.2 ptm -68.08 -25.25 65.24 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.47 -59.65 3.46 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.866 1.267 . . . . 0.0 110.911 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 82.2 m-85 -58.09 -33.55 69.21 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.1 tp -69.17 -41.32 77.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.135 0.879 . . . . 0.0 112.212 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.41 86.14 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 119.237 0.926 . . . . 0.0 112.038 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.259 8.0 pt20 -70.93 -31.6 68.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.483 -1.01 . . . . 0.0 112.969 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -56.9 -54.54 45.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.68 1.127 . . . . 0.0 110.157 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.9 mt -59.83 -39.23 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 118.868 0.758 . . . . 0.0 110.119 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 tpt -65.42 -35.84 82.13 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.38 -50.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.502 1.046 . . . . 0.0 111.17 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -67.46 -15.77 63.85 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.576 1.55 . . . . 0.0 113.179 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 5.0 pt20 46.92 41.88 11.42 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.657 2.783 . . . . 0.0 113.767 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -83.43 54.15 2.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.859 1.664 . . . . 0.0 111.15 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -139.36 167.72 21.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.182 1.393 . . . . 0.0 112.937 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.37 144.01 40.36 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.704 -0.622 . . . . 0.0 111.933 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.15 -46.04 79.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.252 1.021 . . . . 0.0 113.374 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -80.75 -8.85 59.8 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.582 0.753 . . . . 0.0 112.937 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -157.4 86.59 0.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.486 1.136 . . . . 0.0 112.546 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -55.72 -20.47 14.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.198 1.399 . . . . 0.0 112.396 170.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -25.52 67.82 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.067 1.347 . . . . 0.0 113.031 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 tpt -104.72 127.16 52.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.328 1.451 . . . . 0.0 110.798 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 t -110.4 134.38 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.446 1.498 . . . . 0.0 110.456 -170.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -132.72 102.53 5.71 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.111 2.564 . . . . 0.0 110.307 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 98.6 m -97.78 28.88 3.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.496 2.319 . . . . 0.0 113.781 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.83 115.16 6.45 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 121.681 -0.637 . . . . 0.0 112.99 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.22 10.99 75.06 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.288 1.423 . . . . 0.0 115.969 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.2 151.62 19.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 120.241 2.021 . . . . 0.0 112.395 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 mp -57.24 -27.89 62.44 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.824 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.76 -40.15 88.16 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.219 0.918 . . . . 0.0 112.671 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.97 -39.16 96.27 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -65.62 -37.7 87.31 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.889 -0.771 . . . . 0.0 112.464 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.0 tp -66.6 -45.56 78.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.141 1.376 . . . . 0.0 112.296 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.5 -23.04 34.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 113.222 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.35 7.46 86.53 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.856 1.217 . . . . 0.0 114.403 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 147.11 30.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.446 1.899 . . . . 0.0 110.836 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -97.18 9.79 41.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.7 p -152.47 148.38 27.35 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -162.43 176.27 10.66 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.582 2.353 . . . . 0.0 109.764 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.5 p -140.2 168.7 19.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.821 -1.174 . . . . 0.0 112.528 174.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.71 -9.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -95.01 -26.06 16.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.338 1.455 . . . . 0.0 112.456 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -124.06 67.19 42.96 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.434 1.893 . . . . 0.0 112.095 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.05 6.43 5.58 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.287 3.325 . . . . 0.0 114.708 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.5 m -47.41 -34.32 4.69 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -57.75 -26.21 72.29 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.163 2.575 . . . . 0.0 115.884 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.46 -50.55 36.99 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.518 1.054 . . . . 0.0 110.081 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.08 -29.15 68.84 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.332 -0.855 . . . . 0.0 112.561 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.6 -31.35 72.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.152 0.981 . . . . 0.0 112.733 169.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.64 71.57 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.057 1.343 . . . . 0.0 111.835 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.4 mt -83.61 -39.72 19.95 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.096 1.359 . . . . 0.0 113.551 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -56.55 -29.53 62.08 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.6 1.56 . . . . 0.0 113.681 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.53 -28.33 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.347 1.859 . . . . 0.0 112.543 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 123.779 0.832 . . . . 0.0 113.089 175.509 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.39 -178.85 5.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.729 2.812 . . . . 0.0 110.743 -168.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 169.2 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.795 0.438 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -164.72 135.46 3.2 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 128.266 2.626 . . . . 0.0 107.789 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.538 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 10.9 Cg_endo -99.18 176.23 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.9 2.4 . . . . 0.0 114.934 -169.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -104.57 159.72 15.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.595 2.358 . . . . 0.0 106.815 166.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.49 -40.62 77.04 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -67.33 -25.46 42.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.623 2.215 . . . . 0.0 114.246 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.29 -37.17 20.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.215 1.006 . . . . 0.0 111.267 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.72 -31.9 70.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.102 0.961 . . . . 0.0 111.431 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.56 -38.76 72.36 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.61 1.564 . . . . 0.0 112.596 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.6 mt -70.78 -46.73 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.17 1.788 . . . . 0.0 109.552 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.69 -31.41 68.29 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.75 -0.594 . . . . 0.0 112.026 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -65.36 -34.92 79.45 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.468 -1.395 . . . . 0.0 112.979 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.99 64.6 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.19 0.904 . . . . 0.0 112.926 171.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.19 16.78 24.35 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.985 1.714 . . . . 0.0 114.035 172.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.73 15.64 73.69 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.434 1.016 . . . . 0.0 115.549 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -84.4 -162.92 0.72 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.905 1.282 . . . . 0.0 112.311 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -133.47 68.63 1.49 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.724 1.61 . . . . 0.0 111.074 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.37 -144.22 37.04 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.482 0.563 . . . . 0.0 112.583 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.7 mt-10 -125.06 16.45 8.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.55 1.94 . . . . 0.0 112.266 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.8 ttt -79.51 58.28 2.64 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.493 1.117 . . . . 0.0 112.963 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -170.37 175.07 4.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.338 1.855 . . . . 0.0 113.413 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.05 165.23 16.17 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.261 2.224 . . . . 0.0 114.308 -172.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.9 t -47.85 -45.27 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.27 1.828 . . . . 0.0 112.359 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -66.29 -30.57 71.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.62 -47.6 16.79 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.635 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.41 -46.17 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 120.373 1.442 . . . . 0.0 112.676 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -70.63 -27.83 64.36 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.95 -59.7 4.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 110.703 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 54.3 m-85 -55.85 -37.21 68.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.149 0.979 . . . . 0.0 113.548 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.28 -36.72 79.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.844 1.202 . . . . 0.0 113.008 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 -47.37 88.41 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.882 1.219 . . . . 0.0 112.256 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.274 13.3 pt20 -70.91 -31.61 68.29 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.474 -1.015 . . . . 0.0 113.09 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.61 -53.82 49.54 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.562 1.528 . . . . 0.0 110.346 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.25 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.532 1.133 . . . . 0.0 110.382 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttm -69.04 -30.51 68.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.33 -50.84 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.12 0.968 . . . . 0.0 111.239 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.02 -15.94 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.947 0.899 . . . . 0.0 113.239 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.29 6.4 pt20 43.97 44.22 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 128.152 2.581 . . . . 0.0 113.582 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.63 16.53 23.12 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.863 1.665 . . . . 0.0 112.843 -169.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -81.96 165.64 20.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.378 1.471 . . . . 0.0 112.269 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.73 147.98 45.09 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 122.196 0.998 . . . . 0.0 112.989 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.608 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.8 -37.86 76.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.92 1.688 . . . . 0.0 111.483 -176.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -91.33 -20.94 21.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.698 1.599 . . . . 0.0 112.38 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.25 92.02 2.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.365 1.079 . . . . 0.0 112.268 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -57.21 -18.79 17.37 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.419 1.488 . . . . 0.0 112.776 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -24.72 66.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.377 1.071 . . . . 0.0 113.041 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -99.9 133.13 44.73 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.424 1.889 . . . . 0.0 110.776 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.61 132.62 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.543 1.537 . . . . 0.0 110.489 -171.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -113.69 165.71 12.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.871 1.668 . . . . 0.0 110.989 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.7 m -134.8 -25.51 1.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.431 1.093 . . . . 0.0 113.824 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 53.4 31.65 43.54 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.19 13.61 65.74 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.784 1.183 . . . . 0.0 115.758 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -69.3 167.24 16.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.511 1.656 . . . . 0.0 111.904 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.34 -27.99 64.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.648 1.179 . . . . 0.0 112.514 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.11 -41.56 86.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.516 -0.74 . . . . 0.0 112.109 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.73 96.65 Favored Glycine 0 N--CA 1.472 1.04 0 O-C-N 121.696 -0.627 . . . . 0.0 112.215 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.71 -36.86 84.83 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.554 -0.968 . . . . 0.0 112.066 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.41 -43.36 81.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.808 1.243 . . . . 0.0 112.497 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.79 -18.89 42.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.383 1.073 . . . . 0.0 112.975 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.63 -14.22 25.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.985 1.755 . . . . 0.0 113.963 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -125.98 138.74 53.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.762 2.425 . . . . 0.0 108.954 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -98.53 16.3 22.27 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -153.29 146.38 24.62 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.269 -0.894 . . . . 0.0 112.663 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -164.14 174.42 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.528 1.931 . . . . 0.0 110.12 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 p -139.1 171.7 13.92 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.752 -1.218 . . . . 0.0 111.996 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.56 -8.32 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.07 -23.8 17.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.216 1.406 . . . . 0.0 112.574 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -130.38 65.4 75.81 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.49 1.916 . . . . 0.0 111.965 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.1 0.44 9.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.409 3.406 . . . . 0.0 113.888 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.0 m -46.1 -35.35 4.1 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -54.36 -31.21 66.65 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.741 2.294 . . . . 0.0 115.758 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.54 -50.8 33.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.692 1.197 . . . . 0.0 110.488 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -62.89 -37.46 87.04 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.666 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.22 -31.78 72.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 0.0 112.92 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -45.91 90.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.475 1.11 . . . . 0.0 111.117 170.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -93.82 -19.69 20.77 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -27.08 69.09 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.996 1.271 . . . . 0.0 112.904 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.9 -29.94 71.16 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.778 2.431 . . . . 0.0 112.259 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 123.607 0.763 . . . . 0.0 112.826 169.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 CA--C 1.546 0.814 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.67 -178.79 3.91 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.719 2.408 . . . . 0.0 113.981 -167.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 46' ' ' MET . 7.8 t -93.59 172.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.467 1.907 . . . . 0.0 108.941 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -162.44 139.12 6.0 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 129.908 3.283 . . . . 0.0 107.474 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -99.73 168.37 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.514 2.809 . . . . 0.0 113.997 -171.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -86.62 162.81 17.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.014 1.326 . . . . 0.0 110.444 168.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.8 mt -49.18 -48.19 74.19 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.14 -28.61 34.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.2 1.822 . . . . 0.0 113.856 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.23 -37.74 37.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.842 0.747 . . . . 0.0 111.266 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.75 -34.81 73.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.826 1.25 . . . . 0.0 111.169 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -59.28 -40.77 87.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.762 1.225 . . . . 0.0 113.182 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.5 -50.91 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.238 1.415 . . . . 0.0 109.595 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.354 12.5 mt -70.94 -30.37 66.66 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -63.18 -37.91 89.11 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 119.885 -1.76 . . . . 0.0 111.921 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.94 -18.42 65.23 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.794 0.725 . . . . 0.0 112.745 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.03 5.03 46.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.586 1.555 . . . . 0.0 114.332 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.46 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.564 1.078 . . . . 0.0 114.94 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.68 -164.0 1.09 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.432 1.493 . . . . 0.0 112.716 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -124.58 43.18 3.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 110.88 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.19 -113.87 3.76 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.879 -1.138 . . . . 0.0 112.446 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.25 19.29 2.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.555 1.942 . . . . 0.0 111.431 -174.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 28.2 ptm -71.54 38.82 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.585 1.554 . . . . 0.0 115.192 -175.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -166.27 174.78 8.83 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.441 1.897 . . . . 0.0 113.967 -167.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -68.4 168.1 13.32 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.656 2.382 . . . . 0.0 113.628 -172.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -53.01 -43.52 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 126.29 1.836 . . . . 0.0 111.804 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -65.79 -30.06 70.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.47 -46.93 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.014 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.42 -44.8 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 119.929 1.241 . . . . 0.0 112.752 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.9 ptm -71.47 -27.47 63.26 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -61.44 -58.77 6.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.558 1.143 . . . . 0.0 110.395 170.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -56.34 -39.21 72.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.094 0.958 . . . . 0.0 113.253 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.09 -35.02 69.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.624 1.102 . . . . 0.0 112.702 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -47.48 90.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.157 0.89 . . . . 0.0 112.219 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.45 -31.56 71.82 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.419 -1.047 . . . . 0.0 112.378 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -58.53 -53.57 56.81 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.558 1.072 . . . . 0.0 111.654 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -56.25 -42.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.534 0.734 . . . . 0.0 109.983 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.38 -36.14 83.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.25 -48.94 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.06 0.944 . . . . 0.0 111.122 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -66.84 -15.92 63.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.982 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.313 5.3 pt20 46.23 39.63 6.42 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.389 2.676 . . . . 0.0 113.803 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt -84.86 58.23 4.86 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.586 1.554 . . . . 0.0 110.579 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -136.98 168.03 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.172 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.4 135.32 48.64 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.498 -0.751 . . . . 0.0 111.742 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -39.38 25.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.923 1.689 . . . . 0.0 113.867 171.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -90.18 -15.95 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.984 1.313 . . . . 0.0 113.407 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.66 95.03 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.713 1.244 . . . . 0.0 112.396 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -57.75 -18.66 22.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.625 1.57 . . . . 0.0 112.72 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -14.56 61.42 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -110.74 119.86 40.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.602 1.561 . . . . 0.0 110.357 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -96.8 135.01 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.453 1.501 . . . . 0.0 110.555 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -135.75 95.81 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.95 2.5 . . . . 0.0 109.699 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 97.6 m -79.52 -24.03 42.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.104 1.761 . . . . 0.0 114.671 -169.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 50.97 35.74 32.98 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.7 1.143 . . . . 0.0 115.87 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.46 62.54 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.84 158.18 25.8 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.731 1.766 . . . . 0.0 111.441 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.18 -27.84 48.63 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.463 -0.773 . . . . 0.0 112.832 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.1 tp -57.09 -47.98 79.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.899 1.28 . . . . 0.0 111.643 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.79 94.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.834 0.73 . . . . 0.0 112.417 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -65.21 -37.73 88.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.135 0.968 . . . . 0.0 111.992 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.95 -46.87 79.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.17 1.388 . . . . 0.0 111.815 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -79.07 -17.37 55.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.69 -2.3 83.38 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.963 1.268 . . . . 0.0 114.47 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -146.66 142.23 27.66 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 128.084 2.554 . . . . 0.0 109.123 172.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -96.43 12.97 29.42 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.564 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.2 p -147.1 141.33 26.2 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.95 -1.094 . . . . 0.0 112.929 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -164.63 173.38 12.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.214 2.205 . . . . 0.0 109.873 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 p -142.95 175.18 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.087 -1.008 . . . . 0.0 112.624 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.5 m -67.68 -13.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -93.06 -21.94 19.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.713 1.205 . . . . 0.0 113.0 172.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -126.14 60.58 36.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.911 1.684 . . . . 0.0 112.58 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.94 0.3 9.98 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.195 3.263 . . . . 0.0 113.652 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.0 m -45.91 -33.55 2.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 127.079 2.152 . . . . 0.0 116.322 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.24 -29.47 90.42 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.227 1.831 . . . . 0.0 114.769 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.48 -49.34 63.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.263 0.938 . . . . 0.0 110.531 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.54 -34.07 77.38 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.674 -0.641 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -68.52 -31.59 70.95 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -34.46 77.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.341 1.456 . . . . 0.0 111.314 170.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.3 mt -92.89 -37.23 12.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.114 1.366 . . . . 0.0 114.243 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -56.45 -25.92 52.17 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.726 1.611 . . . . 0.0 113.845 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.17 -26.55 63.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.506 1.923 . . . . 0.0 112.636 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 175.221 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m120 . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 122.388 1.09 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.31 -174.68 3.89 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.782 2.833 . . . . 0.0 109.637 -168.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.73 172.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.456 1.502 . . . . 0.0 112.259 -169.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -161.38 145.4 9.88 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 130.652 3.581 . . . . 0.0 108.165 168.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -103.72 172.15 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.834 3.023 . . . . 0.0 114.181 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -86.51 158.57 19.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 108.062 167.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.7 -46.09 71.59 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -66.03 -24.96 51.97 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.711 2.274 . . . . 0.0 114.643 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.37 -35.86 16.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.243 1.017 . . . . 0.0 111.952 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.26 -31.9 72.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.636 1.575 . . . . 0.0 111.36 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -56.17 -38.68 71.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.459 1.504 . . . . 0.0 112.607 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -66.85 -50.9 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.068 1.747 . . . . 0.0 109.417 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.324 12.3 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.748 -0.595 . . . . 0.0 112.571 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -61.81 -33.19 73.68 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.643 -1.285 . . . . 0.0 112.576 169.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.82 -22.61 62.47 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.379 0.99 . . . . 0.0 113.263 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.67 24.45 12.64 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.012 1.725 . . . . 0.0 113.334 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.94 14.02 80.46 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.785 1.183 . . . . 0.0 115.824 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.9 -169.27 2.42 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.46 1.13 . . . . 0.0 113.438 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.53 45.22 2.5 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.69 1.996 . . . . 0.0 110.917 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.71 -119.95 5.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.093 1.33 . . . . 0.0 112.637 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.4 17.04 3.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.557 1.943 . . . . 0.0 110.589 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 58.1 ttp -76.52 50.52 0.67 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.116 1.767 . . . . 0.0 112.889 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -174.37 171.16 3.47 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.438 2.295 . . . . 0.0 112.208 -168.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 168.76 10.83 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.47 1.908 . . . . 0.0 114.092 -171.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.3 t -47.78 -44.14 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.518 1.927 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -67.64 -30.59 70.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -80.46 -44.29 19.46 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.961 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.47 -46.24 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.252 1.387 . . . . 0.0 112.622 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.2 ptm -69.86 -23.96 63.35 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.89 -59.75 3.54 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.975 1.31 . . . . 0.0 110.961 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -56.14 -37.14 69.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.258 1.023 . . . . 0.0 113.281 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tt -72.57 -38.07 68.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.897 0.879 . . . . 0.0 111.623 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.09 -47.4 87.83 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.898 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.257 13.7 pt20 -69.91 -31.54 69.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.416 -1.049 . . . . 0.0 112.873 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CD1' HD22 ' A' ' 81' ' ' LEU . 12.5 t80 -55.66 -51.51 67.01 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.442 1.473 . . . . 0.0 110.457 169.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.2 mt -58.12 -44.89 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.999 0.92 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.0 ttm -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.62 -51.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.36 1.064 . . . . 0.0 111.355 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 -15.97 64.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.92 0.888 . . . . 0.0 113.282 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.3 pt20 43.79 43.51 5.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 128.164 2.585 . . . . 0.0 113.483 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -99.67 23.19 9.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.818 1.647 . . . . 0.0 112.9 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -87.01 163.69 16.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.707 1.603 . . . . 0.0 111.337 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -75.13 134.55 41.25 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.157 -0.964 . . . . 0.0 111.904 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -35.72 61.64 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.637 1.575 . . . . 0.0 113.515 171.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -82.2 -26.6 33.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 112.398 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.7 93.9 1.92 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 122.425 1.107 . . . . 0.0 111.558 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -58.87 -17.68 26.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 112.606 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.06 69.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.249 1.02 . . . . 0.0 112.913 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.3 tpt -98.4 133.06 43.32 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.981 1.712 . . . . 0.0 110.962 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.0 t -125.83 131.83 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.073 1.349 . . . . 0.0 110.957 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -108.51 163.51 13.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.575 1.55 . . . . 0.0 111.795 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 m -145.24 29.69 1.16 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.872 2.069 . . . . 0.0 111.489 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.47 113.44 3.81 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 121.612 -0.68 . . . . 0.0 114.048 -169.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.74 11.76 66.4 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.07 -1.406 . . . . 0.0 115.775 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -100.04 159.18 15.29 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 120.421 2.111 . . . . 0.0 111.99 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.34 -28.04 68.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.093 0.957 . . . . 0.0 111.863 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.4 HD22 ' CD1' ' A' ' 59' ' ' TYR . 46.9 tp -67.2 -37.88 84.39 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.339 -0.85 . . . . 0.0 112.38 171.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.43 -39.24 94.06 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.839 -0.538 . . . . 0.0 111.891 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -65.0 -36.95 86.04 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.795 -0.827 . . . . 0.0 112.138 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.04 -43.57 82.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.665 1.186 . . . . 0.0 112.395 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.78 -21.51 37.73 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.2 -0.31 89.39 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.629 1.109 . . . . 0.0 114.583 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -145.75 156.11 43.39 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.128 1.771 . . . . 0.0 111.897 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -99.55 16.32 23.71 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.0 p -153.57 152.93 31.47 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 169.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -163.12 179.54 7.41 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.62 2.368 . . . . 0.0 109.58 170.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 p -145.26 171.2 14.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.294 -1.504 . . . . 0.0 112.705 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.0 m -73.49 -6.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -95.11 -28.39 15.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.331 . . . . 0.0 112.345 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -128.71 70.62 80.7 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.287 1.835 . . . . 0.0 111.498 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.82 1.62 8.69 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.334 3.356 . . . . 0.0 113.527 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -45.47 -34.46 2.45 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.935 2.094 . . . . 0.0 115.924 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.59 -26.41 80.45 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.362 2.041 . . . . 0.0 114.876 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.34 -46.03 57.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.191 0.905 . . . . 0.0 110.424 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -67.15 -31.68 72.28 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.518 -0.739 . . . . 0.0 112.404 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.68 -31.59 71.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.177 0.899 . . . . 0.0 112.798 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -36.38 81.9 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.076 1.35 . . . . 0.0 111.6 169.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.7 -39.77 15.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.002 1.321 . . . . 0.0 114.233 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -57.71 -28.36 63.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.416 1.486 . . . . 0.0 113.787 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -71.0 -26.69 63.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.855 2.062 . . . . 0.0 112.735 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 m120 . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.604 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.8 -178.23 4.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.427 2.691 . . . . 0.0 113.647 -167.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -92.29 172.16 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.448 1.499 . . . . 0.0 109.99 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -159.94 141.83 9.58 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 130.723 3.609 . . . . 0.0 108.708 169.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 28.0 Cg_endo -99.38 169.58 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.892 3.062 . . . . 0.0 113.858 -175.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -82.88 160.44 22.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.983 1.313 . . . . 0.0 109.177 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.36 -47.75 67.57 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.42 -28.1 33.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 CA-C-N 122.299 1.857 . . . . 0.0 113.339 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.35 -35.66 54.43 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.282 -0.886 . . . . 0.0 111.568 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.3 -35.03 76.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.994 1.318 . . . . 0.0 110.951 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -59.73 -43.22 94.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.547 1.539 . . . . 0.0 112.648 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.0 mt -59.25 -52.87 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 109.492 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.347 11.1 mt -70.79 -30.5 66.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -61.45 -33.82 74.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.689 -1.257 . . . . 0.0 112.417 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.88 -21.78 61.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.299 0.954 . . . . 0.0 113.456 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.54 24.02 13.67 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.773 1.629 . . . . 0.0 113.517 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.87 15.03 78.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.552 1.072 . . . . 0.0 115.743 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.16 -166.86 1.46 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.672 1.189 . . . . 0.0 112.932 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -125.44 48.29 2.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.621 1.969 . . . . 0.0 110.587 169.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.29 -116.55 5.26 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.086 1.327 . . . . 0.0 113.107 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 40.7 mt-10 -139.08 19.95 2.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.066 2.146 . . . . 0.0 110.954 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 58.0 ttp -78.08 47.59 0.67 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.4 1.48 . . . . 0.0 112.924 -172.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -170.58 175.6 4.62 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.111 1.764 . . . . 0.0 113.635 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.55 167.08 11.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.508 2.323 . . . . 0.0 113.721 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.4 -43.27 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.245 1.818 . . . . 0.0 111.804 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -64.34 -30.07 71.13 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -79.97 -48.17 13.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.932 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -55.34 -44.44 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.025 1.284 . . . . 0.0 112.788 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -71.31 -28.65 64.25 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.74 -59.37 5.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 110.874 170.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -55.51 -36.05 66.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.233 1.013 . . . . 0.0 113.592 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.52 -39.07 74.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.63 1.104 . . . . 0.0 113.383 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.71 -47.27 79.18 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 119.697 1.135 . . . . 0.0 112.134 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.01 -31.61 66.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.457 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.1 -51.53 68.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.887 1.676 . . . . 0.0 110.78 169.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -58.52 -44.25 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.952 0.901 . . . . 0.0 110.379 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 36.5 tpp -66.67 -31.6 72.38 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -74.39 -49.38 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.693 1.197 . . . . 0.0 111.414 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -66.02 -16.13 63.64 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.5 pt20 43.35 42.72 3.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.153 2.581 . . . . 0.0 113.259 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -100.65 22.04 12.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.895 1.678 . . . . 0.0 112.66 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -88.29 165.53 14.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.644 1.578 . . . . 0.0 112.069 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -71.21 138.36 49.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.228 -0.92 . . . . 0.0 112.13 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -38.4 51.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.244 1.418 . . . . 0.0 113.482 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -98.69 -16.56 18.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.0 1.32 . . . . 0.0 113.709 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.11 94.34 2.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.786 1.234 . . . . 0.0 109.768 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -63.89 -14.12 50.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.165 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.09 -19.74 61.1 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -96.77 128.08 43.37 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.254 1.822 . . . . 0.0 109.858 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.77 131.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.676 1.59 . . . . 0.0 110.921 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -104.45 161.87 13.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.258 1.423 . . . . 0.0 110.992 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.5 m -145.95 29.57 1.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.515 1.926 . . . . 0.0 111.812 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.89 114.31 6.64 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.357 -0.839 . . . . 0.0 112.339 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.11 72.02 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.001 1.286 . . . . 0.0 115.435 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -96.41 146.45 24.75 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.01 1.905 . . . . 0.0 110.826 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.12 -27.66 62.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.419 0.688 . . . . 0.0 112.477 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.6 tp -65.69 -38.83 90.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.679 0.792 . . . . 0.0 112.581 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.87 -39.56 93.43 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 121.409 -0.807 . . . . 0.0 111.781 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -63.54 -37.32 86.87 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 117.714 0.757 . . . . 0.0 112.005 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.92 -46.02 63.22 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.091 1.357 . . . . 0.0 112.695 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.21 -21.4 53.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.068 0.947 . . . . 0.0 113.052 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 1.07 90.37 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.701 1.143 . . . . 0.0 114.394 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -144.76 148.66 34.37 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.337 1.855 . . . . 0.0 111.458 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.82 12.24 32.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.457 1.103 . . . . 0.0 113.423 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -151.98 146.43 25.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -160.31 176.82 11.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.042 2.137 . . . . 0.0 110.15 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 p -147.59 173.86 12.31 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.543 -1.348 . . . . 0.0 113.166 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.62 -21.12 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.872 0.869 . . . . 0.0 111.732 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -88.88 -28.89 20.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.101 1.36 . . . . 0.0 113.008 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -121.02 65.55 13.64 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.298 1.839 . . . . 0.0 112.207 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.0 -0.9 10.22 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.969 3.113 . . . . 0.0 113.725 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -47.31 -34.37 4.56 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -58.84 -32.15 96.67 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.369 2.046 . . . . 0.0 114.645 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -64.95 -48.32 74.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.176 0.99 . . . . 0.0 110.623 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -69.12 -31.35 69.98 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.427 -0.796 . . . . 0.0 111.922 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.83 -33.05 71.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.097 0.862 . . . . 0.0 113.08 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -64.51 -39.69 94.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.892 1.277 . . . . 0.0 110.271 169.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.0 mt -82.65 -42.43 18.17 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -56.53 -28.48 60.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.686 1.194 . . . . 0.0 113.868 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.99 -26.58 63.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.91 2.084 . . . . 0.0 112.977 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 CA--C 1.551 0.982 0 C-N-CA 124.561 1.145 . . . . 0.0 112.762 173.845 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 122.432 1.11 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.23 -160.14 0.58 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 129.229 3.012 . . . . 0.0 108.656 -168.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.29 172.33 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.497 1.519 . . . . 0.0 110.512 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -160.7 137.97 6.79 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 131.177 3.791 . . . . 0.0 106.867 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 29.4 Cg_endo -101.05 168.71 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.197 2.598 . . . . 0.0 114.432 -170.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.41 159.14 23.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.085 1.354 . . . . 0.0 108.2 167.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -53.11 -39.58 72.09 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -65.3 -29.97 54.38 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.42 2.08 . . . . 0.0 114.109 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.86 -36.65 27.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.508 1.123 . . . . 0.0 111.333 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.87 -45.77 93.26 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.077 1.351 . . . . 0.0 111.207 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 38.0 pttt -70.54 -26.15 63.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.41 -54.39 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.478 1.111 . . . . 0.0 108.765 169.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.251 35.0 mt -70.93 -30.77 67.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.77 0.828 . . . . 0.0 112.32 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -34.1 77.54 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.702 -1.249 . . . . 0.0 113.017 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.49 64.45 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -102.84 22.92 12.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.01 1.724 . . . . 0.0 113.549 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.35 80.85 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.512 1.053 . . . . 0.0 115.721 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.89 -164.61 0.76 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.449 1.125 . . . . 0.0 113.074 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -130.44 48.65 2.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 127.194 2.197 . . . . 0.0 109.193 168.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 -111.77 3.79 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.361 1.458 . . . . 0.0 113.276 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 38.5 mt-10 -139.07 16.78 2.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.588 1.955 . . . . 0.0 111.594 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -75.97 49.83 0.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.515 1.526 . . . . 0.0 113.235 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -173.2 172.12 3.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.461 2.305 . . . . 0.0 112.481 -169.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.38 167.35 16.7 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.121 2.168 . . . . 0.0 114.139 -171.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.78 -43.29 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.779 2.032 . . . . 0.0 112.31 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.54 -30.14 70.38 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -80.54 -46.41 15.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.4 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.17 -44.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 120.03 1.287 . . . . 0.0 112.684 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.04 -28.51 66.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.46 -58.25 7.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.964 171.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -56.69 -37.0 70.27 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.57 -41.73 75.45 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.15 0.886 . . . . 0.0 111.46 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.92 -47.48 88.64 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 112.907 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -70.51 -31.58 68.73 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.527 -0.984 . . . . 0.0 112.598 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -58.19 -52.1 66.96 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.887 1.222 . . . . 0.0 110.964 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -53.68 -46.29 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.045 0.839 . . . . 0.0 109.711 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -33.88 76.06 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.18 -47.42 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.302 1.041 . . . . 0.0 110.883 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -66.69 -11.24 53.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.046 0.938 . . . . 0.0 112.944 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.336 3.0 pt20 46.66 45.55 14.46 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 129.655 3.182 . . . . 0.0 113.311 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.08 58.21 4.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.245 1.418 . . . . 0.0 110.982 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -143.55 164.84 29.25 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.003 1.321 . . . . 0.0 112.574 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -72.86 135.58 45.18 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.649 -0.657 . . . . 0.0 111.721 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -40.23 36.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.162 1.385 . . . . 0.0 113.037 171.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -89.14 -19.16 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.227 1.411 . . . . 0.0 113.094 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -152.69 94.83 1.93 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.404 1.097 . . . . 0.0 111.742 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.92 -17.84 28.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.131 1.372 . . . . 0.0 112.636 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -21.57 65.45 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.091 0.957 . . . . 0.0 112.973 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.5 tpt -104.65 124.1 48.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.303 1.841 . . . . 0.0 110.73 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.96 138.17 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.127 1.771 . . . . 0.0 110.282 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -135.14 94.72 3.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.288 2.235 . . . . 0.0 110.535 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -88.53 30.69 0.88 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.67 2.788 . . . . 0.0 113.472 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.88 116.52 9.15 Favored Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 112.671 -170.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.86 11.3 78.19 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.364 1.459 . . . . 0.0 115.737 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.06 147.93 22.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.363 2.081 . . . . 0.0 111.792 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.99 -27.59 63.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.5 tp -65.93 -43.24 88.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.998 0.919 . . . . 0.0 112.694 171.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.24 -38.31 95.0 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 118.993 0.815 . . . . 0.0 111.719 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -65.07 -38.0 89.36 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.925 -0.75 . . . . 0.0 111.793 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.33 -48.87 63.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.071 0.948 . . . . 0.0 112.399 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.35 -20.35 61.48 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 112.701 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.93 -0.21 89.85 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.732 1.158 . . . . 0.0 114.075 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -145.6 145.29 30.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.38 1.872 . . . . 0.0 111.316 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.99 2.69 55.38 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.413 1.085 . . . . 0.0 113.086 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.5 p -147.39 140.23 24.94 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -160.65 176.48 11.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.959 2.503 . . . . 0.0 109.155 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.6 p -144.19 174.98 10.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.852 -1.155 . . . . 0.0 112.164 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.97 -8.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 169.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.04 -22.84 17.65 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.323 1.449 . . . . 0.0 113.139 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -124.22 62.14 28.87 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 126.116 1.766 . . . . 0.0 112.012 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.2 2.5 7.95 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.053 3.169 . . . . 0.0 114.258 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 m -46.85 -34.68 4.19 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -33.58 97.02 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 122.989 2.103 . . . . 0.0 114.679 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tp -57.78 -56.88 16.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 123.022 1.392 . . . . 0.0 110.219 171.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -70.49 -29.2 65.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.455 -0.778 . . . . 0.0 112.035 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.04 -31.51 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.6 1.091 . . . . 0.0 113.193 173.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.6 ttp -68.41 -37.11 80.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.363 1.065 . . . . 0.0 110.773 169.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.07 -31.48 18.02 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -29.3 65.16 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.463 1.505 . . . . 0.0 113.361 175.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.83 -29.0 70.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.273 1.829 . . . . 0.0 112.473 172.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.18 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -125.94 -175.64 3.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.304 2.642 . . . . 0.0 113.671 -166.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 28' ' ' ARG . 6.3 t -92.2 172.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.813 1.645 . . . . 0.0 109.298 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 27' ' ' VAL . 1.1 tmt_? -164.24 131.98 2.56 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 129.831 3.253 . . . . 0.0 107.15 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -96.59 174.27 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.974 2.449 . . . . 0.0 115.466 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -98.88 160.35 14.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.42 2.288 . . . . 0.0 107.516 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -53.39 -38.81 66.03 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -69.09 -32.53 21.15 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.21 1.94 . . . . 0.0 113.593 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.26 -37.32 61.02 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 111.037 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.74 -40.18 91.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.877 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -53.8 -42.61 68.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.706 1.202 . . . . 0.0 113.329 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -64.18 -50.11 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.565 1.546 . . . . 0.0 109.937 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.36 -37.39 80.41 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.645 -0.659 . . . . 0.0 111.167 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -71.37 -30.63 66.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.886 -1.134 . . . . 0.0 113.404 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.33 -22.7 54.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.495 0.718 . . . . 0.0 112.874 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.14 25.37 11.08 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.959 1.704 . . . . 0.0 113.563 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.48 17.33 79.82 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.36 -161.2 0.3 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.947 1.299 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -132.67 48.65 2.39 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.022 1.729 . . . . 0.0 110.746 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.16 -119.6 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.178 0.894 . . . . 0.0 112.66 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -141.39 19.62 2.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.891 1.677 . . . . 0.0 112.624 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 27.3 ttt -77.64 47.55 0.61 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.1 1.36 . . . . 0.0 112.783 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -168.73 174.47 6.6 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.417 1.887 . . . . 0.0 113.157 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.62 164.97 10.94 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.783 2.433 . . . . 0.0 113.91 -171.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.21 -42.42 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 126.017 1.727 . . . . 0.0 111.874 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.7 -30.19 71.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -79.18 -48.23 14.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.965 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.94 -47.01 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 119.699 1.136 . . . . 0.0 112.066 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -71.49 -23.84 61.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.06 -59.64 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.35 0.977 . . . . 0.0 110.659 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -55.99 -40.72 73.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.873 1.269 . . . . 0.0 113.298 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 tt -73.29 -32.29 64.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.365 1.066 . . . . 0.0 111.515 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.9 -47.31 89.88 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.696 -1.253 . . . . 0.0 112.736 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.01 -31.59 72.24 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.414 -1.05 . . . . 0.0 112.375 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.85 -54.44 47.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.838 1.199 . . . . 0.0 111.077 169.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -52.89 -42.96 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.342 0.974 . . . . 0.0 110.292 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.2 tpp -70.45 -35.27 73.24 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.26 -47.57 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.505 1.122 . . . . 0.0 111.341 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -65.0 -12.1 46.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.502 1.121 . . . . 0.0 112.745 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.33 3.9 pt20 47.92 46.13 18.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 129.407 3.083 . . . . 0.0 113.149 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.22 56.79 4.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.368 1.467 . . . . 0.0 110.887 -171.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.86 166.97 24.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.843 1.257 . . . . 0.0 112.747 -173.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -73.52 148.63 42.89 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.146 0.974 . . . . 0.0 113.279 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.609 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.43 -35.99 76.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.974 1.71 . . . . 0.0 111.716 -176.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -93.1 -20.75 20.2 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.554 1.542 . . . . 0.0 112.335 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -145.95 94.96 2.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.195 0.998 . . . . 0.0 112.69 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -59.01 -17.96 29.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.815 1.246 . . . . 0.0 112.896 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -22.26 66.57 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.339 1.055 . . . . 0.0 112.913 174.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.4 tpt -102.12 128.77 48.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.578 1.551 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.9 t -108.92 134.48 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.876 1.671 . . . . 0.0 110.6 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -136.67 96.93 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 110.468 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.5 m -89.55 27.51 1.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 128.35 2.66 . . . . 0.0 113.686 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.39 118.89 14.9 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.486 -0.759 . . . . 0.0 113.064 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.69 8.97 82.38 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.285 1.421 . . . . 0.0 115.719 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.32 149.2 21.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.132 1.966 . . . . 0.0 112.025 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.3 tp -59.18 -27.8 66.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.529 1.131 . . . . 0.0 111.291 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.1 tp -63.95 -48.98 74.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.326 1.05 . . . . 0.0 111.895 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.48 -37.46 93.77 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 118.621 0.646 . . . . 0.0 112.376 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -64.15 -37.34 87.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.85 0.86 . . . . 0.0 112.006 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.13 -45.96 53.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.876 0.871 . . . . 0.0 112.019 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.43 -28.68 69.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.046 0.938 . . . . 0.0 112.639 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 0.46 89.0 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.559 1.076 . . . . 0.0 114.024 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.66 147.81 32.39 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.847 1.659 . . . . 0.0 111.768 170.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -100.19 5.66 44.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.763 1.225 . . . . 0.0 113.06 -171.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -147.59 145.51 29.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -164.29 -177.37 4.9 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.17 2.588 . . . . 0.0 109.308 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 p -137.36 170.72 15.61 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.682 -1.261 . . . . 0.0 112.331 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.26 -15.69 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -94.37 -18.91 21.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -131.34 63.89 71.4 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.48 1.512 . . . . 0.0 112.587 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.78 13.98 1.99 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 125.11 3.873 . . . . 0.0 114.564 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.1 p -50.67 -27.62 1.61 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 117.648 2.462 . . . . 0.0 117.648 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -60.81 -27.84 85.46 Favored 'Trans proline' 0 C--N 1.357 1.012 0 CA-C-N 123.898 2.428 . . . . 0.0 114.437 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.41 -48.72 66.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.609 0.719 . . . . 0.0 110.297 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -66.85 -30.74 71.0 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.557 -0.714 . . . . 0.0 112.02 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -68.13 -31.63 71.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.293 1.037 . . . . 0.0 112.988 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -35.68 75.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.353 1.461 . . . . 0.0 111.197 169.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -88.33 -36.44 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -58.67 -27.34 64.71 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.071 1.749 . . . . 0.0 114.351 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -71.15 -26.17 62.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.465 1.906 . . . . 0.0 112.593 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 125.442 1.497 . . . . 0.0 112.915 -179.472 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.7 m120 . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -129.2 -174.88 3.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.492 2.317 . . . . 0.0 112.697 -167.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.14 172.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 0.0 109.102 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -165.08 131.3 2.15 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 128.766 2.826 . . . . 0.0 108.24 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -104.11 174.57 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.995 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -106.79 167.7 9.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.782 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -42.15 -53.79 8.21 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.67 -27.56 45.05 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.494 2.129 . . . . 0.0 114.293 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.8 mt -84.39 -34.29 23.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.511 0.725 . . . . 0.0 112.101 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.29 -35.39 77.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.132 0.973 . . . . 0.0 110.957 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -39.35 73.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.9 1.28 . . . . 0.0 112.627 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -63.41 -54.37 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.464 1.505 . . . . 0.0 109.251 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.282 4.7 mp -70.77 -30.36 66.83 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.332 -0.855 . . . . 0.0 113.156 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -35.49 78.33 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.434 -1.416 . . . . 0.0 112.901 169.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.13 -21.15 64.8 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.175 0.898 . . . . 0.0 112.853 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.68 18.72 19.66 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.402 1.881 . . . . 0.0 113.715 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.11 15.5 76.6 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -82.71 -165.55 1.08 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.795 1.238 . . . . 0.0 112.734 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -131.5 56.73 1.79 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.968 1.707 . . . . 0.0 111.318 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.78 -126.17 7.32 Favored Glycine 0 C--O 1.218 -0.86 0 C-N-CA 124.32 0.962 . . . . 0.0 112.134 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -141.62 11.26 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.825 2.05 . . . . 0.0 111.716 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.5 ttt -76.12 54.56 0.87 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.39 1.476 . . . . 0.0 113.445 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -170.65 171.42 6.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.582 1.953 . . . . 0.0 113.037 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 164.84 7.4 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.176 2.19 . . . . 0.0 114.309 -169.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -51.52 -45.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 126.089 1.756 . . . . 0.0 111.929 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.88 -30.11 71.23 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.23 -47.82 15.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.02 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.0 -45.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 120.027 1.285 . . . . 0.0 112.688 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.7 ptm -70.64 -25.28 62.94 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -64.97 -57.85 7.66 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.969 1.307 . . . . 0.0 110.809 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 61.2 m-85 -55.94 -35.85 67.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.918 0.887 . . . . 0.0 113.071 173.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tt -71.34 -38.58 71.64 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.245 -0.91 . . . . 0.0 112.155 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.57 -47.47 88.1 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 120.848 -1.158 . . . . 0.0 112.589 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.302 11.2 pt20 -70.24 -31.45 68.86 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.997 . . . . 0.0 112.719 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -55.68 -50.43 70.3 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.558 1.526 . . . . 0.0 111.6 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -57.11 -47.23 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.605 0.762 . . . . 0.0 109.762 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.63 71.65 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -73.48 -50.19 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.142 1.377 . . . . 0.0 111.312 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.31 -15.94 63.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.895 0.878 . . . . 0.0 112.9 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.288 6.2 pt20 43.55 43.53 4.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.72 2.808 . . . . 0.0 113.348 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -103.77 33.23 3.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 112.656 -169.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -99.87 165.44 11.56 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.188 1.795 . . . . 0.0 111.821 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.81 135.76 50.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.341 -0.85 . . . . 0.0 111.967 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.51 -45.54 62.91 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.304 1.042 . . . . 0.0 113.186 169.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -80.85 -13.94 58.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 112.497 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.17 98.28 1.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 112.282 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -59.28 -17.56 29.84 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.541 1.137 . . . . 0.0 112.867 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -20.4 62.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.254 1.421 . . . . 0.0 110.456 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.23 140.41 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.384 1.474 . . . . 0.0 111.489 -169.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.35 165.72 14.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.973 2.109 . . . . 0.0 111.178 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.4 m -139.51 -29.57 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.745 1.218 . . . . 0.0 114.15 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 52.72 -126.02 31.19 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.154 0.888 . . . . 0.0 111.878 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.05 14.2 50.46 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.78 150.71 45.59 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.676 2.238 . . . . 0.0 112.475 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.09 -27.85 35.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.452 1.101 . . . . 0.0 112.086 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 tp -65.69 -44.88 84.84 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.661 0.784 . . . . 0.0 112.256 173.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 118.773 0.715 . . . . 0.0 111.932 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -64.51 -37.69 88.41 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 117.683 0.742 . . . . 0.0 112.069 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.8 tp -70.63 -46.13 63.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.741 1.216 . . . . 0.0 112.484 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.85 -28.72 64.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.217 1.007 . . . . 0.0 113.06 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.13 -0.45 73.47 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 123.903 0.763 . . . . 0.0 113.396 -169.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -135.05 137.34 42.83 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 128.245 2.618 . . . . 0.0 109.624 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -103.52 11.83 35.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.783 0.833 . . . . 0.0 113.011 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.5 p -153.84 140.66 19.11 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.683 1.193 . . . . 0.0 111.624 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -162.61 175.34 11.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.41 1.884 . . . . 0.0 110.15 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.4 p -143.89 173.83 11.36 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.899 -1.125 . . . . 0.0 113.342 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.02 -20.84 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.107 0.963 . . . . 0.0 112.132 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.2 -19.39 21.49 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.88 1.272 . . . . 0.0 113.644 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -128.59 63.38 64.61 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.976 1.71 . . . . 0.0 112.402 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.56 -2.05 11.3 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.171 3.248 . . . . 0.0 113.783 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.1 m -41.91 -43.36 6.65 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -23.31 70.7 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 122.925 2.08 . . . . 0.0 114.465 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.67 -51.95 50.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.518 1.054 . . . . 0.0 110.147 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -62.87 -37.7 87.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.442 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.01 -31.54 72.83 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 173.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.3 -47.91 80.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.873 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.29 -21.86 21.87 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -63.75 -25.04 68.01 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.8 1.182 . . . . 0.0 113.27 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -70.05 -25.94 63.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.467 2.307 . . . . 0.0 112.549 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.571 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 N--CA 1.475 0.804 0 CA-C-O 122.344 1.068 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.38 -176.91 5.0 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.006 2.922 . . . . 0.0 109.818 -171.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.33 172.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.888 0.875 . . . . 0.0 111.869 -169.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -162.14 134.12 4.09 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 128.903 2.881 . . . . 0.0 107.588 172.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 8.8 Cg_endo -98.66 -178.61 0.27 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.212 2.608 . . . . 0.0 114.574 -169.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -120.65 165.77 14.6 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.301 2.24 . . . . 0.0 108.651 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -39.59 -57.81 2.3 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.467 1.907 . . . . 0.0 116.136 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.83 -25.23 33.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.467 2.111 . . . . 0.0 114.109 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.08 -39.15 23.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.813 0.845 . . . . 0.0 111.065 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.22 -31.58 70.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.678 1.191 . . . . 0.0 111.662 170.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -58.86 -37.62 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.121 1.368 . . . . 0.0 112.787 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.25 -42.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.484 1.514 . . . . 0.0 110.14 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.59 -30.82 67.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.797 -0.564 . . . . 0.0 111.964 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -65.85 -37.13 85.37 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.964 -1.71 . . . . 0.0 112.164 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.65 -22.56 67.01 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.883 0.765 . . . . 0.0 112.435 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.4 2.58 39.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.144 1.378 . . . . 0.0 114.183 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.78 17.31 79.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.492 1.044 . . . . 0.0 114.998 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -90.27 -166.72 1.65 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.602 1.561 . . . . 0.0 112.792 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.38 65.67 1.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.911 1.684 . . . . 0.0 111.101 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.12 -138.81 23.27 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.732 0.682 . . . . 0.0 112.83 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 45.6 mt-10 -131.79 18.06 4.69 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.393 1.877 . . . . 0.0 112.29 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.94 52.64 1.28 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.466 1.506 . . . . 0.0 112.345 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -169.62 170.16 8.25 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.368 1.867 . . . . 0.0 113.209 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.38 165.49 14.09 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.358 2.263 . . . . 0.0 114.663 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -50.83 -44.54 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 126.243 1.817 . . . . 0.0 112.152 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.76 -30.08 71.08 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.09 -48.62 14.01 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.022 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -55.34 -44.96 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 120.194 1.361 . . . . 0.0 112.506 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 14.4 ptm -72.27 -24.95 61.43 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.07 10.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.713 1.205 . . . . 0.0 110.313 169.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 62.7 m-85 -55.56 -42.31 74.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.077 0.951 . . . . 0.0 112.907 173.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.13 -38.0 89.49 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.04 1.291 . . . . 0.0 112.609 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.25 -47.43 89.5 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 119.487 1.04 . . . . 0.0 112.894 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.44 -31.67 67.47 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.548 -0.972 . . . . 0.0 112.873 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.08 -53.63 55.88 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.928 1.24 . . . . 0.0 110.29 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.7 mt -57.72 -42.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.677 0.791 . . . . 0.0 110.192 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.75 -32.22 73.64 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.13 -50.38 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.661 1.185 . . . . 0.0 111.495 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.08 -15.89 64.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.072 1.349 . . . . 0.0 113.11 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.304 6.1 pt20 46.77 43.44 13.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.625 2.77 . . . . 0.0 114.117 172.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.99 3.63 33.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.914 1.285 . . . . 0.0 113.423 -176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -78.73 164.58 24.45 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.666 -1.271 . . . . 0.0 113.413 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -73.14 139.35 46.34 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.682 -0.636 . . . . 0.0 111.986 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -40.38 65.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.376 1.47 . . . . 0.0 112.893 172.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -89.41 -20.35 24.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 112.932 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.21 96.49 2.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.463 1.105 . . . . 0.0 111.538 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -61.24 -14.64 27.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.955 0.902 . . . . 0.0 112.821 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -21.29 66.19 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.996 0.918 . . . . 0.0 112.97 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.8 tpt -104.87 136.01 45.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.662 1.985 . . . . 0.0 110.999 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.56 131.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.686 1.594 . . . . 0.0 110.764 -170.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -99.34 170.54 8.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.369 1.467 . . . . 0.0 111.317 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.03 24.71 0.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 113.457 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.3 113.45 5.45 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.43 -0.794 . . . . 0.0 112.638 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.74 12.81 71.15 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.095 1.331 . . . . 0.0 115.884 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.21 148.28 22.27 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.631 2.216 . . . . 0.0 111.18 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -27.72 63.05 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.53 0.732 . . . . 0.0 112.248 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.13 -40.7 90.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.626 0.77 . . . . 0.0 112.558 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.15 92.64 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 119.101 0.864 . . . . 0.0 112.286 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.24 -40.47 96.1 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.271 1.036 . . . . 0.0 111.539 171.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.25 -44.87 82.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.568 1.147 . . . . 0.0 112.621 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.26 -23.0 43.96 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 113.449 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.91 84.12 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.232 0.92 . . . . 0.0 114.015 -171.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -136.65 137.86 40.51 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.338 1.855 . . . . 0.0 112.526 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -98.64 7.98 45.47 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.601 1.161 . . . . 0.0 113.415 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.4 p -157.09 140.9 16.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 168.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -159.51 176.41 12.1 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.504 1.922 . . . . 0.0 110.506 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 p -143.41 173.33 11.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.764 -1.21 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.67 -20.87 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -94.97 -16.33 22.86 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -125.05 65.39 47.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.85 1.66 . . . . 0.0 112.062 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.03 4.69 5.95 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.364 3.376 . . . . 0.0 113.309 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.6 m -38.88 -45.89 3.08 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 127.717 2.407 . . . . 0.0 116.616 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.42 -20.5 66.25 Favored 'Trans proline' 0 C--N 1.355 0.909 0 CA-C-N 122.521 1.936 . . . . 0.0 115.073 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.52 -49.66 62.37 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.264 1.031 . . . . 0.0 109.722 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -66.77 -30.52 70.75 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.043 -1.035 . . . . 0.0 112.043 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.64 -32.52 74.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.091 -1.006 . . . . 0.0 112.935 170.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -34.15 72.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.235 1.414 . . . . 0.0 111.629 170.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.82 -26.26 21.77 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -26.2 68.61 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.215 1.371 . . . . 0.0 114.394 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.29 -28.84 69.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.389 1.075 . . . . 0.0 111.952 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 171.347 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 CA--C 1.552 1.036 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -124.28 -175.88 3.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.238 2.615 . . . . 0.0 113.857 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.49 172.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.563 1.145 . . . . 0.0 111.393 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -164.34 132.28 2.59 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 129.799 3.24 . . . . 0.0 106.889 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 13.2 Cg_endo -100.24 174.9 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.024 2.483 . . . . 0.0 115.024 -169.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.88 160.23 14.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.949 2.1 . . . . 0.0 107.03 166.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -44.91 -46.28 28.01 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -68.85 -28.2 30.14 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 122.317 1.863 . . . . 0.0 114.037 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.68 -37.02 28.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.39 1.076 . . . . 0.0 111.011 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -57.72 -40.24 79.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 0.0 110.362 170.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -51.62 -41.62 61.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.692 1.597 . . . . 0.0 113.438 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.89 -51.68 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.297 1.039 . . . . 0.0 110.102 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.69 -31.67 68.64 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 111.925 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -31.87 69.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.793 -1.192 . . . . 0.0 112.86 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.05 -20.98 58.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.201 0.6 . . . . 0.0 112.605 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.46 21.65 17.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.381 1.872 . . . . 0.0 113.796 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.42 17.48 78.97 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.89 -161.12 0.32 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.993 1.317 . . . . 0.0 112.86 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -136.76 59.22 1.7 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.36 -130.85 10.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.859 1.219 . . . . 0.0 113.175 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 46.7 mt-10 -138.89 19.37 2.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.882 2.073 . . . . 0.0 111.589 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.6 ttt -77.7 50.34 0.83 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.698 1.199 . . . . 0.0 112.953 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -168.07 171.05 9.89 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.885 1.674 . . . . 0.0 113.876 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -65.38 167.68 8.23 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.555 2.342 . . . . 0.0 114.222 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.05 -42.24 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.801 2.041 . . . . 0.0 111.802 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -65.15 -33.91 77.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -79.01 -45.94 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.504 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.04 -47.16 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.875 1.216 . . . . 0.0 112.453 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.2 ptm -71.66 -24.01 61.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.69 -59.7 4.25 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.529 1.132 . . . . 0.0 110.744 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -55.25 -37.34 67.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.411 1.084 . . . . 0.0 113.214 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.06 -34.2 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.209 -0.932 . . . . 0.0 112.062 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.06 -47.37 91.11 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.711 -1.243 . . . . 0.0 112.154 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.291 13.9 pt20 -68.48 -31.44 70.72 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.147 -1.207 . . . . 0.0 112.925 172.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -54.6 -53.23 57.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 120.544 1.52 . . . . 0.0 110.467 169.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.4 -43.26 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.753 0.821 . . . . 0.0 110.399 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -34.78 78.51 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -78.13 -49.81 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.987 1.315 . . . . 0.0 111.847 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.04 -15.81 62.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.551 1.141 . . . . 0.0 112.858 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 6.4 pt20 47.72 43.49 16.82 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.003 2.521 . . . . 0.0 113.385 172.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.64 11.69 32.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.983 1.713 . . . . 0.0 112.902 -169.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -86.23 164.85 16.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.725 1.61 . . . . 0.0 112.222 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -71.76 146.69 47.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.135 0.969 . . . . 0.0 113.216 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.628 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -67.93 -34.84 77.38 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.004 1.722 . . . . 0.0 111.819 -175.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.54 -20.61 18.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.629 1.572 . . . . 0.0 112.483 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -144.79 93.29 2.39 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.851 0.834 . . . . 0.0 112.352 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -56.79 -21.25 27.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.27 1.428 . . . . 0.0 112.881 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -31.46 65.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.294 1.437 . . . . 0.0 113.018 171.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -98.7 130.08 45.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.117 1.367 . . . . 0.0 111.101 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -122.57 128.01 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.42 1.488 . . . . 0.0 110.258 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.42 166.59 10.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.069 1.348 . . . . 0.0 111.076 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.98 24.87 0.93 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 112.594 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.56 114.35 6.44 Favored Glycine 0 CA--C 1.533 1.169 0 O-C-N 121.531 -0.731 . . . . 0.0 112.741 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.73 11.67 66.21 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.063 1.316 . . . . 0.0 115.778 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -91.8 149.32 21.65 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 120.491 2.146 . . . . 0.0 111.44 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.23 -27.43 63.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.89 0.876 . . . . 0.0 111.991 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 tp -67.14 -40.33 86.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.796 0.838 . . . . 0.0 112.891 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.73 -36.25 92.9 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 119.132 0.878 . . . . 0.0 111.968 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -66.35 -37.43 85.31 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 112.095 171.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.2 tp -66.96 -46.96 73.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.709 0.803 . . . . 0.0 112.176 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.7 mt -77.96 -24.04 48.27 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.485 1.114 . . . . 0.0 113.101 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.73 8.85 87.19 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.253 0.93 . . . . 0.0 113.925 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -140.37 145.89 37.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.035 1.734 . . . . 0.0 113.091 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -104.29 8.29 35.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.364 1.065 . . . . 0.0 113.606 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -157.09 145.3 19.41 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -161.32 -177.42 6.0 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.544 2.338 . . . . 0.0 109.88 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.6 p -141.01 170.5 15.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.419 -1.426 . . . . 0.0 112.965 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.48 -11.24 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -88.24 -32.68 18.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.883 1.273 . . . . 0.0 111.873 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -127.19 71.47 76.23 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.926 1.69 . . . . 0.0 112.232 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.31 8.2 3.02 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.586 3.524 . . . . 0.0 113.734 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -46.13 -34.08 2.86 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 127.334 2.254 . . . . 0.0 116.772 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -59.81 -29.32 89.29 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 122.349 1.875 . . . . 0.0 114.318 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.79 -47.87 73.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.931 0.787 . . . . 0.0 110.579 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -65.52 -32.97 74.85 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.775 -0.578 . . . . 0.0 111.463 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.87 -31.62 68.35 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.174 0.897 . . . . 0.0 113.363 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -35.73 81.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.768 1.227 . . . . 0.0 110.768 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.84 -41.05 12.71 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.89 1.276 . . . . 0.0 114.14 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -27.61 64.84 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.671 1.588 . . . . 0.0 115.183 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.02 -24.63 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.491 1.517 . . . . 0.0 113.085 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -167.938 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 122.264 1.031 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.12 -178.68 6.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.481 2.712 . . . . 0.0 109.829 -168.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.5 172.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.107 0.963 . . . . 0.0 111.303 -169.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -163.42 136.54 4.28 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 128.719 2.808 . . . . 0.0 108.006 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -101.36 174.21 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.311 2.674 . . . . 0.0 114.956 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -98.95 159.52 14.9 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.416 1.886 . . . . 0.0 107.798 167.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.1 tp -47.2 -43.8 46.97 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -66.76 -29.57 42.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.304 2.003 . . . . 0.0 114.119 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.4 mt -84.91 -33.03 22.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.627 0.771 . . . . 0.0 111.839 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.68 -35.77 77.09 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.901 0.881 . . . . 0.0 110.974 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -40.16 68.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.771 1.228 . . . . 0.0 112.717 177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -65.43 -51.92 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.859 1.664 . . . . 0.0 109.409 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.67 -30.3 66.86 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.433 -0.792 . . . . 0.0 112.932 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -34.3 76.67 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.396 -1.44 . . . . 0.0 112.878 169.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.81 -20.23 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 119.288 0.949 . . . . 0.0 112.997 170.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.74 17.51 24.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.343 1.857 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 17.52 75.62 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.98 -165.4 1.19 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.114 1.366 . . . . 0.0 112.616 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.65 52.82 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.231 1.412 . . . . 0.0 110.99 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.79 -124.26 7.39 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.303 -0.873 . . . . 0.0 112.145 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -140.27 20.26 2.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.933 1.693 . . . . 0.0 111.902 -176.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -77.63 42.48 0.37 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.199 1.8 . . . . 0.0 114.361 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -166.29 174.6 8.97 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 -167.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.74 165.89 11.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.051 2.14 . . . . 0.0 114.297 -169.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.36 -44.55 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.848 1.659 . . . . 0.0 112.012 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -64.52 -30.12 71.15 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.46 -48.58 13.69 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.35 -0.834 . . . . 0.0 111.157 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.59 -44.88 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 120.425 1.466 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.5 ptm -71.71 -28.81 63.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.72 -59.14 5.86 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.162 . . . . 0.0 110.501 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -57.62 -33.17 67.97 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -34.7 70.19 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.159 1.345 . . . . 0.0 113.92 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.36 88.15 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 120.151 1.342 . . . . 0.0 111.769 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.261 13.5 pt20 -70.56 -31.63 68.74 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 118.071 -0.966 . . . . 0.0 113.18 173.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -55.66 -53.56 55.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.847 1.658 . . . . 0.0 110.945 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.18 -42.34 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.321 1.048 . . . . 0.0 110.071 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 31.8 tpp -67.18 -30.39 70.32 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.674 0.991 . . . . 0.0 113.674 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.66 -50.59 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.754 1.221 . . . . 0.0 111.489 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -15.99 63.25 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.496 1.118 . . . . 0.0 112.951 175.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.3 pt20 45.55 42.64 8.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.261 2.624 . . . . 0.0 113.448 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.4 19.5 16.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.843 1.657 . . . . 0.0 112.552 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -88.92 166.59 13.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.951 1.701 . . . . 0.0 111.86 171.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -76.33 135.22 39.55 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.234 -0.916 . . . . 0.0 112.07 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -38.84 42.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.263 1.425 . . . . 0.0 113.208 171.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -89.79 -18.26 26.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.214 1.406 . . . . 0.0 113.067 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.91 92.33 1.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.518 1.127 . . . . 0.0 111.257 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -57.51 -18.74 20.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 112.484 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -24.81 67.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.646 1.178 . . . . 0.0 112.957 175.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -102.01 132.66 47.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.444 1.898 . . . . 0.0 110.843 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.3 t -126.8 130.18 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.67 1.588 . . . . 0.0 110.333 -170.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -101.88 165.1 11.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.057 1.343 . . . . 0.0 111.381 172.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.5 m -150.44 23.62 0.81 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.225 1.81 . . . . 0.0 112.75 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.17 114.79 7.03 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 121.409 -0.807 . . . . 0.0 112.645 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.95 12.74 65.51 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.107 1.337 . . . . 0.0 115.528 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.36 149.49 21.19 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.087 1.944 . . . . 0.0 111.452 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -58.04 -27.72 63.84 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.683 -0.635 . . . . 0.0 111.666 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.7 tp -67.19 -39.15 86.33 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.358 -0.839 . . . . 0.0 112.598 172.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.57 90.54 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 118.659 0.663 . . . . 0.0 112.211 171.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.9 -38.0 85.43 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.398 1.099 . . . . 0.0 112.189 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.44 -46.14 70.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.479 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.41 -20.67 43.41 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.457 1.103 . . . . 0.0 113.074 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.16 -9.66 52.81 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.747 1.642 . . . . 0.0 114.407 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -124.84 142.5 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.419 1.888 . . . . 0.0 111.518 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -97.58 12.48 33.37 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.5 p -157.14 148.44 22.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.586 1.154 . . . . 0.0 112.549 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.3 173.92 15.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.392 1.877 . . . . 0.0 110.401 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.0 p -141.4 171.35 14.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.659 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -71.73 -8.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.0 -24.32 16.98 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.346 1.459 . . . . 0.0 112.854 169.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -128.82 63.42 66.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.204 1.802 . . . . 0.0 112.217 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.64 6.18 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.075 3.183 . . . . 0.0 114.077 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.8 m -44.97 -37.96 5.59 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -172.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -56.58 -30.17 82.02 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.634 2.223 . . . . 0.0 115.38 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.53 -53.04 62.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.301 1.524 . . . . 0.0 110.663 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.63 -29.23 63.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.719 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.12 -31.6 72.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.884 0.873 . . . . 0.0 112.582 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.15 -40.08 82.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.515 1.126 . . . . 0.0 110.812 169.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.26 -36.13 35.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.723 1.209 . . . . 0.0 113.842 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -25.38 65.52 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.365 1.439 . . . . 0.0 114.312 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -67.5 -31.84 72.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.644 1.977 . . . . 0.0 112.27 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.7 m120 . . . . . 0 CA--C 1.544 0.748 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.789 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -126.09 -174.94 3.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.261 2.624 . . . . 0.0 113.01 -167.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.47 171.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.077 0.951 . . . . 0.0 110.321 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -164.73 130.43 2.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 127.964 2.505 . . . . 0.0 107.786 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -96.45 172.95 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.886 2.391 . . . . 0.0 114.254 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.1 159.3 15.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.654 1.981 . . . . 0.0 108.192 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.05 -52.9 14.54 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 -22.12 37.23 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.552 2.168 . . . . 0.0 114.008 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.3 mt -84.34 -36.75 22.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.901 0.88 . . . . 0.0 111.979 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.9 -35.95 78.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 111.166 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -51.74 -38.17 54.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.455 1.502 . . . . 0.0 112.77 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -67.49 -51.52 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.74 -30.64 67.21 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -35.14 79.47 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.477 -1.389 . . . . 0.0 112.789 171.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.41 -21.52 62.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.31 21.5 17.05 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.32 1.848 . . . . 0.0 113.661 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.43 78.01 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.981 1.152 . . . . 0.0 115.981 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.08 -164.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.0 1.32 . . . . 0.0 113.035 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -129.19 50.1 2.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.997 1.719 . . . . 0.0 111.674 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.3 -122.49 5.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.425 1.012 . . . . 0.0 113.046 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -143.59 14.8 1.78 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.041 1.736 . . . . 0.0 112.684 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -79.17 52.29 1.29 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.084 1.354 . . . . 0.0 112.549 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -168.89 169.73 9.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.176 1.79 . . . . 0.0 112.532 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 164.78 6.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 127.34 2.256 . . . . 0.0 114.109 -170.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -52.72 -44.13 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.317 1.847 . . . . 0.0 111.786 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.22 -30.08 71.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.65 -47.77 14.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.106 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.25 -46.84 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 120.183 1.356 . . . . 0.0 112.499 173.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.6 ptm -69.46 -24.81 63.85 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.05 -59.66 3.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.822 1.249 . . . . 0.0 110.751 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -56.05 -36.34 67.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.945 0.898 . . . . 0.0 113.05 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -70.88 -38.91 73.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.061 0.944 . . . . 0.0 112.01 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.22 -47.43 89.49 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.865 -1.147 . . . . 0.0 112.54 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.265 13.2 pt20 -68.71 -31.6 70.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.504 -0.997 . . . . 0.0 112.755 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -57.52 -51.08 70.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.123 1.329 . . . . 0.0 111.027 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.16 -41.96 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.198 0.908 . . . . 0.0 110.08 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.25 -34.43 78.08 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.1 -52.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.598 1.159 . . . . 0.0 111.594 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -67.23 -15.76 63.89 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.323 1.049 . . . . 0.0 113.335 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.3 5.6 pt20 46.13 47.14 13.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.445 2.698 . . . . 0.0 113.912 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.8 4.49 32.73 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.75 1.22 . . . . 0.0 113.624 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -78.53 163.3 25.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 112.706 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.57 150.11 41.68 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.952 0.882 . . . . 0.0 112.682 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -64.14 -31.84 73.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.964 1.306 . . . . 0.0 112.65 -174.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -102.66 -30.04 11.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.674 1.59 . . . . 0.0 110.461 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -110.35 80.07 1.27 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.247 1.019 . . . . 0.0 111.789 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -57.3 -22.42 41.63 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.028 -0.42 . . . . 0.0 111.605 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -26.19 54.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.9 tpt -88.62 127.55 35.57 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.087 1.312 . . . . 0.0 110.854 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 t -120.07 125.69 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.394 1.078 . . . . 0.0 110.98 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.86 167.38 10.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.914 1.285 . . . . 0.0 111.065 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.1 m -148.62 29.24 0.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.916 1.686 . . . . 0.0 112.082 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.74 113.85 6.15 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.35 -0.844 . . . . 0.0 112.542 -170.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.37 12.05 72.39 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.08 1.324 . . . . 0.0 115.576 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.21 150.8 19.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.161 1.98 . . . . 0.0 111.4 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -58.06 -27.74 63.9 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.82 -37.64 84.9 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.377 -0.827 . . . . 0.0 112.482 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.43 -38.21 94.63 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.504 -0.748 . . . . 0.0 112.008 170.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -65.8 -37.61 86.74 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.229 1.014 . . . . 0.0 112.262 172.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.87 -44.64 76.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 112.248 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -79.22 -25.0 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.391 0.676 . . . . 0.0 112.626 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.16 4.55 83.87 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.423 1.011 . . . . 0.0 113.437 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -138.24 141.72 39.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.618 1.967 . . . . 0.0 111.492 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -101.97 10.1 39.95 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 -172.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.0 p -154.52 148.87 26.1 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.54 179.05 8.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.957 2.503 . . . . 0.0 109.57 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 p -144.78 172.73 12.6 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.184 -1.572 . . . . 0.0 113.286 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.05 -21.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.422 0.689 . . . . 0.0 112.096 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.72 -21.64 19.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.12 77.21 67.94 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 111.541 174.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.84 3.62 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.394 3.396 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 m -46.68 -37.6 9.4 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.874 1.67 . . . . 0.0 115.343 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.58 -27.25 68.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.407 2.738 . . . . 0.0 116.661 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.96 -49.5 57.45 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 123.021 1.391 . . . . 0.0 110.136 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -67.94 -29.15 68.15 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 121.22 -0.925 . . . . 0.0 112.157 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.56 -31.33 72.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.356 1.062 . . . . 0.0 112.179 169.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -40.52 72.26 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.256 1.022 . . . . 0.0 111.484 169.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.45 -30.78 26.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -59.74 -26.54 65.74 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.627 1.571 . . . . 0.0 113.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -69.6 -31.04 68.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.588 1.955 . . . . 0.0 112.252 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 t30 . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 171.85 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.99 -177.2 4.19 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.969 2.507 . . . . 0.0 112.054 -168.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 28' ' ' ARG . 2.9 t -81.99 172.31 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.362 1.065 . . . . 0.0 109.621 -174.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -162.18 135.9 4.79 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 129.31 3.044 . . . . 0.0 107.344 173.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.544 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 24.1 Cg_endo -93.72 175.74 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.995 2.463 . . . . 0.0 115.468 -168.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -107.67 160.55 15.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.975 2.51 . . . . 0.0 107.65 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.3 tp -40.27 -55.76 3.89 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 126.271 1.828 . . . . 0.0 115.822 -175.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.94 -25.06 28.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.223 1.949 . . . . 0.0 113.452 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.34 -35.47 35.54 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.452 -0.78 . . . . 0.0 111.582 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.53 -32.73 73.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.706 0.802 . . . . 0.0 110.93 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -59.23 -40.22 85.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.919 1.288 . . . . 0.0 112.759 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -65.76 -46.08 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.196 1.398 . . . . 0.0 109.98 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.6 -30.81 67.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.081 0.552 . . . . 0.0 112.225 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -66.37 -37.2 84.74 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.095 -1.628 . . . . 0.0 112.178 169.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.89 -24.07 67.42 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.952 0.796 . . . . 0.0 112.033 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . . . -84.51 4.81 30.14 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.65 1.58 . . . . 0.0 114.339 169.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.56 78.43 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.529 1.061 . . . . 0.0 115.364 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -92.01 -160.93 0.78 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.899 1.68 . . . . 0.0 113.092 -174.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -137.28 68.84 1.41 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.63 -146.09 32.28 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.903 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 48.2 mt-10 -129.48 19.06 5.77 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.235 2.214 . . . . 0.0 112.092 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.1 ttt -79.71 52.73 1.49 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.928 1.291 . . . . 0.0 112.38 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -166.35 175.87 7.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.41 1.884 . . . . 0.0 114.179 -169.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 49' ' ' VAL . 1.6 m -78.13 170.19 17.02 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.782 2.433 . . . . 0.0 114.379 -169.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 48' ' ' THR . 60.4 t -52.77 -42.84 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 126.866 2.066 . . . . 0.0 111.773 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -65.98 -30.11 70.61 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.33 -47.87 13.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.022 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -55.21 -45.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 120.193 1.36 . . . . 0.0 112.697 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.7 ptm -70.75 -25.65 63.01 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.49 -59.8 3.61 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.429 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 52.1 m-85 -55.73 -39.97 71.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.038 0.935 . . . . 0.0 112.849 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.84 -43.03 90.65 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.299 -0.876 . . . . 0.0 112.898 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.12 -46.86 84.32 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.259 0.936 . . . . 0.0 112.595 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 14.2 pt20 -71.8 -31.62 66.76 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.741 -0.858 . . . . 0.0 113.312 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CE2' ' HE3' ' A' ' 63' ' ' LYS . 60.5 t80 -59.09 -51.7 68.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.622 1.556 . . . . 0.0 111.253 169.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.55 -43.34 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.22 1.008 . . . . 0.0 110.081 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.6 tpp -67.48 -32.52 73.42 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.9 t -75.45 -51.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.728 1.211 . . . . 0.0 111.446 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 21.2 mmtp -66.75 -16.02 63.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.895 0.878 . . . . 0.0 112.88 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.296 6.2 pt20 44.25 43.7 6.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 128.36 2.664 . . . . 0.0 113.635 175.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -102.08 21.96 13.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.713 1.605 . . . . 0.0 112.848 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -87.54 169.74 11.92 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.414 1.886 . . . . 0.0 111.895 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.38 144.24 44.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.255 -0.903 . . . . 0.0 112.678 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.533 ' NE2' ' H ' ' A' ' 68' ' ' GLN . 0.6 OUTLIER -64.14 -39.89 94.99 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.543 1.937 . . . . 0.0 112.417 -177.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -92.38 -21.84 20.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.3 1.44 . . . . 0.0 112.362 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -138.99 88.27 2.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.393 1.092 . . . . 0.0 112.93 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -56.17 -17.84 8.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.418 1.087 . . . . 0.0 112.918 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -25.43 68.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.452 1.101 . . . . 0.0 112.978 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -103.11 134.32 46.74 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.884 1.674 . . . . 0.0 111.241 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -126.42 132.48 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.442 1.497 . . . . 0.0 110.778 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -112.9 162.47 15.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.915 1.686 . . . . 0.0 111.35 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.6 m -146.19 28.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.309 1.443 . . . . 0.0 111.864 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.99 106.43 0.23 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.464 1.031 . . . . 0.0 114.642 -169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.86 14.76 65.96 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.994 1.283 . . . . 0.0 115.493 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.35 153.95 20.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.2 1.5 . . . . 0.0 112.365 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -57.55 -27.93 63.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.564 0.746 . . . . 0.0 111.994 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.58 -41.32 88.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.1 0.864 . . . . 0.0 112.213 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.42 -37.79 94.93 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.724 -0.61 . . . . 0.0 111.825 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -66.53 -38.4 87.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.024 0.929 . . . . 0.0 112.274 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 tp -65.6 -46.06 80.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.054 1.342 . . . . 0.0 112.102 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -76.48 -26.81 55.74 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.29 2.01 71.84 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.009 0.814 . . . . 0.0 112.862 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -142.01 136.02 29.86 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 129.807 3.243 . . . . 0.0 108.058 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.284 9.0 pt20 -112.16 17.67 19.33 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.8 p -153.4 145.33 23.6 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.089 -1.007 . . . . 0.0 113.07 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -161.0 170.47 20.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.836 1.655 . . . . 0.0 111.208 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.0 p -137.32 170.88 15.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.671 0.788 . . . . 0.0 111.753 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -7.58 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -95.11 -27.13 15.73 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.133 1.373 . . . . 0.0 112.73 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -131.4 78.67 71.38 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.648 1.579 . . . . 0.0 111.199 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.15 5.44 6.24 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.273 3.315 . . . . 0.0 113.799 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -44.53 -38.0 4.98 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -173.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -59.07 -28.83 88.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.966 2.444 . . . . 0.0 115.932 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 tp -58.87 -53.3 59.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 123.158 1.456 . . . . 0.0 109.929 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.56 -29.17 62.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.296 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -64.38 -31.34 72.51 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.441 1.019 . . . . 0.0 112.529 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.5 ttp -72.2 -42.72 65.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.053 0.941 . . . . 0.0 110.335 169.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.14 -32.25 44.34 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -59.24 -28.1 66.39 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.772 1.629 . . . . 0.0 114.026 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.4 -26.57 58.52 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.629 1.971 . . . . 0.0 112.837 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 124.58 1.152 . . . . 0.0 113.839 -174.698 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -127.61 -175.54 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 129.216 3.007 . . . . 0.0 112.032 -167.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' MET . 2.0 t -92.5 172.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.862 1.265 . . . . 0.0 109.9 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.3 ttp85 -164.77 142.66 5.32 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 130.108 3.363 . . . . 0.0 107.722 168.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -105.67 170.86 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.198 2.599 . . . . 0.0 114.111 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -83.44 158.76 21.95 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.727 1.211 . . . . 0.0 108.149 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.44 -50.43 22.85 Favored Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.43 -25.53 35.5 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.168 1.912 . . . . 0.0 114.274 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -81.19 -37.79 28.12 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.518 0.727 . . . . 0.0 111.436 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.67 -42.57 98.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.091 1.356 . . . . 0.0 111.719 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 40.2 pttt -68.49 -22.95 64.52 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -62.12 -52.79 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 109.347 169.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.69 -30.58 67.2 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -32.16 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.818 -1.176 . . . . 0.0 113.271 170.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.27 -22.64 63.34 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.136 0.88 . . . . 0.0 112.955 170.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.5 23.65 13.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.089 1.756 . . . . 0.0 113.462 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.73 15.6 79.4 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.43 -163.55 0.58 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.384 1.092 . . . . 0.0 113.173 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -132.32 49.2 2.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.019 2.128 . . . . 0.0 109.842 168.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.99 -115.73 4.77 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.737 1.16 . . . . 0.0 112.721 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.86 17.39 3.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.142 1.777 . . . . 0.0 111.241 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 24.5 ttt -74.52 50.73 0.43 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.314 1.846 . . . . 0.0 113.482 -172.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -173.5 170.92 4.04 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.66 1.984 . . . . 0.0 112.666 -169.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.25 165.74 11.05 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.277 2.231 . . . . 0.0 113.594 -172.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -51.55 -44.68 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 126.581 1.952 . . . . 0.0 112.043 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -65.15 -30.18 71.08 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -80.38 -45.39 17.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.124 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -57.35 -45.04 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 120.075 1.307 . . . . 0.0 112.506 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.9 ptm -70.05 -24.16 63.21 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -66.78 -57.72 6.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.127 1.371 . . . . 0.0 110.983 170.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -56.48 -36.84 69.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.026 0.93 . . . . 0.0 113.145 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tt -71.79 -40.36 69.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.483 -0.761 . . . . 0.0 111.742 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.51 -47.43 89.97 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.9 -1.125 . . . . 0.0 112.807 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -69.59 -31.54 69.75 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.212 -1.17 . . . . 0.0 112.641 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.11 -50.61 72.27 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.957 1.253 . . . . 0.0 110.942 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mt -57.89 -43.74 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.706 0.684 . . . . 0.0 110.242 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.16 -32.97 74.72 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.53 -50.9 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.412 1.085 . . . . 0.0 111.518 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -15.87 63.66 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.376 1.07 . . . . 0.0 113.181 176.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.2 pt20 45.44 43.43 8.68 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.331 2.652 . . . . 0.0 113.62 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.03 8.39 43.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.668 1.587 . . . . 0.0 112.936 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -74.39 162.96 28.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.693 1.197 . . . . 0.0 112.268 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.48 147.77 41.61 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -47.1 78.56 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -76.77 -19.92 57.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.41 94.92 2.28 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.462 1.125 . . . . 0.0 113.311 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.84 -17.96 28.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.299 1.44 . . . . 0.0 112.876 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -25.17 65.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.943 0.897 . . . . 0.0 113.104 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.8 tpp -93.95 129.18 40.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 109.742 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.12 113.03 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.812 1.645 . . . . 0.0 109.806 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -86.91 165.12 16.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.783 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.74 25.28 1.18 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.584 1.553 . . . . 0.0 112.596 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.54 114.82 6.64 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.561 -0.712 . . . . 0.0 112.948 -169.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.74 10.93 72.72 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.144 1.354 . . . . 0.0 115.853 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.38 150.01 21.06 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.404 2.102 . . . . 0.0 111.437 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.01 -27.66 63.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.535 -0.728 . . . . 0.0 112.735 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.45 -39.74 94.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.383 0.992 . . . . 0.0 112.068 171.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.61 95.78 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.501 0.572 . . . . 0.0 112.146 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.98 -43.13 95.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.122 0.961 . . . . 0.0 111.995 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -70.65 -46.16 63.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.242 1.017 . . . . 0.0 111.892 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -71.82 -27.76 63.13 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.072 0.949 . . . . 0.0 112.563 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.03 7.24 83.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.345 1.45 . . . . 0.0 114.499 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.54 147.94 30.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.072 1.749 . . . . 0.0 111.721 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -101.98 9.87 40.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 113.448 -173.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -153.25 144.08 22.79 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.82 170.82 20.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.955 2.102 . . . . 0.0 110.67 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -136.58 154.4 50.7 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.701 0.8 . . . . 0.0 112.023 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.29 -14.89 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.87 -7.12 57.63 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.424 1.49 . . . . 0.0 113.731 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -145.24 64.27 10.69 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.707 1.603 . . . . 0.0 111.48 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.73 2.77 7.89 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.206 3.271 . . . . 0.0 114.714 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.9 m -48.5 -33.1 4.48 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -54.5 -31.0 67.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.115 2.543 . . . . 0.0 115.812 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.5 -48.76 46.93 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.621 1.169 . . . . 0.0 110.379 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -67.02 -29.24 69.0 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.011 -1.056 . . . . 0.0 112.177 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.95 -31.56 72.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.708 1.203 . . . . 0.0 112.526 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -32.5 70.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.866 1.267 . . . . 0.0 112.236 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.5 -31.62 16.69 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -62.73 -27.86 69.56 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.855 1.262 . . . . 0.0 113.935 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -62.44 -29.04 70.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.948 0.899 . . . . 0.0 112.109 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 . . . . . 0 CA--C 1.547 0.852 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.51 169.588 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 122.337 1.065 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.55 -173.06 3.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 130.389 3.476 . . . . 0.0 108.457 -169.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.08 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.983 -1.073 . . . . 0.0 111.55 -172.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -158.19 139.18 9.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 131.329 3.852 . . . . 0.0 106.729 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 35.6 Cg_endo -96.72 167.01 1.04 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.242 2.628 . . . . 0.0 113.681 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -79.93 161.48 25.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.399 1.08 . . . . 0.0 108.597 167.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.92 -42.03 66.92 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -68.61 -29.32 30.26 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.264 1.976 . . . . 0.0 114.246 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.89 -31.2 25.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.955 0.902 . . . . 0.0 112.108 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.25 -43.23 87.76 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.943 0.897 . . . . 0.0 111.056 173.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.309 16.9 pttp -72.76 -24.84 61.0 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.67 -52.08 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 109.475 170.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 37' ' ' LEU . 1.2 mm? -67.54 -30.72 70.44 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.483 -0.761 . . . . 0.0 112.463 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -29.9 69.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.678 -1.264 . . . . 0.0 113.378 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.33 59.78 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.4 21.81 16.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.157 1.783 . . . . 0.0 113.684 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.25 17.03 78.63 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.24 -156.23 0.16 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.859 1.264 . . . . 0.0 112.731 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -141.24 60.15 1.51 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.569 1.948 . . . . 0.0 109.624 168.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.29 18.02 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.584 -172.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 40.3 mt-10 -135.64 20.4 3.33 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.699 2.0 . . . . 0.0 110.923 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -76.07 54.74 0.88 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.876 1.67 . . . . 0.0 112.955 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -173.29 172.21 3.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.286 1.834 . . . . 0.0 112.384 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 167.07 13.76 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.814 2.045 . . . . 0.0 114.084 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -49.45 -45.88 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.455 1.902 . . . . 0.0 112.169 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -65.09 -30.07 70.99 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.79 -46.72 16.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.137 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -55.71 -46.72 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 120.477 1.489 . . . . 0.0 112.337 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 23.1 ptm -69.51 -27.44 65.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -62.47 -58.07 8.93 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.558 1.143 . . . . 0.0 110.758 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -58.31 -32.56 68.58 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.13 -41.27 81.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.559 1.072 . . . . 0.0 112.82 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.44 -47.42 88.2 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.963 0.801 . . . . 0.0 112.093 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.252 11.5 pt20 -70.72 -31.7 68.63 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.554 -0.968 . . . . 0.0 113.08 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.45 -51.93 66.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.454 1.479 . . . . 0.0 111.014 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.5 mt -60.59 -41.61 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.068 0.947 . . . . 0.0 110.272 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 37.7 tpp -67.78 -31.97 72.23 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.08 -50.4 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.357 1.063 . . . . 0.0 111.347 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -16.03 63.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.968 0.907 . . . . 0.0 113.125 175.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.4 pt20 43.49 43.07 4.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.455 2.702 . . . . 0.0 113.647 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 tp -99.51 20.21 14.28 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.523 1.529 . . . . 0.0 112.689 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -83.88 165.71 18.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 111.883 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.46 148.52 45.04 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.169 0.985 . . . . 0.0 113.026 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.606 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.7 -38.41 76.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.833 1.653 . . . . 0.0 111.43 -176.343 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -90.94 -20.39 22.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.585 1.554 . . . . 0.0 112.295 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -144.04 93.18 2.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.415 1.103 . . . . 0.0 112.414 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -57.69 -18.51 21.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.152 1.381 . . . . 0.0 112.821 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.78 63.64 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.24 1.016 . . . . 0.0 113.133 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -97.86 129.81 44.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.063 1.745 . . . . 0.0 110.302 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.03 131.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.114 1.366 . . . . 0.0 110.65 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -105.62 165.71 10.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.297 1.439 . . . . 0.0 111.6 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.02 24.24 1.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.151 1.781 . . . . 0.0 112.771 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.38 113.68 5.71 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.603 -0.685 . . . . 0.0 112.647 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.98 13.03 66.07 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.12 1.343 . . . . 0.0 115.676 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -95.25 148.42 22.43 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.39 2.095 . . . . 0.0 111.382 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.88 -27.8 63.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.47 0.708 . . . . 0.0 111.943 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.11 -39.95 90.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.4 -0.812 . . . . 0.0 112.465 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.93 92.59 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 118.543 0.61 . . . . 0.0 112.223 172.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -65.11 -36.68 85.07 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 117.893 0.846 . . . . 0.0 112.19 171.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.27 -50.51 53.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.606 1.162 . . . . 0.0 111.2 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.67 -24.02 58.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.123 0.969 . . . . 0.0 113.082 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.47 7.78 85.87 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.161 1.362 . . . . 0.0 114.634 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 150.19 33.84 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.886 1.674 . . . . 0.0 111.854 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -99.1 11.49 38.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.118 0.967 . . . . 0.0 113.434 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -155.32 149.73 26.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.86 177.84 10.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.65 1.98 . . . . 0.0 111.129 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 t -140.2 154.55 46.96 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.011 -1.056 . . . . 0.0 111.892 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.2 m -66.22 -12.92 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 169.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -83.18 -17.2 43.69 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.65 1.18 . . . . 0.0 113.026 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -140.38 69.87 32.92 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 111.478 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.75 3.95 4.5 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.21 3.273 . . . . 0.0 114.564 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -45.4 -35.45 3.22 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 126.364 1.866 . . . . 0.0 115.736 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -56.69 -30.09 82.56 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.95 2.433 . . . . 0.0 115.73 173.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.74 -45.56 61.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.177 0.899 . . . . 0.0 110.142 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.45 -30.25 69.92 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.621 -0.674 . . . . 0.0 112.275 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -66.72 -31.31 71.88 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.858 1.263 . . . . 0.0 112.872 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -33.33 67.44 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.292 1.437 . . . . 0.0 112.207 170.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.98 -27.02 18.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.959 1.704 . . . . 0.0 114.545 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -61.46 -23.37 65.82 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.4 1.48 . . . . 0.0 113.963 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -65.69 -27.31 68.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.546 1.938 . . . . 0.0 112.344 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 CA--C 1.548 0.882 0 C-N-CA 124.147 0.979 . . . . 0.0 113.331 172.428 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -129.64 -177.66 4.36 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 128.42 2.688 . . . . 0.0 113.114 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.68 172.23 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.851 1.661 . . . . 0.0 111.677 -176.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -163.35 143.42 6.91 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 130.173 3.389 . . . . 0.0 108.22 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -102.65 169.37 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.783 2.989 . . . . 0.0 113.843 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -87.4 164.45 16.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 109.792 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.5 tp -42.82 -56.32 6.22 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.926 1.69 . . . . 0.0 115.377 -172.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.89 -26.8 37.67 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.215 1.943 . . . . 0.0 113.821 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.7 mt -80.83 -34.59 33.78 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.363 -0.836 . . . . 0.0 112.243 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.39 -32.16 73.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.795 1.238 . . . . 0.0 110.988 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -58.57 -41.69 86.28 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.42 1.488 . . . . 0.0 112.861 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.86 -51.31 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.187 1.395 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.32 13.6 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -61.43 -33.96 74.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.613 -1.304 . . . . 0.0 112.399 169.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.05 62.35 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.247 0.93 . . . . 0.0 113.317 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 23.52 13.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.008 1.723 . . . . 0.0 113.434 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.26 79.62 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.676 1.131 . . . . 0.0 115.687 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.0 -169.58 2.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.466 1.106 . . . . 0.0 113.247 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -123.39 44.74 2.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.678 1.991 . . . . 0.0 110.841 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.74 -115.33 4.12 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.983 1.278 . . . . 0.0 112.646 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -139.51 15.77 2.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.741 2.016 . . . . 0.0 110.769 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 56.6 ttp -77.0 52.39 0.87 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.609 1.564 . . . . 0.0 112.772 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -171.61 171.48 5.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.521 1.929 . . . . 0.0 112.693 -168.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -65.63 165.63 12.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.501 1.92 . . . . 0.0 112.214 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.86 -37.92 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.16 0.984 . . . . 0.0 112.185 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.33 -30.04 69.26 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -80.52 -43.48 20.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.512 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 m -54.96 -50.01 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 120.551 1.523 . . . . 0.0 113.016 175.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -68.49 -23.98 64.63 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.043 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.18 -59.17 3.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.989 1.316 . . . . 0.0 111.033 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -56.19 -36.83 68.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.133 0.973 . . . . 0.0 113.119 174.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.86 -42.53 73.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.939 0.895 . . . . 0.0 112.707 174.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.49 -47.36 76.92 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.398 -0.814 . . . . 0.0 111.813 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.93 -31.55 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.543 -0.974 . . . . 0.0 113.555 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -55.34 -50.41 69.72 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.727 1.603 . . . . 0.0 111.06 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.8 mt -63.45 -42.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.151 0.98 . . . . 0.0 110.531 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -45.36 92.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.634 1.174 . . . . 0.0 111.467 177.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.62 -48.39 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.079 0.952 . . . . 0.0 111.72 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -67.1 -16.11 64.13 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.284 6.3 pt20 41.93 42.88 2.44 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.868 2.467 . . . . 0.0 113.462 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -98.32 16.28 22.0 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.511 1.524 . . . . 0.0 113.309 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -81.71 160.4 23.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.985 1.314 . . . . 0.0 111.178 169.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -74.45 133.46 42.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.038 -1.039 . . . . 0.0 112.048 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.46 -33.66 60.04 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.876 1.67 . . . . 0.0 113.579 171.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -83.82 -27.38 28.8 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.012 1.325 . . . . 0.0 112.422 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.33 95.63 1.95 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.546 1.138 . . . . 0.0 111.655 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -60.51 -14.92 22.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.737 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.38 69.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.629 0.772 . . . . 0.0 112.743 173.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.5 tpp -91.84 130.6 37.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.021 1.729 . . . . 0.0 110.356 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.06 118.09 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.041 1.737 . . . . 0.0 109.764 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.41 162.06 14.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.538 1.135 . . . . 0.0 111.736 171.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -153.88 27.12 0.48 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.065 2.146 . . . . 0.0 112.21 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 118.6 13.08 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.33 -0.856 . . . . 0.0 113.349 -169.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.52 8.61 67.25 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.005 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -98.53 156.1 16.95 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 120.573 2.187 . . . . 0.0 112.272 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.56 -27.62 66.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.713 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 tp -66.84 -44.29 81.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.224 -0.922 . . . . 0.0 112.9 173.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.02 86.12 Favored Glycine 0 N--CA 1.477 1.424 0 CA-C-O 118.151 -1.361 . . . . 0.0 112.411 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.48 -40.03 92.63 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.014 1.907 . . . . 0.0 112.334 170.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -70.32 -51.73 28.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.082 0.953 . . . . 0.0 111.144 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.9 -20.14 61.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 112.198 176.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.73 13.04 82.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.749 1.642 . . . . 0.0 114.686 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -129.31 -25.17 2.73 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 121.63 3.937 . . . . 0.0 121.63 -169.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 55.05 2.85 0.05 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.3 p -157.22 138.3 13.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.837 1.255 . . . . 0.0 112.68 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.89 176.11 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.121 1.768 . . . . 0.0 110.681 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 t -140.5 156.93 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.135 -0.978 . . . . 0.0 111.363 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.08 -18.03 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.668 -0.645 . . . . 0.0 112.446 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.15 -1.89 50.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 113.897 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -137.81 60.58 25.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.889 1.676 . . . . 0.0 111.803 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -79.15 -0.11 10.48 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.946 3.097 . . . . 0.0 113.908 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.2 m -46.82 -32.45 2.11 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.72 -24.57 68.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.157 1.904 . . . . 0.0 114.132 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.82 -47.4 53.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.853 0.861 . . . . 0.0 110.11 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -68.22 -30.52 69.61 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.518 -0.739 . . . . 0.0 112.462 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.54 -31.52 72.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.471 1.032 . . . . 0.0 112.917 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -34.2 73.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.39 1.476 . . . . 0.0 112.099 171.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.65 -33.8 15.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 114.443 -175.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -58.25 -28.36 64.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.206 1.403 . . . . 0.0 113.689 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.15 -27.14 68.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.847 2.059 . . . . 0.0 112.556 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 . . . . . 0 CA--C 1.548 0.894 0 C-N-CA 124.72 1.208 . . . . 0.0 113.177 173.234 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.9 m120 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -131.37 -177.65 4.49 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.432 2.293 . . . . 0.0 112.558 -167.475 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' MET . 15.4 m -94.55 172.13 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.528 1.131 . . . . 0.0 110.289 -175.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -162.21 144.14 8.39 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 128.089 2.555 . . . . 0.0 109.001 -172.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 8.5 Cg_endo -98.52 176.27 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.143 2.562 . . . . 0.0 114.705 -169.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -105.83 157.37 17.51 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.674 1.99 . . . . 0.0 107.507 167.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.8 mt -47.37 -46.01 56.93 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.87 -21.74 20.86 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.922 1.748 . . . . 0.0 114.015 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.24 -34.15 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.934 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.5 -41.62 81.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 111.629 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.269 18.3 pttp -72.52 -21.84 61.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.6 mt -69.69 -45.8 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.648 1.179 . . . . 0.0 110.083 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.67 -37.21 86.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.466 -0.771 . . . . 0.0 111.233 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.829 -1.169 . . . . 0.0 113.436 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.43 -22.26 61.22 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 112.99 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.13 22.12 14.59 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.074 1.75 . . . . 0.0 113.543 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 17.55 78.66 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.75 -156.07 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.89 1.276 . . . . 0.0 112.996 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -148.41 67.28 1.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.312 1.845 . . . . 0.0 110.489 169.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.13 -146.62 36.6 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.749 -172.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.48 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 45.4 mt-10 -122.19 15.39 10.62 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.868 2.067 . . . . 0.0 111.958 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 27.6 ttt -79.45 59.15 2.84 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.874 1.27 . . . . 0.0 113.705 -168.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -170.41 177.75 3.96 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.296 1.838 . . . . 0.0 113.719 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.35 165.64 13.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.521 2.328 . . . . 0.0 114.387 -172.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.4 t -52.12 -47.01 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 125.958 1.703 . . . . 0.0 111.843 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -62.52 -30.08 71.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -78.83 -47.93 15.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.067 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -55.88 -45.42 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 120.463 1.483 . . . . 0.0 112.376 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.5 ptm -70.26 -26.28 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -64.61 -59.43 4.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.162 1.385 . . . . 0.0 110.868 171.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -56.41 -36.25 68.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.784 0.834 . . . . 0.0 113.189 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.99 -44.64 88.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.054 0.941 . . . . 0.0 112.343 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.831 0.741 . . . . 0.0 112.249 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.28 11.2 pt20 -70.67 -31.54 68.48 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.392 -1.063 . . . . 0.0 113.087 176.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -55.97 -54.48 44.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.247 1.385 . . . . 0.0 110.496 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.34 -42.25 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.809 0.843 . . . . 0.0 110.146 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -34.93 79.49 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.9 t -78.24 -50.28 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 111.174 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.3 64.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.963 0.905 . . . . 0.0 112.665 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.333 5.8 pt20 46.44 39.44 6.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.667 2.787 . . . . 0.0 114.523 176.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -91.6 51.44 1.87 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.249 1.42 . . . . 0.0 111.42 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -124.97 162.51 24.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.787 2.035 . . . . 0.0 111.376 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.25 138.5 47.52 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.349 -0.844 . . . . 0.0 111.837 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -48.51 79.0 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.06 -1.025 . . . . 0.0 112.864 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -80.93 -6.39 58.64 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.128 0.876 . . . . 0.0 113.031 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.7 86.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.573 1.177 . . . . 0.0 111.365 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.07 -15.42 32.46 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.145 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -22.2 65.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.84 1.256 . . . . 0.0 113.146 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 43.2 tpp -107.24 134.6 50.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.073 2.149 . . . . 0.0 111.143 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.02 133.24 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.996 1.718 . . . . 0.0 110.275 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.41 84.88 2.11 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.301 2.241 . . . . 0.0 110.603 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -80.39 38.59 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.187 2.595 . . . . 0.0 113.451 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 113.03 2.49 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.305 -0.872 . . . . 0.0 114.609 -168.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.59 11.61 77.15 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.057 1.313 . . . . 0.0 116.187 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.93 156.8 20.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.944 1.872 . . . . 0.0 112.366 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.56 -28.06 59.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 112.755 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.23 -37.62 81.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.17 -0.956 . . . . 0.0 112.21 171.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.66 -39.93 98.06 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.415 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -64.83 -38.48 91.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.841 1.321 . . . . 0.0 112.07 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -69.56 -46.48 66.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.258 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.08 -18.64 45.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.816 1.246 . . . . 0.0 113.297 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.01 73.93 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.84 1.686 . . . . 0.0 114.937 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.39 -36.89 0.71 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -169.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 5.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.5 p -145.78 135.53 23.4 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.468 1.485 . . . . 0.0 114.586 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -169.94 168.28 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.717 2.407 . . . . 0.0 109.521 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 p -132.86 171.48 13.86 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.424 -0.797 . . . . 0.0 111.282 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.81 -9.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.261 -0.899 . . . . 0.0 113.378 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -95.05 -25.58 16.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.238 1.415 . . . . 0.0 112.984 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -130.63 70.92 82.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 125.973 1.709 . . . . 0.0 111.907 174.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -88.09 16.31 1.92 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 125.02 3.813 . . . . 0.0 114.853 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.1 p -50.85 -31.01 4.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.3 -31.72 52.37 Favored 'Trans proline' 0 C--N 1.357 0.987 0 CA-C-N 123.959 2.449 . . . . 0.0 114.108 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.4 -49.21 72.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.174 1.39 . . . . 0.0 110.531 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.05 -29.19 57.95 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.366 -0.834 . . . . 0.0 112.452 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.06 -32.96 72.81 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.295 -0.878 . . . . 0.0 113.241 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.3 ttp -68.52 -41.36 80.04 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.267 1.427 . . . . 0.0 110.617 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.04 -48.68 56.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.315 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -58.13 -31.92 67.66 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.92 -26.42 64.14 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.738 2.015 . . . . 0.0 112.917 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 110.55 174.011 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 CA--C 1.544 0.737 0 CA-C-O 122.544 1.164 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.18 -176.62 4.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.055 2.942 . . . . 0.0 109.159 -168.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.46 171.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 120.987 -1.071 . . . . 0.0 111.818 -169.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -162.67 140.48 6.38 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 129.527 3.131 . . . . 0.0 107.279 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 1.1 Cg_endo -103.57 179.37 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.048 2.499 . . . . 0.0 115.28 -169.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -108.73 158.47 17.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.784 2.433 . . . . 0.0 107.213 167.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -45.24 -47.05 33.51 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 -23.13 30.89 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.058 1.839 . . . . 0.0 114.694 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.19 -35.47 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.376 0.67 . . . . 0.0 111.865 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.47 -41.88 81.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.329 1.052 . . . . 0.0 111.601 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -71.38 -20.44 62.14 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.55 -51.68 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 109.285 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.97 -34.2 76.09 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.605 -0.685 . . . . 0.0 111.753 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -30.7 68.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.892 -1.13 . . . . 0.0 113.188 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.98 60.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.519 0.727 . . . . 0.0 112.869 169.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.77 22.35 15.3 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.195 1.798 . . . . 0.0 113.533 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.64 16.98 78.99 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.644 1.018 . . . . 0.0 115.644 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.73 -156.7 0.16 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.97 1.308 . . . . 0.0 112.729 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.27 59.94 1.55 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.559 1.544 . . . . 0.0 110.364 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.64 -141.7 27.88 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.848 -172.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.491 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.3 mt-10 -121.72 21.33 10.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.799 2.04 . . . . 0.0 112.138 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.5 ptm -74.72 41.17 0.15 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -169.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -166.62 174.48 8.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.707 1.603 . . . . 0.0 113.979 -168.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.66 167.66 16.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.32 2.248 . . . . 0.0 114.236 -169.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -49.15 -43.43 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 126.317 1.847 . . . . 0.0 112.75 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -31.28 70.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -77.76 -46.43 21.74 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.098 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.45 -46.24 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 120.319 1.418 . . . . 0.0 112.586 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.2 ptm -69.46 -28.21 65.9 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.52 -59.04 6.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.618 1.167 . . . . 0.0 110.851 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -55.81 -36.77 67.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 113.386 173.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.17 -36.98 80.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.839 1.199 . . . . 0.0 113.129 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.74 -47.42 90.41 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.927 1.24 . . . . 0.0 112.232 173.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.272 13.4 pt20 -70.22 -31.5 68.95 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.451 -1.029 . . . . 0.0 113.081 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -55.89 -54.5 43.95 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.207 1.367 . . . . 0.0 110.07 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.3 mt -59.03 -39.98 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.931 0.892 . . . . 0.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.8 tpp -69.11 -32.35 71.7 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.23 -51.35 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.028 -1.045 . . . . 0.0 111.344 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -68.08 -12.96 61.79 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.307 1.443 . . . . 0.0 113.064 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.31 5.8 pt20 48.76 50.18 17.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.37 3.068 . . . . 0.0 114.023 169.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.6 mt -88.4 3.91 48.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.531 1.133 . . . . 0.0 113.741 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -89.11 162.2 16.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.455 1.102 . . . . 0.0 113.015 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -78.9 152.3 31.25 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.79 -47.34 63.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -77.7 -17.33 57.76 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -149.61 87.07 1.48 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.059 0.933 . . . . 0.0 111.787 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -55.94 -22.81 28.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.763 1.625 . . . . 0.0 112.44 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.09 -34.35 56.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.301 1.84 . . . . 0.0 112.987 170.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tpt -99.51 135.33 41.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.002 1.721 . . . . 0.0 111.158 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -132.08 136.73 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.025 1.73 . . . . 0.0 110.487 -170.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -105.94 175.0 5.64 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.187 1.795 . . . . 0.0 112.194 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.88 20.24 0.32 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.714 1.606 . . . . 0.0 113.733 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.3 115.75 5.01 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.845 0.736 . . . . 0.0 114.115 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.34 6.97 71.38 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.305 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -96.6 158.81 15.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 121.089 2.445 . . . . 0.0 112.506 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -27.69 68.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.996 0.918 . . . . 0.0 112.13 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.38 -41.57 96.62 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.38 -0.825 . . . . 0.0 111.994 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.22 96.94 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 119.339 0.972 . . . . 0.0 112.654 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -43.89 95.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.479 1.14 . . . . 0.0 111.722 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.73 -46.38 66.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.326 1.05 . . . . 0.0 112.245 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.28 -25.71 63.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.804 1.241 . . . . 0.0 113.035 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 4.67 75.5 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.394 0.997 . . . . 0.0 113.796 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -138.39 141.25 39.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 112.393 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -102.99 7.76 39.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.719 1.208 . . . . 0.0 113.27 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.0 p -155.92 143.42 19.41 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.498 1.119 . . . . 0.0 112.462 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.73 178.7 8.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.117 2.167 . . . . 0.0 110.262 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.7 p -142.98 170.38 15.81 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.649 -1.282 . . . . 0.0 112.969 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.51 -19.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.898 0.879 . . . . 0.0 112.943 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.08 -10.74 29.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.037 1.335 . . . . 0.0 113.803 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -132.61 62.73 64.41 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.832 1.653 . . . . 0.0 112.639 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.08 0.17 9.63 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.106 3.204 . . . . 0.0 114.09 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.6 m -42.77 -39.32 3.55 Favored Pre-proline 0 N--CA 1.472 0.663 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.42 -24.19 71.14 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 123.242 2.194 . . . . 0.0 114.89 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.44 -47.47 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.233 1.378 . . . . 0.0 109.802 170.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.11 -33.0 74.77 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.686 -0.633 . . . . 0.0 111.941 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.34 -31.47 69.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.457 1.026 . . . . 0.0 113.401 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.38 77.63 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.986 1.314 . . . . 0.0 111.234 169.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.6 mt -91.16 -34.92 14.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.357 1.463 . . . . 0.0 114.483 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -28.08 62.92 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.562 1.545 . . . . 0.0 113.692 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.69 -28.14 69.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.743 2.017 . . . . 0.0 112.847 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.382 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -128.31 -176.44 3.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.846 2.858 . . . . 0.0 113.085 -167.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.2 172.4 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.269 1.427 . . . . 0.0 109.163 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -164.25 139.93 4.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 130.459 3.503 . . . . 0.0 108.145 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -102.15 164.04 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.123 3.215 . . . . 0.0 113.744 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -82.13 158.78 23.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.585 1.154 . . . . 0.0 108.89 168.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.8 tp -41.79 -49.92 10.26 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.35 -21.55 35.26 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.092 1.862 . . . . 0.0 114.629 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.66 -32.59 16.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.196 0.999 . . . . 0.0 112.422 173.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.8 tt -61.73 -39.02 90.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.28 1.832 . . . . 0.0 112.032 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -72.42 -22.51 61.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -59.14 -52.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.929 1.292 . . . . 0.0 108.978 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 37' ' ' LEU 0.272 0.2 OUTLIER -70.72 -30.49 67.05 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.178 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -60.91 -32.76 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.569 1.532 . . . . 0.0 112.642 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.64 56.43 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.549 1.068 . . . . 0.0 113.434 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.52 19.16 21.04 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.218 1.807 . . . . 0.0 113.807 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 14.27 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.543 1.068 . . . . 0.0 115.495 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.98 -163.51 0.93 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.019 1.328 . . . . 0.0 112.547 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.84 58.1 1.78 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.002 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 -118.79 5.86 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.089 1.328 . . . . 0.0 112.956 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -143.72 17.64 1.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.513 1.925 . . . . 0.0 110.987 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.6 ttp -76.3 49.13 0.56 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.113 1.765 . . . . 0.0 113.128 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -170.02 173.87 5.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.272 1.829 . . . . 0.0 113.42 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 166.11 10.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.103 2.561 . . . . 0.0 113.983 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.1 t -50.95 -46.95 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.414 1.886 . . . . 0.0 112.078 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.57 -30.08 71.1 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -79.0 -46.3 18.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.6 -0.714 . . . . 0.0 110.885 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.69 -45.45 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.257 1.389 . . . . 0.0 112.883 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.4 ptm -68.89 -27.91 66.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -64.37 -59.8 3.93 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 110.987 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -56.79 -35.06 68.27 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.917 0.887 . . . . 0.0 113.216 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.13 -39.43 72.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.086 0.857 . . . . 0.0 112.987 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -47.35 89.04 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 119.316 0.962 . . . . 0.0 111.799 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 12.7 pt20 -69.85 -31.5 69.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.114 -0.945 . . . . 0.0 113.031 174.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.18 -54.08 49.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.822 1.646 . . . . 0.0 110.837 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.13 -44.37 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.595 0.758 . . . . 0.0 110.246 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -33.99 77.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.18 -51.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.339 1.455 . . . . 0.0 111.746 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -66.42 -15.99 63.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.447 0.699 . . . . 0.0 112.423 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.6 pt20 46.97 43.27 13.52 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 128.085 2.554 . . . . 0.0 113.287 172.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.18 18.04 15.86 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.893 1.677 . . . . 0.0 112.847 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -85.91 166.36 16.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.253 1.421 . . . . 0.0 112.799 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.26 135.72 49.23 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.446 -0.784 . . . . 0.0 112.301 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -36.52 44.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.167 1.387 . . . . 0.0 113.365 172.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -91.73 -20.37 21.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.915 1.286 . . . . 0.0 113.021 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -153.55 102.63 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.336 1.054 . . . . 0.0 111.976 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -59.81 -17.42 35.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.924 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -21.55 62.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.67 0.788 . . . . 0.0 113.026 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.6 tpt -96.79 125.57 41.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 109.787 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.7 120.99 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.987 1.315 . . . . 0.0 110.345 -169.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -88.59 165.87 14.52 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.35 1.06 . . . . 0.0 111.422 172.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -151.62 23.85 0.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.478 1.511 . . . . 0.0 113.058 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.2 108.58 2.11 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.311 -0.868 . . . . 0.0 112.732 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 14.13 72.59 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.452 1.025 . . . . 0.0 115.127 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.16 147.64 22.92 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.751 1.775 . . . . 0.0 110.571 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.1 mt -58.51 -27.52 64.57 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.363 -0.836 . . . . 0.0 112.06 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.82 -37.23 85.68 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.303 -0.873 . . . . 0.0 112.525 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.13 -39.03 94.46 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.558 0.617 . . . . 0.0 112.346 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 117.975 0.887 . . . . 0.0 111.607 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.83 -45.77 67.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.519 1.128 . . . . 0.0 113.062 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.25 -19.72 39.05 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 113.494 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.04 8.61 87.22 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.422 1.011 . . . . 0.0 114.754 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.4 154.73 41.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.348 1.459 . . . . 0.0 112.849 172.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.2 11.9 32.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.8 p -157.17 144.59 18.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -155.74 175.82 13.42 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.787 2.035 . . . . 0.0 109.565 172.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 p -149.16 175.29 11.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.347 -1.471 . . . . 0.0 113.226 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.08 -19.95 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.592 0.757 . . . . 0.0 112.098 170.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -90.36 -21.0 22.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.272 1.429 . . . . 0.0 113.495 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -122.33 61.07 14.12 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 126.405 1.882 . . . . 0.0 112.149 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.49 -4.54 10.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.575 2.85 . . . . 0.0 113.84 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -46.53 -35.5 4.96 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.3 -31.79 95.68 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.33 2.02 . . . . 0.0 114.665 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 tt -66.76 -54.87 18.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.202 1.401 . . . . 0.0 109.904 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -61.84 -36.61 81.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.482 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.83 -45.12 91.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.957 0.799 . . . . 0.0 112.411 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ttp -56.15 -39.18 71.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.623 1.569 . . . . 0.0 111.288 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . 0.286 4.5 pp -85.79 -40.79 15.66 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -64.11 -30.57 71.63 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 120.484 1.493 . . . . 0.0 113.485 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -68.32 -22.61 64.69 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.578 0.751 . . . . 0.0 112.525 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 173.027 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -178.7 4.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.639 2.776 . . . . 0.0 111.351 -168.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 46' ' ' MET . 2.2 t -87.74 172.66 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.536 1.534 . . . . 0.0 110.077 -170.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -162.26 144.6 8.54 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 130.211 3.404 . . . . 0.0 108.308 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -104.61 170.47 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -83.26 156.98 22.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.848 1.259 . . . . 0.0 107.895 167.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -50.87 -40.82 67.98 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.84 -23.55 47.71 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.579 2.186 . . . . 0.0 115.08 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.5 mt -92.45 -34.76 13.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.294 1.037 . . . . 0.0 112.027 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.55 -38.26 89.35 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.822 1.649 . . . . 0.0 112.074 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.278 44.3 pttt -70.09 -24.47 63.22 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.68 -53.56 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.439 1.496 . . . . 0.0 109.225 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.3 12.9 mt -70.88 -30.94 67.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -64.4 -32.33 73.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.374 -1.454 . . . . 0.0 112.844 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.43 63.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.447 1.021 . . . . 0.0 113.025 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 25.57 10.78 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.026 1.731 . . . . 0.0 113.375 172.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.15 12.22 81.63 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.75 1.167 . . . . 0.0 115.884 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.17 -169.72 2.67 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 118.714 1.257 . . . . 0.0 113.272 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -125.95 47.95 2.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.787 2.035 . . . . 0.0 110.985 169.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.49 -119.78 5.22 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.98 1.276 . . . . 0.0 112.561 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.02 18.96 3.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.516 1.927 . . . . 0.0 110.853 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 58.7 ttp -75.22 47.1 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.903 2.081 . . . . 0.0 113.067 -170.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -171.82 175.92 3.77 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.312 2.245 . . . . 0.0 112.788 -168.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -74.37 170.31 15.89 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.932 2.093 . . . . 0.0 113.564 -171.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -47.87 -46.55 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 127.01 2.124 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -66.95 -30.13 70.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.31 -45.24 18.19 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.859 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -58.09 -46.1 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.442 1.474 . . . . 0.0 112.763 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.8 ptm -70.02 -26.97 64.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.93 -58.57 6.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.074 1.35 . . . . 0.0 110.766 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -56.73 -36.9 70.26 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.78 -42.86 81.01 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.163 0.892 . . . . 0.0 112.166 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.79 -47.28 89.75 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.843 0.735 . . . . 0.0 112.414 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.254 12.5 pt20 -70.67 -31.65 68.63 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.65 -0.912 . . . . 0.0 112.998 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.11 -51.5 69.44 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.515 1.507 . . . . 0.0 110.833 169.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -57.87 -42.99 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.671 0.789 . . . . 0.0 110.326 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.3 tpp -68.84 -32.0 71.37 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.57 -50.33 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.481 1.112 . . . . 0.0 111.352 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -66.4 -16.08 63.81 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.784 0.834 . . . . 0.0 112.876 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.295 6.5 pt20 45.15 42.86 7.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.191 2.597 . . . . 0.0 113.427 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -99.46 19.87 14.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.653 1.581 . . . . 0.0 112.758 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -84.28 165.45 18.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.61 1.564 . . . . 0.0 111.916 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.91 135.54 48.03 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.243 -0.91 . . . . 0.0 111.913 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -45.28 63.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.244 1.017 . . . . 0.0 113.17 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -81.42 -12.35 58.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.769 0.828 . . . . 0.0 112.488 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.7 93.92 1.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.553 1.141 . . . . 0.0 112.126 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -58.63 -17.62 23.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.721 1.208 . . . . 0.0 112.843 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -26.06 67.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.502 1.121 . . . . 0.0 112.862 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -101.28 130.19 47.38 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.993 1.717 . . . . 0.0 110.918 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.82 133.37 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 110.805 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -111.81 158.46 19.36 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.567 1.547 . . . . 0.0 111.377 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 88' ' ' GLN . 66.7 m -146.67 28.09 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.33 115.17 7.29 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 121.672 -0.642 . . . . 0.0 112.612 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.97 12.82 65.68 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.062 1.315 . . . . 0.0 115.36 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.63 150.06 21.09 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 119.793 1.797 . . . . 0.0 112.014 -175.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.51 -27.74 64.76 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.606 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.46 -39.19 91.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.705 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.68 -37.67 89.31 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.786 -0.571 . . . . 0.0 111.702 173.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -65.63 -37.36 86.35 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 117.984 0.892 . . . . 0.0 112.279 171.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.16 -44.72 79.06 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.008 1.323 . . . . 0.0 112.305 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.65 -18.41 31.38 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.72 5.05 89.53 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.57 1.081 . . . . 0.0 114.38 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -138.76 144.27 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.22 1.808 . . . . 0.0 111.555 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 76' ' ' CYS . 38.5 mt-30 -94.59 6.92 47.41 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.9 p -154.23 149.88 27.46 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 169.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -161.14 176.84 10.86 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.066 2.146 . . . . 0.0 109.734 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.5 p -142.44 171.58 13.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.72 -1.238 . . . . 0.0 112.226 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 m -72.35 -7.24 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.45 -24.82 17.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.195 1.398 . . . . 0.0 112.45 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -129.35 64.56 71.72 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.312 1.845 . . . . 0.0 111.985 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.3 0.04 10.2 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.165 3.243 . . . . 0.0 113.836 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 m -46.29 -34.79 3.64 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -59.47 -28.05 86.53 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.306 2.004 . . . . 0.0 114.941 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tt -68.2 -52.41 34.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.794 1.238 . . . . 0.0 110.405 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -64.92 -36.21 83.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.734 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.76 -31.53 72.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.634 0.773 . . . . 0.0 112.925 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -47.03 83.51 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.247 1.019 . . . . 0.0 111.19 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -92.5 -20.3 21.1 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -62.22 -27.15 68.79 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.943 1.247 . . . . 0.0 112.948 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -65.4 -27.25 68.41 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.051 2.54 . . . . 0.0 112.741 171.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m120 . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.042 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 . . . . . 0 CA--C 1.546 0.811 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.8 pt -60.13 158.99 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.008 1.323 . . . . 0.0 114.21 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.27 48.04 1.56 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.304 1.442 . . . . 0.0 112.674 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -172.57 3.03 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 129.823 3.249 . . . . 0.0 108.434 -168.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.56 169.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 -168.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -164.75 141.03 4.84 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 130.443 3.497 . . . . 0.0 108.82 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HG3' ' H ' ' A' ' 45' ' ' GLU . 11.5 Cg_endo -102.7 175.3 0.19 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.897 3.064 . . . . 0.0 113.944 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -97.05 163.44 12.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.524 1.53 . . . . 0.0 110.287 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -42.59 -55.68 6.73 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.95 -21.13 50.41 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.721 2.281 . . . . 0.0 114.339 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.4 mt -90.63 -33.38 15.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.484 1.114 . . . . 0.0 111.914 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.03 -34.97 72.51 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.555 1.542 . . . . 0.0 110.978 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -54.84 -35.2 63.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.908 2.083 . . . . 0.0 112.964 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -73.99 -47.5 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.515 1.526 . . . . 0.0 109.675 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.267 2.2 mp -70.75 -30.56 67.1 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.533 -0.729 . . . . 0.0 112.486 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -60.65 -35.95 77.47 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.692 -1.255 . . . . 0.0 112.78 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.16 -21.96 64.26 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.028 0.831 . . . . 0.0 113.218 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.08 17.0 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.057 1.743 . . . . 0.0 113.616 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.19 15.15 76.69 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -85.43 -157.75 0.34 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.869 1.268 . . . . 0.0 112.282 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -136.32 54.21 1.9 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.82 1.648 . . . . 0.0 111.902 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.8 -170.39 40.25 Favored Glycine 0 C--O 1.216 -0.979 0 C-N-CA 124.466 1.032 . . . . 0.0 112.184 -169.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' ' 29' ' ' PRO . 45.9 mt-10 -79.16 18.97 0.59 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.016 1.727 . . . . 0.0 113.808 173.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.9 ttp -74.26 48.65 0.33 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.296 2.238 . . . . 0.0 115.036 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' CZ ' ' CD2' ' A' ' 55' ' ' TYR . 0.3 OUTLIER -170.75 177.15 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.971 2.108 . . . . 0.0 112.597 -175.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.07 164.32 10.87 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.173 2.189 . . . . 0.0 113.737 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.9 -45.34 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 126.026 1.73 . . . . 0.0 112.533 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -66.96 -30.29 70.38 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -79.57 -46.2 17.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.361 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 m -58.02 -43.63 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 120.415 1.461 . . . . 0.0 113.348 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 26.2 ptm -68.08 -25.25 65.24 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.47 -59.65 3.46 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.866 1.267 . . . . 0.0 110.911 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 82.2 m-85 -58.09 -33.55 69.21 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 174.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.1 tp -69.17 -41.32 77.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.135 0.879 . . . . 0.0 112.212 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.41 86.14 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 119.237 0.926 . . . . 0.0 112.038 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.259 8.0 pt20 -70.93 -31.6 68.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.483 -1.01 . . . . 0.0 112.969 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -56.9 -54.54 45.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.68 1.127 . . . . 0.0 110.157 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.9 mt -59.83 -39.23 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 118.868 0.758 . . . . 0.0 110.119 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 tpt -65.42 -35.84 82.13 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.8 t -78.38 -50.52 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.502 1.046 . . . . 0.0 111.17 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -67.46 -15.77 63.85 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.576 1.55 . . . . 0.0 113.179 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 5.0 pt20 46.92 41.88 11.42 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.657 2.783 . . . . 0.0 113.767 175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -83.43 54.15 2.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.859 1.664 . . . . 0.0 111.15 -174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -139.36 167.72 21.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.182 1.393 . . . . 0.0 112.937 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.37 144.01 40.36 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.704 -0.622 . . . . 0.0 111.933 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.15 -46.04 79.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.252 1.021 . . . . 0.0 113.374 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -80.75 -8.85 59.8 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.582 0.753 . . . . 0.0 112.937 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -157.4 86.59 0.94 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.486 1.136 . . . . 0.0 112.546 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -55.72 -20.47 14.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.198 1.399 . . . . 0.0 112.396 170.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -25.52 67.82 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.067 1.347 . . . . 0.0 113.031 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.2 tpt -104.72 127.16 52.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.328 1.451 . . . . 0.0 110.798 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 t -110.4 134.38 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.446 1.498 . . . . 0.0 110.456 -170.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -132.72 102.53 5.71 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.111 2.564 . . . . 0.0 110.307 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 98.6 m -97.78 28.88 3.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.496 2.319 . . . . 0.0 113.781 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.83 115.16 6.45 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 121.681 -0.637 . . . . 0.0 112.99 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.22 10.99 75.06 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.288 1.423 . . . . 0.0 115.969 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.2 151.62 19.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 120.241 2.021 . . . . 0.0 112.395 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 mp -57.24 -27.89 62.44 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.824 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.5 tp -66.76 -40.15 88.16 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.219 0.918 . . . . 0.0 112.671 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.97 -39.16 96.27 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -65.62 -37.7 87.31 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.889 -0.771 . . . . 0.0 112.464 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.0 tp -66.6 -45.56 78.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.141 1.376 . . . . 0.0 112.296 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mp -82.5 -23.04 34.83 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 113.222 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.35 7.46 86.53 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.856 1.217 . . . . 0.0 114.403 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 147.11 30.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.446 1.899 . . . . 0.0 110.836 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -97.18 9.79 41.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.7 p -152.47 148.38 27.35 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -162.43 176.27 10.66 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.582 2.353 . . . . 0.0 109.764 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.5 p -140.2 168.7 19.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.821 -1.174 . . . . 0.0 112.528 174.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.71 -9.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -95.01 -26.06 16.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.338 1.455 . . . . 0.0 112.456 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -124.06 67.19 42.96 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.434 1.893 . . . . 0.0 112.095 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.05 6.43 5.58 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.287 3.325 . . . . 0.0 114.708 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.5 m -47.41 -34.32 4.69 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -57.75 -26.21 72.29 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.163 2.575 . . . . 0.0 115.884 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.46 -50.55 36.99 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.518 1.054 . . . . 0.0 110.081 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -67.08 -29.15 68.84 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.332 -0.855 . . . . 0.0 112.561 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.6 -31.35 72.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.152 0.981 . . . . 0.0 112.733 169.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -35.64 71.57 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.057 1.343 . . . . 0.0 111.835 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.4 mt -83.61 -39.72 19.95 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.096 1.359 . . . . 0.0 113.551 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -56.55 -29.53 62.08 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.6 1.56 . . . . 0.0 113.681 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.53 -28.33 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.347 1.859 . . . . 0.0 112.543 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -93.14 -62.97 1.27 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.779 0.832 . . . . 0.0 113.089 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -123.44 150.96 43.18 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.845 1.258 . . . . 0.0 112.717 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.04 117.24 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.4 t -150.31 -176.78 5.61 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.911 1.284 . . . . 0.0 111.663 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.63 160.55 16.61 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.594 1.558 . . . . 0.0 112.696 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -153.27 176.43 11.97 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.405 1.482 . . . . 0.0 111.818 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.119 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . 0.413 ' C4 ' ' C6 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.6 pt -134.78 167.71 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 127.36 2.264 . . . . 0.0 112.679 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -82.15 29.37 0.41 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.476 1.51 . . . . 0.0 114.45 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.39 -178.85 5.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.729 2.812 . . . . 0.0 110.743 -168.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 169.2 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.795 0.438 . . . . 0.0 110.088 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -164.72 135.46 3.2 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 128.266 2.626 . . . . 0.0 107.789 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.538 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 10.9 Cg_endo -99.18 176.23 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.9 2.4 . . . . 0.0 114.934 -169.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -104.57 159.72 15.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.595 2.358 . . . . 0.0 106.815 166.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.49 -40.62 77.04 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -171.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -67.33 -25.46 42.33 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.623 2.215 . . . . 0.0 114.246 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.29 -37.17 20.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.215 1.006 . . . . 0.0 111.267 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.72 -31.9 70.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.102 0.961 . . . . 0.0 111.431 171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.56 -38.76 72.36 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.61 1.564 . . . . 0.0 112.596 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.6 mt -70.78 -46.73 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.17 1.788 . . . . 0.0 109.552 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.69 -31.41 68.29 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.75 -0.594 . . . . 0.0 112.026 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -65.36 -34.92 79.45 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.468 -1.395 . . . . 0.0 112.979 170.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.99 64.6 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.19 0.904 . . . . 0.0 112.926 171.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.19 16.78 24.35 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.985 1.714 . . . . 0.0 114.035 172.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.73 15.64 73.69 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.434 1.016 . . . . 0.0 115.549 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -84.4 -162.92 0.72 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.905 1.282 . . . . 0.0 112.311 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -133.47 68.63 1.49 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.724 1.61 . . . . 0.0 111.074 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.37 -144.22 37.04 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.482 0.563 . . . . 0.0 112.583 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.7 mt-10 -125.06 16.45 8.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.55 1.94 . . . . 0.0 112.266 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.8 ttt -79.51 58.28 2.64 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.493 1.117 . . . . 0.0 112.963 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -170.37 175.07 4.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.338 1.855 . . . . 0.0 113.413 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.05 165.23 16.17 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.261 2.224 . . . . 0.0 114.308 -172.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.9 t -47.85 -45.27 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.27 1.828 . . . . 0.0 112.359 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -66.29 -30.57 71.02 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.62 -47.6 16.79 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.635 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.41 -46.17 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 120.373 1.442 . . . . 0.0 112.676 175.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -70.63 -27.83 64.36 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.95 -59.7 4.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 110.703 170.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 54.3 m-85 -55.85 -37.21 68.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.149 0.979 . . . . 0.0 113.548 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.28 -36.72 79.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.844 1.202 . . . . 0.0 113.008 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 -47.37 88.41 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.882 1.219 . . . . 0.0 112.256 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.274 13.3 pt20 -70.91 -31.61 68.29 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.474 -1.015 . . . . 0.0 113.09 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.61 -53.82 49.54 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.562 1.528 . . . . 0.0 110.346 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.25 -43.21 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.532 1.133 . . . . 0.0 110.382 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.1 ttm -69.04 -30.51 68.88 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.33 -50.84 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.12 0.968 . . . . 0.0 111.239 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.02 -15.94 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.947 0.899 . . . . 0.0 113.239 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.29 6.4 pt20 43.97 44.22 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 128.152 2.581 . . . . 0.0 113.582 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.63 16.53 23.12 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.863 1.665 . . . . 0.0 112.843 -169.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -81.96 165.64 20.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.378 1.471 . . . . 0.0 112.269 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.73 147.98 45.09 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 122.196 0.998 . . . . 0.0 112.989 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.608 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.8 -37.86 76.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.92 1.688 . . . . 0.0 111.483 -176.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -91.33 -20.94 21.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.698 1.599 . . . . 0.0 112.38 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.25 92.02 2.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 122.365 1.079 . . . . 0.0 112.268 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -57.21 -18.79 17.37 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.419 1.488 . . . . 0.0 112.776 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -24.72 66.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.377 1.071 . . . . 0.0 113.041 174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -99.9 133.13 44.73 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.424 1.889 . . . . 0.0 110.776 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.61 132.62 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.543 1.537 . . . . 0.0 110.489 -171.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -113.69 165.71 12.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.871 1.668 . . . . 0.0 110.989 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.7 m -134.8 -25.51 1.42 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.431 1.093 . . . . 0.0 113.824 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 53.4 31.65 43.54 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.19 13.61 65.74 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.784 1.183 . . . . 0.0 115.758 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -69.3 167.24 16.82 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 119.511 1.656 . . . . 0.0 111.904 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.34 -27.99 64.68 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.648 1.179 . . . . 0.0 112.514 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.11 -41.56 86.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.516 -0.74 . . . . 0.0 112.109 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.73 96.65 Favored Glycine 0 N--CA 1.472 1.04 0 O-C-N 121.696 -0.627 . . . . 0.0 112.215 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.71 -36.86 84.83 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.554 -0.968 . . . . 0.0 112.066 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.41 -43.36 81.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.808 1.243 . . . . 0.0 112.497 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.79 -18.89 42.53 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.383 1.073 . . . . 0.0 112.975 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.63 -14.22 25.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.985 1.755 . . . . 0.0 113.963 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -125.98 138.74 53.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.762 2.425 . . . . 0.0 108.954 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -98.53 16.3 22.27 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -174.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -153.29 146.38 24.62 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.269 -0.894 . . . . 0.0 112.663 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -164.14 174.42 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.528 1.931 . . . . 0.0 110.12 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 p -139.1 171.7 13.92 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.752 -1.218 . . . . 0.0 111.996 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.56 -8.32 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -95.07 -23.8 17.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.216 1.406 . . . . 0.0 112.574 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -130.38 65.4 75.81 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.49 1.916 . . . . 0.0 111.965 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.1 0.44 9.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.409 3.406 . . . . 0.0 113.888 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.0 m -46.1 -35.35 4.1 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -54.36 -31.21 66.65 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.741 2.294 . . . . 0.0 115.758 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.54 -50.8 33.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.692 1.197 . . . . 0.0 110.488 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -62.89 -37.46 87.04 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.666 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.22 -31.78 72.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.934 . . . . 0.0 112.92 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -45.91 90.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.475 1.11 . . . . 0.0 111.117 170.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 pp -93.82 -19.69 20.77 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -27.08 69.09 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.996 1.271 . . . . 0.0 112.904 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -62.9 -29.94 71.16 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.778 2.431 . . . . 0.0 112.259 170.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -84.68 -67.63 0.78 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.607 0.763 . . . . 0.0 112.826 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -113.32 143.06 45.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.668 1.187 . . . . 0.0 113.086 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.51 112.26 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 t -153.76 175.98 12.66 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.013 0.925 . . . . 0.0 112.997 -171.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.49 157.05 20.54 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.064 1.746 . . . . 0.0 112.373 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.8 172.55 13.48 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.446 1.499 . . . . 0.0 112.22 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.359 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . 0.41 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.963 0.411 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 pt -135.23 166.14 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.874 1.67 . . . . 0.0 113.055 -174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.4 36.52 0.48 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.863 1.665 . . . . 0.0 114.218 -172.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.67 -178.79 3.91 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.719 2.408 . . . . 0.0 113.981 -167.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 46' ' ' MET . 7.8 t -93.59 172.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.467 1.907 . . . . 0.0 108.941 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -162.44 139.12 6.0 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 129.908 3.283 . . . . 0.0 107.474 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -99.73 168.37 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.514 2.809 . . . . 0.0 113.997 -171.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -86.62 162.81 17.77 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.014 1.326 . . . . 0.0 110.444 168.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.8 mt -49.18 -48.19 74.19 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.14 -28.61 34.24 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.2 1.822 . . . . 0.0 113.856 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -79.23 -37.74 37.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.842 0.747 . . . . 0.0 111.266 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.75 -34.81 73.45 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.826 1.25 . . . . 0.0 111.169 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -59.28 -40.77 87.14 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.762 1.225 . . . . 0.0 113.182 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.5 -50.91 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.238 1.415 . . . . 0.0 109.595 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.354 12.5 mt -70.94 -30.37 66.66 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -63.18 -37.91 89.11 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 119.885 -1.76 . . . . 0.0 111.921 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.94 -18.42 65.23 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.794 0.725 . . . . 0.0 112.745 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.03 5.03 46.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.586 1.555 . . . . 0.0 114.332 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.46 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.564 1.078 . . . . 0.0 114.94 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.68 -164.0 1.09 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.432 1.493 . . . . 0.0 112.716 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -124.58 43.18 3.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 110.88 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.19 -113.87 3.76 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.879 -1.138 . . . . 0.0 112.446 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.25 19.29 2.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.555 1.942 . . . . 0.0 111.431 -174.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 28.2 ptm -71.54 38.82 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.585 1.554 . . . . 0.0 115.192 -175.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -166.27 174.78 8.83 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.441 1.897 . . . . 0.0 113.967 -167.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 m -68.4 168.1 13.32 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.656 2.382 . . . . 0.0 113.628 -172.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -53.01 -43.52 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 126.29 1.836 . . . . 0.0 111.804 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -65.79 -30.06 70.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -80.47 -46.93 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.014 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.42 -44.8 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 119.929 1.241 . . . . 0.0 112.752 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.9 ptm -71.47 -27.47 63.26 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -61.44 -58.77 6.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.558 1.143 . . . . 0.0 110.395 170.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -56.34 -39.21 72.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.094 0.958 . . . . 0.0 113.253 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.09 -35.02 69.1 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.624 1.102 . . . . 0.0 112.702 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -47.48 90.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.157 0.89 . . . . 0.0 112.219 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.45 -31.56 71.82 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.419 -1.047 . . . . 0.0 112.378 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -58.53 -53.57 56.81 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.558 1.072 . . . . 0.0 111.654 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.9 mt -56.25 -42.16 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.534 0.734 . . . . 0.0 109.983 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.38 -36.14 83.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.25 -48.94 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.06 0.944 . . . . 0.0 111.122 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -66.84 -15.92 63.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.982 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.313 5.3 pt20 46.23 39.63 6.42 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.389 2.676 . . . . 0.0 113.803 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt -84.86 58.23 4.86 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.586 1.554 . . . . 0.0 110.579 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -136.98 168.03 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.172 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.4 135.32 48.64 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.498 -0.751 . . . . 0.0 111.742 176.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -39.38 25.04 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.923 1.689 . . . . 0.0 113.867 171.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -90.18 -15.95 30.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.984 1.313 . . . . 0.0 113.407 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.66 95.03 1.96 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.713 1.244 . . . . 0.0 112.396 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -57.75 -18.66 22.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.625 1.57 . . . . 0.0 112.72 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -14.56 61.42 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -110.74 119.86 40.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.602 1.561 . . . . 0.0 110.357 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 t -96.8 135.01 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.453 1.501 . . . . 0.0 110.555 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -135.75 95.81 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.95 2.5 . . . . 0.0 109.699 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 97.6 m -79.52 -24.03 42.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.104 1.761 . . . . 0.0 114.671 -169.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 50.97 35.74 32.98 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.7 1.143 . . . . 0.0 115.87 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.84 13.46 62.54 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 115.902 1.121 . . . . 0.0 115.902 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.84 158.18 25.8 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.731 1.766 . . . . 0.0 111.441 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.2 mt -55.18 -27.84 48.63 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.463 -0.773 . . . . 0.0 112.832 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.1 tp -57.09 -47.98 79.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.899 1.28 . . . . 0.0 111.643 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.79 94.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.834 0.73 . . . . 0.0 112.417 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -65.21 -37.73 88.21 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.135 0.968 . . . . 0.0 111.992 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.95 -46.87 79.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.17 1.388 . . . . 0.0 111.815 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.5 mt -79.07 -17.37 55.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.69 -2.3 83.38 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.963 1.268 . . . . 0.0 114.47 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -146.66 142.23 27.66 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 128.084 2.554 . . . . 0.0 109.123 172.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -96.43 12.97 29.42 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.564 -172.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.2 p -147.1 141.33 26.2 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.95 -1.094 . . . . 0.0 112.929 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -164.63 173.38 12.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.214 2.205 . . . . 0.0 109.873 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 p -142.95 175.18 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.087 -1.008 . . . . 0.0 112.624 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.5 m -67.68 -13.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -93.06 -21.94 19.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.713 1.205 . . . . 0.0 113.0 172.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -126.14 60.58 36.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.911 1.684 . . . . 0.0 112.58 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.94 0.3 9.98 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.195 3.263 . . . . 0.0 113.652 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.0 m -45.91 -33.55 2.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 127.079 2.152 . . . . 0.0 116.322 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.24 -29.47 90.42 Favored 'Trans proline' 0 C--N 1.356 0.928 0 CA-C-N 122.227 1.831 . . . . 0.0 114.769 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.48 -49.34 63.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.263 0.938 . . . . 0.0 110.531 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -64.54 -34.07 77.38 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.674 -0.641 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -68.52 -31.59 70.95 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -34.46 77.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.341 1.456 . . . . 0.0 111.314 170.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.3 mt -92.89 -37.23 12.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.114 1.366 . . . . 0.0 114.243 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -56.45 -25.92 52.17 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.726 1.611 . . . . 0.0 113.845 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -71.17 -26.55 63.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.506 1.923 . . . . 0.0 112.636 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -112.2 -64.93 1.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.88 140.86 57.8 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.828 1.251 . . . . 0.0 109.571 171.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.22 74.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.434 -0.791 . . . . 0.0 109.12 169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.3 t -129.52 171.15 12.87 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.689 1.596 . . . . 0.0 113.007 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.52 148.45 24.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.786 1.634 . . . . 0.0 111.993 -173.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.24 175.6 11.63 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.718 1.607 . . . . 0.0 111.778 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.11 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.0 pt -136.58 158.57 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.771 1.629 . . . . 0.0 113.049 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -91.83 54.42 2.43 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.186 1.395 . . . . 0.0 112.185 -171.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.31 -174.68 3.89 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.782 2.833 . . . . 0.0 109.637 -168.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.73 172.45 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.456 1.502 . . . . 0.0 112.259 -169.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -161.38 145.4 9.88 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 130.652 3.581 . . . . 0.0 108.165 168.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -103.72 172.15 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.834 3.023 . . . . 0.0 114.181 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -86.51 158.57 19.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 108.062 167.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.7 -46.09 71.59 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -66.03 -24.96 51.97 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.711 2.274 . . . . 0.0 114.643 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.37 -35.86 16.91 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.243 1.017 . . . . 0.0 111.952 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.26 -31.9 72.53 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.636 1.575 . . . . 0.0 111.36 170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -56.17 -38.68 71.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.459 1.504 . . . . 0.0 112.607 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -66.85 -50.9 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.068 1.747 . . . . 0.0 109.417 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.324 12.3 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.748 -0.595 . . . . 0.0 112.571 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -61.81 -33.19 73.68 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.643 -1.285 . . . . 0.0 112.576 169.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.82 -22.61 62.47 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 119.379 0.99 . . . . 0.0 113.263 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.67 24.45 12.64 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.012 1.725 . . . . 0.0 113.334 172.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.94 14.02 80.46 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.785 1.183 . . . . 0.0 115.824 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.9 -169.27 2.42 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.46 1.13 . . . . 0.0 113.438 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.53 45.22 2.5 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.69 1.996 . . . . 0.0 110.917 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.71 -119.95 5.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.093 1.33 . . . . 0.0 112.637 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.4 17.04 3.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.557 1.943 . . . . 0.0 110.589 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 58.1 ttp -76.52 50.52 0.67 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.116 1.767 . . . . 0.0 112.889 -169.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -174.37 171.16 3.47 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.438 2.295 . . . . 0.0 112.208 -168.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 168.76 10.83 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.47 1.908 . . . . 0.0 114.092 -171.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.3 t -47.78 -44.14 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.518 1.927 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -67.64 -30.59 70.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -80.46 -44.29 19.46 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.961 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.47 -46.24 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.252 1.387 . . . . 0.0 112.622 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 18.2 ptm -69.86 -23.96 63.35 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.89 -59.75 3.54 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.975 1.31 . . . . 0.0 110.961 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -56.14 -37.14 69.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.258 1.023 . . . . 0.0 113.281 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.6 tt -72.57 -38.07 68.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.897 0.879 . . . . 0.0 111.623 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.09 -47.4 87.83 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.898 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.257 13.7 pt20 -69.91 -31.54 69.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.416 -1.049 . . . . 0.0 112.873 174.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CD1' HD22 ' A' ' 81' ' ' LEU . 12.5 t80 -55.66 -51.51 67.01 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.442 1.473 . . . . 0.0 110.457 169.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.2 mt -58.12 -44.89 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.999 0.92 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.0 ttm -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.62 -51.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.36 1.064 . . . . 0.0 111.355 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.24 -15.97 64.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.92 0.888 . . . . 0.0 113.282 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.3 pt20 43.79 43.51 5.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 128.164 2.585 . . . . 0.0 113.483 176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -99.67 23.19 9.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.818 1.647 . . . . 0.0 112.9 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -87.01 163.69 16.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.707 1.603 . . . . 0.0 111.337 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -75.13 134.55 41.25 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.157 -0.964 . . . . 0.0 111.904 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -35.72 61.64 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.637 1.575 . . . . 0.0 113.515 171.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -82.2 -26.6 33.19 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 112.398 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -151.7 93.9 1.92 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 122.425 1.107 . . . . 0.0 111.558 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -58.87 -17.68 26.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 112.606 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.06 69.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.249 1.02 . . . . 0.0 112.913 174.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.3 tpt -98.4 133.06 43.32 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.981 1.712 . . . . 0.0 110.962 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.0 t -125.83 131.83 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.073 1.349 . . . . 0.0 110.957 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -108.51 163.51 13.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.575 1.55 . . . . 0.0 111.795 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 m -145.24 29.69 1.16 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.872 2.069 . . . . 0.0 111.489 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.47 113.44 3.81 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 121.612 -0.68 . . . . 0.0 114.048 -169.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.74 11.76 66.4 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.07 -1.406 . . . . 0.0 115.775 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -100.04 159.18 15.29 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 120.421 2.111 . . . . 0.0 111.99 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.34 -28.04 68.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.093 0.957 . . . . 0.0 111.863 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.4 HD22 ' CD1' ' A' ' 59' ' ' TYR . 46.9 tp -67.2 -37.88 84.39 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.339 -0.85 . . . . 0.0 112.38 171.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.43 -39.24 94.06 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.839 -0.538 . . . . 0.0 111.891 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -65.0 -36.95 86.04 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.795 -0.827 . . . . 0.0 112.138 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.04 -43.57 82.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.665 1.186 . . . . 0.0 112.395 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.78 -21.51 37.73 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.2 -0.31 89.39 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.629 1.109 . . . . 0.0 114.583 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -145.75 156.11 43.39 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.128 1.771 . . . . 0.0 111.897 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -99.55 16.32 23.71 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.0 p -153.57 152.93 31.47 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 169.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -163.12 179.54 7.41 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.62 2.368 . . . . 0.0 109.58 170.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 p -145.26 171.2 14.9 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.294 -1.504 . . . . 0.0 112.705 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.0 m -73.49 -6.7 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 171.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -95.11 -28.39 15.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.029 1.331 . . . . 0.0 112.345 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -128.71 70.62 80.7 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 126.287 1.835 . . . . 0.0 111.498 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.82 1.62 8.69 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.334 3.356 . . . . 0.0 113.527 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -45.47 -34.46 2.45 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.935 2.094 . . . . 0.0 115.924 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.59 -26.41 80.45 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.362 2.041 . . . . 0.0 114.876 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.34 -46.03 57.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.191 0.905 . . . . 0.0 110.424 171.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -67.15 -31.68 72.28 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.518 -0.739 . . . . 0.0 112.404 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.68 -31.59 71.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.177 0.899 . . . . 0.0 112.798 171.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -36.38 81.9 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.076 1.35 . . . . 0.0 111.6 169.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.7 mt -86.7 -39.77 15.71 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.002 1.321 . . . . 0.0 114.233 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -57.71 -28.36 63.77 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.416 1.486 . . . . 0.0 113.787 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -71.0 -26.69 63.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.855 2.062 . . . . 0.0 112.735 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -105.0 -42.1 5.41 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -128.11 147.52 50.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.793 1.237 . . . . 0.0 112.087 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -76.06 114.09 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 170.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.6 t -152.86 172.88 16.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.081 0.952 . . . . 0.0 112.869 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.1 mt -81.48 158.45 24.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.738 1.615 . . . . 0.0 111.921 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.11 169.17 19.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.816 1.246 . . . . 0.0 113.145 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.717 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . 0.419 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 pt -83.05 167.74 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.98 1.312 . . . . 0.0 112.656 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -80.05 32.62 0.27 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.577 1.551 . . . . 0.0 113.964 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.8 -178.23 4.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.427 2.691 . . . . 0.0 113.647 -167.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -92.29 172.16 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.448 1.499 . . . . 0.0 109.99 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -159.94 141.83 9.58 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 130.723 3.609 . . . . 0.0 108.708 169.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 28.0 Cg_endo -99.38 169.58 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.892 3.062 . . . . 0.0 113.858 -175.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -82.88 160.44 22.15 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.983 1.313 . . . . 0.0 109.177 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.36 -47.75 67.57 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.42 -28.1 33.02 Favored 'Trans proline' 0 C--N 1.353 0.779 0 CA-C-N 122.299 1.857 . . . . 0.0 113.339 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.35 -35.66 54.43 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.282 -0.886 . . . . 0.0 111.568 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.3 -35.03 76.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.994 1.318 . . . . 0.0 110.951 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -59.73 -43.22 94.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.547 1.539 . . . . 0.0 112.648 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.0 mt -59.25 -52.87 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 109.492 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.347 11.1 mt -70.79 -30.5 66.99 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -61.45 -33.82 74.39 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.689 -1.257 . . . . 0.0 112.417 168.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.88 -21.78 61.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.299 0.954 . . . . 0.0 113.456 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.54 24.02 13.67 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.773 1.629 . . . . 0.0 113.517 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.87 15.03 78.22 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.552 1.072 . . . . 0.0 115.743 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.16 -166.86 1.46 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.672 1.189 . . . . 0.0 112.932 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -125.44 48.29 2.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.621 1.969 . . . . 0.0 110.587 169.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.29 -116.55 5.26 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.086 1.327 . . . . 0.0 113.107 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 40.7 mt-10 -139.08 19.95 2.62 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.066 2.146 . . . . 0.0 110.954 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 58.0 ttp -78.08 47.59 0.67 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.4 1.48 . . . . 0.0 112.924 -172.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -170.58 175.6 4.62 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.111 1.764 . . . . 0.0 113.635 -168.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.55 167.08 11.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 127.508 2.323 . . . . 0.0 113.721 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.4 -43.27 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.245 1.818 . . . . 0.0 111.804 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -64.34 -30.07 71.13 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -79.97 -48.17 13.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.932 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -55.34 -44.44 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 120.025 1.284 . . . . 0.0 112.788 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 17.0 ptm -71.31 -28.65 64.25 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.74 -59.37 5.26 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 110.874 170.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -55.51 -36.05 66.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.233 1.013 . . . . 0.0 113.592 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.52 -39.07 74.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.63 1.104 . . . . 0.0 113.383 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.71 -47.27 79.18 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 119.697 1.135 . . . . 0.0 112.134 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.01 -31.61 66.37 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.061 -0.971 . . . . 0.0 113.457 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.1 -51.53 68.91 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.887 1.676 . . . . 0.0 110.78 169.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -58.52 -44.25 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.952 0.901 . . . . 0.0 110.379 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 36.5 tpp -66.67 -31.6 72.38 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.7 t -74.39 -49.38 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.693 1.197 . . . . 0.0 111.414 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -66.02 -16.13 63.64 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.293 6.5 pt20 43.35 42.72 3.87 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.153 2.581 . . . . 0.0 113.259 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -100.65 22.04 12.49 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.895 1.678 . . . . 0.0 112.66 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -88.29 165.53 14.95 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.644 1.578 . . . . 0.0 112.069 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -71.21 138.36 49.44 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.228 -0.92 . . . . 0.0 112.13 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -38.4 51.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.244 1.418 . . . . 0.0 113.482 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -98.69 -16.56 18.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.0 1.32 . . . . 0.0 113.709 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.11 94.34 2.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.786 1.234 . . . . 0.0 109.768 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -63.89 -14.12 50.87 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.165 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.09 -19.74 61.1 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -96.77 128.08 43.37 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.254 1.822 . . . . 0.0 109.858 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.77 131.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.676 1.59 . . . . 0.0 110.921 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -104.45 161.87 13.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.258 1.423 . . . . 0.0 110.992 169.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.5 m -145.95 29.57 1.09 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.515 1.926 . . . . 0.0 111.812 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.89 114.31 6.64 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.357 -0.839 . . . . 0.0 112.339 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.11 72.02 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.001 1.286 . . . . 0.0 115.435 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -96.41 146.45 24.75 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.01 1.905 . . . . 0.0 110.826 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.12 -27.66 62.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.419 0.688 . . . . 0.0 112.477 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.6 tp -65.69 -38.83 90.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.679 0.792 . . . . 0.0 112.581 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.87 -39.56 93.43 Favored Glycine 0 N--CA 1.47 0.935 0 O-C-N 121.409 -0.807 . . . . 0.0 111.781 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -63.54 -37.32 86.87 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 117.714 0.757 . . . . 0.0 112.005 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.92 -46.02 63.22 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.091 1.357 . . . . 0.0 112.695 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.21 -21.4 53.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.068 0.947 . . . . 0.0 113.052 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 1.07 90.37 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.701 1.143 . . . . 0.0 114.394 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -144.76 148.66 34.37 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.337 1.855 . . . . 0.0 111.458 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -96.82 12.24 32.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.457 1.103 . . . . 0.0 113.423 -172.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -151.98 146.43 25.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -160.31 176.82 11.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.042 2.137 . . . . 0.0 110.15 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 p -147.59 173.86 12.31 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.543 -1.348 . . . . 0.0 113.166 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.62 -21.12 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.872 0.869 . . . . 0.0 111.732 169.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -88.88 -28.89 20.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.101 1.36 . . . . 0.0 113.008 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -121.02 65.55 13.64 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 126.298 1.839 . . . . 0.0 112.207 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.0 -0.9 10.22 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.969 3.113 . . . . 0.0 113.725 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.5 m -47.31 -34.37 4.56 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -58.84 -32.15 96.67 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.369 2.046 . . . . 0.0 114.645 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -64.95 -48.32 74.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.176 0.99 . . . . 0.0 110.623 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -69.12 -31.35 69.98 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.427 -0.796 . . . . 0.0 111.922 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.83 -33.05 71.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.097 0.862 . . . . 0.0 113.08 173.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -64.51 -39.69 94.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.892 1.277 . . . . 0.0 110.271 169.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.0 mt -82.65 -42.43 18.17 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -56.53 -28.48 60.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.686 1.194 . . . . 0.0 113.868 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.99 -26.58 63.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.91 2.084 . . . . 0.0 112.977 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -96.7 -88.87 0.28 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.561 1.145 . . . . 0.0 112.762 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -80.58 149.76 29.79 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 120.135 1.334 . . . . 0.0 112.098 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.31 112.87 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 t -155.75 -177.63 6.7 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.96 0.904 . . . . 0.0 112.977 -172.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.11 158.03 36.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.425 1.89 . . . . 0.0 112.172 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.55 176.18 11.58 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.151 1.38 . . . . 0.0 112.124 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -174.659 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . 0.401 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 pt -66.0 156.37 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -89.07 52.63 2.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.225 1.41 . . . . 0.0 112.287 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.23 -160.14 0.58 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 129.229 3.012 . . . . 0.0 108.656 -168.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -103.29 172.33 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.497 1.519 . . . . 0.0 110.512 -169.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -160.7 137.97 6.79 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 131.177 3.791 . . . . 0.0 106.867 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 29.4 Cg_endo -101.05 168.71 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.197 2.598 . . . . 0.0 114.432 -170.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.41 159.14 23.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.085 1.354 . . . . 0.0 108.2 167.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.2 mt -53.11 -39.58 72.09 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -65.3 -29.97 54.38 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.42 2.08 . . . . 0.0 114.109 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.86 -36.65 27.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.508 1.123 . . . . 0.0 111.333 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 tt -60.87 -45.77 93.26 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.077 1.351 . . . . 0.0 111.207 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 38.0 pttt -70.54 -26.15 63.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -170.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.41 -54.39 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.478 1.111 . . . . 0.0 108.765 169.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.251 35.0 mt -70.93 -30.77 67.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.77 0.828 . . . . 0.0 112.32 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -34.1 77.54 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.702 -1.249 . . . . 0.0 113.017 172.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.49 64.45 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -102.84 22.92 12.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.01 1.724 . . . . 0.0 113.549 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.35 80.85 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.512 1.053 . . . . 0.0 115.721 172.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.89 -164.61 0.76 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.449 1.125 . . . . 0.0 113.074 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -130.44 48.65 2.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 127.194 2.197 . . . . 0.0 109.193 168.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 -111.77 3.79 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.361 1.458 . . . . 0.0 113.276 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 38.5 mt-10 -139.07 16.78 2.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.588 1.955 . . . . 0.0 111.594 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -75.97 49.83 0.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.515 1.526 . . . . 0.0 113.235 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -173.2 172.12 3.92 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.461 2.305 . . . . 0.0 112.481 -169.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.38 167.35 16.7 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.121 2.168 . . . . 0.0 114.139 -171.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.78 -43.29 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.779 2.032 . . . . 0.0 112.31 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -66.54 -30.14 70.38 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -80.54 -46.41 15.84 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.4 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.17 -44.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 120.03 1.287 . . . . 0.0 112.684 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.2 ptm -69.04 -28.51 66.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.46 -58.25 7.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.189 1.396 . . . . 0.0 110.964 171.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -56.69 -37.0 70.27 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.57 -41.73 75.45 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.15 0.886 . . . . 0.0 111.46 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.92 -47.48 88.64 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 112.907 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -70.51 -31.58 68.73 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.527 -0.984 . . . . 0.0 112.598 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -58.19 -52.1 66.96 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.887 1.222 . . . . 0.0 110.964 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -53.68 -46.29 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.045 0.839 . . . . 0.0 109.711 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -33.88 76.06 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.18 -47.42 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.302 1.041 . . . . 0.0 110.883 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -66.69 -11.24 53.35 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.046 0.938 . . . . 0.0 112.944 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.336 3.0 pt20 46.66 45.55 14.46 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 129.655 3.182 . . . . 0.0 113.311 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.08 58.21 4.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.245 1.418 . . . . 0.0 110.982 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -143.55 164.84 29.25 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.003 1.321 . . . . 0.0 112.574 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -72.86 135.58 45.18 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.649 -0.657 . . . . 0.0 111.721 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -40.23 36.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.162 1.385 . . . . 0.0 113.037 171.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -89.14 -19.16 25.86 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.227 1.411 . . . . 0.0 113.094 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -152.69 94.83 1.93 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.404 1.097 . . . . 0.0 111.742 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.92 -17.84 28.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.131 1.372 . . . . 0.0 112.636 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -21.57 65.45 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.091 0.957 . . . . 0.0 112.973 175.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.5 tpt -104.65 124.1 48.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.303 1.841 . . . . 0.0 110.73 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.96 138.17 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.127 1.771 . . . . 0.0 110.282 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -135.14 94.72 3.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.288 2.235 . . . . 0.0 110.535 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -88.53 30.69 0.88 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.67 2.788 . . . . 0.0 113.472 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.88 116.52 9.15 Favored Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 112.671 -170.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.86 11.3 78.19 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.364 1.459 . . . . 0.0 115.737 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -95.06 147.93 22.89 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.363 2.081 . . . . 0.0 111.792 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.99 -27.59 63.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.5 tp -65.93 -43.24 88.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.998 0.919 . . . . 0.0 112.694 171.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.24 -38.31 95.0 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 118.993 0.815 . . . . 0.0 111.719 173.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -65.07 -38.0 89.36 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.925 -0.75 . . . . 0.0 111.793 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.33 -48.87 63.7 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.071 0.948 . . . . 0.0 112.399 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.35 -20.35 61.48 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.638 0.775 . . . . 0.0 112.701 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.93 -0.21 89.85 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.732 1.158 . . . . 0.0 114.075 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -145.6 145.29 30.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.38 1.872 . . . . 0.0 111.316 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.99 2.69 55.38 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.413 1.085 . . . . 0.0 113.086 -173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.5 p -147.39 140.23 24.94 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -160.65 176.48 11.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.959 2.503 . . . . 0.0 109.155 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.6 p -144.19 174.98 10.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.852 -1.155 . . . . 0.0 112.164 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.97 -8.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 169.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.04 -22.84 17.65 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.323 1.449 . . . . 0.0 113.139 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -124.22 62.14 28.87 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 126.116 1.766 . . . . 0.0 112.012 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.2 2.5 7.95 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.053 3.169 . . . . 0.0 114.258 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 m -46.85 -34.68 4.19 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -59.53 -33.58 97.02 Favored 'Trans proline' 0 C--N 1.355 0.903 0 CA-C-N 122.989 2.103 . . . . 0.0 114.679 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tp -57.78 -56.88 16.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 123.022 1.392 . . . . 0.0 110.219 171.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -70.49 -29.2 65.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.455 -0.778 . . . . 0.0 112.035 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.04 -31.51 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.6 1.091 . . . . 0.0 113.193 173.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.6 ttp -68.41 -37.11 80.03 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.363 1.065 . . . . 0.0 110.773 169.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.9 mt -89.07 -31.48 18.02 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -29.3 65.16 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.463 1.505 . . . . 0.0 113.361 175.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.83 -29.0 70.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.273 1.829 . . . . 0.0 112.473 172.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -91.94 -65.57 1.0 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -120.89 148.25 44.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.688 1.195 . . . . 0.0 112.901 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.7 t -67.42 126.18 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.5 t -149.12 177.92 9.18 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.544 1.137 . . . . 0.0 112.159 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.33 151.53 46.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.627 1.571 . . . . 0.0 112.802 -175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.51 174.75 12.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.641 1.576 . . . . 0.0 112.01 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -174.765 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.72 167.04 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.083 1.753 . . . . 0.0 112.097 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -82.15 35.43 0.43 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.56 1.544 . . . . 0.0 114.034 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -125.94 -175.64 3.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.304 2.642 . . . . 0.0 113.671 -166.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 28' ' ' ARG . 6.3 t -92.2 172.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.813 1.645 . . . . 0.0 109.298 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 27' ' ' VAL . 1.1 tmt_? -164.24 131.98 2.56 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 129.831 3.253 . . . . 0.0 107.15 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -96.59 174.27 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.974 2.449 . . . . 0.0 115.466 -168.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -98.88 160.35 14.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.42 2.288 . . . . 0.0 107.516 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -53.39 -38.81 66.03 Favored Pre-proline 0 N--CA 1.48 1.06 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -69.09 -32.53 21.15 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.21 1.94 . . . . 0.0 113.593 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.26 -37.32 61.02 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.202 1.001 . . . . 0.0 111.037 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.74 -40.18 91.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.877 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -53.8 -42.61 68.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.706 1.202 . . . . 0.0 113.329 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -64.18 -50.11 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.565 1.546 . . . . 0.0 109.937 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.36 -37.39 80.41 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.645 -0.659 . . . . 0.0 111.167 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -71.37 -30.63 66.37 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.886 -1.134 . . . . 0.0 113.404 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.33 -22.7 54.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.495 0.718 . . . . 0.0 112.874 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.14 25.37 11.08 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.959 1.704 . . . . 0.0 113.563 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.48 17.33 79.82 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.36 -161.2 0.3 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.947 1.299 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -132.67 48.65 2.39 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.022 1.729 . . . . 0.0 110.746 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.16 -119.6 6.35 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.178 0.894 . . . . 0.0 112.66 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -141.39 19.62 2.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.891 1.677 . . . . 0.0 112.624 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 27.3 ttt -77.64 47.55 0.61 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.1 1.36 . . . . 0.0 112.783 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -168.73 174.47 6.6 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.417 1.887 . . . . 0.0 113.157 -169.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.62 164.97 10.94 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.783 2.433 . . . . 0.0 113.91 -171.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.21 -42.42 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 126.017 1.727 . . . . 0.0 111.874 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -64.7 -30.19 71.2 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -79.18 -48.23 14.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.965 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.94 -47.01 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 119.699 1.136 . . . . 0.0 112.066 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.9 ptm -71.49 -23.84 61.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.06 -59.64 4.21 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.35 0.977 . . . . 0.0 110.659 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -55.99 -40.72 73.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.873 1.269 . . . . 0.0 113.298 175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 tt -73.29 -32.29 64.55 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.365 1.066 . . . . 0.0 111.515 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.9 -47.31 89.88 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.696 -1.253 . . . . 0.0 112.736 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -67.01 -31.59 72.24 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.414 -1.05 . . . . 0.0 112.375 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.85 -54.44 47.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.838 1.199 . . . . 0.0 111.077 169.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.1 mt -52.89 -42.96 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 119.342 0.974 . . . . 0.0 110.292 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.2 tpp -70.45 -35.27 73.24 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.26 -47.57 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.505 1.122 . . . . 0.0 111.341 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -65.0 -12.1 46.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.502 1.121 . . . . 0.0 112.745 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.33 3.9 pt20 47.92 46.13 18.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 129.407 3.083 . . . . 0.0 113.149 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.8 mt -85.22 56.79 4.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.368 1.467 . . . . 0.0 110.887 -171.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -145.86 166.97 24.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.843 1.257 . . . . 0.0 112.747 -173.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -73.52 148.63 42.89 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.146 0.974 . . . . 0.0 113.279 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.609 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.43 -35.99 76.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.974 1.71 . . . . 0.0 111.716 -176.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -93.1 -20.75 20.2 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.554 1.542 . . . . 0.0 112.335 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -145.95 94.96 2.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.195 0.998 . . . . 0.0 112.69 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -59.01 -17.96 29.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.815 1.246 . . . . 0.0 112.896 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -22.26 66.57 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.339 1.055 . . . . 0.0 112.913 174.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.4 tpt -102.12 128.77 48.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.578 1.551 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.9 t -108.92 134.48 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.876 1.671 . . . . 0.0 110.6 -169.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -136.67 96.93 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 110.468 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.5 m -89.55 27.51 1.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 128.35 2.66 . . . . 0.0 113.686 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.39 118.89 14.9 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.486 -0.759 . . . . 0.0 113.064 -169.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.69 8.97 82.38 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.285 1.421 . . . . 0.0 115.719 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.32 149.2 21.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 120.132 1.966 . . . . 0.0 112.025 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.3 tp -59.18 -27.8 66.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.529 1.131 . . . . 0.0 111.291 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.1 tp -63.95 -48.98 74.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.326 1.05 . . . . 0.0 111.895 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.48 -37.46 93.77 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 118.621 0.646 . . . . 0.0 112.376 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -64.15 -37.34 87.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.85 0.86 . . . . 0.0 112.006 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.13 -45.96 53.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.876 0.871 . . . . 0.0 112.019 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.43 -28.68 69.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.046 0.938 . . . . 0.0 112.639 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.0 0.46 89.0 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.559 1.076 . . . . 0.0 114.024 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.66 147.81 32.39 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.847 1.659 . . . . 0.0 111.768 170.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -100.19 5.66 44.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.763 1.225 . . . . 0.0 113.06 -171.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.0 p -147.59 145.51 29.04 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -164.29 -177.37 4.9 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.17 2.588 . . . . 0.0 109.308 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 p -137.36 170.72 15.61 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.682 -1.261 . . . . 0.0 112.331 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.26 -15.69 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -94.37 -18.91 21.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -131.34 63.89 71.4 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.48 1.512 . . . . 0.0 112.587 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.78 13.98 1.99 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 125.11 3.873 . . . . 0.0 114.564 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.1 p -50.67 -27.62 1.61 Allowed Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 117.648 2.462 . . . . 0.0 117.648 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -60.81 -27.84 85.46 Favored 'Trans proline' 0 C--N 1.357 1.012 0 CA-C-N 123.898 2.428 . . . . 0.0 114.437 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.41 -48.72 66.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.609 0.719 . . . . 0.0 110.297 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -66.85 -30.74 71.0 Favored 'General case' 0 C--O 1.223 -0.335 0 O-C-N 121.557 -0.714 . . . . 0.0 112.02 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -68.13 -31.63 71.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.293 1.037 . . . . 0.0 112.988 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -35.68 75.73 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.353 1.461 . . . . 0.0 111.197 169.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 mt -88.33 -36.44 16.63 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -58.67 -27.34 64.71 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.071 1.749 . . . . 0.0 114.351 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -71.15 -26.17 62.88 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.465 1.906 . . . . 0.0 112.593 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -97.27 -71.17 0.69 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.442 1.497 . . . . 0.0 112.915 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -96.55 159.04 15.15 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.814 1.188 . . . . 0.0 112.072 171.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.98 106.98 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.45 -0.781 . . . . 0.0 109.054 172.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.8 t -150.46 173.3 14.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.609 1.164 . . . . 0.0 112.525 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.4 mt -79.67 147.28 32.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.67 1.588 . . . . 0.0 111.568 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.15 5.9 0.76 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.239 0.526 0 C-N-CA 125.542 1.537 . . . . 0.0 113.771 179.539 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 121.132 0.492 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.1 pt -73.72 162.96 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.7 m120 -83.31 36.7 0.53 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.763 1.625 . . . . 0.0 114.398 -169.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -129.2 -174.88 3.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.492 2.317 . . . . 0.0 112.697 -167.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.14 172.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 0.0 109.102 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -165.08 131.3 2.15 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 128.766 2.826 . . . . 0.0 108.24 173.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -104.11 174.57 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.966 2.444 . . . . 0.0 113.995 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -106.79 167.7 9.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.782 168.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.1 tp -42.15 -53.79 8.21 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.67 -27.56 45.05 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.494 2.129 . . . . 0.0 114.293 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.8 mt -84.39 -34.29 23.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.511 0.725 . . . . 0.0 112.101 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.29 -35.39 77.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.132 0.973 . . . . 0.0 110.957 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.7 -39.35 73.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.9 1.28 . . . . 0.0 112.627 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -63.41 -54.37 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.464 1.505 . . . . 0.0 109.251 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.282 4.7 mp -70.77 -30.36 66.83 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.332 -0.855 . . . . 0.0 113.156 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -35.49 78.33 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.434 -1.416 . . . . 0.0 112.901 169.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.13 -21.15 64.8 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.175 0.898 . . . . 0.0 112.853 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.68 18.72 19.66 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.402 1.881 . . . . 0.0 113.715 172.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.11 15.5 76.6 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -82.71 -165.55 1.08 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.795 1.238 . . . . 0.0 112.734 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -131.5 56.73 1.79 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.968 1.707 . . . . 0.0 111.318 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.78 -126.17 7.32 Favored Glycine 0 C--O 1.218 -0.86 0 C-N-CA 124.32 0.962 . . . . 0.0 112.134 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -141.62 11.26 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.825 2.05 . . . . 0.0 111.716 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.5 ttt -76.12 54.56 0.87 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.39 1.476 . . . . 0.0 113.445 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -170.65 171.42 6.28 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.582 1.953 . . . . 0.0 113.037 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 164.84 7.4 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.176 2.19 . . . . 0.0 114.309 -169.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -51.52 -45.77 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 126.089 1.756 . . . . 0.0 111.929 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -63.88 -30.11 71.23 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.23 -47.82 15.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.02 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.0 -45.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 120.027 1.285 . . . . 0.0 112.688 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.7 ptm -70.64 -25.28 62.94 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -64.97 -57.85 7.66 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.969 1.307 . . . . 0.0 110.809 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 61.2 m-85 -55.94 -35.85 67.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.918 0.887 . . . . 0.0 113.071 173.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 tt -71.34 -38.58 71.64 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.245 -0.91 . . . . 0.0 112.155 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.57 -47.47 88.1 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 120.848 -1.158 . . . . 0.0 112.589 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.302 11.2 pt20 -70.24 -31.45 68.86 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.506 -0.997 . . . . 0.0 112.719 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -55.68 -50.43 70.3 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.558 1.526 . . . . 0.0 111.6 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.7 mt -57.11 -47.23 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.605 0.762 . . . . 0.0 109.762 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.61 -30.63 71.65 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -73.48 -50.19 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.142 1.377 . . . . 0.0 111.312 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.31 -15.94 63.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.895 0.878 . . . . 0.0 112.9 173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.288 6.2 pt20 43.55 43.53 4.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.72 2.808 . . . . 0.0 113.348 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -103.77 33.23 3.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.697 1.599 . . . . 0.0 112.656 -169.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -99.87 165.44 11.56 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.188 1.795 . . . . 0.0 111.821 174.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.81 135.76 50.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.341 -0.85 . . . . 0.0 111.967 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.51 -45.54 62.91 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.304 1.042 . . . . 0.0 113.186 169.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -80.85 -13.94 58.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 112.497 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.17 98.28 1.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 112.282 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -59.28 -17.56 29.84 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.541 1.137 . . . . 0.0 112.867 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -20.4 62.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -99.58 130.26 45.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.254 1.421 . . . . 0.0 110.456 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.23 140.41 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.384 1.474 . . . . 0.0 111.489 -169.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.35 165.72 14.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.973 2.109 . . . . 0.0 111.178 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 99.4 m -139.51 -29.57 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.745 1.218 . . . . 0.0 114.15 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 52.72 -126.02 31.19 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.154 0.888 . . . . 0.0 111.878 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.05 14.2 50.46 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.78 150.71 45.59 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.676 2.238 . . . . 0.0 112.475 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.09 -27.85 35.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.452 1.101 . . . . 0.0 112.086 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 tp -65.69 -44.88 84.84 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.661 0.784 . . . . 0.0 112.256 173.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 118.773 0.715 . . . . 0.0 111.932 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -64.51 -37.69 88.41 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 117.683 0.742 . . . . 0.0 112.069 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.8 tp -70.63 -46.13 63.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.741 1.216 . . . . 0.0 112.484 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.85 -28.72 64.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.217 1.007 . . . . 0.0 113.06 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.13 -0.45 73.47 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 123.903 0.763 . . . . 0.0 113.396 -169.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -135.05 137.34 42.83 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 128.245 2.618 . . . . 0.0 109.624 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -103.52 11.83 35.84 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.783 0.833 . . . . 0.0 113.011 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.5 p -153.84 140.66 19.11 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.683 1.193 . . . . 0.0 111.624 169.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -162.61 175.34 11.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.41 1.884 . . . . 0.0 110.15 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.4 p -143.89 173.83 11.36 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.899 -1.125 . . . . 0.0 113.342 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.02 -20.84 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.107 0.963 . . . . 0.0 112.132 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -93.2 -19.39 21.49 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.88 1.272 . . . . 0.0 113.644 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -128.59 63.38 64.61 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.976 1.71 . . . . 0.0 112.402 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.56 -2.05 11.3 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.171 3.248 . . . . 0.0 113.783 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.1 m -41.91 -43.36 6.65 Favored Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.54 -23.31 70.7 Favored 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 122.925 2.08 . . . . 0.0 114.465 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.67 -51.95 50.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.518 1.054 . . . . 0.0 110.147 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -62.87 -37.7 87.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.442 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.01 -31.54 72.83 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 173.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.3 -47.91 80.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.873 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 pp -90.29 -21.86 21.87 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -63.75 -25.04 68.01 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.8 1.182 . . . . 0.0 113.27 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -70.05 -25.94 63.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.467 2.307 . . . . 0.0 112.549 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -97.77 -44.89 6.55 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.66 156.74 41.85 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.343 1.428 . . . . 0.0 112.441 172.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.75 100.91 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.796 0.808 . . . . 0.0 111.123 -176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.0 t -151.99 176.93 10.99 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.583 1.153 . . . . 0.0 112.715 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 pp -107.87 174.91 5.67 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.911 2.085 . . . . 0.0 113.648 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.07 162.58 35.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.756 1.222 . . . . 0.0 112.616 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -174.028 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 pt -123.7 152.49 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.589 1.556 . . . . 0.0 113.153 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -90.87 62.04 4.87 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.641 1.177 . . . . 0.0 112.511 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.38 -176.91 5.0 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.006 2.922 . . . . 0.0 109.818 -171.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.33 172.17 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.888 0.875 . . . . 0.0 111.869 -169.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -162.14 134.12 4.09 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 128.903 2.881 . . . . 0.0 107.588 172.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 8.8 Cg_endo -98.66 -178.61 0.27 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.212 2.608 . . . . 0.0 114.574 -169.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -120.65 165.77 14.6 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.301 2.24 . . . . 0.0 108.651 167.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -39.59 -57.81 2.3 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.467 1.907 . . . . 0.0 116.136 -169.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.83 -25.23 33.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.467 2.111 . . . . 0.0 114.109 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.08 -39.15 23.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.813 0.845 . . . . 0.0 111.065 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.22 -31.58 70.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.678 1.191 . . . . 0.0 111.662 170.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -58.86 -37.62 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.121 1.368 . . . . 0.0 112.787 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.25 -42.2 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.484 1.514 . . . . 0.0 110.14 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.59 -30.82 67.6 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.797 -0.564 . . . . 0.0 111.964 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -65.85 -37.13 85.37 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 119.964 -1.71 . . . . 0.0 112.164 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.65 -22.56 67.01 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.883 0.765 . . . . 0.0 112.435 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.4 2.58 39.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.144 1.378 . . . . 0.0 114.183 169.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.78 17.31 79.21 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.492 1.044 . . . . 0.0 114.998 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -90.27 -166.72 1.65 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.602 1.561 . . . . 0.0 112.792 -177.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.38 65.67 1.39 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.911 1.684 . . . . 0.0 111.101 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.12 -138.81 23.27 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.732 0.682 . . . . 0.0 112.83 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 45.6 mt-10 -131.79 18.06 4.69 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.393 1.877 . . . . 0.0 112.29 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -78.94 52.64 1.28 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.466 1.506 . . . . 0.0 112.345 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -169.62 170.16 8.25 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.368 1.867 . . . . 0.0 113.209 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.38 165.49 14.09 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.358 2.263 . . . . 0.0 114.663 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -50.83 -44.54 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 126.243 1.817 . . . . 0.0 112.152 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -64.76 -30.08 71.08 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.09 -48.62 14.01 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.022 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -55.34 -44.96 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 120.194 1.361 . . . . 0.0 112.506 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 14.4 ptm -72.27 -24.95 61.43 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.07 10.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.713 1.205 . . . . 0.0 110.313 169.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 62.7 m-85 -55.56 -42.31 74.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.077 0.951 . . . . 0.0 112.907 173.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.13 -38.0 89.49 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.04 1.291 . . . . 0.0 112.609 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.25 -47.43 89.5 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 119.487 1.04 . . . . 0.0 112.894 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.44 -31.67 67.47 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.548 -0.972 . . . . 0.0 112.873 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.08 -53.63 55.88 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.928 1.24 . . . . 0.0 110.29 169.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.7 mt -57.72 -42.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.677 0.791 . . . . 0.0 110.192 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.4 tpp -65.75 -32.22 73.64 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.13 -50.38 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.661 1.185 . . . . 0.0 111.495 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.08 -15.89 64.0 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.072 1.349 . . . . 0.0 113.11 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.304 6.1 pt20 46.77 43.44 13.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.625 2.77 . . . . 0.0 114.117 172.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.99 3.63 33.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.914 1.285 . . . . 0.0 113.423 -176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -78.73 164.58 24.45 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.666 -1.271 . . . . 0.0 113.413 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -73.14 139.35 46.34 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.682 -0.636 . . . . 0.0 111.986 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -40.38 65.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.376 1.47 . . . . 0.0 112.893 172.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -89.41 -20.35 24.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 112.932 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.21 96.49 2.19 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.463 1.105 . . . . 0.0 111.538 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -61.24 -14.64 27.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.955 0.902 . . . . 0.0 112.821 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -21.29 66.19 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.996 0.918 . . . . 0.0 112.97 173.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 17.8 tpt -104.87 136.01 45.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.662 1.985 . . . . 0.0 110.999 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.56 131.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.686 1.594 . . . . 0.0 110.764 -170.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -99.34 170.54 8.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.369 1.467 . . . . 0.0 111.317 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.03 24.71 0.31 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 113.457 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.3 113.45 5.45 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.43 -0.794 . . . . 0.0 112.638 -171.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.74 12.81 71.15 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.095 1.331 . . . . 0.0 115.884 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.21 148.28 22.27 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.631 2.216 . . . . 0.0 111.18 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.63 -27.72 63.05 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.53 0.732 . . . . 0.0 112.248 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.13 -40.7 90.87 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.626 0.77 . . . . 0.0 112.558 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.15 92.64 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 119.101 0.864 . . . . 0.0 112.286 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.24 -40.47 96.1 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.271 1.036 . . . . 0.0 111.539 171.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.25 -44.87 82.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.568 1.147 . . . . 0.0 112.621 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.26 -23.0 43.96 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 113.449 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.19 6.91 84.12 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.232 0.92 . . . . 0.0 114.015 -171.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -136.65 137.86 40.51 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.338 1.855 . . . . 0.0 112.526 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -98.64 7.98 45.47 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.601 1.161 . . . . 0.0 113.415 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.4 p -157.09 140.9 16.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 168.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -159.51 176.41 12.1 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.504 1.922 . . . . 0.0 110.506 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 p -143.41 173.33 11.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.764 -1.21 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.67 -20.87 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -94.97 -16.33 22.86 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -125.05 65.39 47.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.85 1.66 . . . . 0.0 112.062 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.03 4.69 5.95 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.364 3.376 . . . . 0.0 113.309 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.6 m -38.88 -45.89 3.08 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 127.717 2.407 . . . . 0.0 116.616 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.42 -20.5 66.25 Favored 'Trans proline' 0 C--N 1.355 0.909 0 CA-C-N 122.521 1.936 . . . . 0.0 115.073 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.52 -49.66 62.37 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.264 1.031 . . . . 0.0 109.722 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -66.77 -30.52 70.75 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.043 -1.035 . . . . 0.0 112.043 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.64 -32.52 74.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.091 -1.006 . . . . 0.0 112.935 170.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -34.15 72.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.235 1.414 . . . . 0.0 111.629 170.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.82 -26.26 21.77 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -26.2 68.61 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.215 1.371 . . . . 0.0 114.394 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.29 -28.84 69.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.389 1.075 . . . . 0.0 111.952 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -87.28 -68.2 0.77 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 171.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -130.87 140.86 50.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.663 1.185 . . . . 0.0 113.301 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.81 125.51 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 169.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.3 t -151.32 173.73 14.14 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.79 148.88 44.13 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.994 1.718 . . . . 0.0 111.26 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.33 171.98 13.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.332 1.453 . . . . 0.0 112.183 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -173.446 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.7 pt -125.0 169.41 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 127.498 2.319 . . . . 0.0 111.936 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -77.36 27.84 0.15 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.965 1.306 . . . . 0.0 114.279 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -124.28 -175.88 3.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.238 2.615 . . . . 0.0 113.857 -166.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.49 172.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.563 1.145 . . . . 0.0 111.393 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -164.34 132.28 2.59 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 129.799 3.24 . . . . 0.0 106.889 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 13.2 Cg_endo -100.24 174.9 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.024 2.483 . . . . 0.0 115.024 -169.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.88 160.23 14.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.949 2.1 . . . . 0.0 107.03 166.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -44.91 -46.28 28.01 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -68.85 -28.2 30.14 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 122.317 1.863 . . . . 0.0 114.037 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.2 mp -81.68 -37.02 28.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.39 1.076 . . . . 0.0 111.011 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -57.72 -40.24 79.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 0.0 110.362 170.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.7 tptp -51.62 -41.62 61.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.692 1.597 . . . . 0.0 113.438 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.89 -51.68 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.297 1.039 . . . . 0.0 110.102 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.69 -31.67 68.64 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 111.925 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -31.87 69.38 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 120.793 -1.192 . . . . 0.0 112.86 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.05 -20.98 58.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.201 0.6 . . . . 0.0 112.605 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.46 21.65 17.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.381 1.872 . . . . 0.0 113.796 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.42 17.48 78.97 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.89 -161.12 0.32 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.993 1.317 . . . . 0.0 112.86 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -136.76 59.22 1.7 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.36 -130.85 10.37 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.859 1.219 . . . . 0.0 113.175 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 46.7 mt-10 -138.89 19.37 2.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.882 2.073 . . . . 0.0 111.589 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.6 ttt -77.7 50.34 0.83 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.698 1.199 . . . . 0.0 112.953 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -168.07 171.05 9.89 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.885 1.674 . . . . 0.0 113.876 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -65.38 167.68 8.23 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 127.555 2.342 . . . . 0.0 114.222 -172.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.5 t -53.05 -42.24 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.801 2.041 . . . . 0.0 111.802 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -65.15 -33.91 77.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -79.01 -45.94 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.504 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.04 -47.16 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-N 119.875 1.216 . . . . 0.0 112.453 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.2 ptm -71.66 -24.01 61.78 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.69 -59.7 4.25 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.529 1.132 . . . . 0.0 110.744 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -55.25 -37.34 67.09 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.411 1.084 . . . . 0.0 113.214 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.06 -34.2 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.209 -0.932 . . . . 0.0 112.062 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.06 -47.37 91.11 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 120.711 -1.243 . . . . 0.0 112.154 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.291 13.9 pt20 -68.48 -31.44 70.72 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.147 -1.207 . . . . 0.0 112.925 172.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -54.6 -53.23 57.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 120.544 1.52 . . . . 0.0 110.467 169.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.4 -43.26 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.753 0.821 . . . . 0.0 110.399 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -34.78 78.51 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -78.13 -49.81 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.987 1.315 . . . . 0.0 111.847 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.04 -15.81 62.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.551 1.141 . . . . 0.0 112.858 175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.314 6.4 pt20 47.72 43.49 16.82 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.003 2.521 . . . . 0.0 113.385 172.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.64 11.69 32.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.983 1.713 . . . . 0.0 112.902 -169.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -86.23 164.85 16.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.725 1.61 . . . . 0.0 112.222 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -71.76 146.69 47.94 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 122.135 0.969 . . . . 0.0 113.216 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.628 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -67.93 -34.84 77.38 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.004 1.722 . . . . 0.0 111.819 -175.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.54 -20.61 18.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.629 1.572 . . . . 0.0 112.483 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -144.79 93.29 2.39 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.851 0.834 . . . . 0.0 112.352 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -56.79 -21.25 27.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.27 1.428 . . . . 0.0 112.881 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -31.46 65.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.294 1.437 . . . . 0.0 113.018 171.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -98.7 130.08 45.18 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.117 1.367 . . . . 0.0 111.101 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -122.57 128.01 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.42 1.488 . . . . 0.0 110.258 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.42 166.59 10.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.069 1.348 . . . . 0.0 111.076 171.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.98 24.87 0.93 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 112.594 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.56 114.35 6.44 Favored Glycine 0 CA--C 1.533 1.169 0 O-C-N 121.531 -0.731 . . . . 0.0 112.741 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.73 11.67 66.21 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.063 1.316 . . . . 0.0 115.778 -176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -91.8 149.32 21.65 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 120.491 2.146 . . . . 0.0 111.44 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.23 -27.43 63.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.89 0.876 . . . . 0.0 111.991 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.4 tp -67.14 -40.33 86.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.796 0.838 . . . . 0.0 112.891 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.73 -36.25 92.9 Favored Glycine 0 N--CA 1.47 0.946 0 CA-C-N 119.132 0.878 . . . . 0.0 111.968 172.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -66.35 -37.43 85.31 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 117.951 0.876 . . . . 0.0 112.095 171.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.2 tp -66.96 -46.96 73.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.709 0.803 . . . . 0.0 112.176 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.7 mt -77.96 -24.04 48.27 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.485 1.114 . . . . 0.0 113.101 -176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.73 8.85 87.19 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.253 0.93 . . . . 0.0 113.925 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -140.37 145.89 37.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.035 1.734 . . . . 0.0 113.091 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -104.29 8.29 35.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.364 1.065 . . . . 0.0 113.606 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -157.09 145.3 19.41 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -161.32 -177.42 6.0 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.544 2.338 . . . . 0.0 109.88 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.6 p -141.01 170.5 15.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.419 -1.426 . . . . 0.0 112.965 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 m -71.48 -11.24 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -88.24 -32.68 18.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.883 1.273 . . . . 0.0 111.873 171.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -127.19 71.47 76.23 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.926 1.69 . . . . 0.0 112.232 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.31 8.2 3.02 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.586 3.524 . . . . 0.0 113.734 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.7 m -46.13 -34.08 2.86 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 127.334 2.254 . . . . 0.0 116.772 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -59.81 -29.32 89.29 Favored 'Trans proline' 0 C--N 1.355 0.876 0 CA-C-N 122.349 1.875 . . . . 0.0 114.318 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.79 -47.87 73.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.931 0.787 . . . . 0.0 110.579 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -65.52 -32.97 74.85 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.775 -0.578 . . . . 0.0 111.463 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -70.87 -31.62 68.35 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.174 0.897 . . . . 0.0 113.363 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.11 -35.73 81.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.768 1.227 . . . . 0.0 110.768 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.84 -41.05 12.71 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.89 1.276 . . . . 0.0 114.14 -174.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -27.61 64.84 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.671 1.588 . . . . 0.0 115.183 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.02 -24.63 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.491 1.517 . . . . 0.0 113.085 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -106.07 -45.13 4.41 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -167.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.626 HD13 ' HB ' ' A' ' 108' ' ' THR . 0.6 OUTLIER -105.8 170.1 8.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.54 1.536 . . . . 0.0 112.814 169.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 m -102.68 -21.51 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.626 ' HB ' HD13 ' A' ' 106' ' ' LEU 0.282 6.3 t 46.82 -168.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 129.449 3.1 . . . . 0.0 114.673 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 83.7 mt -76.31 149.47 37.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.167 1.387 . . . . 0.0 111.9 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.02 172.25 15.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.077 1.351 . . . . 0.0 112.656 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.242 0.663 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.782 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 CA--C 1.545 0.768 0 CA-C-O 120.95 0.405 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.7 pt -67.15 156.06 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.43 57.2 2.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.192 1.397 . . . . 0.0 111.983 -171.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.12 -178.68 6.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.481 2.712 . . . . 0.0 109.829 -168.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.5 172.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.107 0.963 . . . . 0.0 111.303 -169.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -163.42 136.54 4.28 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 128.719 2.808 . . . . 0.0 108.006 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -101.36 174.21 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.311 2.674 . . . . 0.0 114.956 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -98.95 159.52 14.9 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.416 1.886 . . . . 0.0 107.798 167.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.1 tp -47.2 -43.8 46.97 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -66.76 -29.57 42.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.304 2.003 . . . . 0.0 114.119 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.4 mt -84.91 -33.03 22.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.627 0.771 . . . . 0.0 111.839 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.68 -35.77 77.09 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.901 0.881 . . . . 0.0 110.974 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -40.16 68.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.771 1.228 . . . . 0.0 112.717 177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -65.43 -51.92 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.859 1.664 . . . . 0.0 109.409 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.67 -30.3 66.86 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.433 -0.792 . . . . 0.0 112.932 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.56 -34.3 76.67 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.396 -1.44 . . . . 0.0 112.878 169.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.81 -20.23 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 119.288 0.949 . . . . 0.0 112.997 170.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.74 17.51 24.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.343 1.857 . . . . 0.0 113.967 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 17.52 75.62 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.98 -165.4 1.19 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.114 1.366 . . . . 0.0 112.616 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.65 52.82 1.4 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.231 1.412 . . . . 0.0 110.99 169.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.79 -124.26 7.39 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 121.303 -0.873 . . . . 0.0 112.145 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -140.27 20.26 2.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.933 1.693 . . . . 0.0 111.902 -176.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -77.63 42.48 0.37 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.199 1.8 . . . . 0.0 114.361 -169.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -166.29 174.6 8.97 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 -167.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.74 165.89 11.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.051 2.14 . . . . 0.0 114.297 -169.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.36 -44.55 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 125.848 1.659 . . . . 0.0 112.012 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -64.52 -30.12 71.15 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.46 -48.58 13.69 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.35 -0.834 . . . . 0.0 111.157 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.59 -44.88 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-N 120.425 1.466 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.5 ptm -71.71 -28.81 63.95 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.72 -59.14 5.86 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.606 1.162 . . . . 0.0 110.501 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -57.62 -33.17 67.97 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -34.7 70.19 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.159 1.345 . . . . 0.0 113.92 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.12 -47.36 88.15 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 120.151 1.342 . . . . 0.0 111.769 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.261 13.5 pt20 -70.56 -31.63 68.74 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 118.071 -0.966 . . . . 0.0 113.18 173.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -55.66 -53.56 55.07 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.847 1.658 . . . . 0.0 110.945 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.18 -42.34 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.321 1.048 . . . . 0.0 110.071 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 31.8 tpp -67.18 -30.39 70.32 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.674 0.991 . . . . 0.0 113.674 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.66 -50.59 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.754 1.221 . . . . 0.0 111.489 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -15.99 63.25 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.496 1.118 . . . . 0.0 112.951 175.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.3 pt20 45.55 42.64 8.25 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.261 2.624 . . . . 0.0 113.448 173.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.4 19.5 16.6 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.843 1.657 . . . . 0.0 112.552 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -88.92 166.59 13.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.951 1.701 . . . . 0.0 111.86 171.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -76.33 135.22 39.55 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.234 -0.916 . . . . 0.0 112.07 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -38.84 42.78 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.263 1.425 . . . . 0.0 113.208 171.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -89.79 -18.26 26.62 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.214 1.406 . . . . 0.0 113.067 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -152.91 92.33 1.63 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.518 1.127 . . . . 0.0 111.257 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -57.51 -18.74 20.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 112.484 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -24.81 67.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.646 1.178 . . . . 0.0 112.957 175.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.7 tpt -102.01 132.66 47.72 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.444 1.898 . . . . 0.0 110.843 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.3 t -126.8 130.18 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.67 1.588 . . . . 0.0 110.333 -170.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -101.88 165.1 11.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.057 1.343 . . . . 0.0 111.381 172.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.5 m -150.44 23.62 0.81 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.225 1.81 . . . . 0.0 112.75 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.17 114.79 7.03 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 121.409 -0.807 . . . . 0.0 112.645 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.95 12.74 65.51 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.107 1.337 . . . . 0.0 115.528 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.36 149.49 21.19 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.087 1.944 . . . . 0.0 111.452 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -58.04 -27.72 63.84 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.683 -0.635 . . . . 0.0 111.666 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.7 tp -67.19 -39.15 86.33 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.358 -0.839 . . . . 0.0 112.598 172.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.24 -35.57 90.54 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 118.659 0.663 . . . . 0.0 112.211 171.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.9 -38.0 85.43 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.398 1.099 . . . . 0.0 112.189 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.44 -46.14 70.66 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.479 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.41 -20.67 43.41 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.457 1.103 . . . . 0.0 113.074 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.16 -9.66 52.81 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.747 1.642 . . . . 0.0 114.407 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -124.84 142.5 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.419 1.888 . . . . 0.0 111.518 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -97.58 12.48 33.37 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.5 p -157.14 148.44 22.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.586 1.154 . . . . 0.0 112.549 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.3 173.92 15.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.392 1.877 . . . . 0.0 110.401 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.0 p -141.4 171.35 14.19 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.761 -1.212 . . . . 0.0 111.659 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -71.73 -8.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 171.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -95.0 -24.32 16.98 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.346 1.459 . . . . 0.0 112.854 169.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -128.82 63.42 66.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.204 1.802 . . . . 0.0 112.217 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.64 6.18 5.94 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.075 3.183 . . . . 0.0 114.077 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.8 m -44.97 -37.96 5.59 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -172.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -56.58 -30.17 82.02 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.634 2.223 . . . . 0.0 115.38 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.53 -53.04 62.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.301 1.524 . . . . 0.0 110.663 173.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.63 -29.23 63.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.719 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.12 -31.6 72.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.884 0.873 . . . . 0.0 112.582 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.15 -40.08 82.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.515 1.126 . . . . 0.0 110.812 169.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.26 -36.13 35.02 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.723 1.209 . . . . 0.0 113.842 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -25.38 65.52 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.365 1.439 . . . . 0.0 114.312 -177.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -67.5 -31.84 72.25 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.644 1.977 . . . . 0.0 112.27 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -109.91 -50.32 2.99 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.14 141.68 31.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.556 1.943 . . . . 0.0 109.837 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.1 m -75.21 41.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 125.087 1.355 . . . . 0.0 113.178 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.4 t -91.23 170.5 9.95 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.661 1.584 . . . . 0.0 113.661 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.64 164.56 16.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.468 1.907 . . . . 0.0 111.483 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.73 158.39 40.22 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.579 1.152 . . . . 0.0 113.767 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.468 0.465 0 C-N-CA 124.103 0.961 . . . . 0.0 113.065 -174.506 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 121.704 0.764 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.7 pt -139.84 167.99 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 127.337 2.255 . . . . 0.0 112.578 -170.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -81.18 35.32 0.38 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.746 1.619 . . . . 0.0 114.327 -173.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -126.09 -174.94 3.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.261 2.624 . . . . 0.0 113.01 -167.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.47 171.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.077 0.951 . . . . 0.0 110.321 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -164.73 130.43 2.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 127.964 2.505 . . . . 0.0 107.786 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -96.45 172.95 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.886 2.391 . . . . 0.0 114.254 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.1 159.3 15.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.654 1.981 . . . . 0.0 108.192 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.05 -52.9 14.54 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 -22.12 37.23 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.552 2.168 . . . . 0.0 114.008 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.3 mt -84.34 -36.75 22.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.901 0.88 . . . . 0.0 111.979 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.9 -35.95 78.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 111.166 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -51.74 -38.17 54.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.455 1.502 . . . . 0.0 112.77 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -67.49 -51.52 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.399 1.88 . . . . 0.0 109.748 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.74 -30.64 67.21 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -35.14 79.47 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.477 -1.389 . . . . 0.0 112.789 171.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.41 -21.52 62.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.31 21.5 17.05 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.32 1.848 . . . . 0.0 113.661 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.43 78.01 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.981 1.152 . . . . 0.0 115.981 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.08 -164.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.0 1.32 . . . . 0.0 113.035 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -129.19 50.1 2.18 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.997 1.719 . . . . 0.0 111.674 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.3 -122.49 5.75 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.425 1.012 . . . . 0.0 113.046 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -143.59 14.8 1.78 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.041 1.736 . . . . 0.0 112.684 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.3 ttt -79.17 52.29 1.29 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.084 1.354 . . . . 0.0 112.549 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -168.89 169.73 9.57 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.176 1.79 . . . . 0.0 112.532 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 164.78 6.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 127.34 2.256 . . . . 0.0 114.109 -170.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -52.72 -44.13 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.317 1.847 . . . . 0.0 111.786 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.22 -30.08 71.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -79.65 -47.77 14.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.106 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.25 -46.84 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 120.183 1.356 . . . . 0.0 112.499 173.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.6 ptm -69.46 -24.81 63.85 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -66.05 -59.66 3.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.822 1.249 . . . . 0.0 110.751 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -56.05 -36.34 67.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.945 0.898 . . . . 0.0 113.05 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -70.88 -38.91 73.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.061 0.944 . . . . 0.0 112.01 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.22 -47.43 89.49 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.865 -1.147 . . . . 0.0 112.54 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.265 13.2 pt20 -68.71 -31.6 70.79 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.504 -0.997 . . . . 0.0 112.755 174.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -57.52 -51.08 70.91 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.123 1.329 . . . . 0.0 111.027 169.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.16 -41.96 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.198 0.908 . . . . 0.0 110.08 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.25 -34.43 78.08 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.1 -52.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.598 1.159 . . . . 0.0 111.594 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -67.23 -15.76 63.89 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.323 1.049 . . . . 0.0 113.335 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.3 5.6 pt20 46.13 47.14 13.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.445 2.698 . . . . 0.0 113.912 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.8 4.49 32.73 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.75 1.22 . . . . 0.0 113.624 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -78.53 163.3 25.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.464 1.106 . . . . 0.0 112.706 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.57 150.11 41.68 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.952 0.882 . . . . 0.0 112.682 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.3 OUTLIER -64.14 -31.84 73.18 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.964 1.306 . . . . 0.0 112.65 -174.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -102.66 -30.04 11.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.674 1.59 . . . . 0.0 110.461 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -110.35 80.07 1.27 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.247 1.019 . . . . 0.0 111.789 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -57.3 -22.42 41.63 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.028 -0.42 . . . . 0.0 111.605 169.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -26.19 54.07 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.9 tpt -88.62 127.55 35.57 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.087 1.312 . . . . 0.0 110.854 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 t -120.07 125.69 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.394 1.078 . . . . 0.0 110.98 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.86 167.38 10.32 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.914 1.285 . . . . 0.0 111.065 170.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.1 m -148.62 29.24 0.85 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.916 1.686 . . . . 0.0 112.082 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.74 113.85 6.15 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.35 -0.844 . . . . 0.0 112.542 -170.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.37 12.05 72.39 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.08 1.324 . . . . 0.0 115.576 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -94.21 150.8 19.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.161 1.98 . . . . 0.0 111.4 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -58.06 -27.74 63.9 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.445 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.82 -37.64 84.9 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.377 -0.827 . . . . 0.0 112.482 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.43 -38.21 94.63 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.504 -0.748 . . . . 0.0 112.008 170.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -65.8 -37.61 86.74 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.229 1.014 . . . . 0.0 112.262 172.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.87 -44.64 76.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.217 1.407 . . . . 0.0 112.248 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.9 mp -79.22 -25.0 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.391 0.676 . . . . 0.0 112.626 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.16 4.55 83.87 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.423 1.011 . . . . 0.0 113.437 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -138.24 141.72 39.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.618 1.967 . . . . 0.0 111.492 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -101.97 10.1 39.95 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.583 0.956 . . . . 0.0 113.583 -172.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.0 p -154.52 148.87 26.1 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.54 179.05 8.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.957 2.503 . . . . 0.0 109.57 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 p -144.78 172.73 12.6 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.184 -1.572 . . . . 0.0 113.286 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.05 -21.66 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.422 0.689 . . . . 0.0 112.096 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -92.72 -21.64 19.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -133.12 77.21 67.94 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 111.541 174.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -81.84 3.62 7.67 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.394 3.396 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.6 m -46.68 -37.6 9.4 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.874 1.67 . . . . 0.0 115.343 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.58 -27.25 68.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.407 2.738 . . . . 0.0 116.661 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.96 -49.5 57.45 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 123.021 1.391 . . . . 0.0 110.136 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -67.94 -29.15 68.15 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 121.22 -0.925 . . . . 0.0 112.157 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -62.56 -31.33 72.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.356 1.062 . . . . 0.0 112.179 169.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -40.52 72.26 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.256 1.022 . . . . 0.0 111.484 169.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.45 -30.78 26.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -59.74 -26.54 65.74 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.627 1.571 . . . . 0.0 113.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -69.6 -31.04 68.95 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.588 1.955 . . . . 0.0 112.252 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -82.87 -71.31 0.5 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -109.77 151.22 27.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.632 1.173 . . . . 0.0 112.411 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.57 115.06 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.4 t -153.74 177.58 10.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.759 1.224 . . . . 0.0 112.32 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.98 151.33 46.2 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.572 1.549 . . . . 0.0 111.412 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.01 2.41 0.9 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 117.303 2.334 . . . . 0.0 117.303 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.322 -0.595 0 C-N-CA 124.898 1.279 . . . . 0.0 114.044 173.585 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 CA--C 1.546 0.82 0 CA-C-O 121.593 0.711 . . . . 0.0 112.801 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 pt -68.42 159.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.68 1.192 . . . . 0.0 112.822 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -82.47 32.52 0.4 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -172.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.99 -177.2 4.19 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.969 2.507 . . . . 0.0 112.054 -168.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 28' ' ' ARG . 2.9 t -81.99 172.31 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.362 1.065 . . . . 0.0 109.621 -174.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -162.18 135.9 4.79 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 129.31 3.044 . . . . 0.0 107.344 173.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.544 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 24.1 Cg_endo -93.72 175.74 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.995 2.463 . . . . 0.0 115.468 -168.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -107.67 160.55 15.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.975 2.51 . . . . 0.0 107.65 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.3 tp -40.27 -55.76 3.89 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 126.271 1.828 . . . . 0.0 115.822 -175.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.94 -25.06 28.13 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.223 1.949 . . . . 0.0 113.452 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.34 -35.47 35.54 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.452 -0.78 . . . . 0.0 111.582 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.53 -32.73 73.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.706 0.802 . . . . 0.0 110.93 169.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -59.23 -40.22 85.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.919 1.288 . . . . 0.0 112.759 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.9 mt -65.76 -46.08 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.196 1.398 . . . . 0.0 109.98 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.6 -30.81 67.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.081 0.552 . . . . 0.0 112.225 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -66.37 -37.2 84.74 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.095 -1.628 . . . . 0.0 112.178 169.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.89 -24.07 67.42 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 118.952 0.796 . . . . 0.0 112.033 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . . . -84.51 4.81 30.14 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.65 1.58 . . . . 0.0 114.339 169.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.56 78.43 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.529 1.061 . . . . 0.0 115.364 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . . . -92.01 -160.93 0.78 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.899 1.68 . . . . 0.0 113.092 -174.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -137.28 68.84 1.41 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.63 -146.09 32.28 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.903 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 48.2 mt-10 -129.48 19.06 5.77 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.235 2.214 . . . . 0.0 112.092 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.1 ttt -79.71 52.73 1.49 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.928 1.291 . . . . 0.0 112.38 -172.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -166.35 175.87 7.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.41 1.884 . . . . 0.0 114.179 -169.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 49' ' ' VAL . 1.6 m -78.13 170.19 17.02 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.782 2.433 . . . . 0.0 114.379 -169.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 48' ' ' THR . 60.4 t -52.77 -42.84 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 126.866 2.066 . . . . 0.0 111.773 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -65.98 -30.11 70.61 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.33 -47.87 13.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.022 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -55.21 -45.64 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 120.193 1.36 . . . . 0.0 112.697 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.7 ptm -70.75 -25.65 63.01 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.49 -59.8 3.61 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.765 1.226 . . . . 0.0 110.721 171.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.429 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 52.1 m-85 -55.73 -39.97 71.86 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.038 0.935 . . . . 0.0 112.849 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.84 -43.03 90.65 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.299 -0.876 . . . . 0.0 112.898 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.12 -46.86 84.32 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.259 0.936 . . . . 0.0 112.595 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 14.2 pt20 -71.8 -31.62 66.76 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.741 -0.858 . . . . 0.0 113.312 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CE2' ' HE3' ' A' ' 63' ' ' LYS . 60.5 t80 -59.09 -51.7 68.9 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.622 1.556 . . . . 0.0 111.253 169.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.55 -43.34 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.22 1.008 . . . . 0.0 110.081 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.6 tpp -67.48 -32.52 73.42 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.9 t -75.45 -51.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.728 1.211 . . . . 0.0 111.446 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 21.2 mmtp -66.75 -16.02 63.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.895 0.878 . . . . 0.0 112.88 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.296 6.2 pt20 44.25 43.7 6.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 128.36 2.664 . . . . 0.0 113.635 175.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -102.08 21.96 13.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.713 1.605 . . . . 0.0 112.848 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -87.54 169.74 11.92 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.414 1.886 . . . . 0.0 111.895 170.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -74.38 144.24 44.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.255 -0.903 . . . . 0.0 112.678 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.533 ' NE2' ' H ' ' A' ' 68' ' ' GLN . 0.6 OUTLIER -64.14 -39.89 94.99 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.543 1.937 . . . . 0.0 112.417 -177.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -92.38 -21.84 20.0 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.3 1.44 . . . . 0.0 112.362 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -138.99 88.27 2.27 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 122.393 1.092 . . . . 0.0 112.93 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -56.17 -17.84 8.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.418 1.087 . . . . 0.0 112.918 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -25.43 68.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.452 1.101 . . . . 0.0 112.978 175.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.0 tpt -103.11 134.32 46.74 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.884 1.674 . . . . 0.0 111.241 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.6 t -126.42 132.48 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.442 1.497 . . . . 0.0 110.778 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -112.9 162.47 15.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.915 1.686 . . . . 0.0 111.35 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.6 m -146.19 28.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.309 1.443 . . . . 0.0 111.864 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.99 106.43 0.23 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.464 1.031 . . . . 0.0 114.642 -169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.86 14.76 65.96 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.994 1.283 . . . . 0.0 115.493 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.35 153.95 20.46 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.2 1.5 . . . . 0.0 112.365 -174.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -57.55 -27.93 63.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.564 0.746 . . . . 0.0 111.994 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.58 -41.32 88.72 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.1 0.864 . . . . 0.0 112.213 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.42 -37.79 94.93 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.724 -0.61 . . . . 0.0 111.825 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -66.53 -38.4 87.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.024 0.929 . . . . 0.0 112.274 173.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.1 tp -65.6 -46.06 80.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.054 1.342 . . . . 0.0 112.102 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -76.48 -26.81 55.74 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.29 2.01 71.84 Favored Glycine 0 CA--C 1.542 1.747 0 C-N-CA 124.009 0.814 . . . . 0.0 112.862 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.3 mtt-85 -142.01 136.02 29.86 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 129.807 3.243 . . . . 0.0 108.058 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . 0.284 9.0 pt20 -112.16 17.67 19.33 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -171.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.8 p -153.4 145.33 23.6 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.089 -1.007 . . . . 0.0 113.07 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -161.0 170.47 20.49 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.836 1.655 . . . . 0.0 111.208 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.0 p -137.32 170.88 15.33 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.671 0.788 . . . . 0.0 111.753 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -7.58 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 171.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -95.11 -27.13 15.73 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.133 1.373 . . . . 0.0 112.73 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -131.4 78.67 71.38 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.648 1.579 . . . . 0.0 111.199 170.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.15 5.44 6.24 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.273 3.315 . . . . 0.0 113.799 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -44.53 -38.0 4.98 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -173.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -59.07 -28.83 88.93 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.966 2.444 . . . . 0.0 115.932 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 tp -58.87 -53.3 59.97 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 123.158 1.456 . . . . 0.0 109.929 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -73.56 -29.17 62.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.296 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -64.38 -31.34 72.51 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.441 1.019 . . . . 0.0 112.529 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.5 ttp -72.2 -42.72 65.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.053 0.941 . . . . 0.0 110.335 169.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.14 -32.25 44.34 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -172.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -59.24 -28.1 66.39 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.772 1.629 . . . . 0.0 114.026 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.4 -26.57 58.52 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.629 1.971 . . . . 0.0 112.837 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -101.06 -47.87 4.61 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.58 1.152 . . . . 0.0 113.839 -174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.24 159.65 29.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.478 1.511 . . . . 0.0 112.09 169.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.85 39.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 125.302 1.441 . . . . 0.0 113.862 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.9 t -82.88 174.86 10.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.648 1.179 . . . . 0.0 112.862 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.79 153.38 41.12 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.342 1.457 . . . . 0.0 112.29 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -147.37 166.78 26.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 112.5 172.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.064 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 CA--C 1.546 0.803 0 CA-C-O 121.012 0.434 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.8 pt -68.17 168.36 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.208 1.403 . . . . 0.0 113.115 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.51 33.75 0.21 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.948 1.699 . . . . 0.0 114.19 -175.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -127.61 -175.54 3.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 129.216 3.007 . . . . 0.0 112.032 -167.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' MET . 2.0 t -92.5 172.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.862 1.265 . . . . 0.0 109.9 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.3 ttp85 -164.77 142.66 5.32 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 130.108 3.363 . . . . 0.0 107.722 168.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -105.67 170.86 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.198 2.599 . . . . 0.0 114.111 -170.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -83.44 158.76 21.95 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.727 1.211 . . . . 0.0 108.149 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -44.44 -50.43 22.85 Favored Pre-proline 0 N--CA 1.48 1.071 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.43 -25.53 35.5 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.168 1.912 . . . . 0.0 114.274 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -81.19 -37.79 28.12 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.518 0.727 . . . . 0.0 111.436 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.67 -42.57 98.03 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.091 1.356 . . . . 0.0 111.719 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.281 40.2 pttt -68.49 -22.95 64.52 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.8 mt -62.12 -52.79 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.823 1.249 . . . . 0.0 109.347 169.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.69 -30.58 67.2 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 111.847 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -32.16 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.818 -1.176 . . . . 0.0 113.271 170.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.27 -22.64 63.34 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.136 0.88 . . . . 0.0 112.955 170.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.5 23.65 13.45 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.089 1.756 . . . . 0.0 113.462 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.73 15.6 79.4 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.43 -163.55 0.58 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.384 1.092 . . . . 0.0 113.173 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -132.32 49.2 2.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.019 2.128 . . . . 0.0 109.842 168.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.99 -115.73 4.77 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.737 1.16 . . . . 0.0 112.721 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.86 17.39 3.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.142 1.777 . . . . 0.0 111.241 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 24.5 ttt -74.52 50.73 0.43 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.314 1.846 . . . . 0.0 113.482 -172.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -173.5 170.92 4.04 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.66 1.984 . . . . 0.0 112.666 -169.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.25 165.74 11.05 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.277 2.231 . . . . 0.0 113.594 -172.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -51.55 -44.68 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 126.581 1.952 . . . . 0.0 112.043 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -65.15 -30.18 71.08 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -80.38 -45.39 17.81 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.124 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.3 m -57.35 -45.04 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 120.075 1.307 . . . . 0.0 112.506 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.9 ptm -70.05 -24.16 63.21 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -66.78 -57.72 6.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.127 1.371 . . . . 0.0 110.983 170.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -56.48 -36.84 69.58 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.026 0.93 . . . . 0.0 113.145 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tt -71.79 -40.36 69.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.483 -0.761 . . . . 0.0 111.742 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.51 -47.43 89.97 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 120.9 -1.125 . . . . 0.0 112.807 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -69.59 -31.54 69.75 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.212 -1.17 . . . . 0.0 112.641 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -57.11 -50.61 72.27 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.957 1.253 . . . . 0.0 110.942 169.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mt -57.89 -43.74 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.706 0.684 . . . . 0.0 110.242 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.16 -32.97 74.72 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.53 -50.9 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.412 1.085 . . . . 0.0 111.518 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.43 -15.87 63.66 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.376 1.07 . . . . 0.0 113.181 176.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.301 6.2 pt20 45.44 43.43 8.68 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.331 2.652 . . . . 0.0 113.62 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.03 8.39 43.06 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.668 1.587 . . . . 0.0 112.936 -170.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -74.39 162.96 28.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.693 1.197 . . . . 0.0 112.268 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -74.48 147.77 41.61 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -47.1 78.56 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -76.77 -19.92 57.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.41 94.92 2.28 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 122.462 1.125 . . . . 0.0 113.311 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -58.84 -17.96 28.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.299 1.44 . . . . 0.0 112.876 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -25.17 65.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.943 0.897 . . . . 0.0 113.104 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.8 tpp -93.95 129.18 40.52 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.479 1.911 . . . . 0.0 109.742 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.12 113.03 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.812 1.645 . . . . 0.0 109.806 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -86.91 165.12 16.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.783 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.74 25.28 1.18 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.584 1.553 . . . . 0.0 112.596 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.54 114.82 6.64 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.561 -0.712 . . . . 0.0 112.948 -169.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.74 10.93 72.72 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.144 1.354 . . . . 0.0 115.853 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.38 150.01 21.06 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.404 2.102 . . . . 0.0 111.437 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.01 -27.66 63.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.535 -0.728 . . . . 0.0 112.735 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.8 tp -64.45 -39.74 94.39 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.383 0.992 . . . . 0.0 112.068 171.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.76 -40.61 95.78 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.501 0.572 . . . . 0.0 112.146 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.98 -43.13 95.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.122 0.961 . . . . 0.0 111.995 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -70.65 -46.16 63.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.242 1.017 . . . . 0.0 111.892 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.8 mt -71.82 -27.76 63.13 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.072 0.949 . . . . 0.0 112.563 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.03 7.24 83.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.345 1.45 . . . . 0.0 114.499 -175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.54 147.94 30.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.072 1.749 . . . . 0.0 111.721 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -101.98 9.87 40.13 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 113.448 -173.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -153.25 144.08 22.79 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.82 170.82 20.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.955 2.102 . . . . 0.0 110.67 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -136.58 154.4 50.7 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.701 0.8 . . . . 0.0 112.023 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.29 -14.89 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -87.87 -7.12 57.63 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.424 1.49 . . . . 0.0 113.731 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -145.24 64.27 10.69 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 125.707 1.603 . . . . 0.0 111.48 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.73 2.77 7.89 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.206 3.271 . . . . 0.0 114.714 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.9 m -48.5 -33.1 4.48 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -54.5 -31.0 67.16 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.115 2.543 . . . . 0.0 115.812 172.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -71.5 -48.76 46.93 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.621 1.169 . . . . 0.0 110.379 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -67.02 -29.24 69.0 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.011 -1.056 . . . . 0.0 112.177 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.95 -31.56 72.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.708 1.203 . . . . 0.0 112.526 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -32.5 70.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.866 1.267 . . . . 0.0 112.236 169.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.9 mt -90.5 -31.62 16.69 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -62.73 -27.86 69.56 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.855 1.262 . . . . 0.0 113.935 -176.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -62.44 -29.04 70.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.948 0.899 . . . . 0.0 112.109 169.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -87.65 -92.97 0.1 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.51 169.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.91 143.81 25.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.391 1.076 . . . . 0.0 112.922 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 m -81.13 62.91 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.732 1.213 . . . . 0.0 111.87 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -66.54 163.64 18.25 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.378 1.071 . . . . 0.0 113.467 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.1 mt -91.04 -0.56 57.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.955 1.702 . . . . 0.0 114.565 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.09 157.03 27.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.402 1.481 . . . . 0.0 112.73 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -171.376 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 pt -143.54 164.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.645 1.978 . . . . 0.0 111.911 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -86.39 45.99 1.3 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.905 1.282 . . . . 0.0 112.776 -173.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.55 -173.06 3.15 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 130.389 3.476 . . . . 0.0 108.457 -169.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.08 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.983 -1.073 . . . . 0.0 111.55 -172.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -158.19 139.18 9.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 131.329 3.852 . . . . 0.0 106.729 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 35.6 Cg_endo -96.72 167.01 1.04 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.242 2.628 . . . . 0.0 113.681 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -79.93 161.48 25.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.399 1.08 . . . . 0.0 108.597 167.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 mp -49.92 -42.03 66.92 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -68.61 -29.32 30.26 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.264 1.976 . . . . 0.0 114.246 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.89 -31.2 25.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.955 0.902 . . . . 0.0 112.108 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.25 -43.23 87.76 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.943 0.897 . . . . 0.0 111.056 173.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.309 16.9 pttp -72.76 -24.84 61.0 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.1 mt -62.67 -52.08 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.043 0.937 . . . . 0.0 109.475 170.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 37' ' ' LEU . 1.2 mm? -67.54 -30.72 70.44 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.483 -0.761 . . . . 0.0 112.463 174.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -29.9 69.87 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.678 -1.264 . . . . 0.0 113.378 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.33 59.78 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.4 21.81 16.53 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.157 1.783 . . . . 0.0 113.684 174.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.25 17.03 78.63 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.24 -156.23 0.16 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.859 1.264 . . . . 0.0 112.731 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -141.24 60.15 1.51 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.569 1.948 . . . . 0.0 109.624 168.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.07 -127.29 18.02 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.584 -172.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 40.3 mt-10 -135.64 20.4 3.33 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.699 2.0 . . . . 0.0 110.923 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.4 ttt -76.07 54.74 0.88 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.876 1.67 . . . . 0.0 112.955 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -173.29 172.21 3.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.286 1.834 . . . . 0.0 112.384 -170.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.63 167.07 13.76 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.814 2.045 . . . . 0.0 114.084 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -49.45 -45.88 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 126.455 1.902 . . . . 0.0 112.169 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -65.09 -30.07 70.99 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.79 -46.72 16.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.137 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -55.71 -46.72 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 120.477 1.489 . . . . 0.0 112.337 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 23.1 ptm -69.51 -27.44 65.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -62.47 -58.07 8.93 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.558 1.143 . . . . 0.0 110.758 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -58.31 -32.56 68.58 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.13 -41.27 81.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.559 1.072 . . . . 0.0 112.82 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.44 -47.42 88.2 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 118.963 0.801 . . . . 0.0 112.093 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.252 11.5 pt20 -70.72 -31.7 68.63 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.554 -0.968 . . . . 0.0 113.08 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.45 -51.93 66.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.454 1.479 . . . . 0.0 111.014 169.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.5 mt -60.59 -41.61 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.068 0.947 . . . . 0.0 110.272 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 37.7 tpp -67.78 -31.97 72.23 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.0 t -73.08 -50.4 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.357 1.063 . . . . 0.0 111.347 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -16.03 63.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.968 0.907 . . . . 0.0 113.125 175.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.4 pt20 43.49 43.07 4.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.455 2.702 . . . . 0.0 113.647 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.3 tp -99.51 20.21 14.28 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.523 1.529 . . . . 0.0 112.689 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -83.88 165.71 18.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.449 1.499 . . . . 0.0 111.883 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -72.46 148.52 45.04 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.169 0.985 . . . . 0.0 113.026 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.606 ' CD ' ' H ' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -69.7 -38.41 76.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.833 1.653 . . . . 0.0 111.43 -176.343 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -90.94 -20.39 22.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.585 1.554 . . . . 0.0 112.295 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -144.04 93.18 2.41 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.415 1.103 . . . . 0.0 112.414 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -57.69 -18.51 21.19 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.152 1.381 . . . . 0.0 112.821 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.43 -22.78 63.64 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.24 1.016 . . . . 0.0 113.133 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.6 tpt -97.86 129.81 44.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.063 1.745 . . . . 0.0 110.302 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.03 131.61 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.114 1.366 . . . . 0.0 110.65 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -105.62 165.71 10.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.297 1.439 . . . . 0.0 111.6 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -148.02 24.24 1.05 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.151 1.781 . . . . 0.0 112.771 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.38 113.68 5.71 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 121.603 -0.685 . . . . 0.0 112.647 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.98 13.03 66.07 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.12 1.343 . . . . 0.0 115.676 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -95.25 148.42 22.43 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.39 2.095 . . . . 0.0 111.382 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.88 -27.8 63.59 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.47 0.708 . . . . 0.0 111.943 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.11 -39.95 90.33 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.4 -0.812 . . . . 0.0 112.465 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.09 -36.93 92.59 Favored Glycine 0 N--CA 1.468 0.821 0 CA-C-N 118.543 0.61 . . . . 0.0 112.223 172.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -65.11 -36.68 85.07 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 117.893 0.846 . . . . 0.0 112.19 171.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.27 -50.51 53.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.606 1.162 . . . . 0.0 111.2 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.67 -24.02 58.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.123 0.969 . . . . 0.0 113.082 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.47 7.78 85.87 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.161 1.362 . . . . 0.0 114.634 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.71 150.19 33.84 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.886 1.674 . . . . 0.0 111.854 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -99.1 11.49 38.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.118 0.967 . . . . 0.0 113.434 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.0 p -155.32 149.73 26.08 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -159.86 177.84 10.38 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.65 1.98 . . . . 0.0 111.129 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 t -140.2 154.55 46.96 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.011 -1.056 . . . . 0.0 111.892 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.2 m -66.22 -12.92 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 169.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -83.18 -17.2 43.69 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.65 1.18 . . . . 0.0 113.026 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -140.38 69.87 32.92 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 125.812 1.645 . . . . 0.0 111.478 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.75 3.95 4.5 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.21 3.273 . . . . 0.0 114.564 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.8 m -45.4 -35.45 3.22 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 126.364 1.866 . . . . 0.0 115.736 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -56.69 -30.09 82.56 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.95 2.433 . . . . 0.0 115.73 173.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.74 -45.56 61.31 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.177 0.899 . . . . 0.0 110.142 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.45 -30.25 69.92 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.621 -0.674 . . . . 0.0 112.275 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -66.72 -31.31 71.88 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.858 1.263 . . . . 0.0 112.872 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.25 -33.33 67.44 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.292 1.437 . . . . 0.0 112.207 170.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.98 -27.02 18.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.959 1.704 . . . . 0.0 114.545 -174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -61.46 -23.37 65.82 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.4 1.48 . . . . 0.0 113.963 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -65.69 -27.31 68.25 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.546 1.938 . . . . 0.0 112.344 169.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -101.96 -71.7 0.71 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.147 0.979 . . . . 0.0 113.331 172.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.96 163.23 21.17 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.115 1.366 . . . . 0.0 113.345 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.5 m -100.36 33.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.89 1.676 . . . . 0.0 111.492 169.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 t -82.01 173.78 11.86 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.33 1.452 . . . . 0.0 114.075 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.0 mt -102.99 165.58 10.94 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.866 2.066 . . . . 0.0 111.95 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.94 161.63 27.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.084 1.354 . . . . 0.0 113.047 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -173.747 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . 0.409 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 . . . . . 0 CA--C 1.545 0.75 0 CA-C-O 120.754 0.311 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.5 pt -92.92 166.32 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.315 1.446 . . . . 0.0 113.072 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -81.26 35.14 0.38 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.586 1.554 . . . . 0.0 113.912 -174.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -129.64 -177.66 4.36 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 128.42 2.688 . . . . 0.0 113.114 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.68 172.23 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.851 1.661 . . . . 0.0 111.677 -176.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -163.35 143.42 6.91 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 130.173 3.389 . . . . 0.0 108.22 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -102.65 169.37 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.783 2.989 . . . . 0.0 113.843 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -87.4 164.45 16.2 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 109.792 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 56.5 tp -42.82 -56.32 6.22 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.926 1.69 . . . . 0.0 115.377 -172.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.89 -26.8 37.67 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.215 1.943 . . . . 0.0 113.821 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.7 mt -80.83 -34.59 33.78 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.363 -0.836 . . . . 0.0 112.243 177.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.39 -32.16 73.67 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.795 1.238 . . . . 0.0 110.988 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -58.57 -41.69 86.28 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.42 1.488 . . . . 0.0 112.861 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.86 -51.31 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.187 1.395 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.32 13.6 mt -70.86 -30.55 66.97 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -61.43 -33.96 74.59 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.613 -1.304 . . . . 0.0 112.399 169.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.05 62.35 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 119.247 0.93 . . . . 0.0 113.317 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 23.52 13.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.008 1.723 . . . . 0.0 113.434 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.49 14.26 79.62 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.676 1.131 . . . . 0.0 115.687 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.0 -169.58 2.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.466 1.106 . . . . 0.0 113.247 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -123.39 44.74 2.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.678 1.991 . . . . 0.0 110.841 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.74 -115.33 4.12 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.983 1.278 . . . . 0.0 112.646 -177.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -139.51 15.77 2.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.741 2.016 . . . . 0.0 110.769 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 56.6 ttp -77.0 52.39 0.87 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.609 1.564 . . . . 0.0 112.772 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -171.61 171.48 5.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.521 1.929 . . . . 0.0 112.693 -168.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -65.63 165.63 12.12 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.501 1.92 . . . . 0.0 112.214 -174.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.86 -37.92 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.16 0.984 . . . . 0.0 112.185 -173.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -60.33 -30.04 69.26 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -80.52 -43.48 20.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.512 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.6 m -54.96 -50.01 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 120.551 1.523 . . . . 0.0 113.016 175.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 20.6 ptm -68.49 -23.98 64.63 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.043 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.18 -59.17 3.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.989 1.316 . . . . 0.0 111.033 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -56.19 -36.83 68.83 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.133 0.973 . . . . 0.0 113.119 174.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.86 -42.53 73.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.939 0.895 . . . . 0.0 112.707 174.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.49 -47.36 76.92 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.398 -0.814 . . . . 0.0 111.813 173.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -70.93 -31.55 68.2 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.543 -0.974 . . . . 0.0 113.555 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -55.34 -50.41 69.72 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.727 1.603 . . . . 0.0 111.06 169.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.8 mt -63.45 -42.72 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.151 0.98 . . . . 0.0 110.531 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -45.36 92.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.634 1.174 . . . . 0.0 111.467 177.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.62 -48.39 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.079 0.952 . . . . 0.0 111.72 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -67.1 -16.11 64.13 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.284 6.3 pt20 41.93 42.88 2.44 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.868 2.467 . . . . 0.0 113.462 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -98.32 16.28 22.0 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.511 1.524 . . . . 0.0 113.309 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -81.71 160.4 23.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.985 1.314 . . . . 0.0 111.178 169.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -74.45 133.46 42.39 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.038 -1.039 . . . . 0.0 112.048 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.46 -33.66 60.04 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.876 1.67 . . . . 0.0 113.579 171.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -83.82 -27.38 28.8 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.012 1.325 . . . . 0.0 112.422 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -153.33 95.63 1.95 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.546 1.138 . . . . 0.0 111.655 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -60.51 -14.92 22.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.737 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -28.38 69.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.629 0.772 . . . . 0.0 112.743 173.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 39.5 tpp -91.84 130.6 37.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.021 1.729 . . . . 0.0 110.356 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.9 t -120.06 118.09 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.041 1.737 . . . . 0.0 109.764 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -92.41 162.06 14.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.538 1.135 . . . . 0.0 111.736 171.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.8 m -153.88 27.12 0.48 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.065 2.146 . . . . 0.0 112.21 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 118.6 13.08 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.33 -0.856 . . . . 0.0 113.349 -169.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.52 8.61 67.25 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.005 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -98.53 156.1 16.95 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 120.573 2.187 . . . . 0.0 112.272 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.56 -27.62 66.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.713 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.3 tp -66.84 -44.29 81.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.224 -0.922 . . . . 0.0 112.9 173.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.02 86.12 Favored Glycine 0 N--CA 1.477 1.424 0 CA-C-O 118.151 -1.361 . . . . 0.0 112.411 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.48 -40.03 92.63 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.014 1.907 . . . . 0.0 112.334 170.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -70.32 -51.73 28.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.082 0.953 . . . . 0.0 111.144 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.9 -20.14 61.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 112.198 176.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.73 13.04 82.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.749 1.642 . . . . 0.0 114.686 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -129.31 -25.17 2.73 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 121.63 3.937 . . . . 0.0 121.63 -169.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 55.05 2.85 0.05 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.3 p -157.22 138.3 13.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.837 1.255 . . . . 0.0 112.68 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.89 176.11 13.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.121 1.768 . . . . 0.0 110.681 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 t -140.5 156.93 46.18 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.135 -0.978 . . . . 0.0 111.363 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.08 -18.03 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.668 -0.645 . . . . 0.0 112.446 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -95.15 -1.89 50.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 113.897 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -137.81 60.58 25.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.889 1.676 . . . . 0.0 111.803 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -79.15 -0.11 10.48 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.946 3.097 . . . . 0.0 113.908 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.2 m -46.82 -32.45 2.11 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.72 -24.57 68.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.157 1.904 . . . . 0.0 114.132 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.82 -47.4 53.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.853 0.861 . . . . 0.0 110.11 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -68.22 -30.52 69.61 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.518 -0.739 . . . . 0.0 112.462 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.54 -31.52 72.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.471 1.032 . . . . 0.0 112.917 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -34.2 73.51 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.39 1.476 . . . . 0.0 112.099 171.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.65 -33.8 15.68 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 114.443 -175.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -58.25 -28.36 64.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.206 1.403 . . . . 0.0 113.689 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -64.15 -27.14 68.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.847 2.059 . . . . 0.0 112.556 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -98.37 -70.0 0.74 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.72 1.208 . . . . 0.0 113.177 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.84 155.29 39.68 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.932 1.693 . . . . 0.0 113.272 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.37 -26.21 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 t 51.07 -178.02 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 129.737 3.215 . . . . 0.0 116.63 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.38 156.91 31.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.96 2.504 . . . . 0.0 109.381 169.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.67 164.77 26.78 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.098 0.959 . . . . 0.0 113.192 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.241 0.638 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.011 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.2 pt -76.53 162.52 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' C ' HE21 ' A' ' 26' ' ' GLN . 19.9 m120 -85.23 38.41 0.72 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.658 1.583 . . . . 0.0 114.384 -169.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -131.37 -177.65 4.49 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.432 2.293 . . . . 0.0 112.558 -167.475 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' MET . 15.4 m -94.55 172.13 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.528 1.131 . . . . 0.0 110.289 -175.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -162.21 144.14 8.39 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 128.089 2.555 . . . . 0.0 109.001 -172.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 8.5 Cg_endo -98.52 176.27 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.143 2.562 . . . . 0.0 114.705 -169.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -105.83 157.37 17.51 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.674 1.99 . . . . 0.0 107.507 167.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.8 mt -47.37 -46.01 56.93 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -173.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.87 -21.74 20.86 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.922 1.748 . . . . 0.0 114.015 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.24 -34.15 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.934 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.5 -41.62 81.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 111.629 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.269 18.3 pttp -72.52 -21.84 61.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.6 mt -69.69 -45.8 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.648 1.179 . . . . 0.0 110.083 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.67 -37.21 86.47 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.466 -0.771 . . . . 0.0 111.233 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -29.48 67.84 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 120.829 -1.169 . . . . 0.0 113.436 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.43 -22.26 61.22 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.723 0.809 . . . . 0.0 112.99 169.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.13 22.12 14.59 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.074 1.75 . . . . 0.0 113.543 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 17.55 78.66 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 173.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.75 -156.07 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.89 1.276 . . . . 0.0 112.996 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -148.41 67.28 1.07 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.312 1.845 . . . . 0.0 110.489 169.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.13 -146.62 36.6 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.749 -172.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.48 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 45.4 mt-10 -122.19 15.39 10.62 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.868 2.067 . . . . 0.0 111.958 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 27.6 ttt -79.45 59.15 2.84 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.874 1.27 . . . . 0.0 113.705 -168.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -170.41 177.75 3.96 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.296 1.838 . . . . 0.0 113.719 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.35 165.64 13.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 127.521 2.328 . . . . 0.0 114.387 -172.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.4 t -52.12 -47.01 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 125.958 1.703 . . . . 0.0 111.843 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -62.52 -30.08 71.02 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -78.83 -47.93 15.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.067 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 m -55.88 -45.42 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 120.463 1.483 . . . . 0.0 112.376 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.5 ptm -70.26 -26.28 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -64.61 -59.43 4.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.162 1.385 . . . . 0.0 110.868 171.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -56.41 -36.25 68.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.784 0.834 . . . . 0.0 113.189 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.99 -44.64 88.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.054 0.941 . . . . 0.0 112.343 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.831 0.741 . . . . 0.0 112.249 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.28 11.2 pt20 -70.67 -31.54 68.48 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.392 -1.063 . . . . 0.0 113.087 176.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -55.97 -54.48 44.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.247 1.385 . . . . 0.0 110.496 169.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.34 -42.25 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.809 0.843 . . . . 0.0 110.146 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -34.93 79.49 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.9 t -78.24 -50.28 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 111.174 176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.3 64.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.963 0.905 . . . . 0.0 112.665 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.333 5.8 pt20 46.44 39.44 6.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.667 2.787 . . . . 0.0 114.523 176.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.6 mt -91.6 51.44 1.87 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.249 1.42 . . . . 0.0 111.42 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -124.97 162.51 24.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.787 2.035 . . . . 0.0 111.376 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -72.25 138.5 47.52 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.349 -0.844 . . . . 0.0 111.837 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.46 -48.51 79.0 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.06 -1.025 . . . . 0.0 112.864 173.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -80.93 -6.39 58.64 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.128 0.876 . . . . 0.0 113.031 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -155.7 86.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.573 1.177 . . . . 0.0 111.365 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -61.07 -15.42 32.46 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.145 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -22.2 65.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.84 1.256 . . . . 0.0 113.146 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 43.2 tpp -107.24 134.6 50.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.073 2.149 . . . . 0.0 111.143 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.02 133.24 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.996 1.718 . . . . 0.0 110.275 -173.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -136.41 84.88 2.11 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.301 2.241 . . . . 0.0 110.603 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.2 m -80.39 38.59 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.187 2.595 . . . . 0.0 113.451 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.83 113.03 2.49 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.305 -0.872 . . . . 0.0 114.609 -168.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.59 11.61 77.15 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.057 1.313 . . . . 0.0 116.187 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.93 156.8 20.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.944 1.872 . . . . 0.0 112.366 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.56 -28.06 59.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 112.755 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.23 -37.62 81.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.17 -0.956 . . . . 0.0 112.21 171.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.66 -39.93 98.06 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.415 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -64.83 -38.48 91.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.841 1.321 . . . . 0.0 112.07 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -69.56 -46.48 66.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.258 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.08 -18.64 45.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.816 1.246 . . . . 0.0 113.297 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.01 73.93 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.84 1.686 . . . . 0.0 114.937 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.39 -36.89 0.71 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -169.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 5.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.5 p -145.78 135.53 23.4 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.468 1.485 . . . . 0.0 114.586 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -169.94 168.28 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.717 2.407 . . . . 0.0 109.521 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.7 p -132.86 171.48 13.86 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.424 -0.797 . . . . 0.0 111.282 174.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.81 -9.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.261 -0.899 . . . . 0.0 113.378 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -95.05 -25.58 16.4 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.238 1.415 . . . . 0.0 112.984 169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -130.63 70.92 82.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 125.973 1.709 . . . . 0.0 111.907 174.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -88.09 16.31 1.92 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 125.02 3.813 . . . . 0.0 114.853 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 92.1 p -50.85 -31.01 4.42 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.3 -31.72 52.37 Favored 'Trans proline' 0 C--N 1.357 0.987 0 CA-C-N 123.959 2.449 . . . . 0.0 114.108 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.4 -49.21 72.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.174 1.39 . . . . 0.0 110.531 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.05 -29.19 57.95 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.366 -0.834 . . . . 0.0 112.452 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -69.06 -32.96 72.81 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.295 -0.878 . . . . 0.0 113.241 172.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.3 ttp -68.52 -41.36 80.04 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.267 1.427 . . . . 0.0 110.617 169.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.04 -48.68 56.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.315 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -58.13 -31.92 67.66 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.92 -26.42 64.14 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.738 2.015 . . . . 0.0 112.917 174.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -99.36 -93.69 0.26 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 110.55 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.2 tp -78.0 114.76 17.18 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 119.92 1.236 . . . . 0.0 110.213 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -60.08 115.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 121.604 -0.685 . . . . 0.0 109.749 169.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.8 t -151.85 175.55 12.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.83 0.852 . . . . 0.0 113.087 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.52 158.17 31.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.605 1.562 . . . . 0.0 112.234 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.54 167.44 22.08 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.766 1.226 . . . . 0.0 113.228 -176.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -176.465 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.32 158.22 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.718 2.007 . . . . 0.0 113.243 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -91.58 53.33 2.23 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.184 1.394 . . . . 0.0 112.102 -171.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.18 -176.62 4.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 129.055 2.942 . . . . 0.0 109.159 -168.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.46 171.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 120.987 -1.071 . . . . 0.0 111.818 -169.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -162.67 140.48 6.38 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 129.527 3.131 . . . . 0.0 107.279 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' H ' ' A' ' 45' ' ' GLU . 1.1 Cg_endo -103.57 179.37 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.048 2.499 . . . . 0.0 115.28 -169.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -108.73 158.47 17.6 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.784 2.433 . . . . 0.0 107.213 167.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -45.24 -47.05 33.51 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 -173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.82 -23.13 30.89 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.058 1.839 . . . . 0.0 114.694 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.19 -35.47 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.376 0.67 . . . . 0.0 111.865 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.47 -41.88 81.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.329 1.052 . . . . 0.0 111.601 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -71.38 -20.44 62.14 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -172.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.5 mt -64.55 -51.68 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 109.285 170.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.97 -34.2 76.09 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.605 -0.685 . . . . 0.0 111.753 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.61 -30.7 68.51 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.892 -1.13 . . . . 0.0 113.188 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.41 -21.98 60.76 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.519 0.727 . . . . 0.0 112.869 169.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.77 22.35 15.3 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.195 1.798 . . . . 0.0 113.533 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.64 16.98 78.99 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.644 1.018 . . . . 0.0 115.644 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.73 -156.7 0.16 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.97 1.308 . . . . 0.0 112.729 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.27 59.94 1.55 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.559 1.544 . . . . 0.0 110.364 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.64 -141.7 27.88 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.848 -172.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.491 ' H ' ' HD3' ' A' ' 29' ' ' PRO . 47.3 mt-10 -121.72 21.33 10.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.799 2.04 . . . . 0.0 112.138 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 28.5 ptm -74.72 41.17 0.15 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -169.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -166.62 174.48 8.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.707 1.603 . . . . 0.0 113.979 -168.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.66 167.66 16.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.32 2.248 . . . . 0.0 114.236 -169.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -49.15 -43.43 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 126.317 1.847 . . . . 0.0 112.75 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -31.28 70.56 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -77.76 -46.43 21.74 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.098 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.45 -46.24 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 120.319 1.418 . . . . 0.0 112.586 174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.2 ptm -69.46 -28.21 65.9 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -60.52 -59.04 6.02 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.618 1.167 . . . . 0.0 110.851 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -55.81 -36.77 67.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.024 0.93 . . . . 0.0 113.386 173.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.17 -36.98 80.47 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.839 1.199 . . . . 0.0 113.129 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.74 -47.42 90.41 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.927 1.24 . . . . 0.0 112.232 173.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.272 13.4 pt20 -70.22 -31.5 68.95 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.451 -1.029 . . . . 0.0 113.081 174.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -55.89 -54.5 43.95 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.207 1.367 . . . . 0.0 110.07 169.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.3 mt -59.03 -39.98 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.931 0.892 . . . . 0.0 110.36 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.8 tpp -69.11 -32.35 71.7 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.23 -51.35 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.028 -1.045 . . . . 0.0 111.344 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -68.08 -12.96 61.79 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.307 1.443 . . . . 0.0 113.064 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.31 5.8 pt20 48.76 50.18 17.79 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.37 3.068 . . . . 0.0 114.023 169.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.6 mt -88.4 3.91 48.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.531 1.133 . . . . 0.0 113.741 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -89.11 162.2 16.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.455 1.102 . . . . 0.0 113.015 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -78.9 152.3 31.25 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.79 -47.34 63.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -77.7 -17.33 57.76 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -149.61 87.07 1.48 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.059 0.933 . . . . 0.0 111.787 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -55.94 -22.81 28.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.763 1.625 . . . . 0.0 112.44 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.09 -34.35 56.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.301 1.84 . . . . 0.0 112.987 170.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tpt -99.51 135.33 41.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.002 1.721 . . . . 0.0 111.158 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -132.08 136.73 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.025 1.73 . . . . 0.0 110.487 -170.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -105.94 175.0 5.64 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.187 1.795 . . . . 0.0 112.194 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.88 20.24 0.32 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.714 1.606 . . . . 0.0 113.733 176.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.3 115.75 5.01 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.845 0.736 . . . . 0.0 114.115 -169.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.34 6.97 71.38 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.305 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -96.6 158.81 15.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 121.089 2.445 . . . . 0.0 112.506 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -27.69 68.99 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.996 0.918 . . . . 0.0 112.13 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.38 -41.57 96.62 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.38 -0.825 . . . . 0.0 111.994 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -39.22 96.94 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 119.339 0.972 . . . . 0.0 112.654 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -60.11 -43.89 95.26 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.479 1.14 . . . . 0.0 111.722 172.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 tp -69.73 -46.38 66.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.326 1.05 . . . . 0.0 112.245 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.28 -25.71 63.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.804 1.241 . . . . 0.0 113.035 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.47 4.67 75.5 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.394 0.997 . . . . 0.0 113.796 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -138.39 141.25 39.62 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 112.393 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -102.99 7.76 39.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.719 1.208 . . . . 0.0 113.27 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.0 p -155.92 143.42 19.41 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.498 1.119 . . . . 0.0 112.462 169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -161.73 178.7 8.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.117 2.167 . . . . 0.0 110.262 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.7 p -142.98 170.38 15.81 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.649 -1.282 . . . . 0.0 112.969 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.51 -19.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.898 0.879 . . . . 0.0 112.943 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.08 -10.74 29.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.037 1.335 . . . . 0.0 113.803 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -132.61 62.73 64.41 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.832 1.653 . . . . 0.0 112.639 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.08 0.17 9.63 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.106 3.204 . . . . 0.0 114.09 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 48.6 m -42.77 -39.32 3.55 Favored Pre-proline 0 N--CA 1.472 0.663 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.42 -24.19 71.14 Favored 'Trans proline' 0 C--N 1.354 0.857 0 CA-C-N 123.242 2.194 . . . . 0.0 114.89 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.44 -47.47 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.233 1.378 . . . . 0.0 109.802 170.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -64.11 -33.0 74.77 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.686 -0.633 . . . . 0.0 111.941 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.34 -31.47 69.94 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.457 1.026 . . . . 0.0 113.401 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.38 77.63 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.986 1.314 . . . . 0.0 111.234 169.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.6 mt -91.16 -34.92 14.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.357 1.463 . . . . 0.0 114.483 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -28.08 62.92 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.562 1.545 . . . . 0.0 113.692 176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -64.69 -28.14 69.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.743 2.017 . . . . 0.0 112.847 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -108.19 -48.34 3.38 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -122.33 144.85 48.76 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.372 1.469 . . . . 0.0 111.638 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.5 t -81.87 67.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 122.176 0.988 . . . . 0.0 110.691 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.24 -9.68 20.21 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -175.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.3 mt 43.53 -133.2 0.59 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.275 3.03 . . . . 0.0 110.076 -172.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.75 170.39 16.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.949 0.9 . . . . 0.0 113.206 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 124.121 0.969 . . . . 0.0 113.588 -171.948 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . 0.416 ' C6 ' ' C3 ' ' A' ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.3 pt -96.28 167.96 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.478 1.511 . . . . 0.0 112.76 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -79.34 33.47 0.24 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.671 1.588 . . . . 0.0 114.007 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -128.31 -176.44 3.81 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.846 2.858 . . . . 0.0 113.085 -167.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.2 172.4 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.269 1.427 . . . . 0.0 109.163 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -164.25 139.93 4.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 130.459 3.503 . . . . 0.0 108.145 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -102.15 164.04 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.123 3.215 . . . . 0.0 113.744 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -82.13 158.78 23.54 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.585 1.154 . . . . 0.0 108.89 168.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.8 tp -41.79 -49.92 10.26 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.35 -21.55 35.26 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.092 1.862 . . . . 0.0 114.629 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 mt -89.66 -32.59 16.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.196 0.999 . . . . 0.0 112.422 173.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.8 tt -61.73 -39.02 90.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.28 1.832 . . . . 0.0 112.032 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -72.42 -22.51 61.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -59.14 -52.05 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.929 1.292 . . . . 0.0 108.978 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 37' ' ' LEU 0.272 0.2 OUTLIER -70.72 -30.49 67.05 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.178 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -60.91 -32.76 72.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.569 1.532 . . . . 0.0 112.642 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.64 56.43 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.549 1.068 . . . . 0.0 113.434 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.52 19.16 21.04 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.218 1.807 . . . . 0.0 113.807 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 14.27 75.82 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 124.543 1.068 . . . . 0.0 115.495 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.98 -163.51 0.93 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.019 1.328 . . . . 0.0 112.547 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.84 58.1 1.78 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.002 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.68 -118.79 5.86 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.089 1.328 . . . . 0.0 112.956 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -143.72 17.64 1.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.513 1.925 . . . . 0.0 110.987 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 55.6 ttp -76.3 49.13 0.56 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.113 1.765 . . . . 0.0 113.128 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -170.02 173.87 5.78 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.272 1.829 . . . . 0.0 113.42 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 166.11 10.32 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 128.103 2.561 . . . . 0.0 113.983 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.1 t -50.95 -46.95 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 126.414 1.886 . . . . 0.0 112.078 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -64.57 -30.08 71.1 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -79.0 -46.3 18.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.6 -0.714 . . . . 0.0 110.885 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.69 -45.45 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 120.257 1.389 . . . . 0.0 112.883 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.4 ptm -68.89 -27.91 66.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -64.37 -59.8 3.93 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.853 1.261 . . . . 0.0 110.987 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -56.79 -35.06 68.27 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.917 0.887 . . . . 0.0 113.216 174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.13 -39.43 72.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.086 0.857 . . . . 0.0 112.987 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -47.35 89.04 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 119.316 0.962 . . . . 0.0 111.799 173.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 12.7 pt20 -69.85 -31.5 69.39 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.114 -0.945 . . . . 0.0 113.031 174.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -56.18 -54.08 49.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.822 1.646 . . . . 0.0 110.837 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.13 -44.37 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.595 0.758 . . . . 0.0 110.246 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -33.99 77.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.5 t -78.18 -51.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.339 1.455 . . . . 0.0 111.746 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -66.42 -15.99 63.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.447 0.699 . . . . 0.0 112.423 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.298 6.6 pt20 46.97 43.27 13.52 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 128.085 2.554 . . . . 0.0 113.287 172.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.18 18.04 15.86 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.893 1.677 . . . . 0.0 112.847 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -85.91 166.36 16.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.253 1.421 . . . . 0.0 112.799 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.26 135.72 49.23 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.446 -0.784 . . . . 0.0 112.301 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -36.52 44.39 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.167 1.387 . . . . 0.0 113.365 172.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -91.73 -20.37 21.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.915 1.286 . . . . 0.0 113.021 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -153.55 102.63 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.336 1.054 . . . . 0.0 111.976 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -59.81 -17.42 35.76 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.924 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.29 -21.55 62.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.67 0.788 . . . . 0.0 113.026 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.6 tpt -96.79 125.57 41.33 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 109.787 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.7 120.99 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.987 1.315 . . . . 0.0 110.345 -169.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -88.59 165.87 14.52 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.35 1.06 . . . . 0.0 111.422 172.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -151.62 23.85 0.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.478 1.511 . . . . 0.0 113.058 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.2 108.58 2.11 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.311 -0.868 . . . . 0.0 112.732 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.79 14.13 72.59 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.452 1.025 . . . . 0.0 115.127 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.16 147.64 22.92 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.751 1.775 . . . . 0.0 110.571 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.1 mt -58.51 -27.52 64.57 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.363 -0.836 . . . . 0.0 112.06 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.82 -37.23 85.68 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.303 -0.873 . . . . 0.0 112.525 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.13 -39.03 94.46 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 118.558 0.617 . . . . 0.0 112.346 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.57 -39.25 93.09 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 117.975 0.887 . . . . 0.0 111.607 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -69.83 -45.77 67.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.519 1.128 . . . . 0.0 113.062 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.9 mp -82.25 -19.72 39.05 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.522 1.129 . . . . 0.0 113.494 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.04 8.61 87.22 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.422 1.011 . . . . 0.0 114.754 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -146.4 154.73 41.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.348 1.459 . . . . 0.0 112.849 172.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.2 11.9 32.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.8 p -157.17 144.59 18.78 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 168.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -155.74 175.82 13.42 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.787 2.035 . . . . 0.0 109.565 172.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 p -149.16 175.29 11.49 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.347 -1.471 . . . . 0.0 113.226 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.08 -19.95 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.592 0.757 . . . . 0.0 112.098 170.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -90.36 -21.0 22.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.272 1.429 . . . . 0.0 113.495 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -122.33 61.07 14.12 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 126.405 1.882 . . . . 0.0 112.149 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.49 -4.54 10.88 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.575 2.85 . . . . 0.0 113.84 -175.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -46.53 -35.5 4.96 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.3 -31.79 95.68 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.33 2.02 . . . . 0.0 114.665 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 tt -66.76 -54.87 18.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.202 1.401 . . . . 0.0 109.904 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -61.84 -36.61 81.69 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.482 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.83 -45.12 91.0 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.957 0.799 . . . . 0.0 112.411 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ttp -56.15 -39.18 71.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.623 1.569 . . . . 0.0 111.288 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . 0.286 4.5 pp -85.79 -40.79 15.66 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -64.11 -30.57 71.63 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 120.484 1.493 . . . . 0.0 113.485 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -68.32 -22.61 64.69 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.578 0.751 . . . . 0.0 112.525 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -91.15 -75.63 0.47 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -90.61 154.29 19.7 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.88 1.218 . . . . 0.0 113.129 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.07 109.95 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -155.76 -176.95 6.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.312 1.045 . . . . 0.0 112.782 -175.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 90.5 mt -110.46 159.24 17.67 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.623 1.969 . . . . 0.0 111.663 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.56 169.81 16.96 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.289 1.436 . . . . 0.0 112.441 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -170.582 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 pt -134.42 163.23 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.953 1.701 . . . . 0.0 112.714 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -88.07 32.06 0.77 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.317 1.447 . . . . 0.0 114.753 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -178.7 4.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 128.639 2.776 . . . . 0.0 111.351 -168.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 46' ' ' MET . 2.2 t -87.74 172.66 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.536 1.534 . . . . 0.0 110.077 -170.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -162.26 144.6 8.54 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 130.211 3.404 . . . . 0.0 108.308 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -104.61 170.47 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -83.26 156.98 22.83 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.848 1.259 . . . . 0.0 107.895 167.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -50.87 -40.82 67.98 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.84 -23.55 47.71 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.579 2.186 . . . . 0.0 115.08 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.5 mt -92.45 -34.76 13.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.294 1.037 . . . . 0.0 112.027 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.55 -38.26 89.35 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.822 1.649 . . . . 0.0 112.074 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.278 44.3 pttt -70.09 -24.47 63.22 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -58.68 -53.56 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.439 1.496 . . . . 0.0 109.225 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.3 12.9 mt -70.88 -30.94 67.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -64.4 -32.33 73.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 120.374 -1.454 . . . . 0.0 112.844 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.43 63.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.447 1.021 . . . . 0.0 113.025 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -106.04 25.57 10.78 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.026 1.731 . . . . 0.0 113.375 172.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.15 12.22 81.63 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.75 1.167 . . . . 0.0 115.884 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.17 -169.72 2.67 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 118.714 1.257 . . . . 0.0 113.272 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -125.95 47.95 2.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.787 2.035 . . . . 0.0 110.985 169.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.49 -119.78 5.22 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.98 1.276 . . . . 0.0 112.561 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.02 18.96 3.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.516 1.927 . . . . 0.0 110.853 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 58.7 ttp -75.22 47.1 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.903 2.081 . . . . 0.0 113.067 -170.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -171.82 175.92 3.77 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.312 2.245 . . . . 0.0 112.788 -168.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -74.37 170.31 15.89 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.932 2.093 . . . . 0.0 113.564 -171.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.2 t -47.87 -46.55 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 127.01 2.124 . . . . 0.0 112.205 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -66.95 -30.13 70.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.31 -45.24 18.19 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.859 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.4 m -58.09 -46.1 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 120.442 1.474 . . . . 0.0 112.763 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.8 ptm -70.02 -26.97 64.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.93 -58.57 6.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.074 1.35 . . . . 0.0 110.766 171.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -56.73 -36.9 70.26 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 173.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.78 -42.86 81.01 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.163 0.892 . . . . 0.0 112.166 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.79 -47.28 89.75 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.843 0.735 . . . . 0.0 112.414 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.254 12.5 pt20 -70.67 -31.65 68.63 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.65 -0.912 . . . . 0.0 112.998 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.11 -51.5 69.44 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.515 1.507 . . . . 0.0 110.833 169.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.7 mt -57.87 -42.99 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.671 0.789 . . . . 0.0 110.326 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 33.3 tpp -68.84 -32.0 71.37 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.57 -50.33 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.481 1.112 . . . . 0.0 111.352 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -66.4 -16.08 63.81 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.784 0.834 . . . . 0.0 112.876 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . 0.295 6.5 pt20 45.15 42.86 7.24 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.191 2.597 . . . . 0.0 113.427 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -99.46 19.87 14.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.653 1.581 . . . . 0.0 112.758 -169.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -84.28 165.45 18.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.61 1.564 . . . . 0.0 111.916 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.91 135.54 48.03 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.243 -0.91 . . . . 0.0 111.913 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -45.28 63.3 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.244 1.017 . . . . 0.0 113.17 169.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -81.42 -12.35 58.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.769 0.828 . . . . 0.0 112.488 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -159.7 93.92 1.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.553 1.141 . . . . 0.0 112.126 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -58.63 -17.62 23.68 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.721 1.208 . . . . 0.0 112.843 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -26.06 67.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.502 1.121 . . . . 0.0 112.862 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.5 tpt -101.28 130.19 47.38 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.993 1.717 . . . . 0.0 110.918 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.82 133.37 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 110.805 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -111.81 158.46 19.36 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.567 1.547 . . . . 0.0 111.377 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 88' ' ' GLN . 66.7 m -146.67 28.09 1.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.583 1.553 . . . . 0.0 112.371 -176.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.33 115.17 7.29 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 121.672 -0.642 . . . . 0.0 112.612 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.97 12.82 65.68 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.062 1.315 . . . . 0.0 115.36 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.63 150.06 21.09 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 119.793 1.797 . . . . 0.0 112.014 -175.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.51 -27.74 64.76 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.606 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.46 -39.19 91.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.11 0.964 . . . . 0.0 112.705 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.68 -37.67 89.31 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.786 -0.571 . . . . 0.0 111.702 173.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -65.63 -37.36 86.35 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 117.984 0.892 . . . . 0.0 112.279 171.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.16 -44.72 79.06 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.008 1.323 . . . . 0.0 112.305 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.65 -18.41 31.38 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.72 5.05 89.53 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.57 1.081 . . . . 0.0 114.38 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -138.76 144.27 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.22 1.808 . . . . 0.0 111.555 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 76' ' ' CYS . 38.5 mt-30 -94.59 6.92 47.41 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.9 p -154.23 149.88 27.46 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 169.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -161.14 176.84 10.86 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.066 2.146 . . . . 0.0 109.734 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.5 p -142.44 171.58 13.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.72 -1.238 . . . . 0.0 112.226 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 m -72.35 -7.24 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.45 -24.82 17.16 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.195 1.398 . . . . 0.0 112.45 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -129.35 64.56 71.72 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.312 1.845 . . . . 0.0 111.985 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.3 0.04 10.2 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.165 3.243 . . . . 0.0 113.836 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.5 m -46.29 -34.79 3.64 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -174.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -59.47 -28.05 86.53 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.306 2.004 . . . . 0.0 114.941 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tt -68.2 -52.41 34.68 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.794 1.238 . . . . 0.0 110.405 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -64.92 -36.21 83.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.734 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.76 -31.53 72.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.634 0.773 . . . . 0.0 112.925 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.46 -47.03 83.51 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.247 1.019 . . . . 0.0 111.19 170.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 pp -92.5 -20.3 21.1 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.172 1.916 . . . . 0.0 116.172 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -62.22 -27.15 68.79 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.943 1.247 . . . . 0.0 112.948 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -65.4 -27.25 68.41 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.051 2.54 . . . . 0.0 112.741 171.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -97.51 -49.37 4.92 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -128.38 144.04 51.08 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.496 1.118 . . . . 0.0 112.654 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -76.68 118.18 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 t -159.67 -177.31 6.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.894 0.877 . . . . 0.0 113.102 -169.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.15 157.39 32.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.268 1.827 . . . . 0.0 112.871 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.33 174.64 12.63 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.635 1.574 . . . . 0.0 112.014 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -177.595 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' 49H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_